[
  {
    "text": "Cup as a Cap on the Diabetic Wound: A Hope for Treatment of Diabetic Ulcers.",
    "entities": [
      {
        "text": "Cap",
        "label": "PERSON"
      },
      {
        "text": "the Diabetic Wound: A Hope for Treatment of Diabetic Ulcers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Author information:",
    "entities": []
  },
  {
    "text": "(1)Department of Biomedical Engineering, Meybod University, Meybod, Iran.",
    "entities": [
      {
        "text": "Biomedical Engineering",
        "label": "ORG"
      },
      {
        "text": "Meybod University",
        "label": "ORG"
      },
      {
        "text": "Meybod",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Diabetes is known as one of the most important widespread diseases in the world.",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Diabetic ulcer is one of the main complications associated with this disease.",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The use of the capabilities of modern science such as nanotechnology can be",
    "entities": []
  },
  {
    "text": "effective in developing new strategies for treating diabetic ulcers. Regulating",
    "entities": []
  },
  {
    "text": "homeostasis, controlling infections, and the ability to regenerate/ heal are",
    "entities": []
  },
  {
    "text": "some of the proposed mechanisms of nanomaterials in wound healing. In this",
    "entities": []
  },
  {
    "text": "regard, cuprorivaite bioceramic, as a bioceramic containing copper nanoparticles",
    "entities": []
  },
  {
    "text": "with effects on angiogenic factors and infection control, can effectively be",
    "entities": []
  },
  {
    "text": "used in the healing of diabetic ulcers. In this prospective article, we have",
    "entities": []
  },
  {
    "text": "presented the potential of this bioceramic in the design of new dressings for",
    "entities": []
  },
  {
    "text": "diabetic wound healing.",
    "entities": []
  },
  {
    "text": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at",
    "entities": [
      {
        "text": "Bentham Science Publishers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "A Comprehensive Review of Acanthosis Nigricans: Pathogenesis, Clinical",
    "entities": []
  },
  {
    "text": "manifestation and Management.",
    "entities": []
  },
  {
    "text": "(1)Department of Pharmaceutics, Laureate Institute of Pharmacy, Kathog",
    "entities": [
      {
        "text": "Pharmaceutics, Laureate Institute of Pharmacy",
        "label": "ORG"
      },
      {
        "text": "Kathog\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Acanthosis Nigricans is a dermatological condition characterized",
    "entities": [
      {
        "text": "Nigricans",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "by hyperpigmented velvet plaques that can be observed in flexural areas such as",
    "entities": []
  },
  {
    "text": "the neck, axilla, and groin. AN is frequently associated with insulin resistance",
    "entities": []
  },
  {
    "text": "and obesity, however, it can also appear in non-obese people and as a",
    "entities": [
      {
        "text": "non-obese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "paraneoplastic disease. Its prevalence varies across different populations, with",
    "entities": []
  },
  {
    "text": "higher rates observed in individuals with obesity, diabetes, and certain genetic",
    "entities": []
  },
  {
    "text": "syndromes. Classification of AN can be based on underlying etiology,",
    "entities": []
  },
  {
    "text": "distinguishing primary and secondary forms. Pathogenesis is the complex",
    "entities": []
  },
  {
    "text": "interplay of genetic, hormonal, and environmental factors, with insulin",
    "entities": []
  },
  {
    "text": "resistance playing a central role. Diagnosis relies on clinical evaluation of",
    "entities": []
  },
  {
    "text": "characteristics of skin changes, often requiring further investigation for",
    "entities": []
  },
  {
    "text": "underlying systemic disease. Topical therapies involve keratolytic agents,",
    "entities": []
  },
  {
    "text": "retinoids, and alpha hydroxyl acids to improve the cosmesis and reduce the",
    "entities": []
  },
  {
    "text": "plaque's thickness. Treatment strategies address underlying conditions by",
    "entities": []
  },
  {
    "text": "emphasizing lifestyle modifications and in some cases, pharmacological",
    "entities": []
  },
  {
    "text": "interventions.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: This review aims to comprehensively examine the pathogenesis,",
    "entities": []
  },
  {
    "text": "clinical manifestation, and management of acanthosis nigricans.",
    "entities": []
  },
  {
    "text": "DISCUSSION: AN is closely linked to insulin resistance, characterized by",
    "entities": []
  },
  {
    "text": "impaired cellular response to insulin, leading to compensatory hyperinsulinemia.",
    "entities": []
  },
  {
    "text": "Recognizing AN's clinical presentation is paramount for early diagnosis and",
    "entities": []
  },
  {
    "text": "CONCLUSION: Acanthosis Nigricans is a skin condition characterized by dark,",
    "entities": [
      {
        "text": "Nigricans",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "thickened patches of skin, typically occurring in skin folds and creases. It can",
    "entities": []
  },
  {
    "text": "be a sign of an underlying health issue such as insulin resistance, obesity,",
    "entities": []
  },
  {
    "text": "hormonal disorders, or certain medications. Proper diagnosis and management of",
    "entities": []
  },
  {
    "text": "the underlying conditions are crucial. Treatment may involve addressing the",
    "entities": []
  },
  {
    "text": "underlying causes, lifestyle changes, and topical medications to improve the",
    "entities": []
  },
  {
    "text": "appearance of the skin. Regular monitoring and follow-up with a health care",
    "entities": []
  },
  {
    "text": "professional are essential for optimal management and to prevent complications.",
    "entities": []
  },
  {
    "text": "Intraosseous versus intravenous fluid resuscitation in gastrointestinal",
    "entities": []
  },
  {
    "text": "tumor-related acute hemorrhage: impact on 30-day mortality and lactate",
    "entities": [
      {
        "text": "30-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "clearance.",
    "entities": []
  },
  {
    "text": "(1)Department of Emergency Medicine, The People's Hospital of Rugao Rugao",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "The People's Hospital of Rugao Rugao",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Gastroenterology, The People's Hospital of Rugao Rugao 226500,",
    "entities": [
      {
        "text": "The People's Hospital of Rugao Rugao",
        "label": "ORG"
      },
      {
        "text": "226500",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(3)Department of Emergency Medicine, PLA Eastern Theater General Hospital",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "PLA Eastern Theater General Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Emergency Medicine, Nanjing Drum Tower Hospital Group Suqian",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "Nanjing",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "This retrospective study evaluated the impact of intraosseous infusion (IO)",
    "entities": []
  },
  {
    "text": "versus traditional intravenous infusion (IV) on 30-day mortality and clinical",
    "entities": [
      {
        "text": "IV",
        "label": "GPE"
      },
      {
        "text": "30-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "outcomes in 518 patients with acute gastrointestinal bleeding (AGIB) secondary",
    "entities": [
      {
        "text": "518",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "to gastrointestinal tumors from January 2022 to July 2024. Patients were divided",
    "entities": [
      {
        "text": "January 2022 to July 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "into IO (n=217) and IV (n=301) groups based on initial resuscitation strategy.",
    "entities": [
      {
        "text": "IO",
        "label": "GPE"
      },
      {
        "text": "IV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Compared to IV group, the IO group demonstrated higher first-attempt",
    "entities": [
      {
        "text": "IV",
        "label": "GPE"
      },
      {
        "text": "IO",
        "label": "GPE"
      },
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "catheterization success rate, shorter vascular access time, and faster blood",
    "entities": []
  },
  {
    "text": "pressure recovery (all P<0.001), alongside higher 6-hour lactate (LA) clearance",
    "entities": [
      {
        "text": "6-hour",
        "label": "TIME"
      },
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(34% vs. 22%, P<0.001) and lower 30-day mortality (11.98% vs. 18.6%, P=0.016).",
    "entities": [
      {
        "text": "34%",
        "label": "PERCENT"
      },
      {
        "text": "22%",
        "label": "PERCENT"
      },
      {
        "text": "30-day",
        "label": "DATE"
      },
      {
        "text": "11.98%",
        "label": "PERCENT"
      },
      {
        "text": "18.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Multivariate analysis identified IO infusion as protective factor for lactate",
    "entities": []
  },
  {
    "text": "metabolism (HR=0.289, 95% CI: 0.092-0.864), while advanced age (HR=1.125),",
    "entities": [
      {
        "text": "HR=0.289",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.092-0.864",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diabetes (HR=3.23), and low LA clearance (HR=0.016) were independent risk factor",
    "entities": [
      {
        "text": "HR=3.23",
        "label": "PERSON"
      },
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "for mortality. Causal mediation analysis revealed that 6-hour LA clearance",
    "entities": [
      {
        "text": "6-hour",
        "label": "TIME"
      },
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "mediated 68% of the IO-associated mortality reduction (P<0.001), whereas",
    "entities": [
      {
        "text": "68%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "diabetes history was not a significant mediator (P=0.156). Complication rates",
    "entities": []
  },
  {
    "text": "were comparable between groups (P>0.05). These findings indicate that IO",
    "entities": [
      {
        "text": "P>0.05",
        "label": "ORG"
      },
      {
        "text": "IO",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "infusion improves survival in AGIB due to gastrointestinal tumors by rapidly",
    "entities": []
  },
  {
    "text": "restoring hemodynamics and enhancing lactate metabolism. The mortality benefit",
    "entities": []
  },
  {
    "text": "is primarily driven by accelerated LA clearance rather than comorbidities like",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "diabetes. Given its safety profile comparable to IV, IO infusion should be",
    "entities": [
      {
        "text": "IV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "AJCR Copyright \u00a9 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: None.",
    "entities": []
  },
  {
    "text": "4. Front Pharmacol. 2025 Jul 1;16:1646006. doi: 10.3389/fphar.2025.1646006.",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic",
    "entities": [
      {
        "text": "CXCR4/CXCL12",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations.",
    "entities": [
      {
        "text": "CXCR4",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Clinical Nutrition, The Affiliated Hospital of Yangzhou",
    "entities": [
      {
        "text": "Clinical Nutrition",
        "label": "ORG"
      },
      {
        "text": "The Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Yangzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Yangzhou University, Jiangsu, China.",
    "entities": [
      {
        "text": "Yangzhou University",
        "label": "ORG"
      },
      {
        "text": "Jiangsu",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Institute of Translational Medicine, Medical College, Yangzhou University,",
    "entities": [
      {
        "text": "2)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "Translational Medicine, Medical College",
        "label": "ORG"
      },
      {
        "text": "Yangzhou University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of General Surgery, The Affiliated Hospital of Yangzhou",
    "entities": [
      {
        "text": "Surgery",
        "label": "PERSON"
      },
      {
        "text": "The Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Yangzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Front Pharmacol. 2025 Apr 16;16:1561112. doi: 10.3389/fphar.2025.1561112.",
    "entities": [
      {
        "text": "Front Pharmacol",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[This corrects the article DOI: 10.3389/fphar.2025.1561112.].",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Wang, Nie, Lu and Chong.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wang",
        "label": "PERSON"
      },
      {
        "text": "Nie",
        "label": "GPE"
      },
      {
        "text": "Lu",
        "label": "PERSON"
      },
      {
        "text": "Chong",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Inverse association between dietary fiber intake and gallstone disease in U.S.",
    "entities": [
      {
        "text": "U.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "adults: a cross-sectional study from the NHANES database.",
    "entities": [
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Research Center for Translational Medicine, Hubei Key Laboratory of Wudang",
    "entities": [
      {
        "text": "Center for Translational Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Local Chinese Medicine Research, Hubei Provincial Clinical Research Center for",
    "entities": [
      {
        "text": "Local Chinese Medicine Research",
        "label": "ORG"
      },
      {
        "text": "Provincial Clinical Research Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Parkinson's Disease at Xiangyang No.1 People's Hospital, Hubei University of",
    "entities": []
  },
  {
    "text": "(2)College of Biomedicine and Health, Huazhong Agricultural University, Wuhan,",
    "entities": [
      {
        "text": "2)College",
        "label": "CARDINAL"
      },
      {
        "text": "Huazhong Agricultural University",
        "label": "ORG"
      },
      {
        "text": "Wuhan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Clinical Medical Research, Binhai County People's Hospital,",
    "entities": [
      {
        "text": "Clinical Medical Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Clinical Medical College of Yangzhou University, Yancheng, Jiangsu, China.",
    "entities": [
      {
        "text": "Clinical Medical College",
        "label": "ORG"
      },
      {
        "text": "Yangzhou University",
        "label": "ORG"
      },
      {
        "text": "Yancheng",
        "label": "GPE"
      },
      {
        "text": "Jiangsu",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The cross-sectional association of dietary fiber intake with",
    "entities": []
  },
  {
    "text": "gallstone disease in United States adults remains to be comprehensively",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: We used the National Health and Nutrition Examination Survey (NHANES)",
    "entities": [
      {
        "text": "the National Health and Nutrition Examination Survey",
        "label": "ORG"
      },
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "data from 2017-2023. The assessment of dietary fiber intake was derived from",
    "entities": [
      {
        "text": "2017-2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "24-h dietary recalls. Stratified analyses were then used to demonstrate dietary",
    "entities": [
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "fiber intake corresponding to different groups of gallstone and non-gallstone",
    "entities": []
  },
  {
    "text": "conditions. The use of weighted logistic regression was employed to explore the",
    "entities": []
  },
  {
    "text": "correlation between dietary fiber intake and gallstone disease. Subgroup and",
    "entities": []
  },
  {
    "text": "interaction analyses were used to identify potential interacting factors.",
    "entities": []
  },
  {
    "text": "Additionally, restricted cubic spline was used to assess the dose-response",
    "entities": []
  },
  {
    "text": "RESULTS: The study population comprised 9,273 patients, with a gallstone",
    "entities": [
      {
        "text": "9,273",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "prevalence of 10.47% (971 cases). In the context of various subgroups, patients",
    "entities": [
      {
        "text": "10.47%",
        "label": "PERCENT"
      },
      {
        "text": "971",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diagnosed with gallstones exhibited a reduced dietary fiber intake in comparison",
    "entities": []
  },
  {
    "text": "with individuals not bearing gallstones. In the fully adjusted model, an inverse",
    "entities": []
  },
  {
    "text": "association was observed between dietary fiber intake and gallstone disease",
    "entities": []
  },
  {
    "text": "value = 0.039). The highest quartile of dietary fiber intake exhibited a lower",
    "entities": [
      {
        "text": "0.039",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "risk of gallstone disease in comparison with the lowest quartile (quartile 4 vs.",
    "entities": []
  },
  {
    "text": "quartile 1: 0.65 (0.45, 0.94), p value = 0.022). The inverse correlation between",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "0.65",
        "label": "CARDINAL"
      },
      {
        "text": "0.45",
        "label": "CARDINAL"
      },
      {
        "text": "0.94",
        "label": "CARDINAL"
      },
      {
        "text": "0.022",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "dietary fiber intake and the prevalence of gallstones was found to be",
    "entities": []
  },
  {
    "text": "statistically significant in several subgroups, including males, Hispanic",
    "entities": [
      {
        "text": "Hispanic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "individuals, those with less than a high school education, alcohol consumers,",
    "entities": []
  },
  {
    "text": "and individuals diagnosed with diabetes. Furthermore, the analysis of",
    "entities": []
  },
  {
    "text": "dose-response curves indicated a nearly linear correlation between dietary fiber",
    "entities": []
  },
  {
    "text": "intake and the risk of gallstone development.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Dietary fiber intake is inversely associated with gallstone disease",
    "entities": []
  },
  {
    "text": "in United States adults. Adequate dietary fiber intake may be beneficial in",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Zuo, Sang, Sun, Chen and Ji.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Chen",
        "label": "PERSON"
      },
      {
        "text": "Ji",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that the research was",
    "entities": []
  },
  {
    "text": "conducted in the absence of any commercial or financial relationships that could",
    "entities": []
  },
  {
    "text": "be construed as a potential conflict of interest.",
    "entities": []
  },
  {
    "text": "6. Open Forum Infect Dis. 2025 Jul 2;12(7):ofaf369. doi: 10.1093/ofid/ofaf369.",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "eCollection 2025 Jul.",
    "entities": [
      {
        "text": "eCollection",
        "label": "ORG"
      },
      {
        "text": "2025 Jul.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Prevalence and Risk Factors of Liver Fibrosis Among People With HIV and",
    "entities": []
  },
  {
    "text": "Metabolic Dysfunction-Associated Steatotic Liver Disease.",
    "entities": [
      {
        "text": "Metabolic Dysfunction-Associated Steatotic Liver Disease",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Infection and Immunity, Shanghai Public Health Clinical Center,",
    "entities": [
      {
        "text": "Infection and Immunity",
        "label": "ORG"
      },
      {
        "text": "Shanghai Public Health Clinical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Fudan University, Shanghai, China.",
    "entities": [
      {
        "text": "Fudan University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: We aimed to investigate the prevalence of liver fibrosis and",
    "entities": []
  },
  {
    "text": "identify the associated risk factors among people with HIV (PWH) and metabolic",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dysfunction-associated steatotic liver disease (MASLD).",
    "entities": []
  },
  {
    "text": "METHODS: Abdominal ultrasonography and transient elastography were performed to",
    "entities": []
  },
  {
    "text": "assess liver fibrosis and steatosis. Lean MASLD was defined as MASLD occurring",
    "entities": []
  },
  {
    "text": "in PWH with a body mass index (BMI) < 24 kg/m2. A cutoff of liver stiffness",
    "entities": [
      {
        "text": "PWH",
        "label": "GPE"
      },
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "24 kg",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "measurement \u2265 7.1 kPa was set for significant liver fibrosis. The prevalence,",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "kPa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "correlation factors, and risk factors were evaluated.",
    "entities": []
  },
  {
    "text": "RESULTS: Among 361 PWH, 250 (69.25%) had a BMI < 24 kg/m2, and 141 (39.06%) were",
    "entities": [
      {
        "text": "361",
        "label": "CARDINAL"
      },
      {
        "text": "PWH",
        "label": "ORG"
      },
      {
        "text": "250",
        "label": "CARDINAL"
      },
      {
        "text": "69.25%",
        "label": "PERCENT"
      },
      {
        "text": "24 kg",
        "label": "QUANTITY"
      },
      {
        "text": "141",
        "label": "CARDINAL"
      },
      {
        "text": "39.06%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "diagnosed with MASLD. The 141 PWH with MASLD were classified as 2 groups based",
    "entities": [
      {
        "text": "141",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "on BMI: 58 (41.13%) as lean MASLD and 83 (58.87%) as overweight MASLD.",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "58",
        "label": "CARDINAL"
      },
      {
        "text": "41.13%",
        "label": "PERCENT"
      },
      {
        "text": "83",
        "label": "DATE"
      },
      {
        "text": "58.87%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Significant fibrosis was observed in 121 of the 361 PWH, including 75 of the 141",
    "entities": [
      {
        "text": "121",
        "label": "CARDINAL"
      },
      {
        "text": "361",
        "label": "CARDINAL"
      },
      {
        "text": "PWH",
        "label": "ORG"
      },
      {
        "text": "75",
        "label": "CARDINAL"
      },
      {
        "text": "141",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with MASLD, 28 of the 58 with lean MASLD, and 47 of the 83 with overweight",
    "entities": [
      {
        "text": "MASLD",
        "label": "ORG"
      },
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "58",
        "label": "CARDINAL"
      },
      {
        "text": "47",
        "label": "CARDINAL"
      },
      {
        "text": "83",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "MASLD. Among PWH with MASLD, independent risk factors for significant liver",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "fibrosis included higher alanine aminotransferase levels and the presence of",
    "entities": []
  },
  {
    "text": "type 2 diabetes. Among PWH with lean MASLD, independent risk factors for",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significant liver fibrosis included elevated aspartate aminotransferase levels",
    "entities": []
  },
  {
    "text": "and the administration of non-nucleoside reverse transcriptase inhibitors.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Significant liver fibrosis is highly prevalent among PWH and MASLD.",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Multiple risk factors are associated with significant liver fibrosis among PWH.",
    "entities": [
      {
        "text": "PWH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "These findings underscore the importance of early identification and management",
    "entities": []
  },
  {
    "text": "of liver fibrosis in PWH.",
    "entities": [
      {
        "text": "PWH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "CLINICAL TRIALS REGISTRATION: NCT04215926.",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Infectious Diseases Society of America.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Potential conflicts of interest. All authors: No",
    "entities": []
  },
  {
    "text": "reported conflicts. All authors have submitted the ICMJE Form for Disclosure of",
    "entities": []
  },
  {
    "text": "Potential Conflicts of Interest.",
    "entities": [
      {
        "text": "Potential Conflicts of Interest",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Differences in immune cell profiles around the time of islet autoimmunity",
    "entities": []
  },
  {
    "text": "seroconversion in children with and without type 1 diabetes.",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "M, Norris JM, Johnson RK.",
    "entities": [
      {
        "text": "Norris",
        "label": "ORG"
      },
      {
        "text": "Johnson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Seroconversion (SV) marks the initiation of islet autoimmunity (IA) and",
    "entities": [
      {
        "text": "Seroconversion (SV",
        "label": "ORG"
      },
      {
        "text": "IA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "pre-clinical phase of type 1 diabetes, yet the contributions of immune cells",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "beyond cytotoxic T cells remain unclear. We applied high-resolution immune",
    "entities": []
  },
  {
    "text": "cell-type deconvolution using peripheral blood DNA methylation data from nested",
    "entities": []
  },
  {
    "text": "case-control samples of the Diabetes Autoimmunity Study in the Young (DAISY;",
    "entities": [
      {
        "text": "the Diabetes Autoimmunity Study",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "n=151) and The Environmental Determinants of Diabetes in the Young (TEDDY;",
    "entities": [
      {
        "text": "The Environmental Determinants of Diabetes",
        "label": "ORG"
      },
      {
        "text": "Young",
        "label": "PERSON"
      },
      {
        "text": "TEDDY",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "n=166) to estimate immune cell proportions across pre-SV and SV timepoints and",
    "entities": [
      {
        "text": "SV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "construct functional ratios, such as the neutrophil-to-lymphocyte ratio (NLR).",
    "entities": [
      {
        "text": "NLR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Using linear models, we evaluated differences between type 1 diabetes cases and",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "controls at pre-SV, SV, and the change across timepoints. Pre-SV, cases had",
    "entities": [
      {
        "text": "pre-SV",
        "label": "ORG"
      },
      {
        "text": "SV",
        "label": "ORG"
      },
      {
        "text": "Pre-SV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "higher NLR and lower CD4T/CD8T cell ratios. At SV, the combined B-CD4T-CD8T",
    "entities": [
      {
        "text": "NLR",
        "label": "ORG"
      },
      {
        "text": "CD4T",
        "label": "PERSON"
      },
      {
        "text": "SV",
        "label": "ORG"
      },
      {
        "text": "B-CD4T-CD8",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "memory/na\u00efve ratio was reduced in cases. From pre-SV to SV, cases showed",
    "entities": [
      {
        "text": "pre-SV",
        "label": "ORG"
      },
      {
        "text": "SV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "attenuations in NLR, B-memory/na\u00efve, and B-CD4T-CD8T memory/na\u00efve ratios. These",
    "entities": [
      {
        "text": "NLR",
        "label": "ORG"
      },
      {
        "text": "B-CD4T-CD8",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "patterns may reflect delayed or disrupted immune maturation with the persistence",
    "entities": []
  },
  {
    "text": "or expansion of na\u00efve cells or impaired transition to memory subsets following",
    "entities": []
  },
  {
    "text": "antigen exposure. Our findings highlight early shifts in innate and adaptive",
    "entities": []
  },
  {
    "text": "immune cell dynamics during type 1 diabetes pathogenesis and support immune cell",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ratios as potential biomarkers for risk stratification and mechanistic insight.",
    "entities": []
  },
  {
    "text": "ARTICLE HIGHLIGHTS: We sought to examine immune cells around the time of IA",
    "entities": [
      {
        "text": "IA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "seroconversion in children at higher risk for type 1 diabetes.We wanted to",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "answer whether immune cell ratio differences exist between type 1 diabetes cases",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and controls around IA at pre-SV, SV, and the change pre-SV to SV.We found",
    "entities": [
      {
        "text": "IA",
        "label": "GPE"
      },
      {
        "text": "SV",
        "label": "ORG"
      },
      {
        "text": "pre-SV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immune cell ratio differences between type 1 diabetes cases and controls before,",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "during, and across SV timepoints, suggesting potential etiological and",
    "entities": [
      {
        "text": "SV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pathophysiological roles.Our findings highlight the complexity of immunodynamics",
    "entities": []
  },
  {
    "text": "around IA seroconversion and potential role for immune cell ratios in type 1",
    "entities": [
      {
        "text": "IA",
        "label": "GPE"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diabetes risk stratification and intervention.",
    "entities": []
  },
  {
    "text": "Spatial transcriptomic profiling of human paravertebral sympathetic chain",
    "entities": []
  },
  {
    "text": "ganglia reveals diabetes-induced neuroplasticity.",
    "entities": []
  },
  {
    "text": "Moreno MM, Patel PJ, Goss K, Mian SM, Nakisli S, Inturi N, Shiers SI, Horton P,",
    "entities": [
      {
        "text": "Moreno MM",
        "label": "PERSON"
      },
      {
        "text": "Patel PJ",
        "label": "PERSON"
      },
      {
        "text": "Goss K",
        "label": "PERSON"
      },
      {
        "text": "Mian SM",
        "label": "PERSON"
      },
      {
        "text": "Nakisli S",
        "label": "ORG"
      },
      {
        "text": "Inturi N",
        "label": "ORG"
      },
      {
        "text": "Shiers SI",
        "label": "ORG"
      },
      {
        "text": "Horton P",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Price TJ, Yousuf MS.",
    "entities": [
      {
        "text": "Yousuf MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The paravertebral sympathetic chain ganglia (SCG) are autonomic ganglia critical",
    "entities": [
      {
        "text": "SCG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for regulating the \"fight-or-flight\" response. Symptoms of sympathetic",
    "entities": []
  },
  {
    "text": "dysfunction are prevalent in diabetes, affecting up to 90% of patients. The",
    "entities": [
      {
        "text": "up to 90%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "molecular and cellular composition of the human SCG and its alteration in",
    "entities": [
      {
        "text": "SCG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "diabetes remains poorly defined. To address this gap, we performed spatial",
    "entities": []
  },
  {
    "text": "transcriptomic profiling of lumbar SCGs from diabetic and non-diabetic organ",
    "entities": []
  },
  {
    "text": "donors. We identified 3 three distinct neuronal populations, two noradrenergic",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(NA1 and NA2) and one cholinergic (CHO), based on tyrosine hydroxylase ( TH )",
    "entities": [
      {
        "text": "NA1",
        "label": "ORG"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "CHO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and SLC18A3 expression, respectively. We also characterized 9 non-neuronal",
    "entities": [
      {
        "text": "9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "populations consisting of Schwann cells, immune cells, fibroblasts, adipocytes,",
    "entities": [
      {
        "text": "Schwann",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and endothelial cells. In diabetic SCGs, we observed a significant loss of",
    "entities": []
  },
  {
    "text": "myelinating Schwann cells and a phenotypic shift of cholinergic neurons toward a",
    "entities": [
      {
        "text": "Schwann",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "noradrenergic identity. Additionally, diabetes was associated with a significant",
    "entities": [
      {
        "text": "noradrenergic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reduction in the transcripts of vasodilatory neuropeptides, such as VIP and",
    "entities": []
  },
  {
    "text": "CALCA , suggesting a mechanism for impaired vascular control. Upstream regulator",
    "entities": [
      {
        "text": "CALCA",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "analysis highlighted altered neurotrophic signaling in diabetes, with enhanced",
    "entities": []
  },
  {
    "text": "NGF/TRKA and diminished BDNF/TRKB activity, potentially driven by target-derived",
    "entities": [
      {
        "text": "NGF",
        "label": "ORG"
      },
      {
        "text": "TRKA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "cues. Comparison between SCG and dorsal root ganglia (DRG) neurons revealed",
    "entities": [
      {
        "text": "SCG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ganglia-specific genes, like SCN3A and NPY (SCG) versus SCN10A and GPX1 (DRG),",
    "entities": [
      {
        "text": "SCN10A",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "offering specific therapeutic targets for autonomic dysfunction or pain. Our",
    "entities": []
  },
  {
    "text": "findings provide a transcriptomic characterization of human SCG, revealing",
    "entities": [
      {
        "text": "SCG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "molecular signatures that underlie diabetic autonomic dysfunction. This work",
    "entities": []
  },
  {
    "text": "lays a foundation for the development of therapies to restore sympathetic",
    "entities": []
  },
  {
    "text": "function and avoid unintended autonomic effects in the development of",
    "entities": []
  },
  {
    "text": "SIGNIFICANCE STATEMENT: Autonomic dysfunction affects up to 90% of people with",
    "entities": [
      {
        "text": "SIGNIFICANCE STATEMENT",
        "label": "PERSON"
      },
      {
        "text": "up to 90%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "diabetes, yet the human sympathetic nervous system remains poorly molecularly",
    "entities": []
  },
  {
    "text": "defined. To address this gap, we present a spatial transcriptomic profile of the",
    "entities": []
  },
  {
    "text": "human sympathetic chain ganglia (SCG), revealing how diabetes affects the human",
    "entities": [
      {
        "text": "SCG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "autonomic nervous system. We show that diabetes shifts the cholinergic neuronal",
    "entities": []
  },
  {
    "text": "population to a noradrenergic phenotype and reduces vasodilation neuropeptide",
    "entities": []
  },
  {
    "text": "expression, potentially explaining impaired vascular control and",
    "entities": []
  },
  {
    "text": "thermoregulation. Comparative analysis of sympathetic and sensory ganglia",
    "entities": []
  },
  {
    "text": "reveals distinct gene profiles that may inform novel therapeutic strategies.",
    "entities": []
  },
  {
    "text": "These findings offer critical insight into the molecular drivers of diabetic",
    "entities": []
  },
  {
    "text": "autonomic neuropathy and lay the groundwork for safer, more precise treatments",
    "entities": [
      {
        "text": "autonomic neuropathy",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "that selectively modulate autonomic or sensory function in chronic disease.",
    "entities": []
  },
  {
    "text": "Stressed \u03b2-cells contribute to loss of peri-islet extracellular matrix in type 1",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Johansen CG, Lam K, Farnsworth NL.",
    "entities": [
      {
        "text": "Johansen CG",
        "label": "PERSON"
      },
      {
        "text": "Lam K",
        "label": "PERSON"
      },
      {
        "text": "Farnsworth NL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Type 1 diabetes (T1D) is characterized by the immune-mediated destruction of",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "insulin-producing \u03b2-cells in pancreatic islets. The peri-islet extracellular",
    "entities": []
  },
  {
    "text": "matrix (ECM) is a complex protein barrier that is lost in T1D, in part due to",
    "entities": [
      {
        "text": "ECM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infiltrating immune cells. The contribution of stressed \u03b2-cells to ECM",
    "entities": [
      {
        "text": "ECM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "degradation during T1D remains unclear. To bridge this gap, we used",
    "entities": []
  },
  {
    "text": "12-15-week-old NOD mice and pancreas sections from healthy, \u22652 autoantibody",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "15-week-old",
        "label": "DATE"
      },
      {
        "text": "NOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "positive (Aab+), and recent onset T1D donors. We focused on MMP-3 due to its",
    "entities": [
      {
        "text": "MMP-3",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "role in degrading type IV collagen (COL IV) in the peri-islet ECM. Treatment",
    "entities": [
      {
        "text": "IV",
        "label": "GPE"
      },
      {
        "text": "COL IV",
        "label": "ORG"
      },
      {
        "text": "ECM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with proinflammatory cytokines or hyperglycemia increased MMP-3 gene expression",
    "entities": [
      {
        "text": "MMP-3",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "and protein levels in mouse and human islets. In NOD pancreas sections,",
    "entities": [
      {
        "text": "NOD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "increased MMP-3 expression in \u03b2-cells correlates with loss of COL IV during",
    "entities": [
      {
        "text": "MMP-3",
        "label": "PRODUCT"
      },
      {
        "text": "COL IV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "insulitis and hyperglycemia; however, this was independent of insulitis score.",
    "entities": []
  },
  {
    "text": "We observed similar increases in MMP-3 and loss of COL IV in islets and exocrine",
    "entities": [
      {
        "text": "MMP-3",
        "label": "PRODUCT"
      },
      {
        "text": "COL IV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "tissue from Aab+ and recent onset T1D donors. These results suggest that",
    "entities": []
  },
  {
    "text": "stressed \u03b2-cells degrade the ECM during preclinical T1D, further weakening the",
    "entities": [
      {
        "text": "ECM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "peri-islet ECM barrier and facilitating islet infiltration and death. Inhibiting",
    "entities": [
      {
        "text": "ECM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "expression of MMP-3 may represent a novel treatment to prevent islet death in",
    "entities": [
      {
        "text": "MMP-3",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "T1D.",
    "entities": [
      {
        "text": "T1D.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "The Chromatin Remodeler Protein CHD4 Cooperates With NKX2.2 to Regulate",
    "entities": [
      {
        "text": "Regulate",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Pancreatic Beta Cell Integrity.",
    "entities": []
  },
  {
    "text": "NKX2.2 is a transcription factor that regulates pancreatic islet beta (\u03b2) cell",
    "entities": [
      {
        "text": "NKX2.2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "identity and function; however, cofactor proteins that modulate the functional",
    "entities": []
  },
  {
    "text": "activity of NKX2.2 in \u03b2 cells are relatively unexplored. An unbiased proteomics",
    "entities": [
      {
        "text": "NKX2.2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "screen identified chromodomain helicase DNA-binding protein 4 (CHD4) as an",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "NKX2.2 interacting partner. CHD4 is a nucleosome remodeler that directs the",
    "entities": [
      {
        "text": "NKX2.2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "appropriate differentiation, maturation and function of many cell types by",
    "entities": []
  },
  {
    "text": "activating or repressing genes. To characterize the NKX2.2-dependent and",
    "entities": [
      {
        "text": "NKX2.2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "independent roles of CHD4 in \u03b2 cells, we generated Chd4 \u03b2KO mice. Deletion of",
    "entities": [
      {
        "text": "CHD4",
        "label": "GPE"
      },
      {
        "text": "Chd4",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Chd4 substantially impaired the maturation and function of \u03b2 cells. The Chd4 \u03b2KO",
    "entities": [
      {
        "text": "Chd4",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "mice were diabetic as early as 3 weeks of age due to the disruption of islet",
    "entities": [
      {
        "text": "early as 3 weeks of age",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "integrity, impaired glucose-stimulated insulin secretion and calcium signaling,",
    "entities": []
  },
  {
    "text": "and downregulation of essential \u03b2 cell regulatory genes. These studies",
    "entities": []
  },
  {
    "text": "demonstrate that CHD4 is an essential transcriptional cofactor of NKX2.2 that is",
    "entities": [
      {
        "text": "CHD4",
        "label": "GPE"
      },
      {
        "text": "NKX2.2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "required for the proper maturation and function of pancreatic \u03b2 cells.",
    "entities": []
  },
  {
    "text": "Improved conditioning for hematopoietic chimerism induces islet tolerance to",
    "entities": []
  },
  {
    "text": "Mixed hematopoietic chimerism after hematopoietic cell transplantation (HCT) can",
    "entities": []
  },
  {
    "text": "modulate the immune system and induce tolerance to allogeneic tissues. However,",
    "entities": []
  },
  {
    "text": "bone marrow conditioning-related toxicities preclude wider adoption of HCT for",
    "entities": [
      {
        "text": "HCT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "transplant allotolerance. We sought agents that reduced conditioning intensity,",
    "entities": []
  },
  {
    "text": "while promoting durable mixed chimerism after HCT across complete major",
    "entities": []
  },
  {
    "text": "histocompatibility complex (MHC) mismatch in diabetic mice, permitting islet",
    "entities": [
      {
        "text": "MHC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "allotransplantation and diabetes reversal. We systematically tested baricitinib",
    "entities": []
  },
  {
    "text": "(JAK1/2 inhibitor), venetoclax (Bcl2 inhibitor), and \u03b1CD47 antibody, agents in",
    "entities": []
  },
  {
    "text": "current clinical use, and quantified hematopoietic chimerism after HCT. Combined",
    "entities": []
  },
  {
    "text": "with \u03b1CD117 antibody, transient T cell depletion, and just 10 centigray (cGy)",
    "entities": [
      {
        "text": "just 10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "total body irradiation (TBI), these agents enabled durable mixed chimerism and",
    "entities": [
      {
        "text": "TBI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "matching allo-islet tolerance, to cure diabetes without evidence of GVHD. Thus,",
    "entities": []
  },
  {
    "text": "we have developed a conditioning regimen to promote allogeneic mixed",
    "entities": []
  },
  {
    "text": "hematopoietic chimerism and transplanted islet allotolerance that minimizes",
    "entities": []
  },
  {
    "text": "conditioning radiation and cures diabetes, a significant achievement.",
    "entities": []
  },
  {
    "text": "Med14 phosphorylation shapes genomic response to GLP-1 Agonist.",
    "entities": [
      {
        "text": "GLP-1 Agonist",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Under feeding conditions, release of glucagon-like peptide (GLP-1) from",
    "entities": [
      {
        "text": "GLP-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "intestinal L cells promotes insulin secretion and pancreatic beta cell",
    "entities": []
  },
  {
    "text": "viability. Binding of GLP-1 to its cognate receptor on the beta cell surface",
    "entities": [
      {
        "text": "GLP-1",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "results in induction of the cAMP signaling pathway, leading to the protein",
    "entities": []
  },
  {
    "text": "kinase A (PKA) mediated phosphorylation of CREB and induction of CREB target",
    "entities": [
      {
        "text": "PKA",
        "label": "ORG"
      },
      {
        "text": "CREB",
        "label": "ORG"
      },
      {
        "text": "CREB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "genes. By contrast with the acute effects of this pathway on immediate early",
    "entities": []
  },
  {
    "text": "CREB target genes, which attenuate the cAMP-CREB response, sustained exposure of",
    "entities": [
      {
        "text": "CREB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "beta cells to the stable GLP-1 receptor agonist Exendin-4 stimulates the",
    "entities": [
      {
        "text": "GLP-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "expression of beta cell specific CREB target genes with delayed kinetics. In a",
    "entities": [
      {
        "text": "CREB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "proteomic screen for transcriptional co-regulators that mediate the long-term",
    "entities": []
  },
  {
    "text": "effects of GLP-1 analogs, we identified Med14, a backbone subunit of the",
    "entities": [
      {
        "text": "GLP-1",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Mediator complex. Exposure to Exendin-4 stimulates Med14 phosphorylation at",
    "entities": []
  },
  {
    "text": "Ser983, corresponding to a conserved PKA recognition site (RRXS) that is located",
    "entities": [
      {
        "text": "PKA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "within an intrinsically disordered region of Med14. Phosphorylation of Med14 by",
    "entities": []
  },
  {
    "text": "PKA is essential for maintenance of enhancers that drive induction of beta",
    "entities": [
      {
        "text": "PKA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cell-specific and diabetes-linked genes. Mutation of Med14 at Ser983 to alanine",
    "entities": []
  },
  {
    "text": "decreased beta cell numbers and repressed Exendin-4 induced gene regulation in",
    "entities": []
  },
  {
    "text": "primary mouse beta cells. Our work reveals how phosphorylation of a general",
    "entities": [
      {
        "text": "primary mouse",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "transcription factor in response to GLP-1 analogs triggers a broad genomic",
    "entities": [
      {
        "text": "transcription",
        "label": "CARDINAL"
      },
      {
        "text": "GLP-1",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "response with salutary effects on beta cell function.",
    "entities": []
  },
  {
    "text": "Long-read transcriptome assembly reveals vast isoform diversity in the placenta",
    "entities": [
      {
        "text": "the placenta\n",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "associated with metabolic and endocrine function.",
    "entities": []
  },
  {
    "text": "Bresnahan ST, Yong H, Wu WH, Lopez S, Yen Chan JK, White F, Jacques P\u00c9, Hivert",
    "entities": [
      {
        "text": "Bresnahan ST",
        "label": "GPE"
      },
      {
        "text": "Yong H",
        "label": "GPE"
      },
      {
        "text": "Wu WH",
        "label": "PERSON"
      },
      {
        "text": "Lopez S",
        "label": "PERSON"
      },
      {
        "text": "Yen Chan JK",
        "label": "ORG"
      },
      {
        "text": "White F",
        "label": "FAC"
      },
      {
        "text": "Jacques P\u00c9",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "MF, Chan SY, Love MI, Huang JY, Bhattacharya A.",
    "entities": [
      {
        "text": "Chan",
        "label": "PERSON"
      },
      {
        "text": "Love MI",
        "label": "ORG"
      },
      {
        "text": "Huang JY",
        "label": "PERSON"
      },
      {
        "text": "Bhattacharya A.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "The placenta plays a critical role in fetal development and mediates maternal",
    "entities": []
  },
  {
    "text": "metabolic effects on offspring health outcomes. Despite its importance, the",
    "entities": []
  },
  {
    "text": "placenta remains understudied in large-scale genomic initiatives, with most",
    "entities": []
  },
  {
    "text": "analyses focusing on gene-level expression based on annotations from adult",
    "entities": []
  },
  {
    "text": "tissue references that obscure isoform diversity particularly vital to",
    "entities": []
  },
  {
    "text": "understanding function in developmental tissues. Here, we employed",
    "entities": []
  },
  {
    "text": "largest-in-class long-read RNA sequencing (N = 72) to generate a comprehensive",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      },
      {
        "text": "72",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "placental transcript reference, yielding 37,661 high-confidence isoforms across",
    "entities": [
      {
        "text": "37,661",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "12,302 genes. Our assembly revealed 14,985 novel isoforms of known genes and",
    "entities": [
      {
        "text": "12,302",
        "label": "CARDINAL"
      },
      {
        "text": "14,985",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "2,759 transcripts representing previously unannotated genes, with extensive",
    "entities": [
      {
        "text": "2,759",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diversity in genes involved in obesity, placental lactogen production, and",
    "entities": []
  },
  {
    "text": "growth control. We demonstrate this approach has two immediate practical",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "advantages: First, the improved reference reduced inferential uncertainty in",
    "entities": [
      {
        "text": "First",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "isoform quantification by approximately 37%, reduced the frequency of",
    "entities": [
      {
        "text": "approximately 37%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "low-confidence annotations and increased the yield (read depth) of",
    "entities": []
  },
  {
    "text": "high-confidence annotations. Second, in analyses of gestational diabetes",
    "entities": [
      {
        "text": "Second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "mellitus (GDM) with short-read RNA-seq datasets from two independent,",
    "entities": [
      {
        "text": "GDM",
        "label": "ORG"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "multi-ancestry birth cohorts (N = 344) as an exemplar, we were able to identify",
    "entities": [
      {
        "text": "344",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "novel isoforms of chorionic somatomammotropin hormone 1 ( CSH1 ) mediating the",
    "entities": [
      {
        "text": "CSH1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effect of maternal hyperglycemia on birth weight that was not apparent in",
    "entities": []
  },
  {
    "text": "conventional gene-level analyses. These findings demonstrate that isoform-level",
    "entities": []
  },
  {
    "text": "annotation of placental transcriptomics provides greater sensitivity and",
    "entities": []
  },
  {
    "text": "specificity than gene-level approaches. This enhanced precision may be essential",
    "entities": []
  },
  {
    "text": "for understanding placental function in developmental programming of metabolism",
    "entities": []
  },
  {
    "text": "and reveal ancestry- and context-specific variation in placental function and",
    "entities": []
  },
  {
    "text": "Exploring the Chemical Profile, Antioxidants, and Anti-Diabetic Properties of",
    "entities": [
      {
        "text": "the Chemical Profile",
        "label": "ORG"
      },
      {
        "text": "Anti-Diabetic Properties",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Coffee Beans From Selected East African Countries: A Comparative In Vitro and",
    "entities": [
      {
        "text": "Selected East African Countries",
        "label": "ORG"
      },
      {
        "text": "Vitro",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Computational Study.",
    "entities": []
  },
  {
    "text": "(1)Department of Biochemistry, School of Life Sciences University of",
    "entities": [
      {
        "text": "Biochemistry, School of Life Sciences University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "KwaZulu-Natal Durban South Africa.",
    "entities": [
      {
        "text": "KwaZulu-Natal Durban South Africa",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Microbiology, School of Life Sciences University of",
    "entities": [
      {
        "text": "Microbiology, School of Life Sciences University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "East Africa, the origin of coffee beans, is renowned for its coffee's cultural",
    "entities": [
      {
        "text": "East Africa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "significance and potential health benefits, particularly in mitigating metabolic",
    "entities": []
  },
  {
    "text": "disorders and their related complications. Despite this, studies that",
    "entities": []
  },
  {
    "text": "comprehensively evaluate their pharmacological potential remain limited. This",
    "entities": []
  },
  {
    "text": "study investigated the antioxidant and antidiabetic properties of coffee beans",
    "entities": []
  },
  {
    "text": "from Uganda, Burundi, and Tanzania using in vitro and computational methods.",
    "entities": [
      {
        "text": "Uganda",
        "label": "GPE"
      },
      {
        "text": "Burundi",
        "label": "GPE"
      },
      {
        "text": "Tanzania",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Antioxidant activities were evaluated via DPPH, FRAP, and nitric oxide",
    "entities": [
      {
        "text": "FRAP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(NO) assays, while antidiabetic potential was assessed using \u03b1-glucosidase and",
    "entities": []
  },
  {
    "text": "\u03b1-amylase inhibitiory assays. Liquid chromatography-mass spectrometry (LC-MS)",
    "entities": [
      {
        "text": "LC-MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was employed to screen and identify the phytochemical compounds in the coffee",
    "entities": []
  },
  {
    "text": "beans. Additionally, computational studies such as molecular docking and",
    "entities": []
  },
  {
    "text": "molecular dynamics (MD) simulation were performed to investigate the",
    "entities": [
      {
        "text": "MD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "interactions and stability between the phytochemicals and target enzymes. The",
    "entities": []
  },
  {
    "text": "results revealed that coffee beans from Burundi exhibited the highest DPPH and",
    "entities": [
      {
        "text": "Burundi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "FRAP scavenging activities, while Ugandan cofee beans demonstrated the strongest",
    "entities": [
      {
        "text": "Ugandan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "NO scavenging activity. Tanzanian beans showed the most potent inhibition of",
    "entities": [
      {
        "text": "Tanzanian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "\u03b1-glucosidase and \u03b1-amylase enzymes. Additionally, Burundian coffee extracts",
    "entities": [
      {
        "text": "Burundian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "stimulated glucose uptake in yeast cells more effectively than other samples.",
    "entities": []
  },
  {
    "text": "The LC-MS analysis highlighted that Burundian and Tanzanian beans were rich in",
    "entities": [
      {
        "text": "Burundian",
        "label": "NORP"
      },
      {
        "text": "Tanzanian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "phenolic acids, whereas Ugandan beans had the highest caffeine content.",
    "entities": [
      {
        "text": "Ugandan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Molecular docking and dynamics simulations confirmed strong inhibitory",
    "entities": []
  },
  {
    "text": "interactions between the identified phytochemicals and target enzymes,",
    "entities": []
  },
  {
    "text": "supporting their role in antioxidant and antidiabetic activities. The study",
    "entities": []
  },
  {
    "text": "underscores East African coffee beans' potent antioxidant and antidiabetic",
    "entities": [
      {
        "text": "East African",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "properties, attributed to their unique phytochemical profiles. These findings",
    "entities": []
  },
  {
    "text": "emphasize their potential as functional foods for managing metabolic disorders,",
    "entities": []
  },
  {
    "text": "providing a scientific basis for their health benefits.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Food Science & Nutrition published by Wiley Periodicals",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Food Science & Nutrition",
        "label": "ORG"
      },
      {
        "text": "Wiley Periodicals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflicts of interest.",
    "entities": []
  },
  {
    "text": "15. Food Sci Nutr. 2025 Jul 15;13(7):e70404. doi: 10.1002/fsn3.70404. eCollection",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "Sci Nutr",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "A Systematic Review and Meta-Analysis of the Impact of Cornus mas L. on",
    "entities": [
      {
        "text": "Meta-Analysis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Anthropometric Indices and Body Composition.",
    "entities": []
  },
  {
    "text": "(1)Medicinal Plants Research Center, Department of Nutrition Maragheh University",
    "entities": [
      {
        "text": "Plants Research Center",
        "label": "ORG"
      },
      {
        "text": "Department of Nutrition Maragheh University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medical Sciences (MRGUMS) Maragheh Iran.",
    "entities": [
      {
        "text": "Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Maragheh Iran",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Student Research Committee, Faculty of Nutrition and Food Sciences Tabriz",
    "entities": [
      {
        "text": "Research Committee",
        "label": "ORG"
      },
      {
        "text": "Faculty of Nutrition and Food Sciences Tabriz",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Medical Sciences Tabriz Iran.",
    "entities": [
      {
        "text": "University of Medical Sciences Tabriz Iran",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Student Research Committee, Department of Nutrition Maragheh University of",
    "entities": [
      {
        "text": "Research Committee",
        "label": "ORG"
      },
      {
        "text": "Department of Nutrition Maragheh University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Sciences (MRGUMS) Maragheh Iran.",
    "entities": [
      {
        "text": "Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Maragheh Iran",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Obesity and its related metabolic disorders have been a global concern in health",
    "entities": []
  },
  {
    "text": "care over the past few decades. Lifestyle modification and evidence-based",
    "entities": [
      {
        "text": "the past few decades",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "dietary interventions, including the usage of nutraceuticals with minimal",
    "entities": []
  },
  {
    "text": "adverse effects, have gained widespread recognition as effective strategies for",
    "entities": []
  },
  {
    "text": "obesity management. Cornelian cherry, scientifically identified as Cornus mas L.",
    "entities": [
      {
        "text": "Cornelian",
        "label": "NORP"
      },
      {
        "text": "Cornus",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(CM) is rich in anthocyanins, flavonoids, tannins, and polyphenols, with",
    "entities": [
      {
        "text": "CM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anti-inflammatory, anti-oxidant, anti-diabetic, anti-obesity, and hypolipidemic",
    "entities": []
  },
  {
    "text": "properties. Cornelian cherry inhibits hepatic lipogenesis, increases hepatic",
    "entities": [
      {
        "text": "Cornelian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "lipid oxidation and clearance, and regulates the expression of peroxisome",
    "entities": []
  },
  {
    "text": "proliferator-activated receptors. Additionally, CM activates the AMP-activated",
    "entities": [
      {
        "text": "CM",
        "label": "ORG"
      },
      {
        "text": "AMP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "protein kinase and adiponectin signaling pathways in the white adipose tissue,",
    "entities": []
  },
  {
    "text": "resulting in adipocytokine level decline. We aimed to perform a systematic",
    "entities": []
  },
  {
    "text": "review and meta-analysis of the impact of CM on anthropometric indices and body",
    "entities": [
      {
        "text": "CM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "composition. A comprehensive search was conducted on the Web of Sciences,",
    "entities": [
      {
        "text": "the Web of Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PubMed, and Scopus databases up to April 2025 for published papers. The quality",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      },
      {
        "text": "April 2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "of methodology and risk of bias of selected studies were assessed by the",
    "entities": []
  },
  {
    "text": "Cochrane Risk of Bias tool. Overall, six randomized controlled trials (RCT) were",
    "entities": [
      {
        "text": "Bias",
        "label": "PERSON"
      },
      {
        "text": "six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "included. Pooled analyses indicated no significant differences observed in cases",
    "entities": []
  },
  {
    "text": "of body weight (BW), body fat percentage (BF%), fat mass (FM), weight",
    "entities": []
  },
  {
    "text": "circumference (WC) and hip circumference (HC). However, a modest but significant",
    "entities": [
      {
        "text": "WC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "increase in body mass index (BMI) was observed after supplementing CM.",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "CM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Furthermore, according to sub-group analyses, BW, BMI, BF%, FM, WC, and HC were",
    "entities": [
      {
        "text": "BW",
        "label": "ORG"
      },
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "BF%",
        "label": "NORP"
      },
      {
        "text": "WC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly increased when administration was accomplished on MAPLD patients,",
    "entities": [
      {
        "text": "MAPLD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the sample size was > 50, the lyophilized dried and CM fruit extract forms were",
    "entities": [
      {
        "text": "50",
        "label": "CARDINAL"
      },
      {
        "text": "CM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "used, intervention duration was < 12 weeks, and doses were \u2265 30 g. Future",
    "entities": [
      {
        "text": "12 weeks",
        "label": "DATE"
      },
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "30 g. Future",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "research should prioritize well-designed, long-term follow-up RCTs investigating",
    "entities": []
  },
  {
    "text": "CM as an adjunct therapy to multimodal lifestyle interventions, focusing on both",
    "entities": [
      {
        "text": "CM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anthropometric indices and biochemical markers.",
    "entities": []
  },
  {
    "text": "Skin microbiota and diabetic foot ulcers.",
    "entities": []
  },
  {
    "text": "(1)Burn Department, Ningbo No.2 Hospital, Ningbo, China.",
    "entities": [
      {
        "text": "Ningbo No.2 Hospital",
        "label": "ORG"
      },
      {
        "text": "Ningbo",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Institute of Pathology, Faculty of Medicine, University of Bonn, Bonn,",
    "entities": [
      {
        "text": "2)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "Faculty of Medicine, University of Bonn",
        "label": "ORG"
      },
      {
        "text": "Bonn",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Germany.",
    "entities": [
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Health Science Center, Ningbo University, Ningbo, China.",
    "entities": [
      {
        "text": "Science Center",
        "label": "ORG"
      },
      {
        "text": "Ningbo University",
        "label": "ORG"
      },
      {
        "text": "Ningbo",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Skin microbiota is the microbial population on the skin surface, which has a",
    "entities": []
  },
  {
    "text": "symbiotic relationship with the host skin and plays an important role in",
    "entities": []
  },
  {
    "text": "maintaining skin health and regulating immune responses. In patients with",
    "entities": []
  },
  {
    "text": "diabetic foot ulcers (DFUs), the skin microbiota is unbalanced. The abundance of",
    "entities": []
  },
  {
    "text": "pathogenic bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa",
    "entities": [
      {
        "text": "Staphylococcus",
        "label": "ORG"
      },
      {
        "text": "Pseudomonas",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "increases, forming biofilms, destroying the skin barrier function, aggravating",
    "entities": []
  },
  {
    "text": "infection, and leading to poor wound healing. Studies have shown that the",
    "entities": []
  },
  {
    "text": "diversity of skin microbiota is positively correlated with the severity of",
    "entities": []
  },
  {
    "text": "ulcers, and regulating its composition and function may be an important strategy",
    "entities": []
  },
  {
    "text": "to improve DFUs healing. In recent years, with the development of molecular",
    "entities": [
      {
        "text": "recent years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "biology technology, progress has been made in the study of skin microbiota, such",
    "entities": []
  },
  {
    "text": "as 16S rRNA gene sequencing technology to understand its composition changes and",
    "entities": [
      {
        "text": "16S",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "explore the interaction mechanism with the host immune system. Based on this,",
    "entities": []
  },
  {
    "text": "some new therapeutic approaches are being explored, such as the use of",
    "entities": []
  },
  {
    "text": "probiotics or antibacterial drugs to modulate the composition of the microbiota",
    "entities": []
  },
  {
    "text": "and the development of microbiota-based personalized treatment regimens.",
    "entities": []
  },
  {
    "text": "However, there are still challenges in current research. For example, the",
    "entities": []
  },
  {
    "text": "composition and function of skin microbiota are affected by many factors, and",
    "entities": []
  },
  {
    "text": "there are relatively few studies on other microorganisms such as fungi and",
    "entities": []
  },
  {
    "text": "viruses. In the future, it is necessary to further explore its diversity and the",
    "entities": []
  },
  {
    "text": "interaction mechanism with the host, and develop more effective treatment",
    "entities": []
  },
  {
    "text": "methods to improve the prognosis of patients with DFUs.",
    "entities": []
  },
  {
    "text": "eCollection 2025 May-Aug.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "May-Aug.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Effect of Ginkgo biloba extracts in the prevention of posterior capsule",
    "entities": []
  },
  {
    "text": "opacification after cataract surgery: A randomized clinical trial.",
    "entities": []
  },
  {
    "text": "(1)Sports Medicine Research Center, Neuroscience Institute, Tehran University of",
    "entities": [
      {
        "text": "Medicine Research Center",
        "label": "ORG"
      },
      {
        "text": "Neuroscience Institute",
        "label": "ORG"
      },
      {
        "text": "Tehran University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Ophthalmology, Bu Ali Sina Hospital, Mazandaran University of",
    "entities": [
      {
        "text": "Bu Ali Sina Hospital",
        "label": "PERSON"
      },
      {
        "text": "Mazandaran University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of",
    "entities": [
      {
        "text": "Pharmaceutics, Faculty of Pharmacy",
        "label": "ORG"
      },
      {
        "text": "Mazandaran University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Behavioral Diseases Counseling Center, Mazandaran University of Medical",
    "entities": []
  },
  {
    "text": "(5)Department of Biostatistics, Health Sciences Research Center, Addiction",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biostatistics, Health Sciences Research Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institute, Mazandaran University of Medical Sciences, ON, Canada.",
    "entities": [
      {
        "text": "Institute, Mazandaran University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "ON",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Diabetes Research Center, Mazandaran University of Medical Sciences and",
    "entities": [
      {
        "text": "6)Diabetes Research Center",
        "label": "ORG"
      },
      {
        "text": "University of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PURPOSE: This study aims to explore the effect of Ginkgo biloba extracts (GbE)",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      },
      {
        "text": "Ginkgo",
        "label": "ORG"
      },
      {
        "text": "GbE",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "on the prevention of posterior capsule opacification (PCO).",
    "entities": []
  },
  {
    "text": "STUDY DESIGN: This study was a double-blinded, placebo-controlled, single-center",
    "entities": []
  },
  {
    "text": "METHODS: Patients with senile cataracts randomly received GbE supplement",
    "entities": [
      {
        "text": "GbE",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "capsules at a dose of 200 mg (n = 74) or an identical placebo (n = 70) daily for",
    "entities": [
      {
        "text": "200",
        "label": "CARDINAL"
      },
      {
        "text": "74",
        "label": "CARDINAL"
      },
      {
        "text": "70",
        "label": "DATE"
      },
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "6 months after cataract surgery. Patients' follow-ups were scheduled for up to 3",
    "entities": [
      {
        "text": "6 months",
        "label": "DATE"
      },
      {
        "text": "up to 3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years after cataract surgery. PCO formation (Pearl/Fibrotic) was graded using",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      },
      {
        "text": "Pearl/Fibrotic",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "slit-lamp examinations. The necessity of a Neodymium-doped yttrium aluminum",
    "entities": []
  },
  {
    "text": "garnet (Nd: YAG) laser capsulotomy was evaluated by patients' complaints of",
    "entities": [
      {
        "text": "garnet",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "reduced visual acuity imputable to PCO.",
    "entities": [
      {
        "text": "PCO",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 144 patients with a mean age of 64.92 \u00b1 7.77 years were",
    "entities": [
      {
        "text": "144",
        "label": "CARDINAL"
      },
      {
        "text": "64.92",
        "label": "CARDINAL"
      },
      {
        "text": "7.77 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "studied. The mean Log MAR visual acuity in the placebo group started to decrease",
    "entities": [
      {
        "text": "Log MAR",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "at 12 months (P = 0.003) and remained significantly lower than the GbE group",
    "entities": [
      {
        "text": "12 months",
        "label": "DATE"
      },
      {
        "text": "0.003",
        "label": "CARDINAL"
      },
      {
        "text": "GbE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "throughout 36 months (P = 0.005). At 1-year postsurgery, a significant",
    "entities": [
      {
        "text": "36 months",
        "label": "DATE"
      },
      {
        "text": "0.005",
        "label": "CARDINAL"
      },
      {
        "text": "1-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "difference between the two groups of GbE and Placebo was observed regarding",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "GbE",
        "label": "PRODUCT"
      },
      {
        "text": "Placebo",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "pearl PCO score, but obvious fibrotic PCO score differences occurred 3 years",
    "entities": [
      {
        "text": "3 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "after surgery. The Nd: YAG capsulotomy was performed in six eyes (6.1%) for the",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      },
      {
        "text": "6.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "GbE group and 18 eyes (20.4%) for the placebo group (P = 0.004) 3 years after",
    "entities": [
      {
        "text": "GbE",
        "label": "PERSON"
      },
      {
        "text": "18",
        "label": "CARDINAL"
      },
      {
        "text": "20.4%",
        "label": "PERCENT"
      },
      {
        "text": "0.004",
        "label": "CARDINAL"
      },
      {
        "text": "3 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the cataract surgery.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Six months of supplementation with GbE was well tolerated and may",
    "entities": [
      {
        "text": "Six months",
        "label": "DATE"
      },
      {
        "text": "GbE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "provide some marginal prevention in the PCO formation. Besides the effect of the",
    "entities": [
      {
        "text": "PCO",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "GbE in the inhibition of PCO, we also observed a noticeable reduction in the",
    "entities": [
      {
        "text": "GbE",
        "label": "WORK_OF_ART"
      },
      {
        "text": "PCO",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "need for Nd: YAG laser capsulotomy.",
    "entities": []
  },
  {
    "text": "Copyright: \u00a9 2025 Oman Ophthalmic Society.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oman Ophthalmic Society",
        "label": "EVENT"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: There are no conflicts of interest.",
    "entities": []
  },
  {
    "text": "A comparative study of retinal vein occlusion and serum 25 hydroxy Vitamin D at",
    "entities": [
      {
        "text": "25",
        "label": "CARDINAL"
      },
      {
        "text": "Vitamin",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Ophthalmology, Calcutta National Medical College and Hospital,",
    "entities": [
      {
        "text": "Ophthalmology, Calcutta National Medical College and Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Biochemistry, Calcutta National Medical College and Hospital,",
    "entities": [
      {
        "text": "Biochemistry, Calcutta National Medical College and Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Prevalence of retinal vascular occlusion is second to diabetic",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "retinopathy and age-related macular degeneration. Various age-related local and",
    "entities": []
  },
  {
    "text": "systemic factors have been associated with retinal vein occlusion (RVO).",
    "entities": [
      {
        "text": "RVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hemodynamic changes (venous stasis), degenerative changes of the vessel wall and",
    "entities": [
      {
        "text": "Hemodynamic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "blood hypercoagulability underlies the pathogenesis. The role of Vitamin D in",
    "entities": [
      {
        "text": "Vitamin D",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "modulating the inflammatory responses within the arterial wall, the capacity to",
    "entities": []
  },
  {
    "text": "attenuate the oxidative stress and direct effect of hypovitaminosis D on",
    "entities": []
  },
  {
    "text": "increased vascular resistance hints at a potential association of Vitamin D",
    "entities": [
      {
        "text": "Vitamin D",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "levels with disorders of retinal vasculature.",
    "entities": []
  },
  {
    "text": "AIM: To estimate serum 25-hydroxyvitamin D (25 OH Vit D) level in patients of",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      },
      {
        "text": "25",
        "label": "CARDINAL"
      },
      {
        "text": "25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RVO and compare it with matched controls.",
    "entities": [
      {
        "text": "RVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: Fifty patients of RVO as cases and 50 without RVO as",
    "entities": [
      {
        "text": "Fifty",
        "label": "CARDINAL"
      },
      {
        "text": "RVO",
        "label": "ORG"
      },
      {
        "text": "50",
        "label": "CARDINAL"
      },
      {
        "text": "RVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "controls underwent systemic and ocular examination including the estimation of",
    "entities": []
  },
  {
    "text": "serum 25 OH Vit D and other biochemical parameters.",
    "entities": [
      {
        "text": "25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "STATISTICAL ANALYSIS: Statistical Package for the Social Sciences (SPSS)",
    "entities": [
      {
        "text": "the Social Sciences",
        "label": "ORG"
      },
      {
        "text": "SPSS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "software version 25 was used for the analysis. An alpha level of 5% was taken,",
    "entities": [
      {
        "text": "25",
        "label": "CARDINAL"
      },
      {
        "text": "5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "that is P < 0.05 was considered statistically significant.",
    "entities": []
  },
  {
    "text": "RESULTS: Mean serum 25 OH Vit D level in cases of RVO was 21.82",
    "entities": [
      {
        "text": "25",
        "label": "CARDINAL"
      },
      {
        "text": "RVO",
        "label": "ORG"
      },
      {
        "text": "21.82",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "nanogram/deciliters (ng/dL) compared to 30.71 ng/dL in the control group which",
    "entities": [
      {
        "text": "30.71 ng/dL",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "was significantly lower in cases compared to control (P < 0.001). The odds ratio",
    "entities": []
  },
  {
    "text": "calculated for RVO cases versus controls was 1.137; 95% confidence interval",
    "entities": [
      {
        "text": "RVO",
        "label": "ORG"
      },
      {
        "text": "1.137",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSION: A positive association of low serum 25 OH Vit D levels and RVO was",
    "entities": [
      {
        "text": "25",
        "label": "CARDINAL"
      },
      {
        "text": "RVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "found highlighting the importance of evaluating serum Vitamin D levels in all",
    "entities": [
      {
        "text": "Vitamin",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the cases of RVO. This correlation may have possible implications for",
    "entities": [
      {
        "text": "RVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prophylaxis and treatment of RVO, even though this part of our country gets",
    "entities": [
      {
        "text": "RVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "abundant sunlight throughout the year.",
    "entities": [
      {
        "text": "the year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "19. Int J Gen Med. 2025 Jul 11;18:3837-3849. doi: 10.2147/IJGM.S526363.",
    "entities": [
      {
        "text": "19",
        "label": "CARDINAL"
      },
      {
        "text": "10.2147",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "25-(OH)D Deficiency and the Risk of Minor Amputation in Patients with Diabetes",
    "entities": [
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Foot Ulcers: A Chinese Cohort Study.",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Department of Orthopedics, The Second Affiliated Hospital of Soochow",
    "entities": [
      {
        "text": "Orthopedics",
        "label": "ORG"
      },
      {
        "text": "The Second Affiliated Hospital of Soochow",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Soochow, 215004, People's Republic of China.",
    "entities": [
      {
        "text": "215004",
        "label": "DATE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Diabetic foot amputation represents the severe complication of",
    "entities": []
  },
  {
    "text": "patients with diabetic foot ulcers (DFU), with worsened clinical outcomes",
    "entities": []
  },
  {
    "text": "concomitant with 25-hydroxyvitamin D [25-(OH)D] deficiency. This study aimed to",
    "entities": [
      {
        "text": "25",
        "label": "CARDINAL"
      },
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "investigate the value of 25-(OH)D deficiency and its association with minor",
    "entities": [
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "lower limb amputation in Chinese patients with DFU in type 2 diabetes mellitus",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(T2DM).",
    "entities": []
  },
  {
    "text": "METHODS: Ninety-one T2DM patients with DFU undergoing minor amputation (surgical",
    "entities": [
      {
        "text": "Ninety-one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "group), 94 T2DM patients without DFU (diabetic control group), and 40 healthy",
    "entities": [
      {
        "text": "94",
        "label": "CARDINAL"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "controls were enrolled in the study finally. Serum 25-(OH)D levels were measured",
    "entities": []
  },
  {
    "text": "by stable isotope dilution-high performance liquid chromatography-tandem mass",
    "entities": []
  },
  {
    "text": "spectrometry. Patients in the surgical group underwent pathogen detection.",
    "entities": []
  },
  {
    "text": "RESULTS: The overall incidence of 25-(OH)D deficiency was 73.0%. Amputation",
    "entities": [
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      },
      {
        "text": "73.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "group exhibited significantly higher prevalence versus control group (85.7% vs",
    "entities": [
      {
        "text": "85.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "60.6%, P<0.001). The levels of serum 25-(OH)D in the minor amputation group were",
    "entities": [
      {
        "text": "60.6%",
        "label": "PERCENT"
      },
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significantly lower than the T2DM group [10.71 (8.2,16.7) vs 18.8 (15.0, 23.9)",
    "entities": [
      {
        "text": "10.71",
        "label": "CARDINAL"
      },
      {
        "text": "18.8",
        "label": "CARDINAL"
      },
      {
        "text": "15.0",
        "label": "CARDINAL"
      },
      {
        "text": "23.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ng/mL, P<0.001]. Compared with the control group, amputation group showed lower",
    "entities": [
      {
        "text": "ng/mL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "25-(OH)D, calcium, albumin and higher WBC, platelet, inflammatory markers (all",
    "entities": [
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      },
      {
        "text": "WBC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "P<0.001). Minor amputation subgroups showed that 25-(OH)D deficiency associated",
    "entities": [
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with elevated WBC (P=0.002), PLT (P=0.011), D-dimer (P=0.041), HbA1c (P=0.033),",
    "entities": [
      {
        "text": "WBC",
        "label": "ORG"
      },
      {
        "text": "PLT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SII (P=0.023). While low expression of 25-(OH)D group had higher WBC (P=0.016),",
    "entities": [
      {
        "text": "SII",
        "label": "ORG"
      },
      {
        "text": "P=0.023",
        "label": "GPE"
      },
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      },
      {
        "text": "WBC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "D-dimer (P=0.004), SIRI (P=0.042), lower albumin (P=0.009) vs high expression",
    "entities": [
      {
        "text": "SIRI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "group. ROC analysis confirmed 25-(OH)D as superior amputation predictor",
    "entities": [
      {
        "text": "ROC",
        "label": "GPE"
      },
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(AUC=0.798, 95% CI 0.734-0.861) compared to inflammatory markers. Multivariate",
    "entities": [
      {
        "text": "AUC=0.798",
        "label": "PERSON"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.734-0.861",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "regression identified deficiency as independent amputation risk factor.",
    "entities": []
  },
  {
    "text": "Polymicrobial infections (26.4%) correlated with lower 25-(OH)D (P=0.003), with",
    "entities": [
      {
        "text": "26.4%",
        "label": "PERCENT"
      },
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Gram-negative (52.4%) and Gram-positive bacteria (47.6%) among bacterial",
    "entities": [
      {
        "text": "Gram-negative",
        "label": "PERSON"
      },
      {
        "text": "52.4%",
        "label": "PERCENT"
      },
      {
        "text": "Gram",
        "label": "PERSON"
      },
      {
        "text": "47.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "infections.",
    "entities": []
  },
  {
    "text": "CONCLUSION: 25-(OH)D deficiency occurs in 85.7% of patients with minor",
    "entities": [
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      },
      {
        "text": "85.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "amputation in DFU, and the levels of 25-(OH)D decreased. 25-(OH)D deficiency is",
    "entities": [
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      },
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "a vital risk factor for minor amputation and measures should be taken to prevent",
    "entities": []
  },
  {
    "text": "25-(OH)D deficiency in T2DM patients with DFU.",
    "entities": [
      {
        "text": "25-(OH)D",
        "label": "CARDINAL"
      },
      {
        "text": "T2DM",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare no conflicts of interest in",
    "entities": []
  },
  {
    "text": "this work.",
    "entities": []
  },
  {
    "text": "20. Int J Womens Health. 2025 Jul 11;17:1985-1999. doi: 10.2147/IJWH.S522635.",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "Int J Womens Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "11;17:1985-1999",
        "label": "DATE"
      },
      {
        "text": "10.2147",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Causal Relationship Between Sex Hormone Binding Globulin and Obstetrical",
    "entities": [
      {
        "text": "Causal Relationship Between Sex Hormone Binding Globulin",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disorders: A Two-Sample Bidirectional Mendelian Randomization Study.",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical",
    "entities": [
      {
        "text": "Obstetrics",
        "label": "GPE"
      },
      {
        "text": "The First Affiliated Hospital of Chongqing Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Chongqing, People's Republic of China.",
    "entities": [
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Obstetrics, The Affiliated Hospital of North Sichuan Medical",
    "entities": [
      {
        "text": "Obstetrics",
        "label": "GPE"
      },
      {
        "text": "The Affiliated Hospital of",
        "label": "ORG"
      },
      {
        "text": "North Sichuan Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College, Nanchong, People's Republic of China.",
    "entities": [
      {
        "text": "Nanchong",
        "label": "GPE"
      },
      {
        "text": "People's Republic of China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(#)Contributed equally",
    "entities": []
  },
  {
    "text": "INTRODUCTION: Obstetrical disorders critically impact maternal and fetal health.",
    "entities": []
  },
  {
    "text": "Sex hormone-binding globulin (SHBG) regulates pregnancy maintenance and",
    "entities": []
  },
  {
    "text": "maternal-infant outcomes through hormonal, metabolic, and inflammatory pathways,",
    "entities": []
  },
  {
    "text": "yet causal relationships with obstetrical disorders remain unclear. This",
    "entities": []
  },
  {
    "text": "Mendelian randomization (MR) study examined SHBG's causal effects on 12",
    "entities": [
      {
        "text": "Mendelian",
        "label": "NORP"
      },
      {
        "text": "SHBG",
        "label": "ORG"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "obstetrical conditions.",
    "entities": []
  },
  {
    "text": "METHODS: Using cis-protein quantitative trait loci (cis-pQTLs) of SHBG as",
    "entities": [
      {
        "text": "cis-pQTLs",
        "label": "GPE"
      },
      {
        "text": "SHBG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "instrumental variables, we conducted MR analyses in FinnGen and UK Biobank",
    "entities": [
      {
        "text": "FinnGen",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(UKBB), followed by meta-analyses. Inverse variance weighting (IVW) was primary",
    "entities": [
      {
        "text": "UKBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "method, with sensitivity analyses ensuring robustness.",
    "entities": []
  },
  {
    "text": "RESULTS: IVW-MR demonstrated reduced risks with elevated SHBG: gestational",
    "entities": []
  },
  {
    "text": "(OR[95%]=0.823[0.728-0.931], P FDR=5.94\u00d710-3), gestational hypertension",
    "entities": [
      {
        "text": "P FDR=5.94\u00d710-3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(OR[95%]=0.917[0.852-0.987], P FDR=0.041), and early-pregnancy hemorrhage",
    "entities": [
      {
        "text": "P FDR=0.041",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(OR[95%]=0.853[0.794-0.916], P FDR=6.90\u00d710-5). Meta-analysis confirmed SHBG's",
    "entities": [
      {
        "text": "P FDR=6.90\u00d710-5",
        "label": "ORG"
      },
      {
        "text": "SHBG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "causal role in gestational diabetes (P_combined<0.05). COLOC revealed shared",
    "entities": [
      {
        "text": "COLOC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "loci between SHBG and five disorders: gestational diabetes, hyperemesis, early",
    "entities": [
      {
        "text": "SHBG",
        "label": "ORG"
      },
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hemorrhage, preterm delivery, and postpartum hemorrhage.",
    "entities": []
  },
  {
    "text": "CONCLUSION: SHBG causally lowers risks of gestational diabetes, hypertension,",
    "entities": []
  },
  {
    "text": "hyperemesis, miscarriage, and preterm delivery, highlighting its clinical",
    "entities": []
  },
  {
    "text": "relevance in obstetrical pathophysiology.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors report no conflicts of interest in",
    "entities": []
  },
  {
    "text": "21. Aust J Psychol. 2024 Sep 15;76(1):2401022. doi:",
    "entities": [
      {
        "text": "21",
        "label": "CARDINAL"
      },
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "Sep",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Alleviation of physiological stress response by apple aroma.",
    "entities": []
  },
  {
    "text": "(1)Graduate School of Engineering, Nagaoka University of Technology, Nagaoka,",
    "entities": [
      {
        "text": "1)Graduate School of Engineering",
        "label": "ORG"
      },
      {
        "text": "Nagaoka University of Technology",
        "label": "ORG"
      },
      {
        "text": "Nagaoka",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Computing and Information Systems, Faculty of Computing,",
    "entities": [
      {
        "text": "Computing and Information Systems",
        "label": "ORG"
      },
      {
        "text": "Faculty of Computing",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Corporate Research & Development, Takasago International Corporation,",
    "entities": [
      {
        "text": "Research & Development",
        "label": "ORG"
      },
      {
        "text": "Takasago International Corporation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: The study evaluated the potential of apple aroma to alleviate",
    "entities": []
  },
  {
    "text": "physiological stress response induced by a short-term cognitive stressor. It",
    "entities": []
  },
  {
    "text": "investigated the effects of apple aroma on cardiac and peripheral autonomic",
    "entities": []
  },
  {
    "text": "nervous system activity under stressful conditions.",
    "entities": []
  },
  {
    "text": "METHODS: Within-subject experiments were conducted with 25 healthy male",
    "entities": [
      {
        "text": "25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "university students with a 30-minute calculation task under three conditions:",
    "entities": [
      {
        "text": "30-minute",
        "label": "TIME"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Apple, Chamomile (CHA), and Di propylene glycol (DPG) (scentless air). The aroma",
    "entities": [
      {
        "text": "Apple",
        "label": "ORG"
      },
      {
        "text": "CHA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "administration was precisely controlled and counterbalanced. Cardiac activity on",
    "entities": [
      {
        "text": "Cardiac",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "electrocardiograms and nose tip temperature were recorded throughout the",
    "entities": []
  },
  {
    "text": "RESULTS: Apple aroma demonstrated a significantly smaller increase in heart rate",
    "entities": [
      {
        "text": "Apple",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(t [24] = 3.36, p = 0.008 vs. DPG, t [24] = 4.06, p = 0.001 vs. CHA), and a",
    "entities": [
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "3.36",
        "label": "CARDINAL"
      },
      {
        "text": "0.008",
        "label": "CARDINAL"
      },
      {
        "text": "DPG",
        "label": "ORG"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "4.06",
        "label": "CARDINAL"
      },
      {
        "text": "0.001",
        "label": "CARDINAL"
      },
      {
        "text": "CHA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "decrease in the high-frequency component of heart rate variability (t",
    "entities": []
  },
  {
    "text": "[24] = 2.81, p = 0.029 vs. DPG, t [24] = 3.48, p = 0.006 vs. CHA) compared to",
    "entities": [
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "2.81",
        "label": "CARDINAL"
      },
      {
        "text": "0.029",
        "label": "CARDINAL"
      },
      {
        "text": "DPG",
        "label": "ORG"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "3.48",
        "label": "CARDINAL"
      },
      {
        "text": "0.006",
        "label": "CARDINAL"
      },
      {
        "text": "CHA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the other conditions, representing a smaller enhancement of cardiac sympathetic",
    "entities": []
  },
  {
    "text": "nervous system activity and smaller suppression of cardiac parasympathetic",
    "entities": []
  },
  {
    "text": "nervous system activity respectively.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Apple aroma showed efficacy in alleviating the physiological stress",
    "entities": [
      {
        "text": "Apple",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "response in terms of cardiac activity. Apple was also considered significantly",
    "entities": [
      {
        "text": "Apple",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "preferable and comfortable compared to the other conditions, which would be",
    "entities": []
  },
  {
    "text": "beneficial in the context of aromatherapy.",
    "entities": []
  },
  {
    "text": "Plain Language Summary: What is already known about this topic: Aromatherapy",
    "entities": []
  },
  {
    "text": "benefits: Aromatherapy, using volatile plant materials such as essential oils,",
    "entities": [
      {
        "text": "Aromatherapy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "is recognised for its potential to improve physiological and psychological",
    "entities": []
  },
  {
    "text": "health. Citrus fruity aromas like orange, bergamot, and yuzu have reduced stress",
    "entities": []
  },
  {
    "text": "and anxiety and improved mood.Apple\u2019s health benefits: Apples are rich in",
    "entities": [
      {
        "text": "Apple",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "bioactive compounds, including polyphenols, which have antioxidant properties.",
    "entities": []
  },
  {
    "text": "Consumption of apples is linked to reduced risks of lung cancer, cardiovascular",
    "entities": []
  },
  {
    "text": "diseases, and type II diabetes.Limited research on apple aroma: While there is",
    "entities": [
      {
        "text": "II",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "extensive research on the health benefits of consuming apples, the effects of",
    "entities": []
  },
  {
    "text": "apple aroma on physiological and psychological health are underexplored.",
    "entities": []
  },
  {
    "text": "Preliminary studies suggest that apple aroma may have a relaxing effect on the",
    "entities": []
  },
  {
    "text": "body and mind. What this topic adds: Apple aroma reduces stress response: This",
    "entities": [
      {
        "text": "Apple",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study demonstrates that apple aroma significantly reduces the physiological",
    "entities": []
  },
  {
    "text": "stress response, as indicated by smaller increases in heart rate and less",
    "entities": []
  },
  {
    "text": "suppression of heart rate variability during a cognitive stressor.Autonomic",
    "entities": []
  },
  {
    "text": "nervous system modulation: The findings show that apple aroma leads to smaller",
    "entities": []
  },
  {
    "text": "cardiac sympathetic nervous system activity enhancements and smaller suppression",
    "entities": []
  },
  {
    "text": "of cardiac parasympathetic nervous system activity, suggesting a balancing",
    "entities": []
  },
  {
    "text": "effect on autonomic nervous system activity under stress.Preference and comfort",
    "entities": []
  },
  {
    "text": "in aromatherapy: Apple aroma was significantly preferable and more comfortable",
    "entities": [
      {
        "text": "Apple",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "than chamomile and scentless air, indicating its potential utility in",
    "entities": []
  },
  {
    "text": "aromatherapy practices aimed at stress alleviation.",
    "entities": []
  },
  {
    "text": "\u00a9 2024 The Author(s). Published by Informa UK Limited, trading as Taylor &",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "Informa UK Limited",
        "label": "ORG"
      },
      {
        "text": "Taylor &\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Francis Group.",
    "entities": [
      {
        "text": "Francis Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: No potential conflict of interest was reported",
    "entities": []
  },
  {
    "text": "by the author(s).",
    "entities": []
  },
  {
    "text": "Metabolomic Analysis of Uremic Pruritus in Patients on Hemodialysis.",
    "entities": []
  },
  {
    "text": "Mobushar JA(1)(2), Hussain SM(3), Amjad W(3), Kishore U(4)(5), Zafar AA(6),",
    "entities": [
      {
        "text": "Mobushar JA(1)(2",
        "label": "PERSON"
      },
      {
        "text": "Hussain SM(3",
        "label": "PERSON"
      },
      {
        "text": "Amjad W(3",
        "label": "ORG"
      },
      {
        "text": "U(4)(5",
        "label": "FAC"
      },
      {
        "text": "Zafar AA(6",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Qureshi MN(7)(8), Jamil MI(9), Naeem I(10), Ahmed A(11).",
    "entities": [
      {
        "text": "Qureshi MN(7)(8",
        "label": "ORG"
      },
      {
        "text": "Jamil MI(9",
        "label": "PERSON"
      },
      {
        "text": "Naeem I(10",
        "label": "PERSON"
      },
      {
        "text": "Ahmed A(11",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Medicine, Rashid Hospital, Dubai, ARE.",
    "entities": [
      {
        "text": "Rashid Hospital",
        "label": "ORG"
      },
      {
        "text": "Dubai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Internal Medicine, Services Hospital Lahore, Lahore, PAK.",
    "entities": [
      {
        "text": "2)Internal Medicine, Services Hospital Lahore, Lahore",
        "label": "ORG"
      },
      {
        "text": "PAK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Dermatology, Combined Military Hospital, Karachi, PAK.",
    "entities": [
      {
        "text": "Combined Military Hospital",
        "label": "ORG"
      },
      {
        "text": "Karachi",
        "label": "GPE"
      },
      {
        "text": "PAK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Nephrology, Islam Medical College, Lahore, PAK.",
    "entities": [
      {
        "text": "Islam Medical College",
        "label": "ORG"
      },
      {
        "text": "Lahore",
        "label": "GPE"
      },
      {
        "text": "PAK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Urology, Frimley Park Hospital, Camberley, GBR.",
    "entities": [
      {
        "text": "Frimley Park Hospital",
        "label": "FAC"
      },
      {
        "text": "Camberley",
        "label": "ORG"
      },
      {
        "text": "GBR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Nephrology, Lahore General Hospital, Lahore, PAK.",
    "entities": [
      {
        "text": "Lahore General Hospital",
        "label": "ORG"
      },
      {
        "text": "Lahore",
        "label": "GPE"
      },
      {
        "text": "PAK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Psychiatry and Behavioral Sciences, Lahore General Hospital, Lahore, PAK.",
    "entities": [
      {
        "text": "10)Psychiatry",
        "label": "CARDINAL"
      },
      {
        "text": "Behavioral Sciences",
        "label": "ORG"
      },
      {
        "text": "Lahore General Hospital",
        "label": "ORG"
      },
      {
        "text": "Lahore",
        "label": "GPE"
      },
      {
        "text": "PAK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Medicine, Lahore General Hospital, Lahore, PAK.",
    "entities": [
      {
        "text": "11)Medicine",
        "label": "CARDINAL"
      },
      {
        "text": "Lahore General Hospital",
        "label": "ORG"
      },
      {
        "text": "Lahore",
        "label": "GPE"
      },
      {
        "text": "PAK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Uremic pruritus (UP) is a prevalent and distressing complication",
    "entities": []
  },
  {
    "text": "among patients with end-stage renal disease (ESRD) receiving maintenance",
    "entities": [
      {
        "text": "ESRD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hemodialysis (HD). Despite its significant impact on quality of life and",
    "entities": []
  },
  {
    "text": "mortality, the underlying pathophysiology remains incompletely understood, with",
    "entities": []
  },
  {
    "text": "evidence implicating metabolic and inflammatory factors.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: This study aimed to determine the prevalence of UP and assess its",
    "entities": []
  },
  {
    "text": "association with selected metabolic and inflammatory biomarkers in patients",
    "entities": []
  },
  {
    "text": "METHODS: A cross-sectional observational study was conducted at the Dialysis",
    "entities": [
      {
        "text": "Dialysis",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Centre of Lahore General Hospital, a tertiary care hospital in Lahore, Pakistan.",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      },
      {
        "text": "Lahore",
        "label": "GPE"
      },
      {
        "text": "Pakistan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "A total of 281 adult HD patients were enrolled. Pruritus was assessed using the",
    "entities": [
      {
        "text": "281",
        "label": "CARDINAL"
      },
      {
        "text": "Pruritus",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "5-D Itch Scale, with a score \u226510 defining cases. Demographic and clinical data",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were recorded, and laboratory parameters including hemoglobin, calcium,",
    "entities": []
  },
  {
    "text": "phosphate, magnesium, intact parathyroid hormone (iPTH), uric acid, lipid",
    "entities": [
      {
        "text": "phosphate",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "profile, high-sensitivity C-reactive protein (hs-CRP), and white blood cell",
    "entities": []
  },
  {
    "text": "(WBC) count were analyzed. Associations were assessed using chi-square and",
    "entities": [
      {
        "text": "WBC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "independent samples t-tests. Multivariate logistic regression identified",
    "entities": []
  },
  {
    "text": "independent predictors of pruritus.",
    "entities": []
  },
  {
    "text": "RESULTS: The prevalence of UP was 82 (29.2%). Significant differences were",
    "entities": [
      {
        "text": "82",
        "label": "DATE"
      },
      {
        "text": "29.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "observed between pruritic and non-pruritic groups in age, dialysis duration, and",
    "entities": []
  },
  {
    "text": "several biochemical parameters. Independent predictors of pruritus included",
    "entities": []
  },
  {
    "text": "advancing age (OR = 1.148, p < 0.001), serum phosphate (OR = 2.069, p < 0.001),",
    "entities": [
      {
        "text": "1.148",
        "label": "CARDINAL"
      },
      {
        "text": "2.069",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "uric acid (OR = 1.680, p < 0.001), iPTH (OR = 1.007, p < 0.001), hs-CRP (OR =",
    "entities": [
      {
        "text": "1.680",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "1.007",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "hs-CRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.596, p = 0.001), magnesium (OR = 9.687, p = 0.020), triglycerides (OR = 1.018,",
    "entities": [
      {
        "text": "1.596",
        "label": "CARDINAL"
      },
      {
        "text": "0.001",
        "label": "CARDINAL"
      },
      {
        "text": "9.687",
        "label": "CARDINAL"
      },
      {
        "text": "0.020",
        "label": "CARDINAL"
      },
      {
        "text": "1.018",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p = 0.025), and HCV infection (OR = 8.098, p = 0.001). No significant",
    "entities": [
      {
        "text": "0.025",
        "label": "CARDINAL"
      },
      {
        "text": "8.098",
        "label": "DATE"
      },
      {
        "text": "0.001",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "associations were found with gender, diabetes, dialysis frequency, or vascular",
    "entities": [
      {
        "text": "associations",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "access.",
    "entities": []
  },
  {
    "text": "CONCLUSION: UP in HD patients is significantly associated with metabolic and",
    "entities": []
  },
  {
    "text": "inflammatory derangements rather than demographic or dialysis-related variables.",
    "entities": []
  },
  {
    "text": "These findings underscore the importance of targeted metabolic control and",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Mobushar et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Mobushar et",
        "label": "PERSON"
      },
      {
        "text": "al.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Human subjects: Informed consent for treatment",
    "entities": []
  },
  {
    "text": "and open access publication was obtained or waived by all participants in this",
    "entities": []
  },
  {
    "text": "study. Postgraduate Medical Institute/Amer-Ud-Din Medical College/Lahore General",
    "entities": [
      {
        "text": "Postgraduate Medical Institute/Amer-Ud-Din Medical College/Lahore General\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, Lahore issued approval 0133/06/2023. Animal subjects: All authors have",
    "entities": []
  },
  {
    "text": "confirmed that this study did not involve animal subjects or tissue. Conflicts",
    "entities": []
  },
  {
    "text": "of interest: In compliance with the ICMJE uniform disclosure form, all authors",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "declare the following: Payment/services info: All authors have declared that no",
    "entities": []
  },
  {
    "text": "financial support was received from any organization for the submitted work.",
    "entities": []
  },
  {
    "text": "Financial relationships: All authors have declared that they have no financial",
    "entities": []
  },
  {
    "text": "relationships at present or within the previous three years with any",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "organizations that might have an interest in the submitted work. Other",
    "entities": []
  },
  {
    "text": "relationships: All authors have declared that there are no other relationships",
    "entities": []
  },
  {
    "text": "or activities that could appear to have influenced the submitted work.",
    "entities": []
  },
  {
    "text": "Multimodal Reconstruction Approaches in Diabetic Foot Ulcers.",
    "entities": [
      {
        "text": "Multimodal Reconstruction Approaches",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)General Surgery, Sree Balaji Medical College and Hospital, Chennai, IND.",
    "entities": [
      {
        "text": "Surgery",
        "label": "PERSON"
      },
      {
        "text": "Sree Balaji Medical College and Hospital",
        "label": "ORG"
      },
      {
        "text": "Chennai",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Plastic Surgery, Sree Balaji Medical College and Hospital, Chennai, IND.",
    "entities": [
      {
        "text": "Surgery",
        "label": "PERSON"
      },
      {
        "text": "Sree Balaji Medical College and Hospital",
        "label": "ORG"
      },
      {
        "text": "Chennai",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Diabetic foot ulcers (DFUs) are a common and serious complication",
    "entities": []
  },
  {
    "text": "of diabetes mellitus, often leading to prolonged morbidity and limb amputation.",
    "entities": []
  },
  {
    "text": "Successful management involves early debridement, infection control, and",
    "entities": []
  },
  {
    "text": "appropriate soft tissue coverage.",
    "entities": []
  },
  {
    "text": "METHODS: The present study is a retrospective case series conducted from March 1",
    "entities": [
      {
        "text": "March 1",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "to August 31, 2024, involving seven patients with chronic DFUs at Sree Balaji",
    "entities": [
      {
        "text": "August 31, 2024",
        "label": "DATE"
      },
      {
        "text": "seven",
        "label": "CARDINAL"
      },
      {
        "text": "Sree Balaji",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical College and Hospital. Each case underwent individualized reconstruction",
    "entities": [
      {
        "text": "Medical College and Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "strategies, including split-thickness skin grafts (STSGs), reverse sural artery",
    "entities": []
  },
  {
    "text": "flaps, medial plantar artery flaps, cross-leg flaps, and conservative healing,",
    "entities": []
  },
  {
    "text": "depending on wound location, depth, and vascular status.",
    "entities": []
  },
  {
    "text": "RESULTS: All patients demonstrated favorable outcomes in terms of graft/flap",
    "entities": []
  },
  {
    "text": "viability and wound healing. Functional recovery was satisfactory in each case.",
    "entities": []
  },
  {
    "text": "No major complications or recurrences were observed during follow-up.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Early and tailored multimodal reconstructive approaches yield",
    "entities": []
  },
  {
    "text": "positive outcomes in DFUs. Strategic planning based on anatomical site and",
    "entities": []
  },
  {
    "text": "biomechanical load is crucial for effective limb salvage.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, LK et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "al.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "study. Animal subjects: All authors have confirmed that this study did not",
    "entities": []
  },
  {
    "text": "involve animal subjects or tissue. Conflicts of interest: In compliance with the",
    "entities": []
  },
  {
    "text": "ICMJE uniform disclosure form, all authors declare the following:",
    "entities": []
  },
  {
    "text": "Payment/services info: All authors have declared that no financial support was",
    "entities": []
  },
  {
    "text": "received from any organization for the submitted work. Financial relationships:",
    "entities": []
  },
  {
    "text": "All authors have declared that they have no financial relationships at present",
    "entities": []
  },
  {
    "text": "or within the previous three years with any organizations that might have an",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "interest in the submitted work. Other relationships: All authors have declared",
    "entities": []
  },
  {
    "text": "that there are no other relationships or activities that could appear to have",
    "entities": []
  },
  {
    "text": "influenced the submitted work.",
    "entities": []
  },
  {
    "text": "Association of Dyslipidemia With Dermatological Manifestations in Patients With",
    "entities": []
  },
  {
    "text": "(1)Dermatology, Hamdard Medical University, Karachi, PAK.",
    "entities": [
      {
        "text": "Hamdard Medical University",
        "label": "ORG"
      },
      {
        "text": "Karachi",
        "label": "GPE"
      },
      {
        "text": "PAK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Internal Medicine, Shaikh Tahnoon Bin Mohammed Medical City, Abu Dhabi, ARE.",
    "entities": [
      {
        "text": "Tahnoon Bin Mohammed Medical City",
        "label": "PERSON"
      },
      {
        "text": "Abu Dhabi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Internal Medicine, Amana Healthcare, Abu Dhabi, ARE.",
    "entities": [
      {
        "text": "Amana Healthcare",
        "label": "ORG"
      },
      {
        "text": "Abu Dhabi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Physiology, Hamdard College of Medicine and Dentistry, Karachi, PAK.",
    "entities": [
      {
        "text": "Hamdard College of Medicine and Dentistry",
        "label": "ORG"
      },
      {
        "text": "Karachi",
        "label": "GPE"
      },
      {
        "text": "PAK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Internal Medicine, Sindh Government Hospital, Karachi, PAK.",
    "entities": [
      {
        "text": "Sindh Government Hospital",
        "label": "ORG"
      },
      {
        "text": "Karachi",
        "label": "GPE"
      },
      {
        "text": "PAK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Pathology, Liaquat National Hospital and Medical College, Karachi, PAK.",
    "entities": [
      {
        "text": "Liaquat National Hospital and Medical College",
        "label": "ORG"
      },
      {
        "text": "Karachi",
        "label": "GPE"
      },
      {
        "text": "PAK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Objectives Type 2 diabetes mellitus (T2DM) is frequently related with various",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cutaneous manifestations, which may be influenced by comorbid conditions such as",
    "entities": []
  },
  {
    "text": "dyslipidemia. Hence, this study compared the demographic to match clinical and",
    "entities": []
  },
  {
    "text": "dermatological profiles of T2DM patients with and without dyslipidemia.",
    "entities": []
  },
  {
    "text": "Methodology This cross-sectional study was conducted at a secondary care",
    "entities": []
  },
  {
    "text": "hospital using a non-probability convenient sampling technique over six months.",
    "entities": [
      {
        "text": "six months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "A total of 280 T2DM patients aged 40-65 years were included in this study.",
    "entities": [
      {
        "text": "280",
        "label": "CARDINAL"
      },
      {
        "text": "40-65 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Patients were distributed into two equal groups: Group A (with dyslipidemia) and",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Group B (without dyslipidemia). Data on demographics, clinical history,",
    "entities": []
  },
  {
    "text": "lifestyle factors, treatment regimens, and dermatological findings were",
    "entities": []
  },
  {
    "text": "collected using structured questionnaires, physical examinations, and laboratory",
    "entities": []
  },
  {
    "text": "tests. A Chi-square test and a Mann-Whitney test were applied to examine the",
    "entities": [
      {
        "text": "Mann-Whitney",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "association of dermatological symptoms in T2DM. A p-value < 0.05 was reflected",
    "entities": [
      {
        "text": "T2DM",
        "label": "GPE"
      },
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "as statistically significant. Results The study findings showed that a",
    "entities": []
  },
  {
    "text": "significant gender disparity was observed: all patients in Group A were male",
    "entities": [
      {
        "text": "Group A",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "subjects at 140 (100%), while Group B were predominantly female subjects at",
    "entities": [
      {
        "text": "140",
        "label": "CARDINAL"
      },
      {
        "text": "100%",
        "label": "PERCENT"
      },
      {
        "text": "Group B",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "88.6% (p<0.001). A larger proportion of Group A had diabetes for more than five",
    "entities": [
      {
        "text": "88.6%",
        "label": "PERCENT"
      },
      {
        "text": "Group A",
        "label": "ORG"
      },
      {
        "text": "more than five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years, 47 (33.6%) compared to Group B at 14 (10.0%), (p<0.001), and more",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      },
      {
        "text": "47",
        "label": "DATE"
      },
      {
        "text": "33.6%",
        "label": "PERCENT"
      },
      {
        "text": "Group B",
        "label": "ORG"
      },
      {
        "text": "14",
        "label": "DATE"
      },
      {
        "text": "10.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "frequent use of insulin and oral hypoglycemic agents (p=0.001). Xerosis with",
    "entities": []
  },
  {
    "text": "fissured skin was significantly more common in Group B at 109(77.9%), (p<0.001).",
    "entities": [
      {
        "text": "Group B",
        "label": "ORG"
      },
      {
        "text": "109(77.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "The presence of bullae was also significantly greater in Group B at 54(38.6%) as",
    "entities": [
      {
        "text": "Group B",
        "label": "ORG"
      },
      {
        "text": "54(38.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "compared to Group A at 25 (17.9%) (p<0.001). Although acanthosis nigricans",
    "entities": [
      {
        "text": "Group A",
        "label": "ORG"
      },
      {
        "text": "25",
        "label": "DATE"
      },
      {
        "text": "17.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "showed no significant difference, it was slightly more prevalent in Group B.",
    "entities": [
      {
        "text": "Group B.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conclusion This study concluded that the dermatological manifestations were",
    "entities": []
  },
  {
    "text": "common among T2DM patients, with notable differences based on dyslipidemia",
    "entities": []
  },
  {
    "text": "status. Patients without dyslipidemia showed a higher prevalence of xerosis,",
    "entities": []
  },
  {
    "text": "ichthyosis, callosities, and bullae, whereas paresthesias were more frequently",
    "entities": []
  },
  {
    "text": "observed in those with dyslipidemia.",
    "entities": []
  },
  {
    "text": "study. Ethical Review Board, Sindh Government Hospital, Karachi issued approval",
    "entities": [
      {
        "text": "Ethical Review Board",
        "label": "ORG"
      },
      {
        "text": "Sindh Government Hospital",
        "label": "ORG"
      },
      {
        "text": "Karachi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "SGH/(2.A/Landhi)1754. Animal subjects: All authors have confirmed that this",
    "entities": []
  },
  {
    "text": "study did not involve animal subjects or tissue. Conflicts of interest: In",
    "entities": []
  },
  {
    "text": "compliance with the ICMJE uniform disclosure form, all authors declare the",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "following: Payment/services info: All authors have declared that no financial",
    "entities": []
  },
  {
    "text": "support was received from any organization for the submitted work. Financial",
    "entities": []
  },
  {
    "text": "relationships: All authors have declared that they have no financial",
    "entities": []
  },
  {
    "text": "CXCR5 engineered human and murine Tregs for targeted suppression in secondary",
    "entities": [
      {
        "text": "CXCR5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and tertiary lymphoid organs.",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "T(3), Toma C(1), Bercher-Brayer C(1), Carulli P(1), Kumar S(2), Monti P(3),",
    "entities": [
      {
        "text": "Toma",
        "label": "PERSON"
      },
      {
        "text": "Bercher-Brayer",
        "label": "ORG"
      },
      {
        "text": "Carulli P(1",
        "label": "PERSON"
      },
      {
        "text": "Kumar S(2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Experimental Hematology Unit, Division of Immunology Transplantation and",
    "entities": [
      {
        "text": "Hematology Unit",
        "label": "ORG"
      },
      {
        "text": "Division of Immunology Transplantation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Infectious Diseases (DITID), IRCCS San Raffaele Scientific Institute,",
    "entities": []
  },
  {
    "text": "(2)Herman B Wells Center for Pediatric Research, Indiana University,",
    "entities": [
      {
        "text": "2)Herman",
        "label": "CARDINAL"
      },
      {
        "text": "Indiana University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Indianapolis, IN, United States.",
    "entities": [
      {
        "text": "Indianapolis",
        "label": "GPE"
      },
      {
        "text": "IN",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Diabetes Research Institute, Division of Immunology, Transplantation and",
    "entities": [
      {
        "text": "Research Institute",
        "label": "ORG"
      },
      {
        "text": "Division of Immunology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Secondary and tertiary lymphoid structures are a critical target",
    "entities": [
      {
        "text": "Secondary",
        "label": "ORDINAL"
      },
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "of suppression in many autoimmune disorders, protein replacement therapies, and",
    "entities": []
  },
  {
    "text": "in transplantation. Although antigen-specific regulatory T cells (Tregs), such",
    "entities": []
  },
  {
    "text": "as chimeric antigen receptor (CAR) Tregs, generally persist longer and localize",
    "entities": []
  },
  {
    "text": "to target tissues more effectively than polyclonal Tregs in animal models, their",
    "entities": []
  },
  {
    "text": "numbers still progressively decline over time. A potential approach to maximize",
    "entities": []
  },
  {
    "text": "Treg activity in vivo is the expression of chemokine receptors such as CXCR5,",
    "entities": [
      {
        "text": "Treg",
        "label": "PERSON"
      },
      {
        "text": "CXCR5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "which would enable localization of a greater number of engineered cells at sites",
    "entities": []
  },
  {
    "text": "of antigen presentation. Indeed, CXCR5 expression on follicular T helper cells",
    "entities": [
      {
        "text": "CXCR5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and follicular Tregs enables migration toward lymph nodes, B cell zones, and",
    "entities": []
  },
  {
    "text": "tertiary lymphoid structures that appear in chronically inflamed non-lymphoid",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "METHODS: In this study, we generated human and murine CXCR5 co-expressing",
    "entities": [
      {
        "text": "CXCR5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "engineered receptor Tregs and tested them in preclinical mouse models of",
    "entities": [
      {
        "text": "Tregs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "allo-immunity and hemophilia A, respectively. Additionally, we engineered a",
    "entities": []
  },
  {
    "text": "murine CXCR5 co-expressing clotting factor VIII (FVIII) specific T cell receptor",
    "entities": [
      {
        "text": "CXCR5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "fusion construct epsilon (FVIII TRuCe CXCR5) Treg to suppress anti-drug antibody",
    "entities": [
      {
        "text": "FVIII TRuCe CXCR5",
        "label": "PERSON"
      },
      {
        "text": "Treg",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "development in a model of FVIII protein replacement therapy for hemophilia A.",
    "entities": [
      {
        "text": "hemophilia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: In vitro, anti-HLA-A2 CXCR5+ CAR-Tregs showed enhanced migratory and",
    "entities": []
  },
  {
    "text": "antigen-specific suppressive capacities compared to untransduced Tregs. When",
    "entities": []
  },
  {
    "text": "injected into an NSG mouse model of HLA-A2+ pancreatic islet transplantation,",
    "entities": [
      {
        "text": "NSG",
        "label": "ORG"
      },
      {
        "text": "HLA-A2+",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anti-HLA-A2 CXCR5+ CAR-Tregs maintained a good safety profile allowing for",
    "entities": [
      {
        "text": "anti-HLA-A2 CXCR5+ CAR-Tregs",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "long-term graft survival in contrast to anti-HLA-A2 CXCR5+ conventional CAR-T",
    "entities": [
      {
        "text": "CXCR5",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "(Tconv) cells that eliminated the graft. Similarly, FVIII TRuCe CXCR5 Treg",
    "entities": [
      {
        "text": "Tconv",
        "label": "WORK_OF_ART"
      },
      {
        "text": "FVIII TRuCe CXCR5 Treg",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "demonstrated increased in vivo persistence and suppressive capacity in a murine",
    "entities": []
  },
  {
    "text": "model of hemophilia A.",
    "entities": [
      {
        "text": "hemophilia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DISCUSSION: Collectively, our findings indicate that CXCR5 co-expression is safe",
    "entities": [
      {
        "text": "CXCR5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and enhances in vivo localization and persistence in target tissues. This",
    "entities": []
  },
  {
    "text": "strategy can potentially promote targeted tolerance without the risk of",
    "entities": []
  },
  {
    "text": "off-target effects in multiple disease models.",
    "entities": []
  },
  {
    "text": "be construed as a potential conflict of interest. The author(s) declared that",
    "entities": []
  },
  {
    "text": "they were an editorial board member of Frontiers, at the time of submission.",
    "entities": [
      {
        "text": "Frontiers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "This had no impact on the peer review process and the final decision.",
    "entities": []
  },
  {
    "text": "The Role of Tumor-associated Macrophages in Colorectal Peritoneal Metastasis in",
    "entities": [
      {
        "text": "Tumor",
        "label": "GPE"
      },
      {
        "text": "Colorectal Peritoneal Metastasis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: In the tumor microenvironment, macrophages function as M1",
    "entities": [
      {
        "text": "M1\n",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "macrophages, which cause cytotoxicity to tumor cells in the early stages, and M2",
    "entities": [
      {
        "text": "M2\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "macrophages, which contribute to the proliferation of cancer cells in the late",
    "entities": []
  },
  {
    "text": "stages. This study aimed to examine the mechanism of action of macrophages in",
    "entities": []
  },
  {
    "text": "ascites using a peritoneal dissemination mouse model of colorectal cancer.",
    "entities": []
  },
  {
    "text": "MATERIALS AND METHODS: Mouse models of peritoneal dissemination were created by",
    "entities": [
      {
        "text": "Mouse",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "injecting murine colorectal cancer cells into the abdominal cavity of non-obese",
    "entities": [
      {
        "text": "murine",
        "label": "CARDINAL"
      },
      {
        "text": "non-obese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "diabetic/severely combined immunodeficient mice. Surface markers for M1 (CD38,",
    "entities": [
      {
        "text": "M1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "CD68) and M2 (CD83, CD206) were used for macrophage differentiation via flow",
    "entities": [
      {
        "text": "M2",
        "label": "PERSON"
      },
      {
        "text": "CD206",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "cytometry. Quantitative PCR and microarray gene expression analyses were",
    "entities": []
  },
  {
    "text": "performed on macrophages isolated from ascites. Additionally, a macrophage",
    "entities": []
  },
  {
    "text": "inhibitor (clodronate) and IL-10 inhibitor (AS101) were injected",
    "entities": [
      {
        "text": "IL-10",
        "label": "ORG"
      },
      {
        "text": "AS101",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "intra-abdominally, and the weight of peritoneally disseminated nodules was",
    "entities": []
  },
  {
    "text": "compared.",
    "entities": []
  },
  {
    "text": "RESULTS: M1 macrophage counts showed no change over time, while M2 counts and",
    "entities": [
      {
        "text": "M1",
        "label": "CARDINAL"
      },
      {
        "text": "M2",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "the expression of arginase 1 and IL-10 increased. Clodronate administration",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "IL-10",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly reduced the weight of peritoneally disseminated nodules. and AS101",
    "entities": [
      {
        "text": "AS101",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "administration reduced tumor size.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Our findings indicate that cytokine and gene expression analyses of",
    "entities": []
  },
  {
    "text": "TAMs should be further explored to improve targeted anticancer therapy.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Juntendo Medical Society.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "The Juntendo Medical Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that there are no conflicts",
    "entities": []
  },
  {
    "text": "of interest.",
    "entities": []
  },
  {
    "text": "Pancreatic \u03b2-cell Dysfunction and Diabetes.",
    "entities": []
  },
  {
    "text": "The prevalence of diabetes continues to increase globally, posing a pressing",
    "entities": []
  },
  {
    "text": "issue for healthcare. Diabetes is primarily characterized by hyperglycemia,",
    "entities": []
  },
  {
    "text": "resulting from an absolute or relative deficiency in insulin activity, and is",
    "entities": []
  },
  {
    "text": "associated with systemic micro- and macro-vascular complications. Although",
    "entities": []
  },
  {
    "text": "diabetes encompasses multiple pathophysiological conditions based on its",
    "entities": []
  },
  {
    "text": "underlying mechanisms, pancreatic \u03b2-cell dysfunction is a common feature.",
    "entities": []
  },
  {
    "text": "Pancreatic \u03b2-cells play a critical role in maintaining normal blood glucose",
    "entities": []
  },
  {
    "text": "levels by producing and secreting insulin in response to blood glucose",
    "entities": []
  },
  {
    "text": "concentrations. However, when \u03b2-cell dysfunction occurs, the cells fail to",
    "entities": []
  },
  {
    "text": "supply sufficient insulin to meet peripheral insulin demands, resulting in",
    "entities": []
  },
  {
    "text": "elevated blood glucose levels. Although multiple mechanisms contribute to \u03b2-cell",
    "entities": []
  },
  {
    "text": "impairment, these mechanisms often share overlapping pathways and can interact",
    "entities": []
  },
  {
    "text": "to exacerbate their detrimental effects. Understanding the causes of \u03b2-cell",
    "entities": []
  },
  {
    "text": "dysfunction is essential for the prevention and treatment of diabetes. This",
    "entities": []
  },
  {
    "text": "review highlights the primary functions of pancreatic \u03b2-cells, including insulin",
    "entities": []
  },
  {
    "text": "biosynthesis and secretion, and provides an overview of the molecular mechanisms",
    "entities": []
  },
  {
    "text": "underlying \u03b2-cell dysfunction.",
    "entities": []
  },
  {
    "text": "10.1021/acsmedchemlett.5c00249. eCollection 2025 Jul 10.",
    "entities": [
      {
        "text": "10.1021",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Development and Preclinical Evaluation of PET Radiotracers Targeting Adenosine",
    "entities": [
      {
        "text": "Development and Preclinical Evaluation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "A(1) Receptors.",
    "entities": [
      {
        "text": "A(1) Receptors",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Freaney ML(1), Jacobson KA(3), Volkow ND(1), Kim SW(1).",
    "entities": [
      {
        "text": "Jacobson KA(3",
        "label": "PERSON"
      },
      {
        "text": "Volkow ND(1",
        "label": "PERSON"
      },
      {
        "text": "Kim SW(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Laboratory of Neuroimaging, National Institute on Alcohol Abuse and",
    "entities": [
      {
        "text": "Neuroimaging, National Institute on Alcohol Abuse",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Alcoholism, National Institutes of Health, Bethesda, Maryland 20892, United",
    "entities": [
      {
        "text": "National Institutes of Health",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "20892",
        "label": "DATE"
      },
      {
        "text": "United",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "States.",
    "entities": [
      {
        "text": "States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Chemistry, Towson University, Towson, Maryland 21252, United",
    "entities": [
      {
        "text": "Chemistry, Towson University",
        "label": "ORG"
      },
      {
        "text": "Towson",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "21252",
        "label": "DATE"
      },
      {
        "text": "United",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Laboratory of Bioorganic Chemistry, National Institute of Diabetes and",
    "entities": [
      {
        "text": "Bioorganic Chemistry",
        "label": "ORG"
      },
      {
        "text": "National Institute of Diabetes",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland",
    "entities": [
      {
        "text": "Kidney Diseases",
        "label": "PERSON"
      },
      {
        "text": "National Institutes of Health",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "20892, United States.",
    "entities": [
      {
        "text": "20892",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Mathematics, Howard University, Washington, District of",
    "entities": [
      {
        "text": "Mathematics",
        "label": "NORP"
      },
      {
        "text": "Howard University",
        "label": "ORG"
      },
      {
        "text": "Washington",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Columbia 20059, United States.",
    "entities": [
      {
        "text": "Columbia",
        "label": "ORG"
      },
      {
        "text": "20059",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Molecular Imaging Branch, National Institute of Mental Health, National",
    "entities": [
      {
        "text": "Imaging Branch",
        "label": "ORG"
      },
      {
        "text": "National Institute of Mental Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institutes of Health, Bethesda, Maryland 20892, United States.",
    "entities": [
      {
        "text": "Institutes of Health",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "20892",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Chemistry and Biochemistry, Queens College, 65-30 Kissena",
    "entities": [
      {
        "text": "Chemistry and Biochemistry, Queens College",
        "label": "ORG"
      },
      {
        "text": "65",
        "label": "CARDINAL"
      },
      {
        "text": "Kissena",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Boulevard, Flushing, New York 11367, United States.",
    "entities": [
      {
        "text": "Boulevard, Flushing",
        "label": "FAC"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "11367",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Several adenosine A1 receptor (A1R) radiotracers for positron emission",
    "entities": [
      {
        "text": "A1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "tomography (PET) have been developed to study their neuromodulatory functions",
    "entities": [
      {
        "text": "PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and role in brain disorders. While two xanthine-based radiotracers ([11C]-MPDX",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "11C]-MPDX",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and [18F]-CPFPX) have been used in humans, we aimed to improve the metabolic",
    "entities": []
  },
  {
    "text": "stability and specific binding. Guided by structure-activity relationship (SAR)",
    "entities": []
  },
  {
    "text": "studies, 10 derivatives were synthesized with binding affinities up to 0.12 nM.",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "0.12 nM.",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "Three subnanomolar candidates (3, 8, 9) were radiolabeled with C-11 (t 1/2 =",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "8",
        "label": "DATE"
      },
      {
        "text": "9",
        "label": "DATE"
      },
      {
        "text": "C-11",
        "label": "PRODUCT"
      },
      {
        "text": "1/2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "20.4 min) for evaluation using in vivo PET imaging and ex vivo rodent brain",
    "entities": [
      {
        "text": "20.4",
        "label": "CARDINAL"
      },
      {
        "text": "PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "biodistribution. Although [11C]8 demonstrated a higher blood-brain barrier (BBB)",
    "entities": [
      {
        "text": "11C]8",
        "label": "CARDINAL"
      },
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "permeability, negligible in vivo specific binding was observed. Ex vivo studies",
    "entities": []
  },
  {
    "text": "indicated that all three compounds are substrates for brain efflux pumps.",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Despite optimized affinity, BBB permeability and in vivo binding specificity",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "remain challenges. These findings inform development of nonxanthine A1R",
    "entities": []
  },
  {
    "text": "radiotracers and highly potent CNS A1R drugs.",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025 American Chemical Society.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "American Chemical Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Editorial: Disorders of sex development in children: advancing multidisciplinary",
    "entities": []
  },
  {
    "text": "approaches for complex diagnosis and management.",
    "entities": []
  },
  {
    "text": "(1)Department of Pediatric Surgery, Zaghouan Hospital, Zghoaun, Faculty of",
    "entities": [
      {
        "text": "Pediatric Surgery",
        "label": "GPE"
      },
      {
        "text": "Zaghouan Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine of Monastir, LR12SP13, Monastir, Tunisia.",
    "entities": [
      {
        "text": "Monastir",
        "label": "GPE"
      },
      {
        "text": "Tunisia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pediatrics and Barnstable Brown Diabetes Center, University of",
    "entities": [
      {
        "text": "Pediatrics and Barnstable Brown Diabetes Center, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Kentucky, Lexington, KY, United States.",
    "entities": [
      {
        "text": "Kentucky",
        "label": "GPE"
      },
      {
        "text": "Lexington",
        "label": "GPE"
      },
      {
        "text": "KY",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Icahn School of Medicine at Mount Sinai Hospital, New York, NY, United",
    "entities": [
      {
        "text": "3)Icahn School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount Sinai Hospital",
        "label": "FAC"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "United",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.3389/fped.2025.1646197",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Immunological Signatures During Type 2 Diabetes Development and Progression",
    "entities": []
  },
  {
    "text": "among Mexican Americans in Starr County, Texas.",
    "entities": [
      {
        "text": "Mexican",
        "label": "NORP"
      },
      {
        "text": "Americans",
        "label": "NORP"
      },
      {
        "text": "Starr County",
        "label": "GPE"
      },
      {
        "text": "Texas",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Biguetti CC, Chaves-Neto AH, Elvin P, Fontaine J, Brown EL, Hanis CL, Fakhouri",
    "entities": [
      {
        "text": "Biguetti CC",
        "label": "ORG"
      },
      {
        "text": "Chaves-Neto AH, Elvin P",
        "label": "ORG"
      },
      {
        "text": "Fontaine J",
        "label": "PERSON"
      },
      {
        "text": "Hanis CL",
        "label": "ORG"
      },
      {
        "text": "Fakhouri",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Previous studies implicate immune dysregulation in the metabolic changes",
    "entities": []
  },
  {
    "text": "accompanying obesity and type 2 diabetes. This study investigated the interplay",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "between metabolic and immunological parameters during the progression of type 2",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diabetes in an obese Mexican American cohort from Starr County, Texas.",
    "entities": [
      {
        "text": "Mexican",
        "label": "NORP"
      },
      {
        "text": "American",
        "label": "NORP"
      },
      {
        "text": "Starr County",
        "label": "GPE"
      },
      {
        "text": "Texas",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Individuals matched for age, gender, and BMI were stratified into five",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "categories: diabetes-free, isolated impaired glucose tolerance, combined glucose",
    "entities": []
  },
  {
    "text": "impairment (fasting or post-load), type 2 diabetes without complications, and",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "type 2 diabetes with lower extremity complications. Buffy samples were analyzed",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "via Luminex Multiplex Assay for IL-4, IL-17A, MCP-1, and HMGB1. HMGB1 levels",
    "entities": [
      {
        "text": "Luminex Multiplex Assay",
        "label": "FAC"
      },
      {
        "text": "IL-17A",
        "label": "PRODUCT"
      },
      {
        "text": "MCP-1",
        "label": "PRODUCT"
      },
      {
        "text": "HMGB1",
        "label": "ORG"
      },
      {
        "text": "HMGB1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were significantly elevated in individuals with prediabetes and the combined",
    "entities": []
  },
  {
    "text": "glucose intolerance group compared to the diabetes-free group and those with",
    "entities": []
  },
  {
    "text": "diabetes. Elevated HMGB1 levels positively correlated with Homeostatic Model",
    "entities": [
      {
        "text": "Homeostatic Model",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Assessment (HOMA) for insulin resistance (p = 0.03) and showed a moderate",
    "entities": [
      {
        "text": "0.03",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "negative correlation with insulin sensitivity (p = 0.060). IL-17A levels were",
    "entities": [
      {
        "text": "0.060",
        "label": "CARDINAL"
      },
      {
        "text": "IL-17A",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "elevated in the diabetes group without complications compared to those with",
    "entities": []
  },
  {
    "text": "combined glucose impairment. The combined diabetes group exhibited the poorest",
    "entities": []
  },
  {
    "text": "glycemic control. In summary, HMGB1 is a potential early marker of insulin",
    "entities": [
      {
        "text": "HMGB1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resistance and diabetes progression in Mexican Americans from an underserved",
    "entities": [
      {
        "text": "Mexican",
        "label": "NORP"
      },
      {
        "text": "Americans",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "community.",
    "entities": []
  },
  {
    "text": "Dissecting the Genetic Relationship Between Severe Mental Disorders and",
    "entities": [
      {
        "text": "the Genetic Relationship Between Severe Mental Disorders",
        "label": "EVENT"
      }
    ]
  },
  {
    "text": "Severe mental disorders have been linked to immune system dysfunction. While a",
    "entities": []
  },
  {
    "text": "genetic association between mental disorders and autoimmune diseases has been",
    "entities": []
  },
  {
    "text": "suggested, their genetic relationship remains incompletely understood. Utilizing",
    "entities": []
  },
  {
    "text": "a complementary set of statistical analyses, we conducted a comprehensive",
    "entities": []
  },
  {
    "text": "investigation of the genetic architecture between severe mental disorders (major",
    "entities": []
  },
  {
    "text": "depression (MD), bipolar disorder (BD), and schizophrenia (SCZ)) and seven",
    "entities": [
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "SCZ",
        "label": "ORG"
      },
      {
        "text": "seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "autoimmune diseases (autoimmune thyroiditis, celiac disease, inflammatory bowel",
    "entities": []
  },
  {
    "text": "disease (IBD), multiple sclerosis, psoriasis, rheumatoid arthritis, and type 1",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diabetes), involving a total of 667,518 cases from 10 genome-wide association",
    "entities": [
      {
        "text": "667,518",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "studies. While MD was positively genetically correlated with five autoimmune",
    "entities": [
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diseases, BD and SCZ were only positively correlated with IBD, suggesting",
    "entities": [
      {
        "text": "BD",
        "label": "ORG"
      },
      {
        "text": "SCZ",
        "label": "ORG"
      },
      {
        "text": "IBD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "differences in the genetic signal shared with autoimmunity across these mental",
    "entities": []
  },
  {
    "text": "disorders. A considerable fraction of genetic variants influencing autoimmune",
    "entities": []
  },
  {
    "text": "diseases (range 17.1-88.4 %) were estimated to overlap with mental disorders;",
    "entities": [
      {
        "text": "17.1-88.4 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "however, this constitutes only a minor part of genetic variants influencing the",
    "entities": []
  },
  {
    "text": "more polygenic mental disorders. Finally, we identified 172 genetic loci jointly",
    "entities": [
      {
        "text": "172",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "affecting mental disorders and autoimmune diseases, implicating both lipid",
    "entities": []
  },
  {
    "text": "metabolism and TNF signaling. In conclusion, MD, BD, and SCZ have a small but",
    "entities": [
      {
        "text": "TNF",
        "label": "ORG"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "SCZ",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "distinct genetic overlap with autoimmune diseases, which may inform new possible",
    "entities": []
  },
  {
    "text": "Heightened Risk of Myocardial Ischemia with Mental Stress Among Black Women",
    "entities": [
      {
        "text": "Heightened Risk of Myocardial Ischemia with Mental Stress Among Black Women",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Survivors of a Myocardial Infarction in Midlife.",
    "entities": [
      {
        "text": "Myocardial Infarction in Midlife",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Vaccarino V, Shah AJ, Lewis TT, Piccinelli M, Elon L, She H, Ko YA, Martin ZT,",
    "entities": [
      {
        "text": "Vaccarino V",
        "label": "PERSON"
      },
      {
        "text": "Shah AJ",
        "label": "ORG"
      },
      {
        "text": "Lewis TT",
        "label": "PERSON"
      },
      {
        "text": "Piccinelli M",
        "label": "ORG"
      },
      {
        "text": "Elon L",
        "label": "ORG"
      },
      {
        "text": "Ko YA",
        "label": "PERSON"
      },
      {
        "text": "Martin ZT",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "BACKGROUND: Stark disparities in the outcome of myocardial infarction (MI)",
    "entities": [
      {
        "text": "Stark",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "persist, with large unexplained variations affecting younger Black women. Mental",
    "entities": []
  },
  {
    "text": "stress induced myocardial ischemia (MSIMI) is an emerging mechanistic pathway",
    "entities": [
      {
        "text": "MSIMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "that may help explain excess risks in this group.",
    "entities": []
  },
  {
    "text": "OBJECTIVES: To determine whether MSIMI is more common in Black women with recent",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      },
      {
        "text": "MSIMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "premature MI than other demographic groups.",
    "entities": []
  },
  {
    "text": "METHODS: We studied 602 individuals \u2264 61 years of age who were hospitalized for",
    "entities": [
      {
        "text": "602",
        "label": "CARDINAL"
      },
      {
        "text": "61 years of age",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "MI in the previous 8 months. Participants underwent 99mTc-sestamibi myocardial",
    "entities": [
      {
        "text": "the previous 8 months",
        "label": "DATE"
      },
      {
        "text": "99mTc",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "perfusion imaging at rest and after mental stress (speech task). A summed",
    "entities": []
  },
  {
    "text": "difference score (SDS) was used to quantify ischemia. Clinically significant",
    "entities": []
  },
  {
    "text": "MSIMI was defined as an SDS \u22653. Log-binomial regression models adjusted for",
    "entities": [
      {
        "text": "MSIMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sociodemographic, lifestyle, clinical and psychosocial factors.",
    "entities": []
  },
  {
    "text": "RESULTS: The mean age was 51 years (range, 25-61), 46% were women and 59%",
    "entities": [
      {
        "text": "51 years",
        "label": "DATE"
      },
      {
        "text": "25",
        "label": "CARDINAL"
      },
      {
        "text": "46%",
        "label": "PERCENT"
      },
      {
        "text": "59%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "self-identified as Black. Black women had a more adverse psychosocial profile",
    "entities": []
  },
  {
    "text": "and higher rates of obesity and diabetes, but a less severe index MI. The",
    "entities": []
  },
  {
    "text": "incidence of MSIMI was approximately doubled in Black women than the other",
    "entities": [
      {
        "text": "MSIMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "groups (p<.001 for interaction). Clinical and psychosocial risk factors did not",
    "entities": []
  },
  {
    "text": "explain these differences. In a fully adjusted model, the risk ratio of MSIMI",
    "entities": [
      {
        "text": "MSIMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for Black women was 2.2 (95% CI, 2.0-2.5) compared to Black men, 2.3 (1.8-2.9)",
    "entities": [
      {
        "text": "2.2",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.0",
        "label": "CARDINAL"
      },
      {
        "text": "2.3",
        "label": "CARDINAL"
      },
      {
        "text": "1.8-2.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "compared to non-Black women, and 1.8 (1.4-2.2) compared to non-Black men.",
    "entities": [
      {
        "text": "non-Black",
        "label": "NORP"
      },
      {
        "text": "1.8",
        "label": "CARDINAL"
      },
      {
        "text": "1.4",
        "label": "CARDINAL"
      },
      {
        "text": "non-Black",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Among midlife individuals with a recent MI, Black women have a",
    "entities": []
  },
  {
    "text": "disproportionately higher risk of MSIMI. Targeted interventions for this",
    "entities": [
      {
        "text": "MSIMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "high-risk group are needed.",
    "entities": []
  },
  {
    "text": "CLINICAL PERSPECTIVE: What is new?: We show for the first time that Black women",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "in midlife who have recently experienced a myocardial infarction face a",
    "entities": []
  },
  {
    "text": "disproportionately high risk of developing myocardial ischemia when under mental",
    "entities": []
  },
  {
    "text": "stress. This elevated risk cannot be attributed to more severe coronary artery",
    "entities": []
  },
  {
    "text": "disease, suggesting a stress-related cardiovascular vulnerability that may help",
    "entities": []
  },
  {
    "text": "explain why Black women experience both higher rates of premature heart attacks",
    "entities": []
  },
  {
    "text": "and worse outcomes following these events.What are the clinical implications?:",
    "entities": []
  },
  {
    "text": "The high rate of ischemia with mental stress in Black women highlights the need",
    "entities": [
      {
        "text": "Black",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "for new targeted risk assessment protocols and prevention strategies that go",
    "entities": []
  },
  {
    "text": "beyond the control of conventional risk factors to address stress-related risk",
    "entities": []
  },
  {
    "text": "pathways. This paradigm shift in cardiac care should help reduce cardiovascular",
    "entities": []
  },
  {
    "text": "disparities and improve outcomes in this historically underserved population.",
    "entities": []
  },
  {
    "text": "GRAPHICAL ABSTRACT: Differences in Myocardial Ischemia with Mental Stress by Sex",
    "entities": [
      {
        "text": "Myocardial Ischemia with Mental Stress",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Race: Among 602 individuals \u2264 61 years of age who were hospitalized for a",
    "entities": [
      {
        "text": "602",
        "label": "CARDINAL"
      },
      {
        "text": "61 years of age",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "myocardial infarction in the previous 8 months, and who underwent myocardial",
    "entities": [
      {
        "text": "the previous 8 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "perfusion imaging with mental stress, Black women had approximately a twofold",
    "entities": []
  },
  {
    "text": "higher risk of developing myocardial ischemia compared with other demographic",
    "entities": []
  },
  {
    "text": "groups, even after adjusting for clinical and psychosocial factors.",
    "entities": []
  },
  {
    "text": "AI-Derived Splenic Response in Cardiac PET Predicts Mortality: A Multi-Site",
    "entities": [
      {
        "text": "Cardiac PET Predicts Mortality",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Study.",
    "entities": []
  },
  {
    "text": "S, Alexanderson E, Carvajal-Juarez I, Packard RR, Rosamond TL, Al-Mallah MH,",
    "entities": [
      {
        "text": "Carvajal-Juarez",
        "label": "PERSON"
      },
      {
        "text": "Rosamond TL",
        "label": "ORG"
      },
      {
        "text": "Al-Mallah MH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Inadequate pharmacologic stress may limit the diagnostic and",
    "entities": []
  },
  {
    "text": "prognostic accuracy of myocardial perfusion imaging (MPI). The splenic ratio",
    "entities": []
  },
  {
    "text": "(SR), a measure of stress adequacy, has emerged as a potential imaging",
    "entities": []
  },
  {
    "text": "OBJECTIVES: To evaluate the prognostic value of artificial intelligence",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(AI)-derived SR in a large multicenter 82 Rb-PET cohort undergoing regadenoson",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      },
      {
        "text": "82",
        "label": "CARDINAL"
      },
      {
        "text": "Rb-PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stress testing.",
    "entities": []
  },
  {
    "text": "METHODS: We retrospectively analyzed 10,913 patients from three sites in the",
    "entities": [
      {
        "text": "10,913",
        "label": "CARDINAL"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "REFINE PET registry with clinically indicated MPI and linked clinical outcomes.",
    "entities": []
  },
  {
    "text": "SR was calculated using fully automated algorithms as the ratio of splenic",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "uptake at stress versus rest. Patients were stratified by SR into high (\u226590th",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      },
      {
        "text": "\u226590th\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "percentile) and low (<90th percentile) groups. The primary outcome was major",
    "entities": []
  },
  {
    "text": "adverse cardiovascular events (MACE). Survival analysis was conducted using",
    "entities": []
  },
  {
    "text": "Kaplan-Meier and Cox proportional hazards models adjusted for clinical and",
    "entities": [
      {
        "text": "Kaplan-Meier",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "imaging covariates, including myocardial flow reserve (MFR \u22652 vs. <2).",
    "entities": [
      {
        "text": "MFR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The cohort had a median age of 68 years, with 57% male patients. Common",
    "entities": [
      {
        "text": "age of 68 years",
        "label": "DATE"
      },
      {
        "text": "57%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "risk factors included hypertension (84%), dyslipidemia (76%), diabetes (33%),",
    "entities": [
      {
        "text": "84%",
        "label": "PERCENT"
      },
      {
        "text": "76%",
        "label": "PERCENT"
      },
      {
        "text": "33%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and prior coronary artery disease (31%). Median follow-up was 4.6 years.",
    "entities": [
      {
        "text": "31%",
        "label": "PERCENT"
      },
      {
        "text": "4.6 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Patients with high SR (n=1,091) had an increased risk of MACE (HR 1.18, 95% CI",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      },
      {
        "text": "MACE",
        "label": "PERSON"
      },
      {
        "text": "1.18",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.06-1.31, p=0.002). Among patients with preserved MFR (\u22652; n=7,310), high SR",
    "entities": [
      {
        "text": "1.06",
        "label": "CARDINAL"
      },
      {
        "text": "MFR",
        "label": "ORG"
      },
      {
        "text": "n=7,310",
        "label": "GPE"
      },
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "remained independently associated with MACE (HR 1.44, 95% CI 1.24-1.67,",
    "entities": [
      {
        "text": "MACE",
        "label": "PERSON"
      },
      {
        "text": "1.44",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.24-1.67",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Elevated AI-derived SR was independently associated with adverse",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cardiovascular outcomes, including among patients with preserved MFR. These",
    "entities": [
      {
        "text": "MFR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "findings support SR as a novel, automated imaging biomarker for risk",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stratification in 82 Rb PET MPI.",
    "entities": [
      {
        "text": "82",
        "label": "CARDINAL"
      },
      {
        "text": "Rb PET MPI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONDENSED ABSTRACT: AI-derived splenic ratio (SR), a marker of pharmacologic",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stress adequacy, was independently associated with increased cardiovascular risk",
    "entities": []
  },
  {
    "text": "in a large 82 Rb PET cohort, even among patients with preserved myocardial flow",
    "entities": [
      {
        "text": "82",
        "label": "CARDINAL"
      },
      {
        "text": "PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reserve (MFR). High SR identified individuals with elevated MACE risk despite",
    "entities": [
      {
        "text": "MFR",
        "label": "ORG"
      },
      {
        "text": "MACE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "normal perfusion and flow findings, suggesting unrecognized physiologic",
    "entities": []
  },
  {
    "text": "vulnerability. Incorporating automated SR into PET MPI interpretation may",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      },
      {
        "text": "PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "enhance risk stratification and identify patients who could benefit from",
    "entities": []
  },
  {
    "text": "intensified preventive care, particularly when traditional imaging markers",
    "entities": []
  },
  {
    "text": "appear reassuring. These findings support SR as a clinically meaningful, easily",
    "entities": [
      {
        "text": "SR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "integrated biomarker in stress PET imaging.",
    "entities": [
      {
        "text": "PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Neurocognition in youth with versus without prediabetes.",
    "entities": []
  },
  {
    "text": "Quillian J, Attuquayefio T, Sung J, Canna A, Ko T, Davis X, Maciejewski K, Li F,",
    "entities": [
      {
        "text": "Quillian",
        "label": "NORP"
      },
      {
        "text": "Sung J",
        "label": "PERSON"
      },
      {
        "text": "Canna A",
        "label": "PERSON"
      },
      {
        "text": "Ko T",
        "label": "PERSON"
      },
      {
        "text": "Davis X",
        "label": "PERSON"
      },
      {
        "text": "Maciejewski K",
        "label": "PERSON"
      },
      {
        "text": "Li F",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Santoro N, Pierpont B, Kullmann S, Preissl H, Morys F, Dagher A, Caprio S, Small",
    "entities": [
      {
        "text": "Santoro N",
        "label": "ORG"
      },
      {
        "text": "Pierpont B",
        "label": "PERSON"
      },
      {
        "text": "Kullmann S",
        "label": "PERSON"
      },
      {
        "text": "Preissl H",
        "label": "ORG"
      },
      {
        "text": "Morys F",
        "label": "PERSON"
      },
      {
        "text": "Caprio S",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "AIMS/HYPOTHESIS: Type 2 diabetes has a well-established link to cognitive",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "impairment in older adults; however, studies often do not control for adiposity",
    "entities": []
  },
  {
    "text": "and co-morbid conditions which might mediate this cognitive impairment. To",
    "entities": []
  },
  {
    "text": "overcome these limitations, we investigated the relation between prediabetes and",
    "entities": []
  },
  {
    "text": "cognition in youth with overweight/obesity while controlling for adiposity in a",
    "entities": []
  },
  {
    "text": "cross-sectional ancillary study to the Pathogenesis of Youth Onset Diabetes",
    "entities": [
      {
        "text": "the Pathogenesis of Youth Onset Diabetes\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(PYOD) study. We reasoned that if glucose control directly impacts brain health,",
    "entities": [
      {
        "text": "PYOD",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "then cognitive function should be worse in youth with versus without",
    "entities": []
  },
  {
    "text": "prediabetes. We also predicted that this effect should be greater on tasks that",
    "entities": []
  },
  {
    "text": "depend on dopaminergic function, such as working memory and that it may be",
    "entities": []
  },
  {
    "text": "related to central insulin sensitivity.",
    "entities": []
  },
  {
    "text": "METHODS: We evaluated 69 youth with overweight/obesity for anthropomorphic and",
    "entities": [
      {
        "text": "69",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "metabolic measures, abdominal adiposity, comprehensive cognitive testing, and",
    "entities": []
  },
  {
    "text": "the effects of intranasal insulin on cognition, resting state brain activity,",
    "entities": []
  },
  {
    "text": "and functional connectivity. Oral glucose tolerance tests classified 22",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participants as having prediabetes (preT2D+) and 44 participants as having",
    "entities": [
      {
        "text": "44",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: Groups did not differ in age, sex, race, diet, or adiposity measures.",
    "entities": [
      {
        "text": "Groups",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "IQ was significantly lower (p=0.032) in the preT2D+ group compared to the",
    "entities": []
  },
  {
    "text": "preT2D-group. The preT2D+ group performed worse than the preT2D-group in tasks",
    "entities": [
      {
        "text": "preT2D-group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of working memory (p<.0.001), reaction time (p=0.01), and visuospatial",
    "entities": []
  },
  {
    "text": "processing (p=0.02). After considering IQ as a model covariate, only spatial",
    "entities": []
  },
  {
    "text": "working memory showed a significant difference between groups (p=0.002). Insulin",
    "entities": []
  },
  {
    "text": "sensitivity across the entire sample was negatively correlated with processing",
    "entities": []
  },
  {
    "text": "speed in two tasks (reaction time index: p=0.022; and trail making test A:",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p=0.022) and with the sensitivity of the intraparietal sulcus to intranasal",
    "entities": []
  },
  {
    "text": "insulin administration. Administration of intranasal insulin showed no effect on",
    "entities": []
  },
  {
    "text": "cognition within or between groups. However, the extent to which intranasal",
    "entities": []
  },
  {
    "text": "insulin administration influenced caudate functional connectivity with the right",
    "entities": []
  },
  {
    "text": "=0.03) was correlated with performance on the spatial working memory task.",
    "entities": [
      {
        "text": "0.03",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS/INTERPRETATION: We find evidence for the presence of global",
    "entities": []
  },
  {
    "text": "cognitive impairment in youth with prediabetes that cannot be accounted for by",
    "entities": []
  },
  {
    "text": "adiposity, as well as a specific deficit in spatial working memory that is not",
    "entities": []
  },
  {
    "text": "attributable to global cognitive impairment. We identified associations between",
    "entities": []
  },
  {
    "text": "central insulin sensitivity and both cognition and peripheral insulin",
    "entities": [
      {
        "text": "central insulin sensitivity",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sensitivity; however, central insulin sensitivity did not appear to account for",
    "entities": []
  },
  {
    "text": "the effect of prediabetes on cognition. These findings show that the association",
    "entities": []
  },
  {
    "text": "between peripheral glucose intolerance and cognition exists early in the course",
    "entities": []
  },
  {
    "text": "of the disease, prior to the onset of significant comorbid conditions and",
    "entities": []
  },
  {
    "text": "independently of adiposity. It also suggests the involvement of both generalized",
    "entities": []
  },
  {
    "text": "and specific mechanisms contributing to cognitive change.",
    "entities": []
  },
  {
    "text": "RESEARCH IN CONTEXT: What is already known about this subject? (maximum of 3",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "bullet points) Type 2 diabetes and prediabetes have been associated with an",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "increased risk of dementia and cognitive impairment on dopaminergic tasksThe",
    "entities": []
  },
  {
    "text": "mechanism of this cognitive impairment and if it is dissociable from adiposity",
    "entities": []
  },
  {
    "text": "or comorbid conditions related to old age is unknownIt is unclear whether youth",
    "entities": []
  },
  {
    "text": "with prediabetes are at risk for cognitive impairment from impaired insulin",
    "entities": []
  },
  {
    "text": "sensitivity/glucose regulation What is the key question? (one bullet point only;",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "formatted as a question) Do youth with prediabetes show cognitive impairment",
    "entities": []
  },
  {
    "text": "independent of adiposity, and is this related to insulin sensitivity of",
    "entities": []
  },
  {
    "text": "dopaminergic systems? What are the new findings? (maximum of 3 bullet points)",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Youth with prediabetes show global cognitive impairment, as well as particular",
    "entities": []
  },
  {
    "text": "impairment of spatial working memory, independent of adiposityInsulin",
    "entities": [
      {
        "text": "adiposityInsulin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "sensitivity of caudate functional connectivity with right intraparietal sulcus",
    "entities": []
  },
  {
    "text": "and bilateral precuneus is correlated with prior performance on a spatial",
    "entities": []
  },
  {
    "text": "working memory task How might this impact on clinical practice in the",
    "entities": []
  },
  {
    "text": "foreseeable future? (one bullet point only) These findings provide evidence that",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "suggests that youth with prediabetes are at risk for cognitive impairment,",
    "entities": []
  },
  {
    "text": "indicating early detection and treatment of impaired insulin sensitivity is",
    "entities": []
  },
  {
    "text": "Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in",
    "entities": []
  },
  {
    "text": "Patients With Essential Thrombocythemia.",
    "entities": []
  },
  {
    "text": "(1)Department of Hematology Tottori Prefectural Central Hospital Tottori Tottori",
    "entities": [
      {
        "text": "Hematology Tottori Prefectural Central Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)First Department of Internal Medicine Kansai Medical University Hirakata",
    "entities": [
      {
        "text": "2)First Department of Internal Medicine Kansai Medical University Hirakata",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Hematology Tokyo Medical University Shinjuku-ku Tokyo Japan.",
    "entities": [
      {
        "text": "Hematology Tokyo Medical University",
        "label": "ORG"
      },
      {
        "text": "Shinjuku-ku",
        "label": "PERSON"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Hematology Osaka Metropolitan University Graduate School of",
    "entities": [
      {
        "text": "Hematology Osaka Metropolitan University Graduate School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Division of Hematology National Defense Medical College Tokorozawa Saitama",
    "entities": [
      {
        "text": "Hematology National Defense Medical College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Hematology Juntendo University Shizuoka Hospital Izunokuni",
    "entities": [
      {
        "text": "6)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology Juntendo University Shizuoka Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Department of Hematology and Oncology University of Yamanashi Chuo-Shi",
    "entities": [
      {
        "text": "Hematology and Oncology University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Department of Hematology NTT Medical Center Tokyo Shinagawa Tokyo Japan.",
    "entities": [
      {
        "text": "Hematology NTT Medical Center Tokyo Shinagawa",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Division of Hematology Keio University School of Medicine Shinjuku-ku Tokyo",
    "entities": [
      {
        "text": "10)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology Keio University School of Medicine Shinjuku-ku",
        "label": "ORG"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Department of Hematology Tokyo Medical and Dental University Bunkyo City",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology Tokyo Medical",
        "label": "ORG"
      },
      {
        "text": "Dental University",
        "label": "ORG"
      },
      {
        "text": "Bunkyo City",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Department of Hematology Nippon Medical School Bunkyo City Tokyo Japan.",
    "entities": [
      {
        "text": "12)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology Nippon Medical School Bunkyo City",
        "label": "ORG"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Clinical Research Center NHO Nagoya Medical Center Nagoya Aichi Japan.",
    "entities": [
      {
        "text": "13)Clinical Research Center NHO Nagoya Medical Center",
        "label": "ORG"
      },
      {
        "text": "Aichi Japan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(14)Division of Hematology Diabetes, and Endocrinology Department of Internal",
    "entities": [
      {
        "text": "14)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Endocrinology Department of Internal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Department of Hematology and Oncology Mie University Tsu Mie Japan.",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology and Oncology Mie University",
        "label": "ORG"
      },
      {
        "text": "Tsu Mie Japan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(16)Department of Hematology Toyama Red Cross Hospital Toyama Japan.",
    "entities": [
      {
        "text": "16)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology Toyama Red Cross Hospital",
        "label": "ORG"
      },
      {
        "text": "Toyama Japan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(17)Department of Hematology Fujita Health University School of Medicine Toyoake",
    "entities": [
      {
        "text": "17)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology Fujita Health University School of Medicine Toyoake",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(18)Department of Hematology Juntendo University School of Medicine Bunkyo City",
    "entities": [
      {
        "text": "18)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology Juntendo University School of Medicine Bunkyo City",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(19)Department of Advanced Hematology Juntendo University School of Medicine",
    "entities": [
      {
        "text": "19)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Advanced Hematology Juntendo University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(20)Department of Hematology and Oncology Nagoya University Graduate School of",
    "entities": [
      {
        "text": "20)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology and Oncology Nagoya University Graduate School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine Nagoya Aichi Japan.",
    "entities": [
      {
        "text": "Medicine Nagoya",
        "label": "PERSON"
      },
      {
        "text": "Aichi Japan",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(21)Department of Medicine and Biosystemic Science Kyushu University Fukuoka",
    "entities": [
      {
        "text": "21)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Fukuoka",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(22)Department of Hematology and Rheumatology Faculty of Medicine Kindai",
    "entities": [
      {
        "text": "22)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology and Rheumatology Faculty of Medicine Kindai",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(23)Department of Hematology Clinical Immunology and Infectious Diseases Ehime",
    "entities": [
      {
        "text": "23)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hematology Clinical Immunology and Infectious Diseases Ehime",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Graduate School of Medicine Toon Ehime Japan.",
    "entities": [
      {
        "text": "University Graduate School of Medicine Toon Ehime Japan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVES: The present study investigated the effects of thrombosis,",
    "entities": []
  },
  {
    "text": "hemorrhagic events, disease progression, and secondary malignancies on patient",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "survival after the diagnosis of essential thrombocythemia (ET).",
    "entities": []
  },
  {
    "text": "METHODS: We analyzed data from 1152 patients enrolled in the JSH-MPN-18 study",
    "entities": [
      {
        "text": "1152",
        "label": "DATE"
      },
      {
        "text": "JSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "using time-dependent Cox regression and multistate Markov models to estimate",
    "entities": [
      {
        "text": "Markov",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "transition hazards and state occupation probabilities.",
    "entities": []
  },
  {
    "text": "RESULTS: Hemorrhagic events (hazard ratio = 2.92, 95% confidence interval =",
    "entities": [
      {
        "text": "Hemorrhagic",
        "label": "ORG"
      },
      {
        "text": "2.92",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "1.78-4.78, p < 0.001) was associated with a poor prognosis. In multistate model,",
    "entities": [
      {
        "text": "1.78",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hazards from the hemorrhagic event to death were higher among cumulative",
    "entities": []
  },
  {
    "text": "transition hazards, and the probability of remaining in the hemorrhagic state",
    "entities": []
  },
  {
    "text": "was lower than the probability of remaining in the other states of thrombosis,",
    "entities": []
  },
  {
    "text": "disease progression, and secondary malignancy in state occupancy probabilities.",
    "entities": [
      {
        "text": "secondary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: The present results demonstrated that hemorrhagic events following",
    "entities": []
  },
  {
    "text": "the diagnosis of ET are a serious risk factor and are directly related to early",
    "entities": []
  },
  {
    "text": "death. Baseline characteristics and post-diagnosis events (intermediate status)",
    "entities": []
  },
  {
    "text": "may both have a significant impact on survival, and treatment strategies that",
    "entities": []
  },
  {
    "text": "take into account the prevention of an intermediate status need to be",
    "entities": []
  },
  {
    "text": "incorporated into clinical practice.",
    "entities": []
  },
  {
    "text": "TRIAL REGISTRATION: The authors have confirmed clinical trial registration is",
    "entities": []
  },
  {
    "text": "not needed for this submission.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). eJHaem published by British Society for Haematology and",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "British Society for Haematology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "John Wiley & Sons Ltd.",
    "entities": [
      {
        "text": "John Wiley & Sons Ltd.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "The Hideous Side of Acute Pancreatitis: A Case of Pancreatitis-Induced Atypical",
    "entities": [
      {
        "text": "A Case of Pancreatitis-Induced Atypical",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Hemolytic Uremic Syndrome.",
    "entities": []
  },
  {
    "text": "Al-Ali H(1), Elmogy A(2)(3), Arsh H(3), Rhee H(3).",
    "entities": [
      {
        "text": "Al-Ali",
        "label": "PERSON"
      },
      {
        "text": "Rhee H(3",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)School of Medicine, St. George's University School of Medicine, True Blue,",
    "entities": [
      {
        "text": "1)School of Medicine",
        "label": "ORG"
      },
      {
        "text": "St. George's University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Cardiovascular Medicine, Cairo University, Cairo, EGY.",
    "entities": [
      {
        "text": "Cairo University",
        "label": "ORG"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      },
      {
        "text": "EGY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital",
    "entities": [
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount Sinai",
        "label": "FAC"
      },
      {
        "text": "Queens Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, New York City, USA.",
    "entities": [
      {
        "text": "New York City",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Thrombotic microangiopathy (TMA) is a medical emergency characterized by",
    "entities": [
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "thrombocytopenia, microangiopathic hemolytic anemia, and acute kidney injury",
    "entities": [
      {
        "text": "thrombocytopenia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(AKI). Its subtypes, including thrombotic thrombocytopenic purpura (TTP),",
    "entities": [
      {
        "text": "TTP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "atypical hemolytic uremic syndrome (aHUS), and secondary TMA, require rapid",
    "entities": [
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "differentiation due to divergent treatments. Acute pancreatitis, in some cases,",
    "entities": []
  },
  {
    "text": "can trigger TMA through systemic inflammation and complement activation. A",
    "entities": [
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "middle-aged male with chronic kidney disease and diabetes was admitted for acute",
    "entities": []
  },
  {
    "text": "pancreatitis, likely in the setting of glucagon-like peptide-1 (GLP-1) use. On",
    "entities": [
      {
        "text": "pancreatitis",
        "label": "PERSON"
      },
      {
        "text": "GLP-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "day 3, he developed progressive thrombocytopenia, anemia, and worsening renal",
    "entities": [
      {
        "text": "day 3",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "function. Peripheral smear showed schistocytes; laboratory values were",
    "entities": []
  },
  {
    "text": "remarkable for hemolysis. Given the high suspicion for TMA and a PLASMIC score",
    "entities": [
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of 5, empiric plasma exchange and corticosteroids were initiated, which showed",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "clinical improvement. ADAMTS13 activity returned at 99%, effectively excluding",
    "entities": [
      {
        "text": "99%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "TTP. Complement studies for aHUS were inconclusive and were obtained post-plasma",
    "entities": [
      {
        "text": "TTP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exchange, which can alter results. The patient completed five sessions of plasma",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "exchange and was discharged in stable condition. A follow-up was arranged for",
    "entities": []
  },
  {
    "text": "hematology. This case highlights the diagnostic complexity of TMA triggered by",
    "entities": [
      {
        "text": "TMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "acute pancreatitis and the necessity of early empiric treatment. It also calls",
    "entities": [
      {
        "text": "acute pancreatitis",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "attention to the limitations of delayed ADAMTS13 and complement testing and",
    "entities": [
      {
        "text": "ADAMTS13",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "advocates for broader implementation of rapid in-house assays to guide timely,",
    "entities": []
  },
  {
    "text": "precise therapy.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Al-Ali et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Al-Ali",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "study. Conflicts of interest: In compliance with the ICMJE uniform disclosure",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "form, all authors declare the following: Payment/services info: All authors have",
    "entities": []
  },
  {
    "text": "declared that no financial support was received from any organization for the",
    "entities": []
  },
  {
    "text": "submitted work. Financial relationships: All authors have declared that they",
    "entities": []
  },
  {
    "text": "have no financial relationships at present or within the previous three years",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with any organizations that might have an interest in the submitted work. Other",
    "entities": []
  },
  {
    "text": "Impact of E-health Literacy on Diabetes Self-Care Activities Among People With",
    "entities": [
      {
        "text": "Literacy on Diabetes Self-Care Activities Among People With\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Type 2 Diabetes Attending Primary Healthcare Centers in Makkah City, Saudi",
    "entities": [
      {
        "text": "Makkah City",
        "label": "GPE"
      },
      {
        "text": "Saudi",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Arabia: A Cross-Sectional Study, 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Public Health, Makkah Health Cluster, Makkah, SAU.",
    "entities": [
      {
        "text": "Health, Makkah Health Cluster",
        "label": "ORG"
      },
      {
        "text": "Makkah",
        "label": "PERSON"
      },
      {
        "text": "SAU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Infection Prevention and Control, King Fahad General Hospital, Jeddah, SAU.",
    "entities": [
      {
        "text": "2)Infection Prevention and Control",
        "label": "ORG"
      },
      {
        "text": "King Fahad General Hospital",
        "label": "ORG"
      },
      {
        "text": "SAU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: The rising prevalence of type 2 diabetes mellitus (T2DM) in Saudi",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "Saudi",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Arabia necessitates effective self-management strategies. E-health literacy, the",
    "entities": []
  },
  {
    "text": "ability to access and utilize digital health information, may play a critical",
    "entities": []
  },
  {
    "text": "role in improving diabetes self-care. This study examined the relationship",
    "entities": []
  },
  {
    "text": "between e-health literacy and self-care activities among patients with T2DM in",
    "entities": []
  },
  {
    "text": "METHODOLOGY: A cross-sectional study was conducted with 360 patients with T2DM",
    "entities": [
      {
        "text": "360",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "attending primary healthcare centers in Makkah. Participants completed a",
    "entities": [
      {
        "text": "Makkah",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "structured questionnaire assessing sociodemographic characteristics, e-health",
    "entities": []
  },
  {
    "text": "literacy, and diabetes self-care activities. Hierarchical regression and",
    "entities": []
  },
  {
    "text": "logistic regression analyses were performed to evaluate associations while",
    "entities": []
  },
  {
    "text": "controlling for confounders.",
    "entities": []
  },
  {
    "text": "RESULTS: The mean e-health literacy score was moderate (3.13/5), with",
    "entities": []
  },
  {
    "text": "significant gaps in evaluating online health resources. Higher e-health literacy",
    "entities": []
  },
  {
    "text": "was strongly associated with improved self-care practices (\u03b2 = 0.497, P < 0.001)",
    "entities": [
      {
        "text": "0.497",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and better glycemic control (odds ratio (OR) = 2.985, P < 0.001). Key barriers",
    "entities": [
      {
        "text": "2.985",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "included difficulty understanding medical terms (205, 56.9%), distrust in online",
    "entities": [
      {
        "text": "205",
        "label": "CARDINAL"
      },
      {
        "text": "56.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "sources (196, 54.4%), and lack of time (220, 61.1%). Significant disparities",
    "entities": [
      {
        "text": "196",
        "label": "CARDINAL"
      },
      {
        "text": "54.4%",
        "label": "PERCENT"
      },
      {
        "text": "220",
        "label": "CARDINAL"
      },
      {
        "text": "61.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "were observed, with males, younger individuals, and those with higher education",
    "entities": []
  },
  {
    "text": "and income reporting greater e-health literacy.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: E-health literacy significantly influences diabetes self-care and",
    "entities": []
  },
  {
    "text": "glycemic outcomes among patients with T2DM in Saudi Arabia. However, barriers",
    "entities": [
      {
        "text": "Saudi Arabia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "such as limited digital skills and distrust in online health information hinder",
    "entities": []
  },
  {
    "text": "optimal utilization. Targeted interventions to enhance e-health literacy,",
    "entities": []
  },
  {
    "text": "particularly for older, less educated, and female patients, are essential for",
    "entities": []
  },
  {
    "text": "improving diabetes management. Future research should explore culturally",
    "entities": []
  },
  {
    "text": "tailored digital health education programs to bridge these gaps.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, AlShehri et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "AlShehri",
        "label": "PERSON"
      },
      {
        "text": "al.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "study. Institutional Review Board (IRB) of the Ministry of Health - Makkah",
    "entities": [
      {
        "text": "Institutional Review Board",
        "label": "ORG"
      },
      {
        "text": "IRB",
        "label": "ORG"
      },
      {
        "text": "the Ministry of Health - Makkah",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "issued approval H-02-K-076-0225-1291. Animal subjects: All authors have",
    "entities": [
      {
        "text": "H-02-K-076-0225-1291",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Spina bifida as a multifactorial birth defect: Risk factors and genetic",
    "entities": [
      {
        "text": "Spina",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "G(1)(4), You W(1)(5), Luo C(1)(6), He TC(1)(7), Reid RR(1)(7), Shi LS(1), Lee",
    "entities": [
      {
        "text": "W(1)(5",
        "label": "GPE"
      },
      {
        "text": "Luo",
        "label": "PERSON"
      },
      {
        "text": "Reid",
        "label": "PERSON"
      },
      {
        "text": "Shi LS(1",
        "label": "PERSON"
      },
      {
        "text": "Lee\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Molecular Oncology Laboratory Department of Orthopaedic Surgery and",
    "entities": [
      {
        "text": "Oncology Laboratory Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Rehabilitation Medicine The University of Chicago Medical Center Chicago IL USA.",
    "entities": [
      {
        "text": "Rehabilitation Medicine The University of Chicago Medical Center Chicago IL USA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Pritzker School of Medicine The University of Chicago Medicine Chicago IL",
    "entities": [
      {
        "text": "School of Medicine The University of Chicago Medicine Chicago IL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Orthopedic Surgery Jiangxi Hospital of Traditional Chinese",
    "entities": [
      {
        "text": "Orthopedic Surgery Jiangxi Hospital of Traditional Chinese\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine Jiangxi University of Traditional Chinese Medicine Nanchang China.",
    "entities": [
      {
        "text": "Medicine Jiangxi University of Traditional Chinese Medicine Nanchang China",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Orthopaedic Surgery BenQ Medical Center The Affiliated BenQ",
    "entities": [
      {
        "text": "Orthopaedic Surgery BenQ Medical Center The Affiliated BenQ",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital of Nanjing Medical University Nanjing China.",
    "entities": [
      {
        "text": "Nanjing Medical University",
        "label": "ORG"
      },
      {
        "text": "Nanjing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Orthopaedic Surgery Wuxi Hospital Affiliated to Nanjing",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Orthopaedic Surgery Wuxi Hospital Affiliated",
        "label": "ORG"
      },
      {
        "text": "Nanjing",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University of Chinese Medicine Wuxi China.",
    "entities": [
      {
        "text": "University of Chinese Medicine Wuxi China",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Orthopaedic Surgery Yibin Second People's Hospital Affiliated",
    "entities": [
      {
        "text": "Yibin Second People's Hospital Affiliated",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "with West China School of Medicine Yibin China.",
    "entities": [
      {
        "text": "West China School of Medicine Yibin China",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Laboratory of Craniofacial Biology and Development Section of Plastic and",
    "entities": [
      {
        "text": "Craniofacial Biology and Development Section of Plastic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Reconstructive Surgery Department of Surgery The University of Chicago Medical",
    "entities": [
      {
        "text": "Reconstructive Surgery Department of Surgery The University of Chicago Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center Chicago IL USA.",
    "entities": [
      {
        "text": "Center Chicago IL USA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Spina bifida is a birth defect resulting from abnormal embryonic development of",
    "entities": [
      {
        "text": "Spina",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "the neural tube. Though spina bifida is divided into several subtypes,",
    "entities": [
      {
        "text": "spina bifida",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "myelomeningocele-the most severe form of spina bifida often associated with a",
    "entities": [
      {
        "text": "spina",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "markedly diminished quality of life-accounts for a significant portion of cases.",
    "entities": []
  },
  {
    "text": "A broad range of genetic and environmental factors, many of which are still",
    "entities": []
  },
  {
    "text": "unknown, influence spina bifida, making it difficult to provide a comprehensive",
    "entities": [
      {
        "text": "spina bifida",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "etiology for the disorder. Folic acid supplementation aided by the mandatory",
    "entities": []
  },
  {
    "text": "fortification of food is preventive; still, spina bifida persists due to",
    "entities": [
      {
        "text": "spina bifida",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "numerous other confounding factors that affect risk. This article reviews the",
    "entities": []
  },
  {
    "text": "latest studies pertaining to the risk factors and genetics involved in spina",
    "entities": [
      {
        "text": "spina\n",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "bifida in an attempt to elucidate the complex background of the congenital",
    "entities": []
  },
  {
    "text": "malformation. Additionally, this review highlights the significant impact of",
    "entities": []
  },
  {
    "text": "environmental pollutants, adverse medication effects, and maternal health",
    "entities": []
  },
  {
    "text": "conditions such as diabetes and obesity on the prevalence of spina bifida.",
    "entities": [
      {
        "text": "spina bifida",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Emerging research on gene-environment interactions provides insight into how",
    "entities": []
  },
  {
    "text": "specific genetic variants may influence susceptibility to these environmental",
    "entities": []
  },
  {
    "text": "factors. We also discuss new technologies in genetic sequencing that show",
    "entities": []
  },
  {
    "text": "promise for the large-scale discovery of genes associated with spina bifida",
    "entities": [
      {
        "text": "spina bifida",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "risk. Understanding these intricate interactions is crucial for developing",
    "entities": []
  },
  {
    "text": "effective prevention and intervention strategies.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Pediatric Discovery published by John Wiley & Sons",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Discovery",
        "label": "PRODUCT"
      },
      {
        "text": "John Wiley & Sons",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Australia, Ltd on behalf of Children's Hospital of Chongqing Medical University.",
    "entities": [
      {
        "text": "Australia",
        "label": "GPE"
      },
      {
        "text": "Children's Hospital of Chongqing Medical University",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: TCH and RRR serve on the Editorial Board of",
    "entities": [
      {
        "text": "TCH",
        "label": "ORG"
      },
      {
        "text": "RRR",
        "label": "ORG"
      },
      {
        "text": "the Editorial Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pediatric Discovery. Both were excluded from all editorial decision\u2010making",
    "entities": []
  },
  {
    "text": "related to the acceptance of this article for publication. All other co\u2010authors",
    "entities": []
  },
  {
    "text": "declare no conflict of interest.",
    "entities": []
  },
  {
    "text": "39. Iran J Basic Med Sci. 2025;28(5):575-583. doi:",
    "entities": [
      {
        "text": "39",
        "label": "CARDINAL"
      },
      {
        "text": "Iran",
        "label": "GPE"
      },
      {
        "text": "Med Sci",
        "label": "PERSON"
      },
      {
        "text": "2025;28(5):575",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Endurance training promotes the browning of WAT by enhancing the NPFF pathway in",
    "entities": [
      {
        "text": "NPFF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the hypothalamus in rats with type 2 diabetes.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "OBJECTIVES: Type 2 diabetes (T2D) represents a complex and multifactorial",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "disorder, and efforts to discover its treatment are necessary. Browning of white",
    "entities": []
  },
  {
    "text": "adipose tissue (WAT) as a therapeutic target for diabetes seems to be induced by",
    "entities": []
  },
  {
    "text": "exercise through neuropeptide FF (NPFF) signaling in the hypothalamus and",
    "entities": [
      {
        "text": "FF",
        "label": "ORG"
      },
      {
        "text": "NPFF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "adipose tissue. This study aimed to explore the role of endurance training on",
    "entities": []
  },
  {
    "text": "the browning of WAT by assessing the expression of the gene and protein of NPFF",
    "entities": [
      {
        "text": "NPFF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and its receptors in the hypothalamus and adipose tissue.",
    "entities": []
  },
  {
    "text": "MATERIALS AND METHODS: Forty adult male Wistar rats were assigned into four",
    "entities": [
      {
        "text": "Forty",
        "label": "CARDINAL"
      },
      {
        "text": "Wistar",
        "label": "ORG"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "groups: control, exercise, diabetic control, and diabetic exercise. The serum",
    "entities": []
  },
  {
    "text": "levels of lipid profile, insulin, and glucose, along with the expression of gene",
    "entities": []
  },
  {
    "text": "and protein of NPFF and its receptors (NPFFR1 and NPFFR2), were evaluated in the",
    "entities": [
      {
        "text": "NPFF",
        "label": "ORG"
      },
      {
        "text": "NPFFR1",
        "label": "ORG"
      },
      {
        "text": "NPFFR2",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "hypothalamus and adipose tissue. A histological examination was performed to",
    "entities": []
  },
  {
    "text": "evaluate the browning of WAT.",
    "entities": []
  },
  {
    "text": "RESULTS: Metabolic parameters notably increased in the diabetic group. The gene",
    "entities": []
  },
  {
    "text": "and protein expression of NPFF and its receptors significantly decreased in the",
    "entities": [
      {
        "text": "NPFF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hypothalamus and fat tissue in the diabetic group. However, these changes in the",
    "entities": []
  },
  {
    "text": "hypothalamus, not in the adipose tissue, were significantly improved in the",
    "entities": []
  },
  {
    "text": "diabetic-exercise group compared to the diabetic group. The high WAT content in",
    "entities": []
  },
  {
    "text": "diabetic rats was decreased by exercise, leading to an increase in the browning",
    "entities": []
  },
  {
    "text": "of WAT.",
    "entities": [
      {
        "text": "WAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Endurance progressive training could centrally, not peripherally,",
    "entities": []
  },
  {
    "text": "promote the browning of WAT in diabetic rats by enhancing the expression of gene",
    "entities": []
  },
  {
    "text": "and protein of NPFF and its receptors in the hypothalamus.",
    "entities": [
      {
        "text": "NPFF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025. This work is openly licensed via CC BY 4.0.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC BY",
        "label": "ORG"
      },
      {
        "text": "4.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that they have no known",
    "entities": []
  },
  {
    "text": "competing financial interests.",
    "entities": []
  },
  {
    "text": "40. Iran J Basic Med Sci. 2025;28(5):662-670. doi:",
    "entities": [
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "Iran",
        "label": "GPE"
      },
      {
        "text": "Med Sci",
        "label": "PERSON"
      },
      {
        "text": "2025;28(5):662-670",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Ethanol extract of Garcinia kola seeds alleviates HGHFD/STZ-induced nonalcoholic",
    "entities": [
      {
        "text": "Garcinia",
        "label": "GPE"
      },
      {
        "text": "HGHFD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "fatty liver disease in diabetic rats by modulating oxidative stress,",
    "entities": []
  },
  {
    "text": "inflammation, and lipid accumulation.",
    "entities": []
  },
  {
    "text": "(1)Department of Pharmaceutical Engineering and Pharmaceutical Chemistry,",
    "entities": [
      {
        "text": "Pharmaceutical Engineering and Pharmaceutical Chemistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Chemical Engineering, Qingdao University of Science and Technology,",
    "entities": [
      {
        "text": "College of Chemical Engineering",
        "label": "ORG"
      },
      {
        "text": "Qingdao University of Science and Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)National Key Laboratory of Chinese Medicine Modernization, State Key",
    "entities": [
      {
        "text": "Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Laboratory of Component-based Chinese Medicine, Tianjin Key Laboratory of TCM",
    "entities": [
      {
        "text": "Laboratory of Component",
        "label": "ORG"
      },
      {
        "text": "Chinese Medicine",
        "label": "ORG"
      },
      {
        "text": "Tianjin Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "TCM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chemistry and Analysis, Tianjin University of Traditional Chinese Medicine,",
    "entities": [
      {
        "text": "Chemistry and Analysis, Tianjin University of Traditional Chinese Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVES: To investigate the ameliorative effects of Garcinia kola ethanol",
    "entities": [
      {
        "text": "Garcinia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "extract (EGK) on type 2 diabetes mellitus (T2DM) combined with nonalcoholic",
    "entities": [
      {
        "text": "EGK",
        "label": "ORG"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "fatty liver disease (NAFLD) and to explore its underlying mechanisms.",
    "entities": []
  },
  {
    "text": "MATERIALS AND METHODS: In vivo, a T2DM rat model was established using",
    "entities": []
  },
  {
    "text": "HGHFD/STZ. In vitro, HepG2 cells were induced with FFA to create a model of",
    "entities": [
      {
        "text": "HGHFD",
        "label": "ORG"
      },
      {
        "text": "STZ",
        "label": "ORG"
      },
      {
        "text": "FFA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lipid accumulation. Lipid accumulation (LA), oxidative stress (OS) levels, and",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "inflammatory markers were measured using kit methods. Additionally, the",
    "entities": []
  },
  {
    "text": "expression of the SREBP-1c pathway was detected by immunohistochemistry and",
    "entities": []
  },
  {
    "text": "western blot (WB) to further understand the potential mechanism of EGK's",
    "entities": [
      {
        "text": "WB",
        "label": "ORG"
      },
      {
        "text": "EGK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "protective effect on diabetic liver injury.",
    "entities": []
  },
  {
    "text": "RESULTS: In vivo, EGK significantly reduced blood glucose levels (P<0.01),",
    "entities": [
      {
        "text": "EGK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "restored body weight (P<0.01), and improved liver LA, OS, and inflammatory",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "levels (P<0.01) in diabetic rats. Histopathological results indicated that EGK",
    "entities": [
      {
        "text": "EGK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effectively ameliorated diabetes-induced liver injury. Immunohistochemistry and",
    "entities": []
  },
  {
    "text": "WB results revealed that EGK significantly down-regulated the expression of the",
    "entities": [
      {
        "text": "WB",
        "label": "ORG"
      },
      {
        "text": "EGK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "SREBP-1c pathway (P<0.01). In vitro, EGK markedly improved lipid accumulation,",
    "entities": [
      {
        "text": "EGK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "oxidative stress, and inflammation levels in HepG2 cells (P<0.01).",
    "entities": []
  },
  {
    "text": "Immunofluorescence and WB results showed that EGK significantly reduced the",
    "entities": [
      {
        "text": "WB",
        "label": "ORG"
      },
      {
        "text": "EGK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "expression of the SREBP-1c pathway (P<0.01).",
    "entities": []
  },
  {
    "text": "CONCLUSION: EGK alleviates T2DM combined with NAFLD by reducing lipid",
    "entities": [
      {
        "text": "EGK",
        "label": "ORG"
      },
      {
        "text": "T2DM",
        "label": "PRODUCT"
      },
      {
        "text": "NAFLD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "accumulation through the inhibition of oxidative stress, inflammatory responses,",
    "entities": []
  },
  {
    "text": "and the SREBP-1c signaling pathway.",
    "entities": []
  },
  {
    "text": "Comparison of two portable metabolic systems for measuring energy expenditure at",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "rest and during exercise in untrained women.",
    "entities": []
  },
  {
    "text": "(1)Department of Physical Therapy, Taihe Hospital, Hubei University of Medicine,",
    "entities": [
      {
        "text": "Physical Therapy",
        "label": "PERSON"
      },
      {
        "text": "Taihe Hospital",
        "label": "FAC"
      },
      {
        "text": "Hubei University of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)School of Biomedical Engineering, Hubei University of Medicine, Shiyan,",
    "entities": [
      {
        "text": "Biomedical Engineering",
        "label": "ORG"
      },
      {
        "text": "Hubei University of Medicine, Shiyan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Center for Diabetes Rehabilitation Research, Taihe Hospital, Hubei University",
    "entities": [
      {
        "text": "Diabetes Rehabilitation Research",
        "label": "ORG"
      },
      {
        "text": "Taihe Hospital",
        "label": "ORG"
      },
      {
        "text": "Hubei University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Shiyan, China.",
    "entities": [
      {
        "text": "Medicine, Shiyan",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Rehabilitation, Taihe Hospital, Hubei University of Medicine,",
    "entities": [
      {
        "text": "Rehabilitation",
        "label": "ORG"
      },
      {
        "text": "Taihe Hospital",
        "label": "ORG"
      },
      {
        "text": "Hubei University of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Physical Education, Shanghai Jiao Tong University, Shanghai,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Physical Education",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "Tong University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: Portable metabolic systems are used as the \"gold standard\" for",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "measuring energy expenditure (EE) in the development and validation of wearable",
    "entities": []
  },
  {
    "text": "devices. This study aimed to compare EE measurements obtained using the COSMED",
    "entities": [
      {
        "text": "the COSMED\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "K5 (K5) and CORTEX METAMAX 3B (M3B) during the resting state and",
    "entities": [
      {
        "text": "K5",
        "label": "PRODUCT"
      },
      {
        "text": "K5",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "submaximal-intensity exercise in women without self-reported regular exercise",
    "entities": []
  },
  {
    "text": "METHODS: Twenty women aged 21.4 \u00b1 1.5 years completed two measurements,",
    "entities": [
      {
        "text": "Twenty",
        "label": "CARDINAL"
      },
      {
        "text": "1.5 years",
        "label": "DATE"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "including resting in a seated position and cycling on a simple upright ergometer",
    "entities": []
  },
  {
    "text": "at 30 W, 40 W, 50 W, and 60 W. Average EE and other metabolic parameters were",
    "entities": [
      {
        "text": "30 W",
        "label": "CARDINAL"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "50",
        "label": "CARDINAL"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "compared between K5 and M3B. Differences between K5 and M3B were assessed using",
    "entities": [
      {
        "text": "K5",
        "label": "ORG"
      },
      {
        "text": "M3B. Differences",
        "label": "ORG"
      },
      {
        "text": "K5",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "the paired-samples t-test, and the effect size was calculated as Cohen's d.",
    "entities": [
      {
        "text": "Cohen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Agreement between the two systems was evaluated by calculating Pearson",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Pearson",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "correlation coefficients and visually examining Bland-Altman plots.",
    "entities": [
      {
        "text": "Bland-Altman",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: The number of participants who completed resting and exercise",
    "entities": []
  },
  {
    "text": "measurements was 18 and 19, respectively. For resting EE, the mean values",
    "entities": [
      {
        "text": "18",
        "label": "DATE"
      },
      {
        "text": "19",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "measured using K5 were 33.4% higher than those measured using M3B (p < 0.001,",
    "entities": [
      {
        "text": "K5",
        "label": "PRODUCT"
      },
      {
        "text": "33.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Cohen's d = 1.47). Similar differences were observed for cycling at 30 W (15.8%,",
    "entities": [
      {
        "text": "Cohen",
        "label": "PERSON"
      },
      {
        "text": "1.47",
        "label": "CARDINAL"
      },
      {
        "text": "30 W",
        "label": "CARDINAL"
      },
      {
        "text": "15.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "p < 0.001, Cohen's d = 1.50), 40 W (16.1%, p < 0.001, Cohen's d = 1.68), 50 W",
    "entities": [
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "Cohen",
        "label": "PERSON"
      },
      {
        "text": "1.50",
        "label": "CARDINAL"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "16.1%",
        "label": "PERCENT"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "Cohen",
        "label": "PERSON"
      },
      {
        "text": "1.68",
        "label": "CARDINAL"
      },
      {
        "text": "50",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(14.8%, p < 0.001, Cohen's d = 1.28), and 60 W (14.6%, p < 0.001, Cohen's d =",
    "entities": [
      {
        "text": "14.8%",
        "label": "PERCENT"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "Cohen",
        "label": "PERSON"
      },
      {
        "text": "1.28",
        "label": "CARDINAL"
      },
      {
        "text": "60 W",
        "label": "CARDINAL"
      },
      {
        "text": "14.6%",
        "label": "PERCENT"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "Cohen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.29). Pearson correlation coefficients between EE measured using K5 and M3B was",
    "entities": [
      {
        "text": "1.29",
        "label": "CARDINAL"
      },
      {
        "text": "K5",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "0.66 for 30 W cycling (p = 0.002) and 0.62 for 40 W cycling (p = 0.005).",
    "entities": [
      {
        "text": "0.66",
        "label": "CARDINAL"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "0.002",
        "label": "CARDINAL"
      },
      {
        "text": "0.62",
        "label": "CARDINAL"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "0.005",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: K5 and M3B show significant differences in EE measurements during",
    "entities": [
      {
        "text": "K5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "rest and exercise among untrained female individuals, indicating systematic bias",
    "entities": []
  },
  {
    "text": "in EE measurement between the two systems. Thus, careful consideration is",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "essential when interpreting the results of wearable device studies that use",
    "entities": []
  },
  {
    "text": "different automated metabolic systems.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Gao, Chan-Yu, Li, Liu, Liu, Liu, Yu, Chen, Wang and Le.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Gao",
        "label": "PERSON"
      },
      {
        "text": "Chan-Yu",
        "label": "PERSON"
      },
      {
        "text": "Li",
        "label": "PERSON"
      },
      {
        "text": "Liu",
        "label": "PERSON"
      },
      {
        "text": "Liu",
        "label": "PERSON"
      },
      {
        "text": "Liu",
        "label": "PERSON"
      },
      {
        "text": "Yu",
        "label": "PERSON"
      },
      {
        "text": "Chen",
        "label": "PERSON"
      },
      {
        "text": "Wang",
        "label": "PERSON"
      },
      {
        "text": "Le",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "42. Sex Med. 2025 Jul 15;13(3):qfaf047. doi: 10.1093/sexmed/qfaf047. eCollection",
    "entities": [
      {
        "text": "42",
        "label": "CARDINAL"
      },
      {
        "text": "Sex Med",
        "label": "PRODUCT"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Anorgasmia following initiation of GLP-1 agonist.",
    "entities": [
      {
        "text": "GLP-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "Visvabharathy V(1), MacPhedran S(1), Shupp K(2), King B(2).",
    "entities": [
      {
        "text": "MacPhedran S(1",
        "label": "ORG"
      },
      {
        "text": "Shupp",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Department of Obstetrics & Gynecology, Case Western Reserve",
    "entities": [
      {
        "text": "Obstetrics & Gynecology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University/MetroHealth Medical Center, Cleveland, OH 44109, United States.",
    "entities": [
      {
        "text": "University/MetroHealth Medical Center",
        "label": "ORG"
      },
      {
        "text": "Cleveland",
        "label": "GPE"
      },
      {
        "text": "OH 44109",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Case Western Reserve University/MetroHealth Medical Center, Cleveland, OH",
    "entities": [
      {
        "text": "2)Case Western Reserve University/MetroHealth Medical Center",
        "label": "ORG"
      },
      {
        "text": "Cleveland",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "44109, United States.",
    "entities": [
      {
        "text": "44109",
        "label": "DATE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: According to the Obesity Medicine Association, obesity is a",
    "entities": [
      {
        "text": "the Obesity Medicine Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "chronic, progressive, relapsing, multifactorial and treatable neurobehavioral",
    "entities": []
  },
  {
    "text": "disease. A small number of drugs have been approved by the Food & Drug",
    "entities": [
      {
        "text": "the Food & Drug",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Administration (FDA) for weight loss. Liraglutide, Tirzepatide, and Semaglutide",
    "entities": [
      {
        "text": "FDA",
        "label": "ORG"
      },
      {
        "text": "Semaglutide\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "are GLP-1 agonists and anti-diabetic drugs, and are some of the latest",
    "entities": [
      {
        "text": "GLP-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "FDA-approved medications for weight loss. Up to 50% of patients experience",
    "entities": [
      {
        "text": "FDA",
        "label": "ORG"
      },
      {
        "text": "Up to 50%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "gastrointestinal (GI) distress, a common side effect, while taking these",
    "entities": [
      {
        "text": "GI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "medications. Other side effects include tachycardia, antibody-mediated",
    "entities": []
  },
  {
    "text": "angioedema, anaphylaxis, irritation at the injection site, and hypoglycemia.",
    "entities": []
  },
  {
    "text": "However, very little is known regarding sexual dysfunction as a side effect of",
    "entities": []
  },
  {
    "text": "GLP-1 agonists. The following case report discusses the potential negative",
    "entities": [
      {
        "text": "GLP-1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "impact on sexual function of these widely prescribed anti-diabetic, weight loss",
    "entities": []
  },
  {
    "text": "medications. The case report also discusses a proposed mechanism of action of",
    "entities": []
  },
  {
    "text": "GLP-1 agonists on sexual function.",
    "entities": [
      {
        "text": "GLP-1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "AIMS: To report the sexual side effects and plausible mechanism of female",
    "entities": []
  },
  {
    "text": "anorgasmia from GLP-1 agonists.",
    "entities": [
      {
        "text": "GLP-1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Chart review of the patient case was conducted. Consultation with a",
    "entities": [
      {
        "text": "Chart",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Doctor of Pharmacy was also requested for additional guidance on possible",
    "entities": []
  },
  {
    "text": "mechanisms of action of GLP-1 agonists on sexual function.",
    "entities": [
      {
        "text": "GLP-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "RESULTS: Several proposed mechanisms causing anorgasmia were theorized, the most",
    "entities": []
  },
  {
    "text": "likely being GLP-1 agonist vasoconstriction of smooth muscle, which results in",
    "entities": [
      {
        "text": "GLP-1",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "reduced oxygen delivery and blood flow to the genitals. This may hinder genital",
    "entities": []
  },
  {
    "text": "engorgement and arousal, in addition to causing impairment of smooth muscle",
    "entities": []
  },
  {
    "text": "contractions essential for orgasms. Other mechanisms of GLP-1 agonist-induced",
    "entities": [
      {
        "text": "GLP-1",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "anorgasmia may involve their signaling in the brain due to their presence in the",
    "entities": []
  },
  {
    "text": "hypothalamus. GLP-1 receptor modulation in the hypothalamus may decrease",
    "entities": [
      {
        "text": "GLP-1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dopamine and norepinephrine signaling, which are neurotransmitters crucial for",
    "entities": []
  },
  {
    "text": "motivation, pleasure, and orgasm as well as disrupt pathways involved in sexual",
    "entities": []
  },
  {
    "text": "desire and arousal.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Further investigation on the prevalence of sexual dysfunction with",
    "entities": []
  },
  {
    "text": "GLP-1 agonists and their mechanism of action is needed.",
    "entities": [
      {
        "text": "GLP-1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of The",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "International Society for Sexual Medicine.",
    "entities": [
      {
        "text": "International Society for Sexual Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: None declared.",
    "entities": []
  },
  {
    "text": "43. Front Digit Health. 2025 Jul 1;7:1596188. doi: 10.3389/fdgth.2025.1596188.",
    "entities": [
      {
        "text": "43",
        "label": "CARDINAL"
      },
      {
        "text": "Front Digit Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "One-year evaluation of automated insulin delivery systems in adults with type 1",
    "entities": [
      {
        "text": "One-year",
        "label": "DATE"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Endocrinology and Nutrition, Hospital Universitario Central de",
    "entities": [
      {
        "text": "Endocrinology and Nutrition, Hospital Universitario Central de\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Asturias, Oviedo, Spain.",
    "entities": [
      {
        "text": "Oviedo",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Endocrinology and Nutrition, Hospital Universitario de",
    "entities": [
      {
        "text": "Endocrinology and Nutrition, Hospital Universitario de\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto",
    "entities": [
      {
        "text": "5)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Biomedical Network Research on Rare Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: This study evaluates the effectiveness of four commercially",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "available automated insulin delivery (AID) systems in routine clinical practice",
    "entities": []
  },
  {
    "text": "for type 1 diabetes management and compares their first-year outcomes.",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "first-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "MATERIALS: This retrospective study (October 2020-October 2023) included",
    "entities": [
      {
        "text": "October 2020-October 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "glucometric data from type 1 diabetes patients collected from the Asturias",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Automatic Insulin Devices Registry. People with type 1 diabetes using four",
    "entities": [
      {
        "text": "Automatic Insulin Devices Registry",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "different AID systems [Minimed\u2122780G (MM780G), Accu-Chek\u00ae Insight-Diabeloop",
    "entities": [
      {
        "text": "AID",
        "label": "ORG"
      },
      {
        "text": "780",
        "label": "CARDINAL"
      },
      {
        "text": "Accu-Chek\u00ae Insight-Diabeloop",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(DBLG), Tandem-Control-IQ, and Ypsopump Cambridge HCL-app (Cam-APS)] were",
    "entities": [
      {
        "text": "Tandem-Control-IQ",
        "label": "ORG"
      },
      {
        "text": "Cam-APS",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "included in the study. Primary outcomes were glycaemic control after one year.",
    "entities": [
      {
        "text": "one year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Secondary outcomes compared the results between the four systems.",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: 174 patients (60: MM780G, 45: DBLG, 30: Control-IQ, 39: Cam-APS), aged",
    "entities": [
      {
        "text": "174",
        "label": "CARDINAL"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "MM780G",
        "label": "PERSON"
      },
      {
        "text": "45",
        "label": "CARDINAL"
      },
      {
        "text": "DBLG",
        "label": "PERSON"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "Control-IQ",
        "label": "ORG"
      },
      {
        "text": "39",
        "label": "CARDINAL"
      },
      {
        "text": "Cam-APS",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "18-73, predominantly women, were enrolled. At baseline, glycemic control,",
    "entities": [
      {
        "text": "18-73",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "measured by the achievement of the international consensus targets [TBR (Time",
    "entities": []
  },
  {
    "text": "Below Range) <4%; TIR(Time in Range) >70% and TAR (Time Above Range) <25%] was",
    "entities": [
      {
        "text": "4%",
        "label": "PERCENT"
      },
      {
        "text": "70%",
        "label": "PERCENT"
      },
      {
        "text": "TAR",
        "label": "ORG"
      },
      {
        "text": "25%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "only met by 9.72% of participants, while after 1 year of an AID system use, it",
    "entities": [
      {
        "text": "9.72%",
        "label": "PERCENT"
      },
      {
        "text": "1 year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "improved to more than 52%. When comparing between systems, TIR improved",
    "entities": [
      {
        "text": "more than 52%",
        "label": "PERCENT"
      },
      {
        "text": "TIR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly after 1 year in all systems. However, Control-IQ did not show",
    "entities": [
      {
        "text": "1 year",
        "label": "DATE"
      },
      {
        "text": "Control-IQ",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "improvement in mean glucose and Glucose management index (GMI) and only users of",
    "entities": [
      {
        "text": "Glucose",
        "label": "ORG"
      },
      {
        "text": "GMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DBLG showed improvement in coefficient of variation (CV). MM780G users achieved",
    "entities": [
      {
        "text": "DBLG",
        "label": "PERSON"
      },
      {
        "text": "CV",
        "label": "PERSON"
      },
      {
        "text": "MM780G",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "the best results after 12 months in mean glucose, TIR and GMI. However, their",
    "entities": [
      {
        "text": "12 months",
        "label": "DATE"
      },
      {
        "text": "TIR",
        "label": "ORG"
      },
      {
        "text": "GMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "baseline situation was also better than that of the other groups.",
    "entities": []
  },
  {
    "text": "DISCUSSION: This study confirms that, after 12 months of routine clinical use,",
    "entities": [
      {
        "text": "12 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the use of commercially available automated insulin delivery (AID) systems",
    "entities": []
  },
  {
    "text": "significantly improves glycemic control in individuals with type 1 diabetes.",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "However, the degree of improvement varies depending on the specific system",
    "entities": []
  },
  {
    "text": "used.These findings underscore the importance of selecting and optimizing AID",
    "entities": [
      {
        "text": "AID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "systems individually to maximize clinical benefits in type 1 diabetes",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and Lambert.",
    "entities": [
      {
        "text": "Lambert",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "DOI: 10.3389/fdgth.2025.1596188",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.3389/fendo.2025.1596127. eCollection 2025.",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "disparities, and risk factor dynamics.",
    "entities": []
  },
  {
    "text": "(1)Hefei Xinzhuan High-tech Zone Huoshuiyuan Traditional Chinese Medicine",
    "entities": [
      {
        "text": "Xinzhuan High-tech",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Nanjing University of Chinese Medicine, First Clinical Medical College,",
    "entities": [
      {
        "text": "2)Nanjing",
        "label": "CARDINAL"
      },
      {
        "text": "University of Chinese Medicine",
        "label": "ORG"
      },
      {
        "text": "First Clinical Medical College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)College of Traditional Chinese Medicine, Anhui University of Chinese",
    "entities": [
      {
        "text": "Traditional Chinese Medicine",
        "label": "ORG"
      },
      {
        "text": "Anhui University of Chinese",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Traditional Chinese Acupuncture and Tuina, the Second People's",
    "entities": [
      {
        "text": "Traditional Chinese Acupuncture and",
        "label": "ORG"
      },
      {
        "text": "Tuina",
        "label": "GPE"
      },
      {
        "text": "Second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Hospital of Anhui Province, Hefei, Anhui, China.",
    "entities": [
      {
        "text": "Anhui Province",
        "label": "GPE"
      },
      {
        "text": "Hefei",
        "label": "GPE"
      },
      {
        "text": "Anhui",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Pediatric Neurorehabilitation Center, the First Affiliated Hospital of Anhui",
    "entities": [
      {
        "text": "5)Pediatric Neurorehabilitation Center",
        "label": "ORG"
      },
      {
        "text": "the First Affiliated Hospital of Anhui",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical University, Hefei, Anhui, China.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Hefei",
        "label": "GPE"
      },
      {
        "text": "Anhui",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)School of Basic Medical Sciences, Yunnan University of Traditional Chinese",
    "entities": [
      {
        "text": "Basic Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Yunnan University of Traditional Chinese",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Kunming, Yunnan, China.",
    "entities": [
      {
        "text": "Kunming",
        "label": "GPE"
      },
      {
        "text": "Yunnan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Diabetes mellitus(DM) remains a significant global health challenge,",
    "entities": []
  },
  {
    "text": "characterized by high incidence and Disability-adjusted life years (DALYs)",
    "entities": [
      {
        "text": "Disability",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rates. A comprehensive understanding of the disease burden of DM is crucial for",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "developing effective prevention and treatment strategies. This study analyzes",
    "entities": []
  },
  {
    "text": "the global burden of diabetes mellitus (DM) from 1990 to 2021 using data from",
    "entities": [
      {
        "text": "1990",
        "label": "DATE"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the Global Burden of Disease Study. In 2021, DM caused 1.66 million deaths, with",
    "entities": [
      {
        "text": "the Global Burden of Disease Study",
        "label": "PRODUCT"
      },
      {
        "text": "2021",
        "label": "DATE"
      },
      {
        "text": "DM",
        "label": "ORG"
      },
      {
        "text": "1.66 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "age-standardized mortality rising by 7.95% since 1990. While Type 1 diabetes",
    "entities": [
      {
        "text": "7.95%",
        "label": "PERCENT"
      },
      {
        "text": "1990",
        "label": "DATE"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(T1DM) mortality declined by 29.24%, Type 2 diabetes (T2DM) accounted for 97.1%",
    "entities": [
      {
        "text": "29.24%",
        "label": "PERCENT"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "97.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "of deaths, with a 9.75% mortality increase. Geospatial analysis revealed extreme",
    "entities": [
      {
        "text": "9.75%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "disparities: Pacific Island nations exhibited incidence rates >800/100,000,",
    "entities": [
      {
        "text": "Pacific Island",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "contrasting with <3/100,000 in Costa Rica and China. T1DM burden predominated in",
    "entities": [
      {
        "text": "Costa Rica",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "high-latitude regions (e.g., Finland), whereas T2DM mirrored overall DM",
    "entities": [
      {
        "text": "Finland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "distribution. DALYs for T2DM surged by 42.32%, disproportionately affecting",
    "entities": [
      {
        "text": "DALYs",
        "label": "PERSON"
      },
      {
        "text": "42.32%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Low-SDI regions. Age-stratified analyses identified distinct patterns: T2DM",
    "entities": []
  },
  {
    "text": "incidence peaked at 59-69 years, while T1DM DALYs peaked in early-middle",
    "entities": [
      {
        "text": "59-69 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "adulthood (40-44 years). Risk factor hierarchies highlighted metabolic risks",
    "entities": [
      {
        "text": "40-44 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(e.g., high BMI) for T2DM and ambient temperature effects for T1DM. Despite",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "progress in T1DM management, rising T2DM burden underscores urgent need for",
    "entities": []
  },
  {
    "text": "targeted prevention strategies addressing obesity, dietary risks, and",
    "entities": []
  },
  {
    "text": "inaccuracies and ecological design constraints. These findings emphasize the",
    "entities": []
  },
  {
    "text": "imperative for region-specific interventions to mitigate the evolving diabetes",
    "entities": []
  },
  {
    "text": "The impact of a complete nutrition diabetic formula on glycemic control and",
    "entities": []
  },
  {
    "text": "nutritional status in hospitalized patients with diabetes mellitus.",
    "entities": []
  },
  {
    "text": "(1)Department of Nutrition, Chung Shan Medical University, Taichung, China.",
    "entities": [
      {
        "text": "Nutrition",
        "label": "ORG"
      },
      {
        "text": "Chung Shan Medical University",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Le Bonta Wellness Co. Ltd, Shanghai, China.",
    "entities": [
      {
        "text": "2)Le Bonta Wellness Co. Ltd",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Research and Development Center, Standard Investment (China) Ltd.,",
    "entities": [
      {
        "text": "Development Center",
        "label": "ORG"
      },
      {
        "text": "Standard Investment (China) Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The clinical application of specialized oral nutritional supplements (ONS) in",
    "entities": []
  },
  {
    "text": "managing hospitalized patients with diabetes mellitus necessitates rigorous",
    "entities": []
  },
  {
    "text": "evaluation of their effects on glycemic stability and nutritional parameters.",
    "entities": []
  },
  {
    "text": "This prospective study aimed to investigate the impact of a diabetes-specific",
    "entities": []
  },
  {
    "text": "ONS, Complete Nutrition Diabetic Formula, on glycemic control and key",
    "entities": [
      {
        "text": "ONS",
        "label": "ORG"
      },
      {
        "text": "Complete Nutrition Diabetic Formula",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "nutritional indices in diabetic inpatients. Forty adult inpatients diagnosed",
    "entities": [
      {
        "text": "Forty",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with diabetes mellitus requiring nutritional support were enrolled and completed",
    "entities": []
  },
  {
    "text": "the intervention. Following assessment of individual caloric requirements,",
    "entities": []
  },
  {
    "text": "participants received an average daily supplementation of 156 g (equivalent to",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      },
      {
        "text": "156",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "2.6 packs) of the Complete Nutrition Diabetic Formula over a mean duration of 29",
    "entities": [
      {
        "text": "2.6",
        "label": "CARDINAL"
      },
      {
        "text": "the Complete Nutrition Diabetic Formula",
        "label": "ORG"
      },
      {
        "text": "29",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "days (range 14-67 days). Glycemic parameters, anthropometric measurements",
    "entities": [
      {
        "text": "14-67 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(including mid-arm circumference, MAC), and pertinent biochemical markers",
    "entities": [
      {
        "text": "MAC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(including serum magnesium) were assessed at baseline and study conclusion.",
    "entities": [
      {
        "text": "serum magnesium",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Post-intervention analysis showed a higher total caloric and fat intake with a",
    "entities": []
  },
  {
    "text": "lower carbohydrate share, accompanied by significant gains in mid- arm",
    "entities": []
  },
  {
    "text": "circumference (MAC), serum magnesium, and a nitrogen-balance flip from -2.7",
    "entities": [
      {
        "text": "MAC",
        "label": "ORG"
      },
      {
        "text": "serum magnesium",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "g/day to +1.25 g/day (p < 0.05), marking a catabolic - to - anabolic shift and",
    "entities": [
      {
        "text": "g/day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "confirming protein repletion. Fasting plasma glucose and other biochemical",
    "entities": []
  },
  {
    "text": "indices - including serum proteins and lipid profiles - remained unchanged (p >",
    "entities": []
  },
  {
    "text": "0.05), indicating that short-term Complete Nutrition Diabetic Formula",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      },
      {
        "text": "Complete Nutrition Diabetic Formula",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "supplementation improves key nutritional indicators without compromising",
    "entities": []
  },
  {
    "text": "glycemic control or broader metabolic stability.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Wang, Li, Sun and Liu.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wang",
        "label": "PERSON"
      },
      {
        "text": "Li",
        "label": "PERSON"
      },
      {
        "text": "Sun",
        "label": "ORG"
      },
      {
        "text": "Liu",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Authors KX and T-CL were employed by Le Bonta",
    "entities": [
      {
        "text": "KX",
        "label": "PERSON"
      },
      {
        "text": "Le Bonta",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Wellness Co. Ltd. S-QS and T-CL were employed Research and Development Center,",
    "entities": [
      {
        "text": "Wellness Co. Ltd.",
        "label": "ORG"
      },
      {
        "text": "S-QS",
        "label": "ORG"
      },
      {
        "text": "Research and Development Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Standard Investment China Ltd. The remaining author declare that the research",
    "entities": [
      {
        "text": "Standard Investment China Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was conducted in the absence of any commercial or financial relationships that",
    "entities": []
  },
  {
    "text": "could be construed as a potential conflict of interest.",
    "entities": []
  },
  {
    "text": "New insights of potential biomarkers in diabetic retinopathy: integrated",
    "entities": []
  },
  {
    "text": "multi-omic analyses.",
    "entities": []
  },
  {
    "text": "(1)Department of Ophthalmology, Shenzhen People's Hospital (The First Affiliated",
    "entities": [
      {
        "text": "Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "Shenzhen People's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, Southern University of Science and Technology, The Second Clinical",
    "entities": [
      {
        "text": "Southern University of Science and Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical College, Jinan University), Shenzhen, China.",
    "entities": [
      {
        "text": "Medical College",
        "label": "ORG"
      },
      {
        "text": "Jinan University",
        "label": "ORG"
      },
      {
        "text": "Shenzhen",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Ophthalmology, South China Hospital, Shenzhen University,",
    "entities": [
      {
        "text": "Ophthalmology, South China Hospital",
        "label": "ORG"
      },
      {
        "text": "Shenzhen University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Diabetes mellitus prevalence is rising worldwide, with a predicted 20% increase",
    "entities": [
      {
        "text": "20%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "between 2021 and 2030, bringing an increased burden of complications such as",
    "entities": [
      {
        "text": "between 2021 and 2030",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "diabetic retinopathy (DR). DR is a common and serious ocular complication of",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      },
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "diabetes, and one of the most common irreversible blinding ophthalmic diseases.",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Its pathogenesis is intricate and complex, involving hypoxia, oxidative stress,",
    "entities": []
  },
  {
    "text": "inflammation, abnormalities in the polyol metabolic pathway, and others.",
    "entities": []
  },
  {
    "text": "Clinical detection of DR is impeded by atypical early symptoms, imperfect",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "imaging screening tools, ocular comorbidities (e.g., cataract), and shortages of",
    "entities": []
  },
  {
    "text": "human resources. Therefore, more in-depth studies are needed to improve DR",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "diagnosis and identify higher-risk patients. \"Omics\" encompasses genomics,",
    "entities": []
  },
  {
    "text": "transcriptomics, proteomics, and metabolomics. Omics technologies are",
    "entities": []
  },
  {
    "text": "increasingly used in research seeking to identify biomarkers or early",
    "entities": []
  },
  {
    "text": "preclinical signs of disease, or to better understand complex pathological",
    "entities": []
  },
  {
    "text": "processes determining disease prognosis. And DR is no exception, as an area in",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "need of improved understanding and prognosis. To date, research has yielded",
    "entities": []
  },
  {
    "text": "significant results advancing DR diagnosis and treatment, informing prevention",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "strategies and reducing global disease impact. This article reviewed recent",
    "entities": []
  },
  {
    "text": "findings of omics in DR diagnosis and treatment, improving our understanding of",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DR pathology and enabling personalized treatments.",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PMID: 40666054 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "10.3389/fendo.2025.1599660. eCollection 2025.",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Kidney transplantation with preformed diabetic nephropathy kidney: review of",
    "entities": [
      {
        "text": "Kidney",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "pathological changes and clinical outcomes.",
    "entities": []
  },
  {
    "text": "(1)Department of Urinary Nephropathy Center, The Second Affiliated Hospital of",
    "entities": [
      {
        "text": "Urinary Nephropathy Center",
        "label": "FAC"
      },
      {
        "text": "The Second Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chongqing Medical University, Chongqing, China.",
    "entities": [
      {
        "text": "Chongqing Medical University",
        "label": "ORG"
      },
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Clinical Laboratory, The First Naval Hospital of Southern",
    "entities": [
      {
        "text": "Clinical Laboratory",
        "label": "ORG"
      },
      {
        "text": "The First Naval Hospital of Southern\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Theater Command, Zhanjiang, China.",
    "entities": [
      {
        "text": "Theater Command",
        "label": "ORG"
      },
      {
        "text": "Zhanjiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Kidney transplantation from expanded-criteria donors represents an",
    "entities": [
      {
        "text": "Kidney",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "effective approach to alleviate organ shortages. The feasibility for",
    "entities": []
  },
  {
    "text": "transplantation of donor kidneys with preformed diabetic nephropathy (DN) has",
    "entities": []
  },
  {
    "text": "not been extensively investigated.",
    "entities": []
  },
  {
    "text": "SEARCH STRATEGY: We performed a literature review to explore the pathological",
    "entities": []
  },
  {
    "text": "changes and clinical outcomes of kidney transplantation using preformed DN",
    "entities": []
  },
  {
    "text": "kidney. A systematic and comprehensive search was conducted from the inception",
    "entities": []
  },
  {
    "text": "to June 13, 2024.",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: Data from eight articles encompassing 103 cases were included for",
    "entities": [
      {
        "text": "eight",
        "label": "CARDINAL"
      },
      {
        "text": "103",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "analysis. The pooled proportions of stable, progressive, and reversed DN-related",
    "entities": []
  },
  {
    "text": "pathological change were 0.66 (95% CI 0.56-0.77, I2 = 21.77%), 0.27 (95% CI",
    "entities": [
      {
        "text": "0.66",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.56-0.77",
        "label": "PRODUCT"
      },
      {
        "text": "21.77%",
        "label": "PERCENT"
      },
      {
        "text": "0.27",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "0.18-0.36, I2 = 10.04%) and 0.05 (95% CI 0.01-0.10, I2 = 0.00%), respectively.",
    "entities": [
      {
        "text": "0.18-0.36",
        "label": "PRODUCT"
      },
      {
        "text": "10.04%",
        "label": "PERCENT"
      },
      {
        "text": "0.05",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.01-0.10",
        "label": "CARDINAL"
      },
      {
        "text": "0.00%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Eight-six cases were divided into post-transplant hyperglycemia group and normal",
    "entities": [
      {
        "text": "Eight-six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "post-transplant blood glucose group to evaluate the effect of post-transplant",
    "entities": []
  },
  {
    "text": "hyperglycemia on DN pathology, indicating the normal post-transplant blood",
    "entities": []
  },
  {
    "text": "glucose group had higher proportions of stable and reversed pathological states.",
    "entities": [
      {
        "text": "glucose group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Most cases achieved a graft survival rate of more than 80% at around five years",
    "entities": [
      {
        "text": "more than 80%",
        "label": "PERCENT"
      },
      {
        "text": "around five years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSION: A majority of transplantations use donor kidneys with preformed DN",
    "entities": []
  },
  {
    "text": "exhibit acceptable renal pathological changes and graft survival. However,",
    "entities": []
  },
  {
    "text": "post-transplant hyperglycemia may adversely affect the pathological progression",
    "entities": []
  },
  {
    "text": "of the kidneys, particularly in cases with long-term follow-up.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Li, Wang, Chen, Tang, Zhang and Shen.",
    "entities": [
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "Li",
        "label": "PERSON"
      },
      {
        "text": "Wang",
        "label": "PERSON"
      },
      {
        "text": "Chen",
        "label": "PERSON"
      },
      {
        "text": "Tang",
        "label": "PERSON"
      },
      {
        "text": "Zhang",
        "label": "GPE"
      },
      {
        "text": "Shen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "PMID: 40666053 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40666053",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "be construed as a potential conflict interest.",
    "entities": []
  },
  {
    "text": "Back With Vengeance: Delayed Gastrointestinal Sequelae of Histoplasmosis in a",
    "entities": []
  },
  {
    "text": "Patient With STAT3 Hyper-IgE Syndrome.",
    "entities": []
  },
  {
    "text": "(1)Digestive Diseases Branch, National Institute of Diabetes and Digestive and",
    "entities": [
      {
        "text": "Diseases Branch",
        "label": "ORG"
      },
      {
        "text": "National Institute of Diabetes and",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Kidney Diseases, National Institutes of Health, Bethesda, MD.",
    "entities": [
      {
        "text": "Kidney Diseases",
        "label": "PERSON"
      },
      {
        "text": "National Institutes of Health",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Gastroenterology, University of Maryland Medical Center,",
    "entities": [
      {
        "text": "Gastroenterology, University of Maryland Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Clinical Research Directorate, Frederick National Laboratory for Cancer",
    "entities": [
      {
        "text": "3)Clinical Research Directorate",
        "label": "ORG"
      },
      {
        "text": "Frederick National Laboratory for Cancer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research, Frederick, MD.",
    "entities": [
      {
        "text": "Frederick",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Laboratory of Pathology, National Cancer Institute, Bethesda, MD.",
    "entities": [
      {
        "text": "4)Laboratory",
        "label": "CARDINAL"
      },
      {
        "text": "Pathology",
        "label": "ORG"
      },
      {
        "text": "National Cancer Institute",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Laboratory of Clinical Immunology and Microbiology, National Institute of",
    "entities": [
      {
        "text": "Clinical Immunology and Microbiology",
        "label": "ORG"
      },
      {
        "text": "National Institute of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.",
    "entities": [
      {
        "text": "National Institutes of Health",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and",
    "entities": []
  },
  {
    "text": "(1)Department of Nephrology, Caidian District People's Hospital, Wuhan, China.",
    "entities": [
      {
        "text": "Nephrology, Caidian District People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Wuhan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Chronic kidney disease (CKD) represents a major global public health challenge,",
    "entities": []
  },
  {
    "text": "significantly impacting patients' quality of life and placing a heavy burden on",
    "entities": []
  },
  {
    "text": "healthcare systems. While diabetes and hypertension are the primary risk factors",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for CKD, non-diabetic CKD also constitutes a significant proportion, with its",
    "entities": [
      {
        "text": "CKD",
        "label": "ORG"
      },
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "complex pathological mechanisms necessitating the development of novel",
    "entities": []
  },
  {
    "text": "therapeutic strategies. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors,",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "initially developed for diabetes management, have recently demonstrated",
    "entities": []
  },
  {
    "text": "remarkable renal and cardiovascular protective effects in patients with",
    "entities": []
  },
  {
    "text": "non-diabetic CKD. SGLT-2 inhibitors exert their effects through multiple",
    "entities": [
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mechanisms, including reactivating the tubulo-glomerular feedback, reducing",
    "entities": []
  },
  {
    "text": "inflammation and fibrosis, and improving systemic metabolic parameters such as",
    "entities": []
  },
  {
    "text": "lowering blood pressure, uric acid levels, and body weight. These effects not",
    "entities": []
  },
  {
    "text": "only slow the progression of kidney function decline but also significantly",
    "entities": []
  },
  {
    "text": "reduce the risk of end-stage renal disease (ESRD) and cardiovascular events.",
    "entities": [
      {
        "text": "ESRD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Landmark clinical trials such as DAPA-CKD, CREDENCE, and EMPA-KIDNEY provide",
    "entities": [
      {
        "text": "CREDENCE",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "strong scientific evidence supporting the use of SGLT-2 inhibitors in",
    "entities": []
  },
  {
    "text": "non-diabetic CKD, demonstrating their broad clinical benefits and excellent",
    "entities": [
      {
        "text": "CKD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "safety profile. Despite potential adverse effects such as urinary tract",
    "entities": []
  },
  {
    "text": "infections, hypotension, and diabetic ketoacidosis, appropriate patient",
    "entities": []
  },
  {
    "text": "selection and personalized treatment strategies can effectively manage these",
    "entities": []
  },
  {
    "text": "risks. The multi-system effects of SGLT-2 inhibitors not only expand their",
    "entities": []
  },
  {
    "text": "clinical indications but also offer new hope for the comprehensive management of",
    "entities": []
  },
  {
    "text": "non-diabetic CKD patients, with significant clinical implications and broad",
    "entities": []
  },
  {
    "text": "Artificial intelligence in ophthalmology: a bibliometric analysis of the 5-year",
    "entities": [
      {
        "text": "5-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "trends in literature.",
    "entities": []
  },
  {
    "text": "(1)Department of Ophthalmology, West China Hospital, Sichuan University,",
    "entities": [
      {
        "text": "Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "Sichuan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chengdu, China.",
    "entities": [
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: This study aims to generate and elucidate the latest perspectives on",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the application of artificial intelligence (AI) in ophthalmology using",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "bibliometric methods. By analyzing literature from the past 5 years (2020-2024),",
    "entities": [
      {
        "text": "the past 5 years",
        "label": "DATE"
      },
      {
        "text": "2020-2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "we seek to outline the development trends of this technology, provide guidance",
    "entities": []
  },
  {
    "text": "for its future directions, and assist clinicians in adapting to these",
    "entities": [
      {
        "text": "clinicians",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "innovations.",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a comprehensive search of all literature related to AI and",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ophthalmology in the Web of Science Core Collection (WoSCC) using bibliometric",
    "entities": []
  },
  {
    "text": "methods. The collected data were analyzed and visualized using three widely",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "recognized bibliometric software tools: CiteSpace, VOSviewer, and the R package",
    "entities": [
      {
        "text": "CiteSpace",
        "label": "ORG"
      },
      {
        "text": "VOSviewer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 21,725 documents were included from 134 countries and 7,126",
    "entities": [
      {
        "text": "21,725",
        "label": "CARDINAL"
      },
      {
        "text": "134",
        "label": "CARDINAL"
      },
      {
        "text": "7,126",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "institutions, consisting of 19,978 articles (91.96%) and 1,714 reviews (8.04%),",
    "entities": [
      {
        "text": "19,978",
        "label": "CARDINAL"
      },
      {
        "text": "91.96%",
        "label": "PERCENT"
      },
      {
        "text": "1,714",
        "label": "CARDINAL"
      },
      {
        "text": "8.04%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "with China and the United States leading the contributions. The number of",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "publications in AI and ophthalmology has increased annually, with the University",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      },
      {
        "text": "annually",
        "label": "DATE"
      },
      {
        "text": "University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of California System, the National University of Singapore, and the University",
    "entities": [
      {
        "text": "California System",
        "label": "ORG"
      },
      {
        "text": "the National University of Singapore",
        "label": "ORG"
      },
      {
        "text": "University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of London being the primary research institutions. Ophthalmology and Proc CVPR",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "IEEE are the most co-cited journals and conferences in this field. These papers",
    "entities": []
  },
  {
    "text": "were authored by 87,695 individuals, with Wang Y, Liu Y, and Zhang Y the most",
    "entities": [
      {
        "text": "87,695",
        "label": "CARDINAL"
      },
      {
        "text": "Wang Y",
        "label": "PERSON"
      },
      {
        "text": "Liu Y",
        "label": "PERSON"
      },
      {
        "text": "Zhang Y",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "prolific authors. Ting DSW was the most co-cited author. Major research topics",
    "entities": [
      {
        "text": "Ting DSW",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "include using various models to scan retinal images for diagnosing conditions",
    "entities": []
  },
  {
    "text": "such as age-related macular degeneration, diabetic retinopathy, and retinal",
    "entities": []
  },
  {
    "text": "nerve fiber layer thinning caused by glaucoma. The intersection of AI with other",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "subfields of ophthalmology, such as in the diagnosis of ametropia, strabismus,",
    "entities": []
  },
  {
    "text": "eyelid disease, and orbital tumors, as well as in postoperative follow-up, is",
    "entities": []
  },
  {
    "text": "also rapidly developing. Key research hot spots are identified by keywords such",
    "entities": []
  },
  {
    "text": "as \"deep learning,\" \"machine learning,\" \"convolutional neural network,\"",
    "entities": []
  },
  {
    "text": "\"diabetic retinopathy,\" and \"ophthalmology.\"",
    "entities": []
  },
  {
    "text": "CONCLUSION: Our bibliometric analysis outlines the dynamic evolution and",
    "entities": []
  },
  {
    "text": "structural relationships within the AI and ophthalmology field. In contrast to",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "previous studies, our research transcends individual domains to offer a more",
    "entities": []
  },
  {
    "text": "comprehensive insight. Notably, our analysis encompasses literature published",
    "entities": []
  },
  {
    "text": "beyond the year 2022, a pivotal year marking both the post-pandemic era and the",
    "entities": [
      {
        "text": "the year 2022",
        "label": "DATE"
      },
      {
        "text": "year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "rapid advancement of AI technologies. This temporal scope potentially fills a",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "gap that prior bibliometric studies have not addressed. This information",
    "entities": []
  },
  {
    "text": "identifies recent research frontiers and hot spot areas, providing valuable",
    "entities": []
  },
  {
    "text": "reference points for scholars engaging in future AI and ophthalmology studies.",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Peng, Mu, Xu, Guo, Sun and Fan.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Peng",
        "label": "PERSON"
      },
      {
        "text": "Mu",
        "label": "ORG"
      },
      {
        "text": "Xu",
        "label": "PERSON"
      },
      {
        "text": "Guo",
        "label": "PERSON"
      },
      {
        "text": "Sun and Fan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Effects of combined training on quality of life in individuals with",
    "entities": []
  },
  {
    "text": "overweight-related type 2 diabetes: a pilot study of correlations with",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "metabolic, inflammatory and thermogenic markers.",
    "entities": []
  },
  {
    "text": "(1)Laboratory of Exercise Physiology, School of Physical Education, University",
    "entities": [
      {
        "text": "School of Physical Education",
        "label": "ORG"
      },
      {
        "text": "University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Postdoctoral Researcher Program (PPPD), University of Campinas, Campinas, S\u00e3o",
    "entities": [
      {
        "text": "2)Postdoctoral Researcher Program",
        "label": "ORG"
      },
      {
        "text": "University of Campinas",
        "label": "ORG"
      },
      {
        "text": "Campinas",
        "label": "GPE"
      },
      {
        "text": "S\u00e3o",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Higher Interdisciplinary Training Program (PROFIS), University of Campinas,",
    "entities": [
      {
        "text": "Interdisciplinary Training Program",
        "label": "ORG"
      },
      {
        "text": "PROFIS",
        "label": "ORG"
      },
      {
        "text": "University of Campinas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)The Rowett Institute of Nutrition and Health, University of Aberdeen,",
    "entities": [
      {
        "text": "Rowett Institute of Nutrition and Health, University of Aberdeen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Turku Pet Centre, University of Turku, Turku, Finland.",
    "entities": [
      {
        "text": "Pet Centre, University of Turku",
        "label": "ORG"
      },
      {
        "text": "Turku",
        "label": "GPE"
      },
      {
        "text": "Finland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Laboratory of Cell Signalling, Department of Internal Medicine, University of",
    "entities": [
      {
        "text": "Cell Signalling, Department of Internal Medicine, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Obesity and Comorbidities Research Center, University of Campinas, Campinas,",
    "entities": [
      {
        "text": "Comorbidities Research Center",
        "label": "ORG"
      },
      {
        "text": "University of Campinas",
        "label": "ORG"
      },
      {
        "text": "Campinas",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Radiology, University of Campinas, Campinas, S\u00e3o Paulo, Brazil.",
    "entities": [
      {
        "text": "Radiology, University of Campinas",
        "label": "ORG"
      },
      {
        "text": "Campinas",
        "label": "GPE"
      },
      {
        "text": "S\u00e3o Paulo",
        "label": "PERSON"
      },
      {
        "text": "Brazil",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: There is still a lack of information regarding the impact of",
    "entities": []
  },
  {
    "text": "training on the domains that constitute quality of life (QoL), and the",
    "entities": [
      {
        "text": "QoL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "relationship between QoL with hormonal, inflammatory and",
    "entities": [
      {
        "text": "QoL",
        "label": "EVENT"
      }
    ]
  },
  {
    "text": "pro-thermogenic/anti-inflammatory components. Thus, the present work aimed to",
    "entities": [
      {
        "text": "pro-thermogenic",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "evaluate the effects of combined training (CT) on the QoL of individuals with",
    "entities": []
  },
  {
    "text": "overweight-related type 2 diabetes mellitus (T2DM) and to correlate (baseline",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "values and CT-induced delta percentage changes (\u0394%)) QoL variables with",
    "entities": [
      {
        "text": "QoL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "hormonal, inflammatory, and pro-thermogenic/anti-inflammatory components.",
    "entities": []
  },
  {
    "text": "METHODS: Middle-aged individuals of both sexes and with overweight-related T2DM",
    "entities": []
  },
  {
    "text": "were assigned to either the control group (CONT group) or the combined training",
    "entities": [
      {
        "text": "CONT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "group (CTG). The CT consisted of strength training followed by aerobic training",
    "entities": [
      {
        "text": "CTG",
        "label": "ORG"
      },
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "three times/week for 16 weeks. Pre- and post-intervention assessments included",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "16 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "QoL perception, clinical variables, serum biochemical markers, and brown adipose",
    "entities": [
      {
        "text": "QoL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "tissue (BAT) activity.",
    "entities": []
  },
  {
    "text": "RESULTS: The CTG showed improvement in the perception of general QoL (20.0%) and",
    "entities": [
      {
        "text": "CTG",
        "label": "ORG"
      },
      {
        "text": "QoL",
        "label": "PERSON"
      },
      {
        "text": "20.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "in the physical (12.7%) and social (10.1%) domains. Significant positive",
    "entities": [
      {
        "text": "12.7%",
        "label": "PERCENT"
      },
      {
        "text": "10.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "correlations were observed between QoL variables with interleukin- 4 (IL-4),",
    "entities": [
      {
        "text": "QoL",
        "label": "EVENT"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "IL-10, IL-13, IL-33, Fibroblast growth factor- 21 (FGF-21), bone morphogenetic",
    "entities": [
      {
        "text": "IL-10",
        "label": "PRODUCT"
      },
      {
        "text": "IL-33",
        "label": "PRODUCT"
      },
      {
        "text": "21",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "protein- 4 (BMP4), irisin, and BAT activity, alongside negative correlations",
    "entities": []
  },
  {
    "text": "with IL-1, IL-2, IL-6, c reactive protein (CRP), tumor necrosis factor-alpha",
    "entities": [
      {
        "text": "IL-1",
        "label": "ORG"
      },
      {
        "text": "IL-6",
        "label": "ORG"
      },
      {
        "text": "CRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(TNF-\u03b1) and incretin hormones at baseline and/or in the \u0394% changes induced by",
    "entities": [
      {
        "text": "baseline and/or",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: CT improves the perception of general QoL and the physical and",
    "entities": [
      {
        "text": "QoL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "social domains of individuals with overweight-related T2DM. Baseline and in the",
    "entities": []
  },
  {
    "text": "\u0394% of CT change, QoL components are related with several clinical, hormonal,",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "QoL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "inflammatory, and pro-thermogenic/anti-inflammatory markers, besides BAT",
    "entities": []
  },
  {
    "text": "increased activity.",
    "entities": []
  },
  {
    "text": "PMID: 40665959 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "10.1161/CIRCIMAGING.125.018370. Online ahead of print.",
    "entities": [
      {
        "text": "10.1161",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Assessing LV Contractility Identifies Populations With Preserved Ejection",
    "entities": []
  },
  {
    "text": "Fraction at Risk of Adverse Heart Failure Outcomes.",
    "entities": []
  },
  {
    "text": "Straw S(1), Brown OI(1), Cole CA(2), Lowry JE(2), Conning-Rowland M(1),",
    "entities": [
      {
        "text": "Straw S(1",
        "label": "PRODUCT"
      },
      {
        "text": "Brown OI(1",
        "label": "PERSON"
      },
      {
        "text": "Cole CA(2",
        "label": "PERSON"
      },
      {
        "text": "Lowry JE(2",
        "label": "PERSON"
      },
      {
        "text": "Conning-Rowland",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "TA(1), Relton SD(4), Levelt E(1)(5), Witte KK(1), Kearney MT(1), Cubbon RM(1),",
    "entities": [
      {
        "text": "TA(1",
        "label": "PERSON"
      },
      {
        "text": "Relton",
        "label": "PERSON"
      },
      {
        "text": "Levelt",
        "label": "GPE"
      },
      {
        "text": "Witte KK(1",
        "label": "PERSON"
      },
      {
        "text": "Kearney MT(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Leeds Institute of Cardiovascular and Metabolic Medicine, University of",
    "entities": [
      {
        "text": "Institute of Cardiovascular",
        "label": "ORG"
      },
      {
        "text": "Metabolic Medicine, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Leeds, United Kingdom. (S.S., O.I.B., M.C.-R., M.F.P., M.D., T.A.S., E.L.,",
    "entities": [
      {
        "text": "Leeds",
        "label": "PERSON"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      },
      {
        "text": "S.S.",
        "label": "GPE"
      },
      {
        "text": "O.I.B.",
        "label": "ORG"
      },
      {
        "text": "M.C.-R.",
        "label": "PERSON"
      },
      {
        "text": "M.F.P.",
        "label": "ORG"
      },
      {
        "text": "M.D.",
        "label": "GPE"
      },
      {
        "text": "T.A.S.",
        "label": "GPE"
      },
      {
        "text": "E.L.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Leeds Teaching Hospitals NHS Trust, United Kingdom (C.A.C., J.E.L., S.K.,",
    "entities": [
      {
        "text": "Teaching Hospitals NHS Trust",
        "label": "ORG"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      },
      {
        "text": "J.E.L.",
        "label": "GPE"
      },
      {
        "text": "S.K.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)York and Scarborough Teaching Hospitals, United Kingdom (S.D.).",
    "entities": [
      {
        "text": "Scarborough Teaching Hospitals",
        "label": "ORG"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Leeds Institute for Data Analytics, University of Leeds, United Kingdom.",
    "entities": [
      {
        "text": "Institute for Data Analytics,",
        "label": "ORG"
      },
      {
        "text": "University of Leeds",
        "label": "ORG"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Baker Heart and Diabetes Institute, Melbourne, Australia (E.L.).",
    "entities": [
      {
        "text": "5)Baker",
        "label": "CARDINAL"
      },
      {
        "text": "Diabetes Institute",
        "label": "ORG"
      },
      {
        "text": "Melbourne",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      },
      {
        "text": "E.L.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Left ventricular ejection fraction (LVEF) is an essential tool for",
    "entities": []
  },
  {
    "text": "heart failure (HF) assessment but is limited by load dependence. Additional",
    "entities": []
  },
  {
    "text": "tools are needed to risk-stratify normal LVEF populations. We aimed to assess",
    "entities": []
  },
  {
    "text": "the prognostic value of systolic blood pressure-indexed left ventricular",
    "entities": []
  },
  {
    "text": "end-systolic volume ratio, or cardiac contractility index (CCI).",
    "entities": [
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: In a prospective observational cohort study of people newly diagnosed",
    "entities": []
  },
  {
    "text": "with HF, we defined characteristics and outcomes associated with LVEF and CCI,",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      },
      {
        "text": "LVEF",
        "label": "GPE"
      },
      {
        "text": "CCI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "including after stratification into HF with reduced ejection fraction or HF with",
    "entities": [
      {
        "text": "HF",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "preserved ejection fraction. We used UK Biobank to assess whether CCI is",
    "entities": [
      {
        "text": "UK Biobank",
        "label": "ORG"
      },
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with subclinical myocardial dysfunction and incident HF.",
    "entities": []
  },
  {
    "text": "RESULTS: In people with HF, mortality increased over tertiles of declining CCI",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      },
      {
        "text": "CCI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(P<0.001). Within the HF preserved ejection fraction group, below-median CCI was",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      },
      {
        "text": "CCI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "associated with distinct clinical characteristics and an all-cause mortality",
    "entities": []
  },
  {
    "text": "risk approximately twice that of those with above median CCI (observed event",
    "entities": []
  },
  {
    "text": "rate 17.3/100 patient-years versus 8.8/100 patient-years; P<0.001), similar to",
    "entities": [
      {
        "text": "17.3/100",
        "label": "CARDINAL"
      },
      {
        "text": "years",
        "label": "DATE"
      },
      {
        "text": "8.8/100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "those with HF with reduced ejection fraction. Modeled as continuous variables,",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "there was a curvilinear relationship between mortality across the detected range",
    "entities": []
  },
  {
    "text": "of CCI, while there was no clear association with mortality risk across a wide",
    "entities": [
      {
        "text": "CCI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "range of LVEF (20%-55%). In UK Biobank for participants without HF and normal",
    "entities": [
      {
        "text": "LVEF",
        "label": "ORG"
      },
      {
        "text": "20%-55%",
        "label": "PERCENT"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "Biobank",
        "label": "ORG"
      },
      {
        "text": "HF",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "LVEF, below-median CCI was associated with \u224833% increased risk of incident heart",
    "entities": [
      {
        "text": "LVEF",
        "label": "GPE"
      },
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "failure (adjusted hazard ratio, 1.33 [1.01-1.75]; P=0.043). Decreasing CCI was",
    "entities": [
      {
        "text": "1.33",
        "label": "CARDINAL"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "also associated with lower myocardial contractility defined using global radial",
    "entities": []
  },
  {
    "text": "and circumferential strain.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: CCI is a simple, noninvasive, relatively afterload-independent",
    "entities": [
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "method to stratify HF risk in populations with normal LVEF. Its simplicity means",
    "entities": []
  },
  {
    "text": "CCI could be applied to existing clinical trial data sets or used be as an",
    "entities": [
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inclusion criterion in future randomized controlled trials.",
    "entities": []
  },
  {
    "text": "53. CPT Pharmacometrics Syst Pharmacol. 2025 Jul 16. doi: 10.1002/psp4.70074.",
    "entities": [
      {
        "text": "53",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Online ahead of print.",
    "entities": []
  },
  {
    "text": "From In Vitro Efficacy to Long-Term HbA1c Response for GLP-1R/GlucagonR Agonism",
    "entities": []
  },
  {
    "text": "Using the 4GI-HbA1c Systems Model.",
    "entities": []
  },
  {
    "text": "(1)LAP&P Consultants, Leiden, the Netherlands.",
    "entities": [
      {
        "text": "1)LAP&P",
        "label": "CARDINAL"
      },
      {
        "text": "Consultants",
        "label": "GPE"
      },
      {
        "text": "Leiden",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Internal Medicine, Erasmus MC, University Medical Centre,",
    "entities": [
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "University Medical Centre",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Rotterdam, the Netherlands.",
    "entities": [
      {
        "text": "Rotterdam",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, UK.",
    "entities": [
      {
        "text": "AstraZeneca",
        "label": "ORG"
      },
      {
        "text": "Cambridge",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)AstraZeneca, Gaithersburg, Maryland, USA.",
    "entities": [
      {
        "text": "4)AstraZeneca",
        "label": "CARDINAL"
      },
      {
        "text": "Gaithersburg",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "For the treatment of Type 2 Diabetes, high efficacy approaches such as",
    "entities": []
  },
  {
    "text": "Glucagon-like peptide 1 (GLP-1)-based therapies are recommended for glucose",
    "entities": [
      {
        "text": "Glucagon",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "control. Prediction of the clinical outcome of these therapies on glucose and",
    "entities": []
  },
  {
    "text": "hemoglobin A1c (HbA1c), using early available pharmacokinetic and in vitro",
    "entities": [
      {
        "text": "A1c",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "efficacy information, can be a valuable tool for compound selection and",
    "entities": []
  },
  {
    "text": "supporting drug development. Our previously developed glucose homeostasis model",
    "entities": []
  },
  {
    "text": "(the 4GI model) is a systems model that is able to quantify drug effects on",
    "entities": []
  },
  {
    "text": "glucose based on in vitro potency and PK information. In this research, the",
    "entities": []
  },
  {
    "text": "model was coupled to an existing integrated glucose-red blood cell-HbA1c (IGRH)",
    "entities": []
  },
  {
    "text": "model for predicting the effects of GLP-1 and GLP-1/glucagon (dual) receptor",
    "entities": [
      {
        "text": "GLP-1",
        "label": "LOC"
      },
      {
        "text": "GLP-1",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "agonists, liraglutide and cotadutide, on glucose and HbA1c. The 4GI model was",
    "entities": []
  },
  {
    "text": "validated for predicting 24-h glucose (Cglc,av) with minimal model calibration",
    "entities": [
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "Cglc",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "using short-term Ph2a continuous glucose monitoring (CGM) data. Subsequently,",
    "entities": [
      {
        "text": "CGM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the predicted Cglc,av served as input for the HbA1c model to assess the",
    "entities": [
      {
        "text": "Cglc",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "predictiveness of the combined 4GI-HbA1c model on HbA1c. The resulting combined",
    "entities": []
  },
  {
    "text": "model was used in cotadutide's clinical development by providing predictive",
    "entities": []
  },
  {
    "text": "insights into the 26 weeks glucose and HbA1c dynamics of the Ph2b study prior to",
    "entities": [
      {
        "text": "the 26 weeks",
        "label": "DATE"
      },
      {
        "text": "Ph2b",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "its initiation. Retrospective analysis showed that the model adequately",
    "entities": []
  },
  {
    "text": "predicted the effect of cotadutide and liraglutide on fasting plasma glucose and",
    "entities": []
  },
  {
    "text": "HbA1c (Root Means Square Percent Error (RMSPE) 5.9% and 13%, respectively). This",
    "entities": [
      {
        "text": "Root Means Square Percent Error",
        "label": "ORG"
      },
      {
        "text": "RMSPE",
        "label": "ORG"
      },
      {
        "text": "5.9%",
        "label": "PERCENT"
      },
      {
        "text": "13%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "demonstrates the potential of the 4GI-HbA1c systems model as a valuable tool in",
    "entities": []
  },
  {
    "text": "supporting the clinical development of novel GLP-1 and/or glucagon agonists.",
    "entities": [
      {
        "text": "GLP-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). CPT: Pharmacometrics & Systems Pharmacology published by",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Pharmacometrics & Systems Pharmacology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology",
    "entities": [
      {
        "text": "Wiley Periodicals",
        "label": "ORG"
      },
      {
        "text": "American Society for Clinical Pharmacology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Therapeutics.",
    "entities": []
  },
  {
    "text": "54. J Mater Chem B. 2025 Jul 16. doi: 10.1039/d5tb00836k. Online ahead of print.",
    "entities": [
      {
        "text": "54",
        "label": "CARDINAL"
      },
      {
        "text": "10.1039",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Recombinant human collagen microneedle patches loaded with PRP for diabetic",
    "entities": [
      {
        "text": "PRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "wound treatment.",
    "entities": []
  },
  {
    "text": "(1)West China Second University Hospital, Sichuan University, South Renmin Road,",
    "entities": [
      {
        "text": "China Second University Hospital",
        "label": "ORG"
      },
      {
        "text": "Sichuan University",
        "label": "ORG"
      },
      {
        "text": "South Renmin Road",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Chengdu 610041, China.",
    "entities": [
      {
        "text": "Chengdu 610041",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)National Engineering Research Center for Biomaterials, Sichuan University,",
    "entities": [
      {
        "text": "Sichuan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)College of Biomedical Engineering, Sichuan University, 29# Wangjiang Road,",
    "entities": [
      {
        "text": "Biomedical Engineering",
        "label": "ORG"
      },
      {
        "text": "Sichuan University",
        "label": "ORG"
      },
      {
        "text": "29# Wangjiang",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "(4)Jiangsu Trautec Medical Technology Co., Ltd, 18# Jincheng Road, Changzhou,",
    "entities": [
      {
        "text": "Trautec Medical Technology Co., Ltd",
        "label": "ORG"
      },
      {
        "text": "18#",
        "label": "DATE"
      },
      {
        "text": "Changzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Sichuan Testing Center for Biomaterials and Medical Devices, Chengdu 610064,",
    "entities": [
      {
        "text": "5)Sichuan Testing Center for Biomaterials and Medical Devices",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chronic nonhealing wounds represent significant complications of diabetes,",
    "entities": []
  },
  {
    "text": "bearing a substantial burden and posing risks of disability or mortality. In",
    "entities": []
  },
  {
    "text": "diabetic wounds, continuous tissue fluid exudation, inflammatory cell migration,",
    "entities": []
  },
  {
    "text": "fibrosis, and bacterial biofilm formation create a \"barrier\", which decreases",
    "entities": []
  },
  {
    "text": "the treating efficacy of therapeutics. To address these limitations, a",
    "entities": []
  },
  {
    "text": "recombinant human collagen type III microneedle patch (rhCol III-PRPM) loaded",
    "entities": [
      {
        "text": "III",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with platelet-rich plasma (PRP) was developed, in which methacrylated rhCol III",
    "entities": [
      {
        "text": "PRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(rhCol III-MA) loaded with PRP was utilized to form needle tips, while rhCol",
    "entities": [
      {
        "text": "PRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "III-MA formed the base part of the patch. RhCol III-PRPM featured adequate",
    "entities": []
  },
  {
    "text": "mechanical qualities, swelling capacity, and sustained in vitro release of",
    "entities": []
  },
  {
    "text": "growth factors from the activation of PRP for over 7 days. Leveraging the",
    "entities": [
      {
        "text": "PRP",
        "label": "ORG"
      },
      {
        "text": "7 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "synergistic effects of rhCol III and PRP, rhCol III-PRPM patches facilitated",
    "entities": [
      {
        "text": "PRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cell proliferation, migration, and angiogenesis, and reduced oxidative stress.",
    "entities": []
  },
  {
    "text": "In animal experiments, this microneedle patch effectively promoted the healing",
    "entities": []
  },
  {
    "text": "of diabetic wounds during a 20-day treatment, partially due to upregulating",
    "entities": [
      {
        "text": "20-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "integrins and phosphorylated ERK protein levels. Diverging from other",
    "entities": [
      {
        "text": "ERK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "microneedle strategies, the rhCol III exhibited \"dual functionality,\" serving as",
    "entities": []
  },
  {
    "text": "both the microneedle patch matrix and therapeutic agent, promoting wound healing",
    "entities": []
  },
  {
    "text": "upon patch dissolution while delivering PRP. The combination of rhCol III and",
    "entities": [
      {
        "text": "PRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PRP in the form of a microneedle patch offered a straightforward and efficacious",
    "entities": [
      {
        "text": "PRP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "way for effective diabetic wound management, and showed promise in bringing new",
    "entities": []
  },
  {
    "text": "10.1177/19322968251358229. Online ahead of print.",
    "entities": []
  },
  {
    "text": "Recycling Insulin Pens: A Call for Action!",
    "entities": []
  },
  {
    "text": "(1)Working Group Diabetes, Environment & Climate of the German Diabetes",
    "entities": [
      {
        "text": "1)Working",
        "label": "CARDINAL"
      },
      {
        "text": "Group Diabetes, Environment & Climate",
        "label": "ORG"
      },
      {
        "text": "German",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Association (DDG), Berlin, Germany.",
    "entities": [
      {
        "text": "DDG",
        "label": "ORG"
      },
      {
        "text": "Berlin",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Science Consulting in Diabetes GmbH, D\u00fcsseldorf, Germany.",
    "entities": [
      {
        "text": "2)Science Consulting",
        "label": "ORG"
      },
      {
        "text": "D\u00fcsseldorf",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Clinical Research Unit and Working Group Experimental Diabetology and Islet",
    "entities": [
      {
        "text": "Research Unit",
        "label": "ORG"
      },
      {
        "text": "Working Group Experimental Diabetology",
        "label": "ORG"
      },
      {
        "text": "Islet",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Cell Biology, Medical Clinic and Polyclinic III, Center of Internal Medicine,",
    "entities": [
      {
        "text": "Cell Biology, Medical Clinic",
        "label": "ORG"
      },
      {
        "text": "Center of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Insulin pens are widely used by people with diabetes for insulin application.",
    "entities": [
      {
        "text": "Insulin",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Most often ready-to-use pens are used; however, disposal of these pens generates",
    "entities": []
  },
  {
    "text": "a considerable amount of plastic waste. Until now such pens have almost always",
    "entities": []
  },
  {
    "text": "been disposed of with household waste. We recommend to establish a nationwide",
    "entities": []
  },
  {
    "text": "recycling process for insulin pens in Germany over the next few years (PenDE).",
    "entities": [
      {
        "text": "Germany",
        "label": "GPE"
      },
      {
        "text": "the next few years",
        "label": "DATE"
      },
      {
        "text": "PenDE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Collecting and sorting of the finished pens have several facets, which are",
    "entities": []
  },
  {
    "text": "discussed in this commentary. It is primarily about recycling the actual",
    "entities": []
  },
  {
    "text": "product, ie, the finished pens, and not their packaging and packaging inserts.",
    "entities": []
  },
  {
    "text": "Such a project is only possible in close cooperation with the insulin pen",
    "entities": []
  },
  {
    "text": "manufacturers. The goal is to establish material cycles, ie, multiple use of",
    "entities": []
  },
  {
    "text": "materials such as recycled plastic.",
    "entities": []
  },
  {
    "text": "ahead of print.",
    "entities": []
  },
  {
    "text": "Liraglutide-Conjugated Poly(methyl vinyl ether-alt-maleic acid)-Coated",
    "entities": [
      {
        "text": "Liraglutide-Conjugated",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Core-Shell Upconversion Nanoparticles for Theranostics of Diabetes.",
    "entities": [
      {
        "text": "Core-Shell Upconversion Nanoparticles for Theranostics of Diabetes",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Institute of Macromolecular Chemistry of the Czech Academy of Sciences,",
    "entities": [
      {
        "text": "Macromolecular Chemistry",
        "label": "ORG"
      },
      {
        "text": "the Czech Academy of Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Institute of Physiology of the Czech Academy of Sciences, V\u00edde\u0148sk\u00e1 1083, 142",
    "entities": [
      {
        "text": "2)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "the Czech Academy of Sciences",
        "label": "ORG"
      },
      {
        "text": "1083",
        "label": "DATE"
      },
      {
        "text": "142",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "20 Prague 4, Czech Republic.",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "Prague",
        "label": "GPE"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "Czech Republic",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Prague 4, Czech Republic.",
    "entities": [
      {
        "text": "Prague",
        "label": "GPE"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "Czech Republic",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Institute of Biophysics and Informatics, First Faculty of Medicine, Charles",
    "entities": [
      {
        "text": "Informatics",
        "label": "ORG"
      },
      {
        "text": "First Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Charles\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, 121 08 Prague 1, Czech Republic.",
    "entities": [
      {
        "text": "121",
        "label": "CARDINAL"
      },
      {
        "text": "08",
        "label": "CARDINAL"
      },
      {
        "text": "Prague",
        "label": "GPE"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "Czech Republic",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Faculty of Health Studies, Technical University of Liberec, 461 17 Liberec,",
    "entities": [
      {
        "text": "Health Studies, Technical University of Liberec",
        "label": "ORG"
      },
      {
        "text": "461",
        "label": "CARDINAL"
      },
      {
        "text": "Liberec",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "In the diagnostics of diabetes, specific targeting of drugs (e.g., liraglutide)",
    "entities": []
  },
  {
    "text": "to insulin-deficient \u03b2-cells with their simultaneous noninvasive imaging is",
    "entities": []
  },
  {
    "text": "currently needed. In this report, liraglutide (LGL)-conjugated poly(methyl vinyl",
    "entities": [
      {
        "text": "LGL)-conjugated poly(methyl vinyl\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ether-alt-maleic acid) (PMVEMA)-coated core-shell NaYF4:Yb,Er,Fe@NaYF4:Nd",
    "entities": []
  },
  {
    "text": "upconversion nanoparticles (CS-UCNPs) have been developed, thoroughly",
    "entities": [
      {
        "text": "CS-UCNPs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "physicochemically characterized, and evaluated in vivo. Novel codoping of Fe2+,",
    "entities": []
  },
  {
    "text": "Yb3+, and Er3+ ions in the host NaYF4 induced upconversion emission in the red",
    "entities": []
  },
  {
    "text": "region at both 980 and 808 nm excitation, making the particles suitable for",
    "entities": [
      {
        "text": "980",
        "label": "CARDINAL"
      },
      {
        "text": "808",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "deep-tissue imaging. Surface functionalization with PMVEMA provided colloidal",
    "entities": [
      {
        "text": "PMVEMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stability and facilitated covalent conjugation with LGL, enabling targeted",
    "entities": [
      {
        "text": "LGL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "binding to GLP-1 receptors on pancreatic \u03b2-cells, increasing glucose-stimulated",
    "entities": [
      {
        "text": "GLP-1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "insulin secretion from isolated Langerhans islets. Biocompatibility of",
    "entities": [
      {
        "text": "Langerhans",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "CS-UCNP@PMVEMA-LGL nanoparticles was confirmed by the trypan blue dye exclusion",
    "entities": [
      {
        "text": "CS-UCNP@PMVEMA-LGL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "assay. When the fluorescent dye Flamma was conjugated to the nanoparticles, in",
    "entities": [
      {
        "text": "Flamma",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "vivo fluorescence imaging revealed significantly enhanced accumulation of",
    "entities": []
  },
  {
    "text": "CS-UCNP@PMVEMA-LGL-Flamma nanoparticles in the pancreas 24 h after intramuscular",
    "entities": [
      {
        "text": "CS-UCNP@PMVEMA-LGL-Flamma",
        "label": "ORG"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "injection compared with intravenous administration, with luminescence intensity",
    "entities": []
  },
  {
    "text": "approximately doubled. The improved pancreatic targeting efficiency was",
    "entities": []
  },
  {
    "text": "attributed to enhanced binding to GLP-1 receptors. Confocal microscopy and",
    "entities": [
      {
        "text": "GLP-1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "elemental analysis confirmed receptor-mediated uptake of the nanoparticles by",
    "entities": []
  },
  {
    "text": "internalization and their localization within pancreatic \u03b2-cells. These findings",
    "entities": []
  },
  {
    "text": "highlight the potential of CS-UCNP@PMVEMA-LGL nanoparticles as biocompatible",
    "entities": [
      {
        "text": "CS-UCNP@PMVEMA-",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "targetable imaging agents with future applications in pancreatic diagnostics.",
    "entities": []
  },
  {
    "text": "10.1177/15910199251342841. Online ahead of print.",
    "entities": [
      {
        "text": "10.1177/15910199251342841",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Baseline predictors of poor clinical outcome despite recanalization of distal",
    "entities": []
  },
  {
    "text": "middle cerebral artery occlusions.",
    "entities": []
  },
  {
    "text": "Sheth SA(20), Essibayi MA(21), Puri AS(8), Dyzmann C(22), Colasurdo M(23),",
    "entities": [
      {
        "text": "Sheth",
        "label": "PERSON"
      },
      {
        "text": "Puri AS(8",
        "label": "PERSON"
      },
      {
        "text": "Dyzmann C(22",
        "label": "PERSON"
      },
      {
        "text": "Colasurdo M(23",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "TR(16), Spears J(16), Ota T(29), Mowla A(30), Jabbour P(5), Biswas A(31),",
    "entities": [
      {
        "text": "Mowla A(30",
        "label": "PERSON"
      },
      {
        "text": "Jabbour P(5",
        "label": "PERSON"
      },
      {
        "text": "Biswas A(31",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pedicelli A(43), Alexandre AM(43), Tancredi I(44), Faizy TD(45), Kalsoum E(11),",
    "entities": [
      {
        "text": "Pedicelli A(43",
        "label": "PERSON"
      },
      {
        "text": "Alexandre",
        "label": "PERSON"
      },
      {
        "text": "Faizy",
        "label": "PERSON"
      },
      {
        "text": "Kalsoum E(11",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Diagnostic and Interventional Neuroradiology, Erasme University",
    "entities": [
      {
        "text": "Diagnostic and Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Erasme University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Radiology, Division of Neuroradiology, Johns Hopkins Medical",
    "entities": [
      {
        "text": "Radiology, Division of Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, Baltimore, Maryland, USA.",
    "entities": [
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Neuroendovascular Program, Massachusetts General Hospital, Harvard",
    "entities": [
      {
        "text": "3)Neuroendovascular",
        "label": "CARDINAL"
      },
      {
        "text": "Program",
        "label": "GPE"
      },
      {
        "text": "Massachusetts General Hospital",
        "label": "ORG"
      },
      {
        "text": "Harvard",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Boston, MA, USA.",
    "entities": [
      {
        "text": "University,",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Neurosurgery and Interventional Neuroradiology, Louisiana State",
    "entities": [
      {
        "text": "Neurosurgery and Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Louisiana State",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Shreveport, LA, USA.",
    "entities": [
      {
        "text": "University",
        "label": "GPE"
      },
      {
        "text": "Shreveport",
        "label": "GPE"
      },
      {
        "text": "LA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery",
        "label": "PERSON"
      },
      {
        "text": "Thomas Jefferson University",
        "label": "PERSON"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Neurology, University of Massachusetts Chan Medical School,",
    "entities": [
      {
        "text": "Neurology, University of Massachusetts Chan Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Worcester, MA, USA.",
    "entities": [
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Endovascular Neurosurgery and Neuroradiology, Rutgers Health",
    "entities": [
      {
        "text": "Endovascular Neurosurgery and Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Rutgers Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "New Jersey Medical School (NJMS), Newark, NJ, USA.",
    "entities": [
      {
        "text": "New Jersey Medical School (NJMS",
        "label": "ORG"
      },
      {
        "text": "Newark",
        "label": "GPE"
      },
      {
        "text": "NJ",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Division of Neurointerventional Radiology, Department of Radiology,",
    "entities": [
      {
        "text": "Neurointerventional Radiology,",
        "label": "ORG"
      },
      {
        "text": "Department of Radiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Massachusetts Medical Center, Worcester, MA, USA.",
    "entities": [
      {
        "text": "University of Massachusetts Medical Center",
        "label": "ORG"
      },
      {
        "text": "Worcester",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Cooper Neurological Institute, Cooper University Hospital, Cooper Medical",
    "entities": [
      {
        "text": "Neurological Institute",
        "label": "ORG"
      },
      {
        "text": "Cooper University Hospital",
        "label": "ORG"
      },
      {
        "text": "Cooper Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Rowan University, Camden, NJ, USA.",
    "entities": [
      {
        "text": "School of Rowan University",
        "label": "ORG"
      },
      {
        "text": "Camden",
        "label": "GPE"
      },
      {
        "text": "NJ",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Departments of Neurological Surgery & Radiology, Mayo Clinic, Rochester, MN,",
    "entities": [
      {
        "text": "10)Departments",
        "label": "CARDINAL"
      },
      {
        "text": "Neurological Surgery & Radiology",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "MN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Neurology, University of Chicago, Chicago, IL, USA.",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology, University of Chicago",
        "label": "ORG"
      },
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Department of Neuroradiology, Henri Mondor Hospital, Creteil, France.",
    "entities": [
      {
        "text": "12)Department of Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Henri Mondor Hospital",
        "label": "ORG"
      },
      {
        "text": "Creteil",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Department of Medicine, Yong Loo Lin School of Medicine, National University",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Yong Loo Lin School of Medicine",
        "label": "ORG"
      },
      {
        "text": "National University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(14)Division of Neurology, Department of Medicine, National University Hospital,",
    "entities": [
      {
        "text": "14)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology, Department of Medicine,",
        "label": "ORG"
      },
      {
        "text": "National University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Department of Interventional Neuroradiology, Stanford Medical Center, Palo",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Stanford Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(16)Neurovascular Centre, Divisions of Therapeutic Neuroradiology and",
    "entities": []
  },
  {
    "text": "Neurosurgery, St Michael's Hospital, Toronto, ON, Canada.",
    "entities": [
      {
        "text": "St Michael's",
        "label": "PERSON"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "ON",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical",
    "entities": [
      {
        "text": "17)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery, Brigham and Women's Hospital",
        "label": "ORG"
      },
      {
        "text": "Harvard Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School, Boston, MA, USA.",
    "entities": [
      {
        "text": "School",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)University Hospital of Limoges, Neuroradiology Department, Dupuytren,",
    "entities": [
      {
        "text": "Neuroradiology Department",
        "label": "ORG"
      },
      {
        "text": "Dupuytren",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(19)Department of Diagnostic and Interventional Neuroradiology, University",
    "entities": [
      {
        "text": "19)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Interventional Neuroradiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Center Hamburg-Eppendorf, Hamburg, Germany.",
    "entities": [
      {
        "text": "Hamburg",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(20)Department of Neurology, UTHealth McGovern Medical School, Houston, TX, USA.",
    "entities": [
      {
        "text": "20)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "UTHealth McGovern Medical School",
        "label": "ORG"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(21)Department of Neurological Surgery and Montefiore-Einstein Cerebrovascular",
    "entities": [
      {
        "text": "21)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Montefiore-Einstein Cerebrovascular",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research Lab, Montefiore Medical Center, Albert Einstein College of Medicine,",
    "entities": [
      {
        "text": "Montefiore Medical Center",
        "label": "ORG"
      },
      {
        "text": "Albert Einstein College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bronx, NY, USA.",
    "entities": [
      {
        "text": "Bronx",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(23)Department of Interventional Radiology, Oregon Health and Science",
    "entities": [
      {
        "text": "23)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Interventional Radiology",
        "label": "ORG"
      },
      {
        "text": "Oregon Health and Science\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Portland, OR, USA.",
    "entities": [
      {
        "text": "Portland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(24)Interventional Neuroradiology Department, Bordeaux University Hospital,",
    "entities": [
      {
        "text": "24)Interventional Neuroradiology Department",
        "label": "ORG"
      },
      {
        "text": "Bordeaux University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Italy.",
    "entities": [
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(26)Department of Diagnostic and Interventional Neuroradiology, Centro",
    "entities": [
      {
        "text": "26)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Diagnostic and Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Centro",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(27)Department of Neurology, University of Cincinnati Medical Center,",
    "entities": [
      {
        "text": "27)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology, University of Cincinnati Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(28)Department of Neuroradiology, Gui de Chauliac Hospital, Montpellier",
    "entities": [
      {
        "text": "28)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Gui de Chauliac Hospital",
        "label": "ORG"
      },
      {
        "text": "Montpellier",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Medical Center, Montpellier, France.",
    "entities": [
      {
        "text": "University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Montpellier",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(29)Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Tokyo,",
    "entities": [
      {
        "text": "29)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "Tokyo Metropolitan Tama Medical Center",
        "label": "ORG"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(30)Division of Stroke and Endovascular Neurosurgery, Department of Neurological",
    "entities": [
      {
        "text": "Department of Neurological",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Surgery, Keck School of Medicine, University of Southern California (USC), Los",
    "entities": [
      {
        "text": "Keck School of Medicine, University of Southern California",
        "label": "ORG"
      },
      {
        "text": "USC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(31)Department of Neurosurgery, Westchester Medical Center at New York Medical",
    "entities": [
      {
        "text": "31)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery, Westchester Medical Center",
        "label": "ORG"
      },
      {
        "text": "New York Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(33)GRC BioFast. Sorbonne University Paris VI, Paris, France.",
    "entities": [
      {
        "text": "BioFast",
        "label": "ORG"
      },
      {
        "text": "Sorbonne University",
        "label": "ORG"
      },
      {
        "text": "Paris VI",
        "label": "PERSON"
      },
      {
        "text": "Paris",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(34)Departments of Radiology & Neurology, Boston Medical Center, Boston, MA,",
    "entities": [
      {
        "text": "34)Departments of Radiology & Neurology",
        "label": "ORG"
      },
      {
        "text": "Boston Medical Center",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(36)Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, CA,",
    "entities": [
      {
        "text": "36)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery",
        "label": "PRODUCT"
      },
      {
        "text": "Cedars-Sinai Medical Center",
        "label": "ORG"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(38)Department of Interventional Neuroradiology, Nancy University Hospital,",
    "entities": [
      {
        "text": "38)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Nancy University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Nancy, France.",
    "entities": [
      {
        "text": "Nancy",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(39)INSERM U1254, Laboratory of Adaptive Diagnostic and Interventional Imaging",
    "entities": [
      {
        "text": "39)INSERM",
        "label": "CARDINAL"
      },
      {
        "text": "U1254, Laboratory of Adaptive Diagnostic",
        "label": "ORG"
      },
      {
        "text": "Interventional Imaging",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(40)Department of Radiology, Interventional Neuroradiology Section, University",
    "entities": [
      {
        "text": "40)Department of Radiology, Interventional Neuroradiology Section",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(41)Departments of Neurology & Neurosurgery, Christian Doppler Clinic,",
    "entities": [
      {
        "text": "41)Departments",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology & Neurosurgery",
        "label": "ORG"
      },
      {
        "text": "Christian Doppler Clinic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Paracelsus Medical University Salzburg, Salzburg, Austria.",
    "entities": [
      {
        "text": "Paracelsus Medical University Salzburg",
        "label": "ORG"
      },
      {
        "text": "Salzburg",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(42)UCLA Stroke Center and Department of Neurology Department, UCLA, Los",
    "entities": [
      {
        "text": "42)UCLA Stroke Center and Department of Neurology Department",
        "label": "WORK_OF_ART"
      },
      {
        "text": "UCLA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "A. Gemelli IRCCS Roma, Roma, Italy.",
    "entities": [
      {
        "text": "A. Gemelli IRCCS Roma",
        "label": "PERSON"
      },
      {
        "text": "Roma",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(44)Department of Neurology, H\u00f4pital Civil Marie Curie, Charleroi, Belgium.",
    "entities": [
      {
        "text": "Marie Curie",
        "label": "PERSON"
      },
      {
        "text": "Charleroi",
        "label": "GPE"
      },
      {
        "text": "Belgium",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(45)Department of Radiology, Neuroendovascular Program, University Medical",
    "entities": [
      {
        "text": "Radiology, Neuroendovascular Program",
        "label": "ORG"
      },
      {
        "text": "University Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(46)Department of Medicine - Division of Neurology; The Ottawa Hospital, Ottawa",
    "entities": [
      {
        "text": "46)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Medicine - Division of Neurology",
        "label": "ORG"
      },
      {
        "text": "The Ottawa Hospital",
        "label": "ORG"
      },
      {
        "text": "Ottawa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospital Research Institute and University of Ottawa, Ottawa-Ontario, Canada.",
    "entities": [
      {
        "text": "Hospital Research Institute",
        "label": "ORG"
      },
      {
        "text": "University of Ottawa",
        "label": "ORG"
      },
      {
        "text": "Ottawa",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "ObjectiveMechanical thrombectomy (MT) is well-established for the treatment of",
    "entities": [
      {
        "text": "ObjectiveMechanical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "acute ischemic stroke (AIS) from large vessel occlusion (LVO), with growing data",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      },
      {
        "text": "LVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "supporting the expansion to distal and medium vessel occlusions (DMVO). Despite",
    "entities": []
  },
  {
    "text": "successful recanalization in DMVO, certain patients still experience poor",
    "entities": [
      {
        "text": "DMVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "long-term clinical outcomes, prompting our study to comprehensively explore",
    "entities": []
  },
  {
    "text": "pre-MT factors influencing outcome despite excellent recanalization (final",
    "entities": []
  },
  {
    "text": "modified Thrombolysis in Cerebral Infarction [mTICI] score \u22652c).MethodsWe",
    "entities": [
      {
        "text": "\u22652c).MethodsWe",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "retrospectively examined data from patients who consecutively underwent MT for a",
    "entities": []
  },
  {
    "text": "primary middle cerebral artery (MCA) DMVO across 37 centers in North America,",
    "entities": [
      {
        "text": "MCA",
        "label": "ORG"
      },
      {
        "text": "DMVO",
        "label": "ORG"
      },
      {
        "text": "37",
        "label": "CARDINAL"
      },
      {
        "text": "North America",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Asia, and Europe. We identified baseline clinical and imaging factors associated",
    "entities": [
      {
        "text": "Asia",
        "label": "LOC"
      },
      {
        "text": "Europe",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "with poor clinical outcome (defined as a modified Rankin Scale [mRS] score of",
    "entities": [
      {
        "text": "Rankin Scale",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "3-6) at 3 months, despite excellent recanalization using a multivariable",
    "entities": [
      {
        "text": "3-6",
        "label": "CARDINAL"
      },
      {
        "text": "3 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "model.ResultsBetween September 2017 and July 2021, 623 patients achieved",
    "entities": [
      {
        "text": "ResultsBetween September 2017 and July 2021",
        "label": "EVENT"
      },
      {
        "text": "623",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mTICI > 2b and they were included in our study. Among them, 198 (32%)",
    "entities": [
      {
        "text": "2b",
        "label": "CARDINAL"
      },
      {
        "text": "198",
        "label": "CARDINAL"
      },
      {
        "text": "32%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "experienced a poor clinical outcome (mRS 3-6). Predictors of poor clinical",
    "entities": [
      {
        "text": "3-6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "outcome included higher age (OR 1.05 [1.03-1.07], p < 0.001), higher NIHSS at",
    "entities": [
      {
        "text": "1.05",
        "label": "CARDINAL"
      },
      {
        "text": "1.03",
        "label": "CARDINAL"
      },
      {
        "text": "NIHSS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "admission (OR 1.12 [1.08-1.15], p < 0.001), higher baseline mRS (OR 1.77",
    "entities": [
      {
        "text": "1.12",
        "label": "CARDINAL"
      },
      {
        "text": "1.08",
        "label": "CARDINAL"
      },
      {
        "text": "1.77",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[0.96-3.26], p = 0.067), and diabetes (OR 1.59 [1.01-2.48], p = 0.044). Higher",
    "entities": [
      {
        "text": "0.96",
        "label": "CARDINAL"
      },
      {
        "text": "3.26",
        "label": "CARDINAL"
      },
      {
        "text": "0.067",
        "label": "CARDINAL"
      },
      {
        "text": "1.59",
        "label": "CARDINAL"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "0.044",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ASPECTS was associated with a decreased risk of poor clinical outcome (OR 0.82",
    "entities": [
      {
        "text": "0.82",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[0.71-0.94], p = 0.006).ConclusionOlder age, diabetes, higher baseline mRS, and",
    "entities": [
      {
        "text": "0.71",
        "label": "CARDINAL"
      },
      {
        "text": "0.006).ConclusionOlder age",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "NIHSS were associated with poor clinical outcome in MCA DMVO despite excellent",
    "entities": [
      {
        "text": "NIHSS",
        "label": "ORG"
      },
      {
        "text": "MCA DMVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "recanalization. Conversely, a higher ASPECTS decreased the probability of such",
    "entities": [
      {
        "text": "ASPECTS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "an outcome.",
    "entities": []
  },
  {
    "text": "58. J Complement Integr Med. 2025 Jul 16. doi: 10.1515/jcim-2024-0434. Online",
    "entities": [
      {
        "text": "58",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1515",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "A Comparative evaluation of locally delivered licorice gel and tetracycline gel",
    "entities": []
  },
  {
    "text": "as an adjunct to non-surgical therapy in the treatment of controlled type -2",
    "entities": []
  },
  {
    "text": "diabetic patients with periodontitis stage II and grade B - A split mouth",
    "entities": []
  },
  {
    "text": "(1)Vishnu Dental College, Bhimavaram, Andhra Pradesh, India.",
    "entities": [
      {
        "text": "Dental College",
        "label": "ORG"
      },
      {
        "text": "Bhimavaram",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Periodontics and Implantology, 77203 Vishnu Dental College ,",
    "entities": [
      {
        "text": "Periodontics and Implantology",
        "label": "ORG"
      },
      {
        "text": "Vishnu Dental College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVES: Periodontitis is an inflammatory disease affecting tooth-supporting",
    "entities": [
      {
        "text": "Periodontitis",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "structures due to dysbiosis in plaque bio-film. While NSPT remains the gold",
    "entities": [
      {
        "text": "NSPT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "standard treatment, it limits in its capacity to fully eradicate pathogens,",
    "entities": []
  },
  {
    "text": "necessitating adjunct antimicrobial therapy. Local drug delivery(LDD) offers",
    "entities": [
      {
        "text": "necessitating adjunct",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "targeted treatment with fewer side effects compared to systemic antimicrobial",
    "entities": []
  },
  {
    "text": "therapy. Recent studies highlight herbal extracts, such as licorice (Glycyrrhiza",
    "entities": [
      {
        "text": "Glycyrrhiza",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "glabra), which exhibit antimicrobial and anti-inflammatory properties, making",
    "entities": []
  },
  {
    "text": "them promising candidates for LDD. Therefore, the goal was to evaluate the",
    "entities": [
      {
        "text": "LDD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effectiveness of licorice gel and tetracycline gel as a non-surgical treatment",
    "entities": []
  },
  {
    "text": "auxiliary for individuals with stage II periodontitis and grade B type-2",
    "entities": [
      {
        "text": "II",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "METHODS: In this randomized, double-blind clinical trial, 20 patients with",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Type-II diabetes were included. Following NSPT, licorice and tetracycline gel",
    "entities": [
      {
        "text": "NSPT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were applied locally as adjuncts to both the test and control groups. Clinical",
    "entities": []
  },
  {
    "text": "parameters such as Probing pocket depth (PPD), Clinical attachment level (CAL),",
    "entities": [
      {
        "text": "CAL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bleeding on probing (BOP) were evaluated at base line and 1 month and Landry's",
    "entities": [
      {
        "text": "BOP",
        "label": "ORG"
      },
      {
        "text": "1 month",
        "label": "DATE"
      },
      {
        "text": "Landry",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "healing index at 7th day.",
    "entities": [
      {
        "text": "7th day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: In intergroup analysis, licorice gel has shown statistically",
    "entities": []
  },
  {
    "text": "significant reduction in PPD and CAL with better healing when compared to",
    "entities": [
      {
        "text": "CAL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "tetracycline gel.However, there was no statistically significant difference",
    "entities": []
  },
  {
    "text": "between the groups in terms of bleeding on probing.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Both licorice and tetracycline gel are equally effective in",
    "entities": []
  },
  {
    "text": "treating pockets but licorice gel as an LDD agent has shown better and",
    "entities": [
      {
        "text": "LDD",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "encouragingoutcomes in terms of healing, PPD and CAL.",
    "entities": [
      {
        "text": "CAL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "10.1080/17446651.2025.2532560. Online ahead of print.",
    "entities": []
  },
  {
    "text": "Association of thyroid function within the normal range with glycemic control",
    "entities": []
  },
  {
    "text": "and cardiovascular risk factors in type 1 diabetes.",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Faculty of Medicine of University of Porto, Porto, Portugal.",
    "entities": [
      {
        "text": "Medicine of University of Porto",
        "label": "ORG"
      },
      {
        "text": "Porto",
        "label": "GPE"
      },
      {
        "text": "Portugal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Endocrinology, Diabetes and Metabolism, S\u00e3o Jo\u00e3o Local Health",
    "entities": [
      {
        "text": "S\u00e3o Jo\u00e3o Local Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)RISE-Health, Department of Surgery and Physiology, Faculty of Medicine,",
    "entities": [
      {
        "text": "3)RISE-Health, Department of Surgery and Physiology, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Porto, Porto, Portugal.",
    "entities": [
      {
        "text": "University of Porto",
        "label": "ORG"
      },
      {
        "text": "Porto",
        "label": "GPE"
      },
      {
        "text": "Portugal",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Medicine, Faculty of Medicine of University of Porto, Porto,",
    "entities": [
      {
        "text": "Medicine, Faculty of Medicine of University of Porto",
        "label": "ORG"
      },
      {
        "text": "Porto",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Thyroid hormone (TH) variations, even within the normal range,",
    "entities": []
  },
  {
    "text": "influence cardiometabolic health. In type 1 diabetes (T1D), optimizing glycemic",
    "entities": [
      {
        "text": "influence cardiometabolic",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "control and cardiovascular risk is crucial to prevent complications. We aim to",
    "entities": []
  },
  {
    "text": "explore the association of TH within normal range with cardiometabolic profile",
    "entities": [
      {
        "text": "TH",
        "label": "ORG"
      },
      {
        "text": "cardiometabolic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESEARCH DESIGN AND METHODS: Cross-sectional analysis including adult patients",
    "entities": [
      {
        "text": "RESEARCH DESIGN",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "with T1D followed at our Endocrinology Department between 2022-2024. We excluded",
    "entities": [
      {
        "text": "Endocrinology Department",
        "label": "ORG"
      },
      {
        "text": "between 2022-2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patients with TSH or fT4 outside the reference range. Associations between TH",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      },
      {
        "text": "fT4",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(TSH, fT4, fT3 and fT3/fT4 ratio) and glycemic, anthropometric, and",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      },
      {
        "text": "fT4",
        "label": "ORG"
      },
      {
        "text": "fT3",
        "label": "PRODUCT"
      },
      {
        "text": "fT3/fT4",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cardiometabolic parameters, were evaluated using linear regression models",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "unadjusted and adjusted for relevant variables. Restricted cubic splines between",
    "entities": []
  },
  {
    "text": "TH and glycemic control parameters were performed to assess non-linear",
    "entities": []
  },
  {
    "text": "associations.",
    "entities": [
      {
        "text": "associations",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: We included 296 patients (median age 35 years, 42.6% female). Patients",
    "entities": [
      {
        "text": "296",
        "label": "CARDINAL"
      },
      {
        "text": "age 35 years",
        "label": "DATE"
      },
      {
        "text": "42.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "with mid-range TSH had better glycemic control, with higher time in range and a",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lower time above range. Waist circumference and body mass index were negatively",
    "entities": []
  },
  {
    "text": "associated with fT4, and positively with fT3 and fT3/fT4 ratio. Estimated",
    "entities": [
      {
        "text": "fT4",
        "label": "ORG"
      },
      {
        "text": "fT3 and fT3/fT4",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "glomerular filtration rate was negatively associated with TSH and fT4, and",
    "entities": [
      {
        "text": "TSH",
        "label": "ORG"
      },
      {
        "text": "fT4",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "positively with fT3 and fT3/fT4.",
    "entities": [
      {
        "text": "fT3 and fT3/fT4",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Variations in TH within the normal range were associated with",
    "entities": []
  },
  {
    "text": "glycemic control and cardiovascular risk factors in T1D.",
    "entities": [
      {
        "text": "T1D.",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "60. Diabet Med. 2025 Jul 15:e70105. doi: 10.1111/dme.70105. Online ahead of",
    "entities": [
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "Diabet Med",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Type 2 diabetes risk communication following a diagnosis of gestational diabetes",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Caba M(1), Northern A(2), Virdee A(2), Khunti K(1)(2)(3)(4), Davies MJ(1)(2)(4),",
    "entities": [
      {
        "text": "Caba",
        "label": "PERSON"
      },
      {
        "text": "Virdee A(2",
        "label": "PERSON"
      },
      {
        "text": "Khunti K(1)(2)(3)(4",
        "label": "PERSON"
      },
      {
        "text": "Davies",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Diabetes Research Centre, College of Life Sciences, University of Leicester,",
    "entities": [
      {
        "text": "Research Centre",
        "label": "ORG"
      },
      {
        "text": "College of Life Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Leicester",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust,",
    "entities": [
      {
        "text": "2)Leicester",
        "label": "CARDINAL"
      },
      {
        "text": "Leicester NHS Trust",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)NIHR Applied Research Collaboration East Midlands, Leicester, UK.",
    "entities": [
      {
        "text": "3)NIHR",
        "label": "CARDINAL"
      },
      {
        "text": "Applied Research Collaboration",
        "label": "ORG"
      },
      {
        "text": "Leicester",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)NIHR Leicester Biomedical Research Centre, Leicester, UK.",
    "entities": [
      {
        "text": "4)NIHR Leicester Biomedical Research Centre",
        "label": "ORG"
      },
      {
        "text": "Leicester",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Gestational diabetes mellitus (GDM) increases women's risk of",
    "entities": [
      {
        "text": "GDM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "developing type 2 diabetes (T2DM) tenfold. Understanding of T2DM risk in women",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with GDM is variable and can impact health behaviours. To better understand how",
    "entities": [
      {
        "text": "GDM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "T2DM risk is communicated by healthcare professionals, we explored women's",
    "entities": []
  },
  {
    "text": "experiences of T2DM risk communication and support following a diagnosis of GDM.",
    "entities": [
      {
        "text": "GDM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: A qualitative study was conducted utilising semi-structured interviews.",
    "entities": []
  },
  {
    "text": "Participants were 10 women previously diagnosed with GDM. Transcripts were",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "GDM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analysed following reflexive thematic analysis guidelines.",
    "entities": []
  },
  {
    "text": "RESULTS: Three themes and four sub-themes were created to describe women's",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "experiences of, and responses to, T2DM risk communication and support following",
    "entities": []
  },
  {
    "text": "a diagnosis of GDM. Minimal T2DM risk communication during GDM and postnatally",
    "entities": [
      {
        "text": "GDM",
        "label": "ORG"
      },
      {
        "text": "GDM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was a common experience, and as a result, women forgot about their increased",
    "entities": []
  },
  {
    "text": "risk and felt forgotten by the health service. The lack of correspondence and",
    "entities": []
  },
  {
    "text": "support further fostered a dearth of knowledge and misunderstandings regarding",
    "entities": []
  },
  {
    "text": "what T2DM is, how it affects a person's body, and the necessity of preventative",
    "entities": []
  },
  {
    "text": "actions, all of which could impact women's management of their risk. Several",
    "entities": []
  },
  {
    "text": "strategies were suggested by women to remedy the currently absent communication",
    "entities": []
  },
  {
    "text": "and support. This included group education sessions, tangible and digital",
    "entities": []
  },
  {
    "text": "support resources, providing individualised information, and continuous and",
    "entities": []
  },
  {
    "text": "harmonious T2DM risk communication from healthcare professionals and health",
    "entities": []
  },
  {
    "text": "services.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Current deficiencies for communicating T2DM risk and providing",
    "entities": []
  },
  {
    "text": "avenues of support following a diagnosis of GDM leaves many women feeling",
    "entities": [
      {
        "text": "GDM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "under-supported. Improvements to current care are recommended to ameliorate",
    "entities": []
  },
  {
    "text": "this.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Diabetic Medicine published by John Wiley & Sons Ltd on",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "John Wiley & Sons Ltd",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "behalf of Diabetes UK.",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PMID: 4066556461. Nephrology (Carlton). 2025 Jul;30(7):e70097. doi: 10.1111/nep.70097.",
    "entities": [
      {
        "text": "4066556461",
        "label": "DATE"
      },
      {
        "text": "Carlton",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Machine Learning Models for Predicting Acute and Chronic Kidney Diseases During",
    "entities": [
      {
        "text": "Predicting Acute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Post-Covid-19 Pandemic.",
    "entities": []
  },
  {
    "text": "(1)Quantitative Life Sciences, McGill University, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "Life Sciences",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)McGill Genome Centre, McGill University, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "2)McGill",
        "label": "CARDINAL"
      },
      {
        "text": "Genome Centre",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Canada Excellence Research Chair in Genomic Medicine, McGill University,",
    "entities": [
      {
        "text": "Excellence Research Chair",
        "label": "ORG"
      },
      {
        "text": "Genomic Medicine",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Human Genetics, McGill University, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "Human Genetics",
        "label": "ORG"
      },
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Diabetes, Endocrinology and Nutrition, Kyoto University",
    "entities": [
      {
        "text": "Diabetes, Endocrinology and Nutrition",
        "label": "ORG"
      },
      {
        "text": "Kyoto University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Graduate School of Medicine, Kyoto, Japan.",
    "entities": [
      {
        "text": "Graduate School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Kyoto",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "62. Br J Pharmacol. 2025 Jul 15. doi: 10.1111/bph.70140. Online ahead of print.",
    "entities": [
      {
        "text": "62",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1111",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Combination therapy in preclinical studies and clinical trials: Evidence, gaps",
    "entities": []
  },
  {
    "text": "and the path ahead.",
    "entities": []
  },
  {
    "text": "(1)III. Department of Medicine and Hamburg Center for Kidney Health (HCKH),",
    "entities": [
      {
        "text": "Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Hamburg",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University Medical Center Hamburg-Eppendorf, Hamburg, Germany.",
    "entities": [
      {
        "text": "University Medical Center Hamburg-Eppendorf",
        "label": "ORG"
      },
      {
        "text": "Hamburg",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Division of Pharmacology, Department of Internal Medicine, Erasmus MC,",
    "entities": [
      {
        "text": "Pharmacology, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Rotterdam, The Netherlands.",
    "entities": [
      {
        "text": "Rotterdam",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Neonatal Outcomes Among Neonates of Women With and Without Type 1 Diabetes in",
    "entities": [
      {
        "text": "Neonatal Outcomes Among Neonates of Women With",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sweden From 2010 to 2022.",
    "entities": [
      {
        "text": "Sweden",
        "label": "GPE"
      },
      {
        "text": "2010",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Department of Clinical Science and Education, Karolinska Institutet Soder",
    "entities": [
      {
        "text": "Clinical Science and Education",
        "label": "ORG"
      },
      {
        "text": "Karolinska Institutet Soder",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Department of Women's and Children's Health, Uppsala University, Uppsala,",
    "entities": [
      {
        "text": "Women's and Children's Health",
        "label": "ORG"
      },
      {
        "text": "Uppsala University",
        "label": "ORG"
      },
      {
        "text": "Uppsala",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "AIM: This register-based study aimed to investigate differences in adverse",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "neonatal outcomes between neonates born to mothers with and without type 1",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "METHODS: A nationwide cohort study was conducted using the Swedish Medical Birth",
    "entities": [
      {
        "text": "Swedish",
        "label": "NORP"
      },
      {
        "text": "Birth\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Register, including all singleton births from 22 gestational weeks between 2010",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      },
      {
        "text": "2010",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and 2022. The neonatal outcomes among neonates of women with and without type 1",
    "entities": [
      {
        "text": "2022",
        "label": "DATE"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diabetes were studied with descriptive statistics and logistic regressions.",
    "entities": []
  },
  {
    "text": "Adjusted odds ratios (aORs) with 95% confidence intervals are presented.",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "RESULTS: The study consisted of 1 402 394 neonates, and 0.5% had a mother with",
    "entities": [
      {
        "text": "1 402",
        "label": "CARDINAL"
      },
      {
        "text": "0.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "type 1 diabetes. Neonates of mothers with type 1 diabetes had increased odds of",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "stillbirth (aOR 2.54; 95% CI 1.98-3.28), congenital malformations (aOR 1.66; 95%",
    "entities": [
      {
        "text": "2.54",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.98-3.28",
        "label": "CARDINAL"
      },
      {
        "text": "1.66",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI 1.50-1.84), preterm birth (aOR 3.80; 95% CI 3.41-4.23), large for gestational",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.50-1.84",
        "label": "DATE"
      },
      {
        "text": "3.80",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "3.41",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and neonatal death (aOR 4.1; 95% CI 3.00-5.83).",
    "entities": [
      {
        "text": "4.1",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "3.00-5.83",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: Neonates of mothers with type 1 diabetes continue to experience",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "poorer neonatal outcomes, highlighting the need for more research on the causes",
    "entities": []
  },
  {
    "text": "and how care can be improved for their mothers during pregnancy.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Acta Paediatrica published by John Wiley & Sons Ltd on",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Acta Paediatrica",
        "label": "PERSON"
      },
      {
        "text": "John Wiley & Sons Ltd",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "behalf of Foundation Acta Paediatrica.",
    "entities": [
      {
        "text": "Foundation Acta Paediatrica",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "64. J Basic Clin Physiol Pharmacol. 2025 Jul 17. doi: 10.1515/jbcpp-2025-0115.",
    "entities": [
      {
        "text": "64",
        "label": "CARDINAL"
      },
      {
        "text": "Clin Physiol Pharmacol",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1515",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Long-term retention of diabetes management skills in type 1 diabetic patients",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "trained with advanced technologies.",
    "entities": []
  },
  {
    "text": "(1)Department of Translational Medical Sciences, 165474 Federico II University",
    "entities": [
      {
        "text": "Translational Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "165474",
        "label": "DATE"
      },
      {
        "text": "Federico II University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Diabetology Clinic San Luca, Ariano Irpino, Italy.",
    "entities": [
      {
        "text": "Clinic San Luca",
        "label": "LOC"
      },
      {
        "text": "Ariano Irpino",
        "label": "PERSON"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Moscati Hospital, Endocrinology Unit, Avellino, Italy.",
    "entities": [
      {
        "text": "Hospital, Endocrinology Unit",
        "label": "ORG"
      },
      {
        "text": "Avellino",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: The effectiveness of diabetes management depends significantly on",
    "entities": []
  },
  {
    "text": "patients' knowledge of key concepts such as carbohydrate counting, bolus timing,",
    "entities": []
  },
  {
    "text": "duration of insulin action, and the interpretation of trend arrows. This study",
    "entities": []
  },
  {
    "text": "aims to evaluate the understanding of these concepts among patients with type 1",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diabetes who are using advanced technologies.",
    "entities": []
  },
  {
    "text": "METHODS: From January 2024 to July 2024, consecutive patients with type 1",
    "entities": [
      {
        "text": "January 2024 to July 2024",
        "label": "DATE"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diabetes who met inclusion criteria were enrolled. Participants were asked to",
    "entities": []
  },
  {
    "text": "complete a questionnaire to assess their retention of key concepts for T1D",
    "entities": []
  },
  {
    "text": "management. Each patient completed the questionnaire independently in a private",
    "entities": []
  },
  {
    "text": "room before their medical appointment.",
    "entities": []
  },
  {
    "text": "RESULTS: This study evaluated therapeutic education in adult T1D patients in",
    "entities": []
  },
  {
    "text": "Campania, Italy, who use advanced diabetes technologies. Despite most patients",
    "entities": [
      {
        "text": "Campania",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "having long-term diabetes, significant knowledge gaps were found in diabetes",
    "entities": []
  },
  {
    "text": "management. Only 40 % of CGM users correctly correlated sensor data with",
    "entities": [
      {
        "text": "Only 40 %",
        "label": "PERCENT"
      },
      {
        "text": "CGM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "capillary glucose, and 19 % erroneously believed they were identical. Just 25 %",
    "entities": [
      {
        "text": "19 %",
        "label": "PERCENT"
      },
      {
        "text": "Just 25 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "patients knew their insulin-to-carbohydrate ratio, and only 56 % accurately",
    "entities": [
      {
        "text": "only 56 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "calculated carbohydrates. Even among users of advanced hybrid closed-loop",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Understanding of key concepts necessary for effective management of",
    "entities": []
  },
  {
    "text": "diabetes using advanced technologies remains insufficient in a cohort of Italian",
    "entities": [
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "65. Gen Thorac Cardiovasc Surg Cases. 2025 Jul 15;4(1):31. doi:",
    "entities": [
      {
        "text": "65",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15;4(1):31",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1186/s44215-025-00216-3.",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Minimally invasive video-assisted resection of a papillary fibroelastoma",
    "entities": []
  },
  {
    "text": "originating from the papillary muscle of the left ventricle: a case report.",
    "entities": []
  },
  {
    "text": "(1)Department of Cardiovascular Surgery, Sakurabashi Watanabe Advanced",
    "entities": [
      {
        "text": "Sakurabashi Watanabe Advanced",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Healthcare Hospital, Osaka, Japan.",
    "entities": [
      {
        "text": "Healthcare Hospital",
        "label": "ORG"
      },
      {
        "text": "Osaka",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Cardiovascular Surgery, The University of Osaka Graduate School",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "The University of Osaka Graduate School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Osaka, Japan.",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "Osaka",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Cardiovascular Surgery, Sakurabashi Watanabe Advanced",
    "entities": [
      {
        "text": "Sakurabashi Watanabe Advanced",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Healthcare Hospital, Osaka, Japan. sekiyan73@gmail.com.",
    "entities": [
      {
        "text": "Healthcare Hospital",
        "label": "ORG"
      },
      {
        "text": "Osaka",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Papillary fibroelastoma is a rare, benign cardiac tumor that",
    "entities": []
  },
  {
    "text": "typically originates from the cardiac valves, with papillary muscle involvement",
    "entities": []
  },
  {
    "text": "being extremely rare. However, optimal management of papillary fibroelastoma",
    "entities": []
  },
  {
    "text": "CASE PRESENTATION: A 79-year-old female with multiple comorbidities, including",
    "entities": [
      {
        "text": "79-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Parkinson's syndrome, diabetes, and frailty, was referred to our hospital",
    "entities": []
  },
  {
    "text": "because an incidental left ventricular mass was detected during a preoperative",
    "entities": []
  },
  {
    "text": "evaluation for knee osteoarthritis. Echocardiography and computed tomography",
    "entities": []
  },
  {
    "text": "revealed a mobile, 17-mm mass in the left ventricle, possibly attached to the",
    "entities": [
      {
        "text": "17-mm",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "posterior papillary muscle. The morphological findings were suspicious for",
    "entities": []
  },
  {
    "text": "papillary fibroelastoma. The tumor was surgically resected from the papillary",
    "entities": []
  },
  {
    "text": "muscle using a three-dimensional thoracoscopy-assisted right limited-thoracotomy",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "approach. Histopathological analysis confirmed the diagnosis of papillary",
    "entities": []
  },
  {
    "text": "fibroelastoma. Postoperatively, the patient was discharged without",
    "entities": []
  },
  {
    "text": "complications, and no recurrence was observed at the 1-year follow-up.",
    "entities": [
      {
        "text": "1-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSION: This case demonstrates the feasibility and efficacy of minimally",
    "entities": []
  },
  {
    "text": "invasive video-assisted right thoracotomy for the resection of a papillary",
    "entities": []
  },
  {
    "text": "fibroelastoma originating from the papillary muscle.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s).",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s44215-025-00216-3",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethics approval and consent to",
    "entities": []
  },
  {
    "text": "participate: This work does not require ethical considerations or approval.",
    "entities": []
  },
  {
    "text": "Informed consent to participate in this study was obtained from the patients.",
    "entities": []
  },
  {
    "text": "Consent for publication: Written informed consent was obtained from the parents",
    "entities": []
  },
  {
    "text": "of the patient for publication of this case report and accompanying images.",
    "entities": []
  },
  {
    "text": "Competing interests: The authors declare that they have no competing interests.",
    "entities": []
  },
  {
    "text": "Association between pressure ulcer and 28-day mortality in septic patients: a",
    "entities": [
      {
        "text": "28-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "retrospective study based on the MIMIC-IV database.",
    "entities": [
      {
        "text": "MIMIC",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "(1)Department of Emergency and Critical Care, Shanghai Changzheng Hospital of",
    "entities": [
      {
        "text": "Emergency and Critical Care",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Naval Medical University, No.415 of Fengyang Road, Huangpu District, Shanghai,",
    "entities": [
      {
        "text": "Naval Medical University",
        "label": "ORG"
      },
      {
        "text": "Fengyang Road",
        "label": "FAC"
      },
      {
        "text": "Huangpu District",
        "label": "GPE"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Information Science and Engineering, Xinjiang College of",
    "entities": [
      {
        "text": "Xinjiang College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Science & Technology, Xinjiang, 841000, China.",
    "entities": [
      {
        "text": "Science & Technology",
        "label": "ORG"
      },
      {
        "text": "Xinjiang",
        "label": "GPE"
      },
      {
        "text": "841000",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Emergency and Critical Care, Shanghai Changzheng Hospital of",
    "entities": [
      {
        "text": "Emergency and Critical Care",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Emergency and Critical Care, Shanghai Changzheng Hospital of",
    "entities": [
      {
        "text": "Emergency and Critical Care",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Emergency and Critical Care, Shanghai Changzheng Hospital of",
    "entities": [
      {
        "text": "Emergency and Critical Care",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Pressure ulcer is a significant issue that cannot be overlooked in",
    "entities": []
  },
  {
    "text": "septic patients. This study aims to explore the impact of pressure ulcers on the",
    "entities": []
  },
  {
    "text": "28 day mortality rate of septic patients.",
    "entities": [
      {
        "text": "28 day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "METHODS: The data for this study were obtained from the MIMIC-IV v3.0 database.",
    "entities": [
      {
        "text": "MIMIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Univariate and multivariate analysis methods were employed to conduct an",
    "entities": []
  },
  {
    "text": "in-depth exploration of the 28 day mortality rate of septic patients.",
    "entities": [
      {
        "text": "28 day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Kaplan-Meier survival curves were plotted to verify the influence of pressure",
    "entities": [
      {
        "text": "Kaplan-Meier",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "ulcer on the 28 day mortality rate of septic patients. In addition, subgroup",
    "entities": [
      {
        "text": "28 day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "analysis was carried out to reveal the relationship between pressure ulcer and",
    "entities": []
  },
  {
    "text": "other confounding factors.",
    "entities": []
  },
  {
    "text": "RESULTS: Among the 20,280 patients included in the MIMIC-IV cohort, 880 had",
    "entities": [
      {
        "text": "20,280",
        "label": "CARDINAL"
      },
      {
        "text": "MIMIC",
        "label": "LOC"
      },
      {
        "text": "880",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "pressure ulcers. Both the results of univariate and multivariate analyses showed",
    "entities": []
  },
  {
    "text": "that pressure ulcers were a significant influencing factor for the 28 day",
    "entities": [
      {
        "text": "the 28 day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mortality rate of septic patients (p = 0.002). The survival curves indicated",
    "entities": [
      {
        "text": "0.002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "that the 28 day mortality rate of septic patients with pressure ulcers was",
    "entities": [
      {
        "text": "28 day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "significantly higher than that of septic patients without pressure ulcers. The",
    "entities": []
  },
  {
    "text": "Cox proportional hazards model analysis demonstrated that septic patients with",
    "entities": []
  },
  {
    "text": "pressure ulcers had a 28 day mortality hazard ratio of 1.30 compared with septic",
    "entities": [
      {
        "text": "28 day",
        "label": "DATE"
      },
      {
        "text": "1.30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients without pressure ulcers. The results of subgroup analysis suggested",
    "entities": []
  },
  {
    "text": "that more attention should be paid to the prevention of pressure ulcers in",
    "entities": []
  },
  {
    "text": "patients younger than 65 years old, male patients, patients with a SOFA score",
    "entities": [
      {
        "text": "65 years old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "greater than 3, and patients with comorbid diabetes or renal diseases .",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: Pressure ulcers may independently associate with increased mortality",
    "entities": []
  },
  {
    "text": "in septic patients.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s40001-025-02909-5",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665447 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665447",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: This study was conducted in accordance with the declaration of",
    "entities": []
  },
  {
    "text": "Helsinki. Patient information within the database has been anonymized;",
    "entities": []
  },
  {
    "text": "therefore, informed consent was not required. Consent for publication: Not",
    "entities": []
  },
  {
    "text": "applicable. Competing interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Analysis of risk factors of cholangiocarcinoma, role of diabetes mellitus and",
    "entities": []
  },
  {
    "text": "hepatitis B virus infection in the intrahepatic and extrahepatic",
    "entities": []
  },
  {
    "text": "cholangiocarcinoma: a retrospective case-based study in China.",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Biliary-Pancreatical Surgery, General Surgery, The Second",
    "entities": [
      {
        "text": "Biliary-Pancreatical Surgery",
        "label": "ORG"
      },
      {
        "text": "Surgery",
        "label": "PERSON"
      },
      {
        "text": "Second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Affiliated Hospital of Harbin Medical University, Harbin, 150086, Heilongjiang",
    "entities": [
      {
        "text": "Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Harbin Medical University",
        "label": "ORG"
      },
      {
        "text": "Harbin",
        "label": "GPE"
      },
      {
        "text": "150086",
        "label": "DATE"
      },
      {
        "text": "Heilongjiang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Province, China.",
    "entities": [
      {
        "text": "Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Biliary-Pancreatical Surgery, General Surgery, The Second",
    "entities": [
      {
        "text": "Biliary-Pancreatical Surgery",
        "label": "ORG"
      },
      {
        "text": "Surgery",
        "label": "PERSON"
      },
      {
        "text": "Second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Province, China. yfcui7@163.com.",
    "entities": [
      {
        "text": "Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The cause and carcinogenesis of cholangiocarcinoma (CCA) remain",
    "entities": [
      {
        "text": "CCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "unclear. In this study, we conducted a population-based case-control study in",
    "entities": []
  },
  {
    "text": "China to evaluate the effects of diabetes mellitus (DM), hepatitis B virus (HBV)",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "infection, and other potential risk factors for cholangiocarcinoma (CCA).",
    "entities": [
      {
        "text": "CCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: A hospital-based, case-control study was conducted, including 245 CCA",
    "entities": [
      {
        "text": "245",
        "label": "CARDINAL"
      },
      {
        "text": "CCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients (168 with extrahepatic cholangiocarcinoma (eCCA) and 77 with",
    "entities": [
      {
        "text": "168",
        "label": "CARDINAL"
      },
      {
        "text": "77",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "intrahepatic cholangiocarcinoma (iCCA), diagnosed at The Second Affiliated",
    "entities": []
  },
  {
    "text": "Hospital of Harbin Medical University in China between January 2019 and June",
    "entities": [
      {
        "text": "Harbin Medical University",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "between January 2019 and June\n",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2024, along with 490 healthy controls matched in a 2:1 ratio. Conditional",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "490",
        "label": "CARDINAL"
      },
      {
        "text": "2:1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "logistic regression and the synergism index were used to analyze risk factors",
    "entities": []
  },
  {
    "text": "for cholangiocarcinoma and their potential correlations.",
    "entities": []
  },
  {
    "text": "RESULTS: There was an association between DM, HBV infection, cholelithiasis,",
    "entities": [
      {
        "text": "HBV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "choledocholithiasis, hepatolithiasis, and thyroid diseases were significantly",
    "entities": []
  },
  {
    "text": "and positively correlated with CCA, with adjusted odds ratios (AOR = 1.53; 95%",
    "entities": [
      {
        "text": "CCA",
        "label": "ORG"
      },
      {
        "text": "1.53",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI = 1.26-1.85; P < 0.001), (AOR = 2.55; 95% CI = 1.25-5.20; P < 0.010),",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.26-1.85",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.001",
        "label": "ORG"
      },
      {
        "text": "2.55",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.25-5.20",
        "label": "CARDINAL"
      },
      {
        "text": "0.010",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(AOR = 1.71; 95% CI = 1.14-2.58; P < 0.009), (AOR = 4.67; 95% CI = 1.76-12.37;",
    "entities": [
      {
        "text": "1.71",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.14",
        "label": "CARDINAL"
      },
      {
        "text": "4.67",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.76",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "P < 0.002), (AOR = 3.00; 95% CI = 1.24-7.25; P < 0.015), and (AOR = 5.46; 95%",
    "entities": [
      {
        "text": "0.002",
        "label": "CARDINAL"
      },
      {
        "text": "3.00",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.24",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.015",
        "label": "ORG"
      },
      {
        "text": "5.46",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI = 2.04-14.60; P < 0.001) respectively. A synergistic interaction between HBV",
    "entities": [
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "2.04-14.60",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.001",
        "label": "ORG"
      },
      {
        "text": "HBV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infection and DM was investigated using an interactive bar chart. In the",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "subgroup analyses, the results for eCCA included DM (AOR = 1.40; 95%",
    "entities": [
      {
        "text": "1.40",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI = 1.10-1.78; P < 0.006), cholelithiasis (AOR = 1.60; 95% CI = 1.14-2.31;",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.10-1.78",
        "label": "CARDINAL"
      },
      {
        "text": "0.006",
        "label": "CARDINAL"
      },
      {
        "text": "AOR",
        "label": "ORG"
      },
      {
        "text": "1.60",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "P < 0.013), CBD stones (AOR = 4.05; 95% CI = 1.47-11.12; P < 0.007),",
    "entities": [
      {
        "text": "0.013",
        "label": "CARDINAL"
      },
      {
        "text": "4.05",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.47-11.12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hepatolithiasis (AOR = 5.80; 95% CI = 1.50-22.40; P < 0.010), and thyroid",
    "entities": [
      {
        "text": "5.80",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.50",
        "label": "CARDINAL"
      },
      {
        "text": "0.010",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diseases (AOR = 11.18; 95% CI = 2.57-48.5; P < 0.001), all of which were",
    "entities": [
      {
        "text": "11.18",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "2.57",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significant for eCCA. Whereas DM (AOR = 2.61; 95%CI = 1.52-4.48; P < 0.001),",
    "entities": [
      {
        "text": "2.61",
        "label": "CARDINAL"
      },
      {
        "text": "1.52",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cholelithiasis (AOR = 4.34; 95%CI = 1.53-12.34; P < 0.006), hepatolithiasis",
    "entities": [
      {
        "text": "4.34",
        "label": "CARDINAL"
      },
      {
        "text": "1.53-12.34",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(AOR = 3.55; 95%CI = 1.05-12.00; P < 0.042), and HBV infection (AOR = 3.55;",
    "entities": [
      {
        "text": "3.55",
        "label": "CARDINAL"
      },
      {
        "text": "1.05-12.00",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.042",
        "label": "ORG"
      },
      {
        "text": "HBV",
        "label": "ORG"
      },
      {
        "text": "3.55",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95%CI = 1.55-8.15; P < 0.003) were significant risk factors for iCCA.",
    "entities": [
      {
        "text": "1.55-8.15",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.003",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Synergistic interaction between HBV infection and DM was also observed,",
    "entities": [
      {
        "text": "HBV",
        "label": "ORG"
      },
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resulting in a stronger association. Furthermore, a history of cholecystectomy",
    "entities": []
  },
  {
    "text": "(AOR = 0.39; 95%CI = (0.15-0.99); p < 0.048) demonstrates a protective function.",
    "entities": [
      {
        "text": "0.39",
        "label": "CARDINAL"
      },
      {
        "text": "0.15-0.99",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSION: This Chinese study found that DM is an independent risk factor for",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CCA, particularly iCCA, and also increases the risk of eCCA. HBV infection is",
    "entities": [
      {
        "text": "CCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exclusively associated with iCCA, whereas choledocholithiasis, hepatolithiasis,",
    "entities": []
  },
  {
    "text": "and DM can cause both eCCA and iCCA. CBD stones enhance CCA risk, especially",
    "entities": [
      {
        "text": "DM",
        "label": "ORG"
      },
      {
        "text": "CCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "eCCA. By understanding this synergy, effective prevention methods for high-risk",
    "entities": []
  },
  {
    "text": "CCA may be established.",
    "entities": [
      {
        "text": "CCA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: The authors",
    "entities": []
  },
  {
    "text": "declare no competing interests. Ethical statement: The protocol for this",
    "entities": []
  },
  {
    "text": "research project has been approved by the Ethics Committee of The Second",
    "entities": [
      {
        "text": "the Ethics Committee of The Second\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Affiliated Hospital of Harbin Medical University, which approved the",
    "entities": [
      {
        "text": "Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Harbin Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "investigation. Ethics Committee approved number KY2025- 096. All the patients in",
    "entities": [
      {
        "text": "Ethics Committee",
        "label": "ORG"
      },
      {
        "text": "KY2025-",
        "label": "ORG"
      },
      {
        "text": "096",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "this study signed written informed consent. Conflict of interest: All the",
    "entities": []
  },
  {
    "text": "authors report having no conflicts of interest for this article.",
    "entities": []
  },
  {
    "text": "68. Br J Dermatol. 2025 Jul 16:ljaf213. doi: 10.1093/bjd/ljaf213. Online ahead of",
    "entities": [
      {
        "text": "68",
        "label": "CARDINAL"
      },
      {
        "text": "Br J Dermatol",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Prurigo nodularis: disease burden, clinical features and approach to management.",
    "entities": []
  },
  {
    "text": "(1)Department of Dermatology, University of Maryland School of Medicine,",
    "entities": [
      {
        "text": "Dermatology, University of Maryland School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Baltimore, Maryland, USA.",
    "entities": [
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Maryland Itch Center, University of Maryland School of Medicine, Baltimore,",
    "entities": [
      {
        "text": "Itch Center",
        "label": "ORG"
      },
      {
        "text": "University of Maryland School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Maryland, USA.",
    "entities": [
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Institute of Allergology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate",
    "entities": []
  },
  {
    "text": "(4)Fraunhofer Institute for Translational Medicine and Pharmacology ITMP,",
    "entities": [
      {
        "text": "Institute for Translational Medicine and Pharmacology ITMP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Immunology and Allergology Berlin, Berlin, Germany.",
    "entities": [
      {
        "text": "Allergology Berlin",
        "label": "GPE"
      },
      {
        "text": "Berlin",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Dermatology, French Expert Itch Center, University Hospital,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "French",
        "label": "NORP"
      },
      {
        "text": "Itch Center",
        "label": "ORG"
      },
      {
        "text": "University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Dermatology, University of Pennsylvania Perelman School of",
    "entities": [
      {
        "text": "Dermatology, University of Pennsylvania Perelman School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.",
    "entities": [
      {
        "text": "7)Regeneron Pharmaceuticals Inc.",
        "label": "ORG"
      },
      {
        "text": "Tarrytown",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Sanofi, Reading, UK.",
    "entities": [
      {
        "text": "Reading",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Prurigo nodularis (PN) is a distinct, chronic inflammatory skin disease",
    "entities": []
  },
  {
    "text": "characterised by intensely pruritic, fibrotic nodular lesions. Despite continued",
    "entities": []
  },
  {
    "text": "progress in the field, lack of clarity regarding the definition of PN as a",
    "entities": []
  },
  {
    "text": "disease, clinical presentation and therapeutic options results in delayed",
    "entities": []
  },
  {
    "text": "diagnosis and management. PN can arise following other diseases, but once",
    "entities": []
  },
  {
    "text": "established, it is an independent disease. Here, we summarise the current",
    "entities": []
  },
  {
    "text": "knowledge of epidemiology, clinical characteristics, disease burden and",
    "entities": []
  },
  {
    "text": "management approaches that may help healthcare providers recognise PN as a",
    "entities": []
  },
  {
    "text": "primary diagnosis independent of triggers or associated comorbidities. PN is",
    "entities": []
  },
  {
    "text": "more common among patients aged 50-60 years, and some evidence suggests it is",
    "entities": [
      {
        "text": "50-60 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "more frequent among Black populations than White and Asian populations. A subset",
    "entities": [
      {
        "text": "Asian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "of PN patients have an atopic background and can present with comorbid atopic",
    "entities": []
  },
  {
    "text": "dermatitis; however, PN can also exist without atopic comorbidities. Other",
    "entities": []
  },
  {
    "text": "comorbidities typically include diabetes, obesity, thyroid disease, kidney",
    "entities": []
  },
  {
    "text": "disease, chronic liver disease, hypertension, HIV infection, skin infections,",
    "entities": []
  },
  {
    "text": "malignancies and mental health disorders. Multiple intensely pruritic lesions",
    "entities": []
  },
  {
    "text": "induce chronic scratching, which leads to inflammation, hyperkeratotic nodules",
    "entities": []
  },
  {
    "text": "and perpetuation of a vicious itch-scratch cycle. PN is associated with a high",
    "entities": []
  },
  {
    "text": "disease burden and negative effect on quality of life; patients often report",
    "entities": []
  },
  {
    "text": "intense and relentless itching, poor sleep, absence from work, anxiety and",
    "entities": []
  },
  {
    "text": "depression. Early diagnosis of PN and identification of comorbidities are",
    "entities": []
  },
  {
    "text": "important to facilitate better disease management. By increasing their awareness",
    "entities": []
  },
  {
    "text": "of PN epidemiology, disease burden, clinical presentation and management,",
    "entities": []
  },
  {
    "text": "physicians may begin to identify the disease as a distinct condition independent",
    "entities": []
  },
  {
    "text": "of its triggers or associated comorbidities and provide patients with",
    "entities": []
  },
  {
    "text": "appropriate care earlier in their treatment journeys.",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of British",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      },
      {
        "text": "British",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Association of Dermatologists. All rights reserved. For commercial re-use,",
    "entities": [
      {
        "text": "Association of Dermatologists",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "please contact reprints@oup.com for reprints and translation rights for",
    "entities": []
  },
  {
    "text": "reprints. All other permissions can be obtained through our RightsLink service",
    "entities": []
  },
  {
    "text": "via the Permissions link on the article page on our site\u2014for further information",
    "entities": [
      {
        "text": "Permissions",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "please contact journals.permissions@oup.com.",
    "entities": [
      {
        "text": "journals.permissions@oup.com",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Self-Care behaviors and their association with self-efficacy and health literacy",
    "entities": []
  },
  {
    "text": "among adolescents with type 1 diabetes mellitus in palestine: a cross-sectional",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "palestine",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Head Nurse PICU, Registered Nurse, Palestine Medical Complex, Ramallah,",
    "entities": [
      {
        "text": "Registered Nurse",
        "label": "ORG"
      },
      {
        "text": "Palestine Medical Complex",
        "label": "ORG"
      },
      {
        "text": "Ramallah",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Community Health Nursing, Faculty of Nursing, Al- Zaytoonah University of",
    "entities": [
      {
        "text": "Health Nursing",
        "label": "ORG"
      },
      {
        "text": "Zaytoonah University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)American University of the Middle East, Egaila 54200,, Kuwait.",
    "entities": [
      {
        "text": "3)American University of the Middle East",
        "label": "ORG"
      },
      {
        "text": "Kuwait",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Mental Health Nursing, Faculty of Nursing, Arab American University, Jenin,",
    "entities": [
      {
        "text": "Health Nursing, Faculty of Nursing",
        "label": "ORG"
      },
      {
        "text": "Arab American University",
        "label": "ORG"
      },
      {
        "text": "Jenin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "PURPOSE: Type 1 diabetes mellitus (T1DM) is the most common endocrine disorder",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "during adolescence. Self-care behaviors are the cornerstone of diabetes",
    "entities": []
  },
  {
    "text": "management. Effective self-care behaviors require individuals to perform a range",
    "entities": []
  },
  {
    "text": "of complex daily tasks, including monitoring blood glucose, adhering to dietary",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "recommendations, administering insulin, and recognizing symptoms of hypo- or",
    "entities": []
  },
  {
    "text": "hyperglycemia. Two critical psychosocial and cognitive factors that influence",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the success of self-management are self-efficacy and health literacy. There are",
    "entities": []
  },
  {
    "text": "limited studies on the factors related to self-efficacy and health literacy",
    "entities": []
  },
  {
    "text": "associated with self-care behaviors among adolescents with T1DM in the Arab",
    "entities": [
      {
        "text": "Arab",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "World, including Palestine. Therefore, this study investigated the associations",
    "entities": [
      {
        "text": "Palestine",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "between self-efficacy, health literacy, select demographic variables, and",
    "entities": []
  },
  {
    "text": "self-care behaviors among adolescents with T1DM in Palestine.",
    "entities": [
      {
        "text": "Palestine",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: A cross-sectional correlational design was used, and 156 adolescents",
    "entities": [
      {
        "text": "156",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "aged 14-18 years were selected by a convenience sampling method from primary",
    "entities": [
      {
        "text": "14-18 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "healthcare settings in Palestine between February and June 2024. A self-reported",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      },
      {
        "text": "Palestine",
        "label": "GPE"
      },
      {
        "text": "between February and June 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "questionnaire was used to collect data, which included demographic variables,",
    "entities": []
  },
  {
    "text": "the Diabetic Health Literacy Scale, the Self-Efficacy for Diabetes Scale, and",
    "entities": [
      {
        "text": "the Diabetic Health Literacy Scale",
        "label": "ORG"
      },
      {
        "text": "the Self-Efficacy for Diabetes Scale",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Self-Care Inventory. Descriptive statistics, Pearson's and point biserial",
    "entities": [
      {
        "text": "the Self-Care Inventory",
        "label": "ORG"
      },
      {
        "text": "Pearson",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "correlation tests, and multiple linear regression were used to examine the",
    "entities": []
  },
  {
    "text": "relationships between the study variables.",
    "entities": []
  },
  {
    "text": "RESULTS: Participants reported high levels of self-efficacy (M = 108.80,",
    "entities": [
      {
        "text": "108.80",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "SD = 14.92), low levels of health literacy (M = 2.12, SD = 0.78), and low",
    "entities": [
      {
        "text": "14.92",
        "label": "CARDINAL"
      },
      {
        "text": "2.12",
        "label": "CARDINAL"
      },
      {
        "text": "0.78",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "engagement in self-care behaviors (M = 33.82, SD = 7.79). A positive correlation",
    "entities": [
      {
        "text": "33.82",
        "label": "CARDINAL"
      },
      {
        "text": "7.79",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "was found between self-efficacy and self-care behaviors (r = 0.396, p < 0.01).",
    "entities": [
      {
        "text": "0.396",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "In contrast, age was negatively associated with self-care behaviors (r = -0.249,",
    "entities": []
  },
  {
    "text": "p < 0.01). Furthermore, self-efficacy and age were significant predictors of",
    "entities": []
  },
  {
    "text": "self-care behaviors (\u03b2 = 0.196, p < 0.001; \u03b2 = -1.256, p < 0.01, respectively).",
    "entities": [
      {
        "text": "0.196",
        "label": "PRODUCT"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: This study helps policymakers, healthcare providers, and parents",
    "entities": []
  },
  {
    "text": "develop strategies to enhance self-care behaviors through targeted interventions",
    "entities": []
  },
  {
    "text": "and educational programs. The findings may guide any future educational program",
    "entities": []
  },
  {
    "text": "or training sessions to improve self-care behaviors among adolescents with T1DM.",
    "entities": []
  },
  {
    "text": "PMID: 40665435 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665435",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: Approval was obtained in accordance with the Declaration of",
    "entities": [
      {
        "text": "the Declaration of\n",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Helsinki from the Helsinki Committee in Palestine, and the Institutional Review",
    "entities": [
      {
        "text": "the Helsinki Committee",
        "label": "ORG"
      },
      {
        "text": "Palestine",
        "label": "GPE"
      },
      {
        "text": "the Institutional Review",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Board (IRB) at the Arab American University with reference No# R-2024/A/10/N.",
    "entities": [
      {
        "text": "IRB",
        "label": "ORG"
      },
      {
        "text": "the Arab American University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Informed consent to participate was obtained from the parents. Confidentiality",
    "entities": []
  },
  {
    "text": "of the data was maintained throughout data collection and analysis. Consent for",
    "entities": []
  },
  {
    "text": "publication: Not Applicable. Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "competing interests. Clinical trial: Not applicable.",
    "entities": []
  },
  {
    "text": "70. Genome Med. 2025 Jul 15;17(1):78. doi: 10.1186/s13073-025-01508-7.",
    "entities": [
      {
        "text": "70",
        "label": "CARDINAL"
      },
      {
        "text": "Genome Med",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The dynamics of the gut microbiota in prediabetes during a four-year follow-up",
    "entities": [
      {
        "text": "four-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "among European patients-an IMI-DIRECT prospective study.",
    "entities": [
      {
        "text": "European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Lyu L(#)(1)(2), Fan Y(#)(1), Vogt JK(#)(1)(3), Clos-Garcia M(#)(1), Bonnefond",
    "entities": [
      {
        "text": "Clos-Garcia",
        "label": "PERSON"
      },
      {
        "text": "Bonnefond\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Mari A(25), McDonald TJ(26)(27), Musholt PB(28), Pavo I(29), Prehn C(20),",
    "entities": [
      {
        "text": "Mari A(25",
        "label": "PERSON"
      },
      {
        "text": "McDonald TJ(26)(27",
        "label": "ORG"
      },
      {
        "text": "Musholt",
        "label": "PERSON"
      },
      {
        "text": "Pavo I(29",
        "label": "PERSON"
      },
      {
        "text": "Prehn C(20",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of",
    "entities": [
      {
        "text": "Nordisk Foundation Center for Basic Metabolic Research, Faculty",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.",
    "entities": [
      {
        "text": "Health and Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Center for Clinical Metabolic Research, Herlev-Gentofte University Hospital,",
    "entities": [
      {
        "text": "2)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical Metabolic Research",
        "label": "ORG"
      },
      {
        "text": "Herlev-Gentofte University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)INSERM UMR 1283, CNRS UMR 8199, European Genomic Institute for Diabetes",
    "entities": [
      {
        "text": "4)INSERM UMR 1283",
        "label": "DATE"
      },
      {
        "text": "UMR 8199",
        "label": "ORG"
      },
      {
        "text": "European Genomic Institute for Diabetes\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Oxford Centre for Diabetes, Endocrinology and Metabolism, University of",
    "entities": [
      {
        "text": "Metabolism, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Oxford, Churchill Hospital, Oxford, UK.",
    "entities": [
      {
        "text": "Oxford",
        "label": "ORG"
      },
      {
        "text": "Churchill Hospital",
        "label": "PERSON"
      },
      {
        "text": "Oxford",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Clinical Sciences, Lund University, Malm\u00f6, Sweden.",
    "entities": [
      {
        "text": "Clinical Sciences",
        "label": "ORG"
      },
      {
        "text": "Lund University",
        "label": "ORG"
      },
      {
        "text": "Malm\u00f6",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "for Environmental Health, Neuherberg, Bavaria, Germany.",
    "entities": [
      {
        "text": "Neuherberg",
        "label": "GPE"
      },
      {
        "text": "Bavaria",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg",
    "entities": [
      {
        "text": "Clinical Research and Prevention",
        "label": "ORG"
      },
      {
        "text": "Bispebjerg",
        "label": "PERSON"
      },
      {
        "text": "Frederiksberg",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospital, The Capital Region, Copenhagen, Denmark.",
    "entities": [
      {
        "text": "The Capital Region",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Section for Bioinformatics, Department of Health Technology, Technical",
    "entities": [
      {
        "text": "10)Section",
        "label": "CARDINAL"
      },
      {
        "text": "Bioinformatics, Department of Health Technology, Technical\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Disease Systems Biology Program, Faculty of Health and Medical Sciences,",
    "entities": [
      {
        "text": "11)Disease",
        "label": "CARDINAL"
      },
      {
        "text": "Faculty of Health and Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Novo Nordisk Foundation Center for Protein Research, University of Copenhagen,",
    "entities": [
      {
        "text": "Novo Nordisk Foundation Center for Protein Research, University of Copenhagen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Institute of Clinical Medicine, Internal Medicine, University of Eastern",
    "entities": [
      {
        "text": "12)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "Internal Medicine,",
        "label": "ORG"
      },
      {
        "text": "University of Eastern",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)Department of Diagnostic Radiology, Copenhagen University Hospital Herlev",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Copenhagen University Hospital Herlev",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(14)Department of Genetic Medicine and Development, University of Geneva Medical",
    "entities": [
      {
        "text": "14)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Genetic Medicine and Development, University of Geneva Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Department of General Practice, Amsterdam UMC- location VUmc, Amsterdam",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "General Practice",
        "label": "ORG"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      },
      {
        "text": "VUmc",
        "label": "PRODUCT"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Public Health Research Institute, Amsterdam, The Netherlands.",
    "entities": [
      {
        "text": "Public Health Research Institute",
        "label": "ORG"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Section for Nutrition Research, Faculty of Medicine, Imperial College",
    "entities": [
      {
        "text": "16)Section for Nutrition Research, Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "Imperial College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(17)Population Health & Genomics, School of Medicine, University of Dundee,",
    "entities": [
      {
        "text": "17)Population Health & Genomics, School of Medicine, University of Dundee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(18)Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences,",
    "entities": [
      {
        "text": "18)Genetic",
        "label": "CARDINAL"
      },
      {
        "text": "Molecular Epidemiology Unit",
        "label": "ORG"
      },
      {
        "text": "Department of Clinical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Lund University Diabetes Centre, Lund University and Helsingborg Hospital,",
    "entities": [
      {
        "text": "Lund University Diabetes Centre, Lund University",
        "label": "ORG"
      },
      {
        "text": "Helsingborg Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(19)Research Unit of Molecular Epidemiology, Institute of Epidemiology,",
    "entities": [
      {
        "text": "19)Research",
        "label": "CARDINAL"
      },
      {
        "text": "Molecular Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Institute of Epidemiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(20)Research Unit Molecular Endocrinology and Metabolism, Genome Analysis",
    "entities": [
      {
        "text": "20)Research Unit Molecular Endocrinology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(21)Department of Clinical Medicine, Faculty of Health and Medical Sciences,",
    "entities": [
      {
        "text": "21)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Faculty of Health and Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Copenhagen, Copenhagen, Denmark.",
    "entities": [
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(22)Medical Department, Zealand University Hospital, K\u00f8ge, Denmark.",
    "entities": [
      {
        "text": "22)Medical Department",
        "label": "ORG"
      },
      {
        "text": "Zealand University Hospital",
        "label": "ORG"
      },
      {
        "text": "K\u00f8ge",
        "label": "GPE"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(24)Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.",
    "entities": [
      {
        "text": "University of Oxford",
        "label": "ORG"
      },
      {
        "text": "Oxford",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(25)CNR Institute of Neuroscience, Padova, Italy.",
    "entities": [
      {
        "text": "25)CNR Institute of Neuroscience",
        "label": "ORG"
      },
      {
        "text": "Padova",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(26)Institute of Clinical and Biological Sciences, University of Exeter Medical",
    "entities": [
      {
        "text": "26)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "Biological Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Exeter Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School, Exeter, UK.",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(27)Blood Sciences, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.",
    "entities": [
      {
        "text": "Royal Devon",
        "label": "PERSON"
      },
      {
        "text": "Exeter NHS Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "Exeter",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(28)R&D Global Development, Translational Medicine & Clinical Pharmacology",
    "entities": [
      {
        "text": "28)R&D",
        "label": "CARDINAL"
      },
      {
        "text": "Global Development",
        "label": "ORG"
      },
      {
        "text": "Translational Medicine & Clinical Pharmacology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(29)Eli Lilly , Regional Operations GmbH, Vienna, Austria.",
    "entities": [
      {
        "text": "Regional Operations GmbH",
        "label": "ORG"
      },
      {
        "text": "Vienna",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(30)Clinical Obesity, Department of Clinical Sciences, Lund University Diabetes",
    "entities": [
      {
        "text": "30)Clinical Obesity, Department of Clinical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Centre, CRC, Lund University, Sk\u00e5ne University Hospital, Malm\u00f6, Sweden.",
    "entities": [
      {
        "text": "CRC",
        "label": "ORG"
      },
      {
        "text": "Lund University",
        "label": "ORG"
      },
      {
        "text": "Sk\u00e5ne University Hospital",
        "label": "ORG"
      },
      {
        "text": "Malm\u00f6",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(32)Amsterdam UMC, Location VUmc, Department of Epidemiology and Data Science,",
    "entities": [
      {
        "text": "Location VUmc",
        "label": "PERSON"
      },
      {
        "text": "Department of Epidemiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.",
    "entities": [
      {
        "text": "Amsterdam Public Health Research Institute",
        "label": "ORG"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      },
      {
        "text": "The Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(33)Affinity Proteomics, Science for Life Laboratory, School of Engineering",
    "entities": [
      {
        "text": "33)Affinity",
        "label": "CARDINAL"
      },
      {
        "text": "Science for Life Laboratory",
        "label": "ORG"
      },
      {
        "text": "School of Engineering",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences in Chemistry, Biotechnology and Health, KTH - Royal Institute of",
    "entities": [
      {
        "text": "Chemistry, Biotechnology and Health",
        "label": "ORG"
      },
      {
        "text": "KTH - Royal Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Technology, Solna, Sweden.",
    "entities": [
      {
        "text": "Solna",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(34)Faculty of Medical and Health Sciences, University of Copenhagen,",
    "entities": [
      {
        "text": "34)Faculty of Medical and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(36)Translational and Clinical Research Institute, Faculty of Medical Sciences,",
    "entities": [
      {
        "text": "36)Translational and Clinical Research Institute",
        "label": "ORG"
      },
      {
        "text": "Faculty of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Newcastle University, Newcastle, UK.",
    "entities": [
      {
        "text": "Newcastle University",
        "label": "ORG"
      },
      {
        "text": "Newcastle",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(37)Novo Nordisk Foundation Center for Protein Research, Faculty of Health and",
    "entities": [
      {
        "text": "Nordisk Foundation Center for Protein Research, Faculty of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Sciences, University of Copenhagen, Copenhagen, Denmark.",
    "entities": [
      {
        "text": "Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(38)Oxford NIHR Biomedical Research Centre, Oxford University Hospitals NHS",
    "entities": [
      {
        "text": "38)Oxford NIHR Biomedical Research Centre",
        "label": "ORG"
      },
      {
        "text": "Oxford University Hospitals NHS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Foundation Trust, John Radcliffe Hospital, Oxford, UK.",
    "entities": [
      {
        "text": "Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "John Radcliffe Hospital",
        "label": "PERSON"
      },
      {
        "text": "Oxford",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(39)Department of Metabolism, Digestion and Reproduction, Imperial College",
    "entities": [
      {
        "text": "39)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Metabolism, Digestion and Reproduction",
        "label": "ORG"
      },
      {
        "text": "Imperial College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(41)Department of Biochemistry, Yong Loo Lin School of Medicine, National",
    "entities": [
      {
        "text": "41)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biochemistry",
        "label": "GPE"
      },
      {
        "text": "Yong Loo Lin School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Singapore, 8 Medical Drive, Singapore, Singapore.",
    "entities": [
      {
        "text": "University of Singapore",
        "label": "ORG"
      },
      {
        "text": "8 Medical Drive",
        "label": "ORG"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(42)Institute of Biochemistry, Faculty of Medicine, University of Ljubljana,",
    "entities": [
      {
        "text": "Biochemistry, Faculty of Medicine, University of Ljubljana",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(43)Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of",
    "entities": [
      {
        "text": "Nordisk Foundation Center for Basic Metabolic Research, Faculty",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(44)Center for Clinical Metabolic Research, Herlev-Gentofte University Hospital,",
    "entities": [
      {
        "text": "44)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical Metabolic Research",
        "label": "ORG"
      },
      {
        "text": "Herlev-Gentofte University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Previous case-control studies have reported aberrations of the gut",
    "entities": []
  },
  {
    "text": "microbiota in individuals with prediabetes. The primary objective of the present",
    "entities": []
  },
  {
    "text": "study was to explore the dynamics of the gut microbiota of individuals with",
    "entities": []
  },
  {
    "text": "prediabetes over 4 years with a secondary aim of relating microbiota dynamics to",
    "entities": [
      {
        "text": "4 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "temporal changes of metabolic phenotypes.",
    "entities": []
  },
  {
    "text": "METHODS: The study included 486 European patients with prediabetes. Gut",
    "entities": [
      {
        "text": "486",
        "label": "CARDINAL"
      },
      {
        "text": "European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "microbiota profiling was conducted using shotgun metagenomic sequencing and the",
    "entities": []
  },
  {
    "text": "same bioinformatics pipelines at study baseline and after 4 years. The same",
    "entities": [
      {
        "text": "4 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "phenotyping protocols and core laboratory analyses were applied at the two",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "timepoints. Phenotyping included anthropometrics and measurement of fasting",
    "entities": []
  },
  {
    "text": "plasma glucose and insulin levels, mean plasma glucose and insulin under an oral",
    "entities": [
      {
        "text": "plasma glucose",
        "label": "PERSON"
      },
      {
        "text": "plasma glucose",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "glucose tolerance test (OGTT), 2-h plasma glucose after an OGTT, oral glucose",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "OGTT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "insulin sensitivity index, Matsuda insulin sensitivity index, body mass index,",
    "entities": [
      {
        "text": "Matsuda",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "waist circumference, and systolic and diastolic blood pressure. Measures of the",
    "entities": []
  },
  {
    "text": "dynamics of bacterial microbiota were related to concomitant changes in markers",
    "entities": []
  },
  {
    "text": "of host metabolism.",
    "entities": []
  },
  {
    "text": "RESULTS: Over 4 years, significant declines in richness were observed in gut",
    "entities": [
      {
        "text": "4 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "bacterial and viral species and microbial pathways accompanied by significant",
    "entities": []
  },
  {
    "text": "changes in the relative abundance and the genetic composition of multiple",
    "entities": []
  },
  {
    "text": "bacterial species. Additionally, bacterial-viral interactions diminished over",
    "entities": []
  },
  {
    "text": "time. Despite the overall reduction in bacterial richness and microbial pathway",
    "entities": []
  },
  {
    "text": "richness, 80 dominant core bacterial species and 78 core microbial pathways were",
    "entities": [
      {
        "text": "80",
        "label": "CARDINAL"
      },
      {
        "text": "78",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "identified at both timepoints in 99% of the individuals, representing a",
    "entities": [
      {
        "text": "99%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "resilient component of the gut microbiota. Over the same period, individuals",
    "entities": []
  },
  {
    "text": "with prediabetes exhibited a significant increase in glycemia and insulinemia",
    "entities": []
  },
  {
    "text": "alongside a significant decline in insulin sensitivity. Estimates of the gut",
    "entities": []
  },
  {
    "text": "bacterial microbiota dynamics were significantly correlated with temporal",
    "entities": []
  },
  {
    "text": "impairments in host metabolic health.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: In this 4-year prospective study of European patients with",
    "entities": [
      {
        "text": "4-year",
        "label": "DATE"
      },
      {
        "text": "European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "prediabetes, the gut microbiota exhibited major changes in taxonomic",
    "entities": []
  },
  {
    "text": "composition, bacterial species genetics, and microbial functional potentials,",
    "entities": []
  },
  {
    "text": "many of which paralleled an aggravation of host metabolism. Whether the temporal",
    "entities": []
  },
  {
    "text": "gut microbiota changes represent an adaptation to the progression of metabolic",
    "entities": []
  },
  {
    "text": "abnormalities or actively contribute to these in prediabetes cases remains",
    "entities": []
  },
  {
    "text": "TRIAL REGISTRATION: The Diabetes Research on Patient Stratification (DIRECT)",
    "entities": [
      {
        "text": "The Diabetes Research on Patient Stratification",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study, an exploratory observational study initiated on October 15, 2012, was",
    "entities": [
      {
        "text": "October 15, 2012",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "registered on ClinicalTrials.gov under the number NCT03814915.",
    "entities": [
      {
        "text": "NCT03814915",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s13073-025-01508-7",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665409 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665409",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate.: The DIRECT study (Diabetes Research on Patient Stratification) was",
    "entities": [
      {
        "text": "Diabetes Research on Patient Stratification",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "registered under ClinicalTrials.gov ID NCT03814915. Approval of the study",
    "entities": []
  },
  {
    "text": "protocol was obtained from each of the regional research ethics review boards",
    "entities": []
  },
  {
    "text": "and H-1\u20132012-100; Amsterdam, the Netherlands: NL40099.029.12; Newcastle, Dundee,",
    "entities": [
      {
        "text": "Amsterdam",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      },
      {
        "text": "NL40099.029.12",
        "label": "GPE"
      },
      {
        "text": "Newcastle",
        "label": "GPE"
      },
      {
        "text": "Dundee",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and Exeter, UK: 12/NE/0132. All participants gave written informed consent to",
    "entities": [
      {
        "text": "Exeter",
        "label": "PRODUCT"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate in the study at enrollment and the research conformed to the ethical",
    "entities": []
  },
  {
    "text": "principles for medical research involving human participants outlined in the",
    "entities": []
  },
  {
    "text": "Declaration of Helsinki. Consent for publication: Not applicable. Competing",
    "entities": []
  },
  {
    "text": "interests: RK has received consulting fees from Novo Nordisk; he was also funded",
    "entities": [
      {
        "text": "Novo Nordisk",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by a STAR Award Novo Nordisk co-financed PhD fellowship and a Novo Nordisk",
    "entities": [
      {
        "text": "Award Novo Nordisk",
        "label": "PERSON"
      },
      {
        "text": "PhD",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Foundation postdoctoral fellowship (NNF18OC0031650). PWF has received research",
    "entities": []
  },
  {
    "text": "Aventis and Servier, received consulting fees from Eli Lilly, Novo Nordisk and",
    "entities": [
      {
        "text": "Aventis",
        "label": "GPE"
      },
      {
        "text": "Servier",
        "label": "PERSON"
      },
      {
        "text": "Eli Lilly",
        "label": "ORG"
      },
      {
        "text": "Novo Nordisk",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Zoe Global Ltd and has stock options in Zoe Global Ltd. HR is an employee of",
    "entities": [
      {
        "text": "Zoe Global Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boehringer Ingelheim and a shareholder of Sanofi Aventis. MMcC declares that the",
    "entities": [
      {
        "text": "Boehringer Ingelheim",
        "label": "ORG"
      },
      {
        "text": "Sanofi Aventis",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "views expressed in this article are those of the authors and not necessarily",
    "entities": []
  },
  {
    "text": "those of the NHS, the NIHR, or the Department of Health; he has served on",
    "entities": [
      {
        "text": "NHS",
        "label": "ORG"
      },
      {
        "text": "NIHR",
        "label": "ORG"
      },
      {
        "text": "the Department of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "advisory panels for Pfizer, Novo Nordisk and Zoe Global, has received honoraria",
    "entities": [
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Novo Nordisk",
        "label": "PERSON"
      },
      {
        "text": "Zoe Global",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "from Merck, Pfizer, Novo Nordisk and Eli Lilly, and research funding from",
    "entities": [
      {
        "text": "Merck",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Novo Nordisk",
        "label": "PERSON"
      },
      {
        "text": "Eli Lilly",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Nordisk, Pfizer, Roche, Sanofi Aventis, Servier, and Takeda; as of June 2019, he",
    "entities": [
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Roche",
        "label": "ORG"
      },
      {
        "text": "Sanofi Aventis",
        "label": "PERSON"
      },
      {
        "text": "Servier",
        "label": "PERSON"
      },
      {
        "text": "Takeda",
        "label": "PRODUCT"
      },
      {
        "text": "June 2019",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "is an employee of Genentech, and a holder of Roche stock. BJ and PBM are",
    "entities": [
      {
        "text": "Genentech",
        "label": "ORG"
      },
      {
        "text": "Roche",
        "label": "ORG"
      },
      {
        "text": "BJ",
        "label": "ORG"
      },
      {
        "text": "PBM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "employees of Sanofi Deutschland GmbH. IP is employed by Eli Lilly Regional",
    "entities": [
      {
        "text": "Sanofi Deutschland",
        "label": "ORG"
      },
      {
        "text": "IP",
        "label": "ORG"
      },
      {
        "text": "Eli Lilly Regional",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Operations GmbH. HR is an employee of Boehringer Ingelheim International GmbH.",
    "entities": [
      {
        "text": "Operations",
        "label": "ORG"
      },
      {
        "text": "Boehringer Ingelheim International",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MR is employed by Novo Nordisk A/S. OP and YF are co-founders of GutCRINE. The",
    "entities": [
      {
        "text": "Novo Nordisk A/S. OP",
        "label": "ORG"
      },
      {
        "text": "YF",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "remaining authors declare that they have no competing interests.",
    "entities": []
  },
  {
    "text": "Burden level and quality of life of caregivers of hemodialysis patient's in",
    "entities": []
  },
  {
    "text": "central India: a mixed-method cross-sectional study.",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)School of Public Health (at time of study), All India Institute of Medical",
    "entities": [
      {
        "text": "1)School of Public Health",
        "label": "ORG"
      },
      {
        "text": "All India Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Raipur, Chhattisgarh, India.",
    "entities": [
      {
        "text": "Raipur",
        "label": "GPE"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Vedanta Medical Research Foundation (BALCO Medical Centre), Raipur,",
    "entities": [
      {
        "text": "2)Vedanta Medical Research Foundation",
        "label": "ORG"
      },
      {
        "text": "BALCO Medical Centre",
        "label": "ORG"
      },
      {
        "text": "Raipur",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(3)Department of Nephrology, All India Institute of Medical Sciences, Raipur,",
    "entities": [
      {
        "text": "Nephrology",
        "label": "ORG"
      },
      {
        "text": "All India Institute of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Raipur",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of Nephrology, Dau Kalyan Singh Post Graduate Institute and",
    "entities": [
      {
        "text": "Nephrology",
        "label": "ORG"
      },
      {
        "text": "Dau Kalyan Singh Post Graduate Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research center, Raipur, Chhattisgarh, India.",
    "entities": [
      {
        "text": "Raipur",
        "label": "PERSON"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Community & Family Medicine, All India Institute of Medical",
    "entities": [
      {
        "text": "Community & Family Medicine",
        "label": "ORG"
      },
      {
        "text": "All India Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Raipur, Chhattisgarh, India. abhiruchigalhotra@aiimsraipur.edu.in.",
    "entities": [
      {
        "text": "Raipur",
        "label": "GPE"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: Caregivers of hemodialysis patients are at high risk of developing",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reduced quality of life (QoL) and increased caregiver burden.",
    "entities": [
      {
        "text": "QoL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "AIM: This study aims to explore the level of caregiver burden and quality of",
    "entities": [
      {
        "text": "AIM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "life in caregivers of hemodialysis patients in central India.",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: This cross-sectional mixed-method study was undertaken among caregivers",
    "entities": []
  },
  {
    "text": "of stable hemodialysis patients attending a tertiary care hospital in central",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "India. The Zarit Burden Interview (ZBI) and WHOQoL BREF questionnaire measured",
    "entities": [
      {
        "text": "India",
        "label": "GPE"
      },
      {
        "text": "The Zarit Burden Interview",
        "label": "ORG"
      },
      {
        "text": "BREF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "caregiver burden and QoL. The qualitative data was gathered through in-depth",
    "entities": []
  },
  {
    "text": "interviews using a semi-structured open-ended questionnaire that delved into",
    "entities": []
  },
  {
    "text": "their personal experiences with caregiving. The transcripts of these interviews",
    "entities": []
  },
  {
    "text": "were analysed using applied thematic analysis, allowing for the identification",
    "entities": []
  },
  {
    "text": "and exploration of recurring themes and patterns within the data.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 105 caregivers took part in this study, with a mean age of",
    "entities": [
      {
        "text": "105",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "40.04 \u00b1 12.96 years. 56 (53.3%) caregivers were female. Most (48.6%, n = 51)",
    "entities": [
      {
        "text": "40.04",
        "label": "CARDINAL"
      },
      {
        "text": "12.96 years",
        "label": "DATE"
      },
      {
        "text": "56",
        "label": "CARDINAL"
      },
      {
        "text": "53.3%",
        "label": "PERCENT"
      },
      {
        "text": "48.6%",
        "label": "PERCENT"
      },
      {
        "text": "51",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were spouses/partners. Ten caregivers (9.5%) had to change their occupations due",
    "entities": [
      {
        "text": "Ten",
        "label": "CARDINAL"
      },
      {
        "text": "9.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "to caregiving responsibilities. 14 (23.33%) had comorbidities (diabetes,",
    "entities": [
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "23.33%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "hypertension, asthma, and arthritis) themselves. The mean caregiver burden level",
    "entities": []
  },
  {
    "text": "(ZBI) was 18.55 \u00b1 7.58. Most (59.0%) experienced mild to moderate burden, while",
    "entities": [
      {
        "text": "ZBI",
        "label": "ORG"
      },
      {
        "text": "18.55",
        "label": "CARDINAL"
      },
      {
        "text": "59.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "28.6% reported a high burden. The WHOQoL BREF mean score of various domains of",
    "entities": [
      {
        "text": "28.6%",
        "label": "PERCENT"
      },
      {
        "text": "BREF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "physical health, psychological, social relationship and environmental was",
    "entities": []
  },
  {
    "text": "35.70 \u00b1 12.14, 44.20 \u00b1 13.28, 44.28 \u00b1 15.10 and 40.07 \u00b1 13.36 respectively. The",
    "entities": [
      {
        "text": "35.70",
        "label": "CARDINAL"
      },
      {
        "text": "12.14",
        "label": "DATE"
      },
      {
        "text": "44.20",
        "label": "CARDINAL"
      },
      {
        "text": "13.28",
        "label": "CARDINAL"
      },
      {
        "text": "44.28",
        "label": "CARDINAL"
      },
      {
        "text": "15.10",
        "label": "CARDINAL"
      },
      {
        "text": "40.07",
        "label": "CARDINAL"
      },
      {
        "text": "13.36",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "thematic analysis revealed, difficulty in continuing education and employment,",
    "entities": []
  },
  {
    "text": "changing jobs, the need to travel long distances to reach dialysis facilities",
    "entities": []
  },
  {
    "text": "and hardship due to COVID-19 pandemic as recurring challenges among caregivers.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Caregivers of Hemodialysis patients had significant caregiver burden",
    "entities": []
  },
  {
    "text": "and poor QoL. Regular assessment and special attention are needed for these",
    "entities": []
  },
  {
    "text": "PMID: 40665407 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665407",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethical approval and consent to",
    "entities": []
  },
  {
    "text": "participate: This study was approved by the Institutional Ethical Committee with",
    "entities": [
      {
        "text": "the Institutional Ethical Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "IEC Proposal No: AIIMSRPR/IEC/2021/1041 from the All India Institute of Medical",
    "entities": [
      {
        "text": "the All India Institute of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Raipur, Chhattisgarh, India. All participants signed an informed",
    "entities": [
      {
        "text": "Raipur",
        "label": "GPE"
      },
      {
        "text": "Chhattisgarh",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "written consent before participation and informed consent was obtained from",
    "entities": []
  },
  {
    "text": "parents and/or legal guardians of minor/illiterate study participants. The study",
    "entities": []
  },
  {
    "text": "was conducted under the principles of the Helsinki Declaration. Consent for",
    "entities": [
      {
        "text": "the Helsinki Declaration",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "publication: Not applicable. Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "competing interests.",
    "entities": []
  },
  {
    "text": "Respiratory syncytial virus (RSV) enhances translation of virus-resembling",
    "entities": [
      {
        "text": "RSV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "AU-rich host transcripts.",
    "entities": []
  },
  {
    "text": "Kerkhofs K(1)(2), Guydosh NR(3), Bayfield MA(4).",
    "entities": [
      {
        "text": "Kerkhofs",
        "label": "ORG"
      },
      {
        "text": "Guydosh NR(3",
        "label": "PERSON"
      },
      {
        "text": "Bayfield MA(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Biology, Faculty of Science, York University, Toronto, ON, M3J",
    "entities": [
      {
        "text": "Biology, Faculty of Science, York University",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "ON",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Section On mRNA Regulation and Translation, Laboratory of Biochemistry &",
    "entities": [
      {
        "text": "2)Section",
        "label": "CARDINAL"
      },
      {
        "text": "Laboratory of Biochemistry &\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Genetics, National Institute of Diabetes and Digestive and Kidney Diseases,",
    "entities": [
      {
        "text": "Genetics, National Institute of Diabetes and Digestive",
        "label": "ORG"
      },
      {
        "text": "Kidney Diseases",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "National Institutes of Health, Bethesda, MD, 20892, USA.",
    "entities": [
      {
        "text": "National Institutes of Health",
        "label": "ORG"
      },
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "20892",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Section On mRNA Regulation and Translation, Laboratory of Biochemistry &",
    "entities": [
      {
        "text": "Laboratory of Biochemistry &\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Biology, Faculty of Science, York University, Toronto, ON, M3J",
    "entities": [
      {
        "text": "Biology, Faculty of Science, York University",
        "label": "ORG"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "ON",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Viruses strongly rely on the host's translational machinery to",
    "entities": []
  },
  {
    "text": "produce viral proteins required for replication. However, it is unknown how",
    "entities": []
  },
  {
    "text": "viruses that do not globally inhibit cap-dependent translation compete with",
    "entities": []
  },
  {
    "text": "abundant host transcripts for ribosomes. Viral infection often triggers",
    "entities": []
  },
  {
    "text": "eukaryotic initiator factor 2\u03b1 (eIF2\u03b1) phosphorylation, leading to global",
    "entities": [
      {
        "text": "2\u03b1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "5'-cap-dependent translation inhibition. Respiratory syncytial virus (RSV)",
    "entities": [
      {
        "text": "5'-cap-dependent",
        "label": "DATE"
      },
      {
        "text": "RSV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "encodes mRNAs mimicking 5'-cap structures of host mRNAs and thus inhibition of",
    "entities": [
      {
        "text": "5'-cap",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cap-dependent translation initiation would likely also reduce viral translation.",
    "entities": []
  },
  {
    "text": "METHODS: RSV-infected HEp-2 and A549 cells were analyzed to determine",
    "entities": [
      {
        "text": "RSV",
        "label": "ORG"
      },
      {
        "text": "HEp-2",
        "label": "PRODUCT"
      },
      {
        "text": "A549",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "translation levels using western blotting, indirect immunofluorescent staining",
    "entities": []
  },
  {
    "text": "and polysome profiling. Transcriptome-wide translation efficiencies of",
    "entities": []
  },
  {
    "text": "virus-infected cells were compared against mock-infected cells using",
    "entities": []
  },
  {
    "text": "high-throughput sequencing of poly(A)-tail enriched total mRNA and transcripts",
    "entities": []
  },
  {
    "text": "associated with heavy polysomes.",
    "entities": []
  },
  {
    "text": "RESULTS: We confirmed that RSV limits widespread translation initiation",
    "entities": [
      {
        "text": "RSV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inhibition and unexpectedly found that the fraction of ribosomes within",
    "entities": []
  },
  {
    "text": "polysomes increases during infection, indicating higher ribosome loading on",
    "entities": []
  },
  {
    "text": "mRNAs during infection. High-throughput sequencing revealed that",
    "entities": []
  },
  {
    "text": "virus-resembling, AU-rich host transcripts become more efficient at ribosome",
    "entities": []
  },
  {
    "text": "recruitment. Using a previously published dataset, we observe similar trends in",
    "entities": []
  },
  {
    "text": "another negative-sense single-stranded RNA virus, vesicular stomatitis virus",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: These findings revealed that RSV changes the translational",
    "entities": [
      {
        "text": "RSV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "landscape by enhancing translation of virus-resembling AU-rich host transcripts",
    "entities": []
  },
  {
    "text": "rather than inhibiting host translation.",
    "entities": []
  },
  {
    "text": "PMID: 40665364 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "participate: Not applicable. Consent for publication: Not applicable. Competing",
    "entities": []
  },
  {
    "text": "interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Association of temporal MASLD with type 2 diabetes, cardiovascular disease and",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mortality.",
    "entities": []
  },
  {
    "text": "Fatty LiverResearch Group of the Korean Diabetes Association.",
    "entities": [
      {
        "text": "Fatty LiverResearch Group",
        "label": "ORG"
      },
      {
        "text": "the Korean Diabetes Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Keimyung University School of Medicine, Daegu, Korea.",
    "entities": [
      {
        "text": "Keimyung University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Daegu",
        "label": "GPE"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Statistics and Actuarial Science, Soongsil University, Seoul,",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Soongsil University",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Yonsei University College of Medicine, Seoul, Korea.",
    "entities": [
      {
        "text": "Yonsei University College of Medicine, Seoul,",
        "label": "ORG"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.",
    "entities": [
      {
        "text": "CHA Bundang Medical Center",
        "label": "ORG"
      },
      {
        "text": "CHA University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Seongnam",
        "label": "GPE"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hanyang Guri Hospital, Hanyang University College of Medicine, Guri, Korea.",
    "entities": [
      {
        "text": "Hanyang Guri Hospital",
        "label": "PERSON"
      },
      {
        "text": "Hanyang University College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Guri",
        "label": "GPE"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hanyang University College of Medicine, Seoul, Korea.",
    "entities": [
      {
        "text": "Hanyang University College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Endocrinology and Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29",
    "entities": [
      {
        "text": "Kangbuk Samsung Hospital",
        "label": "ORG"
      },
      {
        "text": "Sungkyunkwan University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "29",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "BACKGROUND: We investigated the risk of type 2 diabetes (T2DM) and related",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "comorbidities including cardiovascular disease (CVD), and mortality, based on",
    "entities": []
  },
  {
    "text": "changes in metabolic dysfunction associated steatotic liver disease (MASLD).",
    "entities": []
  },
  {
    "text": "METHODS: We analyzed data from the Korean National Health Insurance Service for",
    "entities": [
      {
        "text": "the Korean National Health Insurance Service",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "individuals aged \u2265 20 years. MASLD was defined as a fatty liver index (FLI), a",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "20 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "prediction formula based on metabolic parameters, with a cutoff of \u2265 60. FLI",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "measurements were compared within each individual over a 2 years period. Based",
    "entities": [
      {
        "text": "2 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "on changes in FLI between two health checkups, individuals were classified into",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "four categories; never MASLD (FLI consistently < 60), incident MASLD (FLI < 60",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "to \u2265 60), regressed MASLD (\u2265 60 to < 60), and persistent MASLD (FLI",
    "entities": [
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "consistently \u2265 60). The primary outcome was T2DM occurrence in the general",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "population and myocardial infarction (MI), ischemic stroke, heart failure (HF)",
    "entities": []
  },
  {
    "text": "and mortality events in individuals with preexisting T2DM with adjustment for",
    "entities": []
  },
  {
    "text": "age, sex, smoking, alcohol drinking, and regular exercise.",
    "entities": []
  },
  {
    "text": "RESULTS: In 4,397,808 individuals without T2DM, 229,475 (5.2%) developed T2DM",
    "entities": [
      {
        "text": "4,397,808",
        "label": "CARDINAL"
      },
      {
        "text": "229,475",
        "label": "CARDINAL"
      },
      {
        "text": "5.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "during a median follow-up period of 7.3 years. The risk of incident T2DM was the",
    "entities": [
      {
        "text": "7.3 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "highest in individuals with persistent MASLD compared to those who never had",
    "entities": []
  },
  {
    "text": "MASLD (HR = 5.28, 95% CI = 5.22-5.34). Individuals with incident or regressed",
    "entities": [
      {
        "text": "5.28",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "5.22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "MASLD also had increased risk of developing T2DM (HR = 3.30, 95% CI = 3.25-3.35",
    "entities": [
      {
        "text": "MASLD",
        "label": "ORG"
      },
      {
        "text": "3.30",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "3.25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "for incident MASLD, HR = 2.87, 95% CI = 2.82-2.92 for regressed MASLD). In a",
    "entities": [
      {
        "text": "2.87",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "2.82-2.92",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cohort of 636,520 individuals with preexisting T2DM followed for a median of 6.2",
    "entities": [
      {
        "text": "636,520",
        "label": "CARDINAL"
      },
      {
        "text": "6.2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years, those with persistent MASLD had a higher risk of HF (HR = 1.28, 95%",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      },
      {
        "text": "1.28",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "95% CI = 1.09 to 1.19) and all-cause mortality (HR = 1.11, 95% CI = 1.09-1.14)",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.09",
        "label": "CARDINAL"
      },
      {
        "text": "1.19",
        "label": "CARDINAL"
      },
      {
        "text": "1.11",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.09",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "compared to individuals who never had MASLD. Similarly, both incident and",
    "entities": []
  },
  {
    "text": "regressed MASLD were associated with an increased risk for HF, MI, stroke and",
    "entities": [
      {
        "text": "HF",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Persistent MASLD is associated with an increased risk of incident",
    "entities": []
  },
  {
    "text": "T2DM, and further elevates the risk of CVD, and mortality among individuals with",
    "entities": [
      {
        "text": "CVD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "T2DM. Even individuals with incident or regressed MASLD exhibit an increased",
    "entities": []
  },
  {
    "text": "risk of these adverse outcomes compared to those who never had MASLD.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s12933-025-02824-3",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665356 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665356",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethics approval: This study",
    "entities": []
  },
  {
    "text": "complied with the Declaration of Helsinki; the study protocol was approved by",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "the institutional review board (Soongsil University, SSU-202007-HR-236-01).",
    "entities": [
      {
        "text": "Soongsil University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Written informed consent was waived, as this study was based on deidentified",
    "entities": []
  },
  {
    "text": "administrative data. Consent for publication: Not applicable. Competing",
    "entities": []
  },
  {
    "text": "Impact of diabetes mellitus on myocardial function and clinical outcomes in",
    "entities": []
  },
  {
    "text": "patients with significant aortic regurgitation.",
    "entities": []
  },
  {
    "text": "(1)Department of Medical Ultrasound, West China Hospital of Sichuan University,",
    "entities": [
      {
        "text": "Medical Ultrasound",
        "label": "ORG"
      },
      {
        "text": "West China Hospital of Sichuan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chengdu, Sichuan Province, China.",
    "entities": [
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "Sichuan Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Medical Ultrasound, Union Hospital, Tongji Medical College,",
    "entities": [
      {
        "text": "Medical Ultrasound",
        "label": "ORG"
      },
      {
        "text": "Union Hospital",
        "label": "ORG"
      },
      {
        "text": "Tongji Medical College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Huazhong University of Science and Technology, Wuhan, Hubei Province, China.",
    "entities": [
      {
        "text": "Huazhong University of Science and Technology",
        "label": "ORG"
      },
      {
        "text": "Wuhan",
        "label": "GPE"
      },
      {
        "text": "Hubei Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Medical Ultrasound, West China School of Public Health and West",
    "entities": [
      {
        "text": "Medical Ultrasound",
        "label": "ORG"
      },
      {
        "text": "West China School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "China, Fourth Hospital, Sichuan University, Chengdu, Sichuan Province, China.",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "Fourth Hospital",
        "label": "ORG"
      },
      {
        "text": "Sichuan University",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "Sichuan Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Medical Ultrasound, West China Hospital of Sichuan University,",
    "entities": [
      {
        "text": "Medical Ultrasound",
        "label": "ORG"
      },
      {
        "text": "West China Hospital of Sichuan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chengdu, Sichuan Province, China. qiulihx@scu.edu.cn.",
    "entities": [
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "Sichuan Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Medical Ultrasound, Union Hospital, Tongji Medical College,",
    "entities": [
      {
        "text": "Medical Ultrasound",
        "label": "ORG"
      },
      {
        "text": "Union Hospital",
        "label": "ORG"
      },
      {
        "text": "Tongji Medical College",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Type 2 diabetes mellitus (T2DM) causes myocardial dysfunction and",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "has been linked to an increased risk of unfavorable cardiovascular events.",
    "entities": []
  },
  {
    "text": "However, the additive effects of T2DM on myocardial function and its association",
    "entities": []
  },
  {
    "text": "with clinical outcomes in patients with aortic regurgitation (AR) is",
    "entities": []
  },
  {
    "text": "undetermined. The study aimed to verify whether T2DM aggravates the",
    "entities": []
  },
  {
    "text": "deterioration of myocardial deformation and clinical outcomes in AR patients.",
    "entities": [
      {
        "text": "AR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: A total of two hundred and fifty-five AR patients, differentiated by",
    "entities": [
      {
        "text": "two hundred and fifty-five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the presence or absence of T2DM [AR(T2DM+) and AR(T2DM-), respectively], along",
    "entities": []
  },
  {
    "text": "with 65 age-matched healthy individuals, underwent echocardiographic",
    "entities": [
      {
        "text": "65",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "examination. Left ventricular (LV) and left atrial (LA) geometry and function,",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "as well as LV global longitudinal strain (LVGLS) and left atrial reservoir",
    "entities": []
  },
  {
    "text": "strain (LARS), were compared among the different groups. Linear regression",
    "entities": [
      {
        "text": "Linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analyses were performed to identify the effects of T2DM on LVGLS and LARS in AR",
    "entities": [
      {
        "text": "AR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "patients. In addition, major adverse cardiac events (MACEs) were recorded during",
    "entities": []
  },
  {
    "text": "follow-up. Kaplan-Meier analysis and Cox proportional hazards models were used",
    "entities": [
      {
        "text": "Kaplan-Meier",
        "label": "PERSON"
      },
      {
        "text": "Cox",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "to explore the relationship between T2DM and the risk of MACEs in AR patients.",
    "entities": [
      {
        "text": "AR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: Compared with controls, both AR(T2DM-) and AR(T2DM+) patients exhibited",
    "entities": []
  },
  {
    "text": "significantly increased LV and LA volumes, along with reduced LV and LA ejection",
    "entities": [
      {
        "text": "LV",
        "label": "GPE"
      },
      {
        "text": "LA",
        "label": "GPE"
      },
      {
        "text": "LV",
        "label": "GPE"
      },
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "fractions (all P < 0.05). LVGLS and LARS progressively declined from the",
    "entities": [
      {
        "text": "LARS",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "controls to the AR (T2DM-) group to the AR (T2DM+) group (all P < 0.05). The",
    "entities": []
  },
  {
    "text": "presence of T2DM was independently associated with impaired LVGLS and LARS in",
    "entities": []
  },
  {
    "text": "patients with AR (both P < 0.05). During a median follow-up of 29 months, 42",
    "entities": [
      {
        "text": "AR",
        "label": "ORG"
      },
      {
        "text": "29 months",
        "label": "DATE"
      },
      {
        "text": "42",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "MACEs were recorded. The incidence of MACEs was significantly higher in patients",
    "entities": []
  },
  {
    "text": "with T2DM than in those without (30.8% vs. 11.6%; \u03c72 = 20.10; P < 0.001). In",
    "entities": [
      {
        "text": "30.8%",
        "label": "PERCENT"
      },
      {
        "text": "11.6%",
        "label": "PERCENT"
      },
      {
        "text": "20.10",
        "label": "CARDINAL"
      },
      {
        "text": "P < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "multivariable analysis adjusting for clinical and echocardiographic predictors",
    "entities": []
  },
  {
    "text": "and aortic valve surgery as a time-dependent covariate, T2DM remained",
    "entities": [
      {
        "text": "T2DM",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "independently associated with MACEs (HR, 2.22; 95% CI, 1.12-4.38; P = 0.022).",
    "entities": [
      {
        "text": "2.22",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.12",
        "label": "CARDINAL"
      },
      {
        "text": "P =",
        "label": "ORG"
      },
      {
        "text": "0.022",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: In patients with AR, T2DM exerts an additive deleterious effect on",
    "entities": [
      {
        "text": "AR, T2DM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "both LA and LV function and is an independent predictor of MACEs. These findings",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      },
      {
        "text": "LV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "underscore the need for earlier evaluation and intervention targeting cardiac",
    "entities": []
  },
  {
    "text": "function in the context of AR complicated by T2DM.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s12933-025-02843-0",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665315 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665315",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "participate: The study was approved by the Human Subjects Review Committee at",
    "entities": [
      {
        "text": "the Human Subjects Review Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Wuhan Union Hospital (No. UHCT22412) and informed consent was obtained from all",
    "entities": [
      {
        "text": "Wuhan Union Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "participants. Consent for publication: Not applicable. Competing interests: The",
    "entities": []
  },
  {
    "text": "authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "75. BMC Oral Health. 2025 Jul 15;25(1):1166. doi: 10.1186/s12903-025-06485-2.",
    "entities": [
      {
        "text": "75",
        "label": "CARDINAL"
      },
      {
        "text": "BMC Oral Health",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Non-surgical periodontal therapy with and without hyaluronic acid gel in type 2",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Al-Abbadi R(1), Shemais N(2), Nawwar A(3)(4), Fawzy El-Sayed KM(1)(5)(6).",
    "entities": [
      {
        "text": "Al-Abbadi",
        "label": "PERSON"
      },
      {
        "text": "Shemais N(2",
        "label": "PERSON"
      },
      {
        "text": "Nawwar",
        "label": "ORG"
      },
      {
        "text": "Fawzy El-Sayed",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Oral Medicine & Periodontology Department, Faculty of Dentistry, Cairo",
    "entities": [
      {
        "text": "Medicine & Periodontology Department",
        "label": "ORG"
      },
      {
        "text": "Faculty of Dentistry",
        "label": "ORG"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Al Saraya Str. 11, Manial, Cairo, Egypt.",
    "entities": [
      {
        "text": "Al Saraya Str",
        "label": "PERSON"
      },
      {
        "text": "11",
        "label": "CARDINAL"
      },
      {
        "text": "Manial",
        "label": "GPE"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Oral Medicine & Periodontology Department, Faculty of Dentistry, Cairo",
    "entities": [
      {
        "text": "2)Oral Medicine & Periodontology Department",
        "label": "ORG"
      },
      {
        "text": "Faculty of Dentistry",
        "label": "ORG"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Oral and Maxillofacial Radiology Department, Faculty of Dentistry, Cairo",
    "entities": [
      {
        "text": "Maxillofacial Radiology Department, Faculty of Dentistry",
        "label": "ORG"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Cairo, Egypt.",
    "entities": [
      {
        "text": "Cairo",
        "label": "GPE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Oral and Maxillofacial Radiology Department, School of Dentistry, New Giza",
    "entities": [
      {
        "text": "Maxillofacial Radiology Department",
        "label": "ORG"
      },
      {
        "text": "School of Dentistry",
        "label": "ORG"
      },
      {
        "text": "New Giza",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Giza, Egypt.",
    "entities": [
      {
        "text": "Giza",
        "label": "GPE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Clinic for Conservative Dentistry and Periodontology, School of Dental",
    "entities": [
      {
        "text": "5)Clinic",
        "label": "CARDINAL"
      },
      {
        "text": "Conservative Dentistry",
        "label": "ORG"
      },
      {
        "text": "Periodontology, School of Dental",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Christian Albrechts University, Kiel, Germany.",
    "entities": [
      {
        "text": "Christian Albrechts University",
        "label": "ORG"
      },
      {
        "text": "Kiel",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Stem Cells and Tissue Engineering Research Unit, Faculty of Dentistry, Cairo",
    "entities": [
      {
        "text": "Tissue Engineering Research Unit",
        "label": "ORG"
      },
      {
        "text": "Faculty of Dentistry",
        "label": "ORG"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The present trial evaluated clinically and radiographically the",
    "entities": []
  },
  {
    "text": "effect of topically applied hyaluronic acid (HA) gel in conjunction with",
    "entities": []
  },
  {
    "text": "professional mechanical plaque removal (PMPR) in type 2 diabetic stage-II",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "METHODOLOGY: 26 controlled (HbA1c < 7%) type 2 diabetic stage-II grade B",
    "entities": [
      {
        "text": "26",
        "label": "CARDINAL"
      },
      {
        "text": "7%",
        "label": "PERCENT"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "periodontitis patients were included in the current trial and randomly assigned",
    "entities": []
  },
  {
    "text": "to test (n = 13 patients; PMPR + HA) or control (n = 13; PMPR) groups. At",
    "entities": [
      {
        "text": "13",
        "label": "CARDINAL"
      },
      {
        "text": "PMPR",
        "label": "GPE"
      },
      {
        "text": "13",
        "label": "CARDINAL"
      },
      {
        "text": "PMPR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "baseline, three- and six-months clinical attachment level (CAL; primary",
    "entities": [
      {
        "text": "three- and",
        "label": "DATE"
      },
      {
        "text": "six-months",
        "label": "DATE"
      },
      {
        "text": "CAL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "outcome), probing pocket depth (PPD), gingival recession depth (GRD), bleeding",
    "entities": [
      {
        "text": "GRD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "on probing (BOP), O'Leary plaque index (PI), HbA1c level, radiographic bone",
    "entities": [
      {
        "text": "BOP",
        "label": "ORG"
      },
      {
        "text": "O'Leary",
        "label": "ORG"
      },
      {
        "text": "PI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "density (RBD) and defect depth (DD; all secondary outcomes) were assessed.",
    "entities": [
      {
        "text": "RBD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Although CAL, PPD, BOP, PI, DD and RBD independently significantly",
    "entities": [
      {
        "text": "CAL",
        "label": "ORG"
      },
      {
        "text": "BOP",
        "label": "ORG"
      },
      {
        "text": "PI",
        "label": "GPE"
      },
      {
        "text": "DD",
        "label": "GPE"
      },
      {
        "text": "RBD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "improved in the PMPR + HA and the PMPR groups (p < 0.05), no significant",
    "entities": [
      {
        "text": "PMPR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "differences were notable between both groups. HbA1c significantly decreased",
    "entities": []
  },
  {
    "text": "solely in the PMPR + HA group (p < 0.05).",
    "entities": []
  },
  {
    "text": "CONCLUSION: Type 2 diabetic patients with stage-II periodontitis, benefit",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "clinically from PMPR in the presence or absence of adjunctive HA gel",
    "entities": [
      {
        "text": "PMPR",
        "label": "GPE"
      },
      {
        "text": "HA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "application. Interestingly, HA as an adjunct to PMPR significantly improved",
    "entities": [
      {
        "text": "PMPR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "HbA1c levels in controlled type 2 diabetic stage-II periodontitis patients.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "TRIAL REGISTRATION: The study was registered in the US National Institutes of",
    "entities": [
      {
        "text": "the US National Institutes of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Clinical Trials Registry (NCT05543434) in September 2022.",
    "entities": [
      {
        "text": "Health Clinical Trials Registry",
        "label": "ORG"
      },
      {
        "text": "NCT05543434",
        "label": "PERSON"
      },
      {
        "text": "September 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s12903-025-06485-2",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665270 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665270",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: The study protocols involving human participants adhered to the",
    "entities": []
  },
  {
    "text": "ethical standards set by the institutional and/or national research committee",
    "entities": [
      {
        "text": "the institutional and/or national research committee\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and were conducted in accordance with the principles outlined in the 2013",
    "entities": [
      {
        "text": "2013",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Helsinki Declaration and its subsequent revisions, or similar ethical standards.",
    "entities": [
      {
        "text": "Helsinki Declaration",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Both the research protocol and informed consent form were approved by the Ethics",
    "entities": [
      {
        "text": "Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Committee of the Faculty of Dentistry, Cairo University, Egypt in June 2022",
    "entities": [
      {
        "text": "Committee of the Faculty of Dentistry",
        "label": "ORG"
      },
      {
        "text": "Cairo University",
        "label": "ORG"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      },
      {
        "text": "June 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(IRB: 10|6|22). All participants included in the study gave written informed",
    "entities": [
      {
        "text": "IRB",
        "label": "ORG"
      },
      {
        "text": "10|6|22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "consents before their participation. Consent for publication: Not applicable.",
    "entities": []
  },
  {
    "text": "Competing interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "The effects of non-insulin anti-diabetic medications on the diabetic",
    "entities": []
  },
  {
    "text": "microvascular complications: a systematic review and meta-analysis of randomized",
    "entities": []
  },
  {
    "text": "(1)Department of Endocrinology, Shanghai Pudong Hospital, Fudan University,",
    "entities": [
      {
        "text": "Endocrinology",
        "label": "GPE"
      },
      {
        "text": "Shanghai Pudong Hospital",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Endocrinology, Shanghai Pudong Hospital, Fudan University,",
    "entities": [
      {
        "text": "Endocrinology",
        "label": "GPE"
      },
      {
        "text": "Shanghai Pudong Hospital",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Endocrinology, Shanghai Pudong Hospital, Fudan University,",
    "entities": [
      {
        "text": "Endocrinology",
        "label": "GPE"
      },
      {
        "text": "Shanghai Pudong Hospital",
        "label": "ORG"
      },
      {
        "text": "Fudan University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Shanghai Key Laboratory of Vascular Lesions Regulation and Remodeling,",
    "entities": [
      {
        "text": "5)Shanghai",
        "label": "CARDINAL"
      },
      {
        "text": "Key Laboratory of Vascular Lesions Regulation and Remodeling",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Although the onset and progression of diabetic microvascular",
    "entities": []
  },
  {
    "text": "complications are linked to glycemic control, various antihyperglycemic drugs",
    "entities": []
  },
  {
    "text": "with distinct treatment targets may positively impact microvascular lesions",
    "entities": []
  },
  {
    "text": "beyond their glucose-lowering effects. Therefore, this systematic review",
    "entities": []
  },
  {
    "text": "emphasizes the clinical therapeutic implications of non-insulin anti-diabetic",
    "entities": []
  },
  {
    "text": "medications for diabetic microvascular complications.",
    "entities": []
  },
  {
    "text": "METHODS: We retrieved published literature reporting randomized clinical trials",
    "entities": []
  },
  {
    "text": "(RCTs) on the effects of microvascular complications, including diabetic",
    "entities": []
  },
  {
    "text": "nephropathy (DN), diabetic peripheral neuropathy (DPN), and diabetic retinopathy",
    "entities": []
  },
  {
    "text": "(DR), from authenticated clinical databases: PubMed, Excerpta Medica database",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      },
      {
        "text": "Excerpta Medica",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(EMBASE), and Web of Science. We synthesized data, including the continuous",
    "entities": []
  },
  {
    "text": "to creatinine ratio (UACR), and urinary albumin excretion rate (UAE). Indices",
    "entities": [
      {
        "text": "UACR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "measuring cardiovascular autonomic neuropathy (CAN), vibration detection",
    "entities": []
  },
  {
    "text": "threshold (VDT), and retinal nerve fiber thickness (RNFL) were used to calculate",
    "entities": [
      {
        "text": "VDT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "microvascular effects. We also synthesized dichotomous variable indices,",
    "entities": []
  },
  {
    "text": "including the risks for DR and DPN.",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: According to our analyses, there was sparse evidence strongly",
    "entities": []
  },
  {
    "text": "supporting that metformin (MET), Sulfonylurea (SUs), Repaglinide (Repa), or",
    "entities": [
      {
        "text": "MET",
        "label": "ORG"
      },
      {
        "text": "Sulfonylurea",
        "label": "PERSON"
      },
      {
        "text": "Repaglinide",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "complications when adopted as monotherapy. Regardless of the no change in eGFR,",
    "entities": []
  },
  {
    "text": "two trials reporting Thiazolidinediones (TZDs) significantly reduced the UACR,",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Thiazolidinediones",
        "label": "PERSON"
      },
      {
        "text": "UACR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "while other clinical trials reported an increase in VDT and improvement in DR.",
    "entities": [
      {
        "text": "VDT",
        "label": "ORG"
      },
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Sodium glucose co-transporter inhibitors (SGLT-2i) and Glucagon-like peptide-1",
    "entities": [
      {
        "text": "Glucagon",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "receptor agonists (GLP-1RA) both showed protective effects in preventing eGFR",
    "entities": []
  },
  {
    "text": "decline, with only SGLT-2i demonstrating a significant reduction in UACR. A",
    "entities": [
      {
        "text": "SGLT-2i",
        "label": "NORP"
      },
      {
        "text": "UACR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "recent trial showed that Dipeptidyl Peptidase IV inhibitors (DPP-IVi) may",
    "entities": [
      {
        "text": "Dipeptidyl Peptidase IV",
        "label": "PERSON"
      },
      {
        "text": "DPP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "potentially reduce the risk of DPN, while GLP-1RA did not prove to alter the",
    "entities": [
      {
        "text": "DPN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "measures of CAN and DPN. However, the SUSTAIN 6 trial revealed that Semaglutide",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "Semaglutide\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "may increase the risk of DR.",
    "entities": [
      {
        "text": "DR",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "CONCLUSION: Besides their anti-hyperglycemic properties, some currently reviewed",
    "entities": []
  },
  {
    "text": "and conflicting available results, more emerging or ongoing trials will address",
    "entities": []
  },
  {
    "text": "this issue and could benefit clinical strategies for personalized treatment",
    "entities": []
  },
  {
    "text": "CLINICAL TRIAL NUMBER: Not applicable.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s12902-025-01985-2",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665260 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665260",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Hyperglycemia and insulin use in patients with COVID-19 and severe hypoxemia",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "allocated to 12 mg vs. 6 mg of dexamethasone: a secondary analysis of the COVID",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "COVID",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "STEROID 2 randomized trial.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Center of Clinical Research and Disruption of Infectious Diseases (CREDID),",
    "entities": [
      {
        "text": "1)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical Research and Disruption of Infectious Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Copenhagen University Hospital - Amager and Hvidovre, Kettegaard Alle 30, 2650,",
    "entities": [
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      },
      {
        "text": "Hvidovre",
        "label": "GPE"
      },
      {
        "text": "Kettegaard Alle",
        "label": "PERSON"
      },
      {
        "text": "30, 2650",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(2)Department of Infectious Diseases, Copenhagen University Hospital - Amager",
    "entities": [
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Infectious Diseases, Copenhagen University Hospital -",
    "entities": [
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Clinical Medicine, University of Copenhagen, Copenhagen,",
    "entities": [
      {
        "text": "Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Public Health, Section of Biostatistics, University of",
    "entities": []
  },
  {
    "text": "(6)Department of Nephrology and Endocrinology, Copenhagen University Hospital,",
    "entities": [
      {
        "text": "Nephrology and Endocrinology",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Department of Immunology and Microbiology, Faculty of Health and Medical",
    "entities": [
      {
        "text": "Immunology and Microbiology, Faculty of Health and Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, University of Copenhagen, Copenhagen,, Denmark.",
    "entities": [
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Endocrinology, Copenhagen University Hospital - Amager and",
    "entities": [
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Department of Clinical Biochemistry, Copenhagen University Hospital - Amager",
    "entities": [
      {
        "text": "Clinical Biochemistry",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Neuroanaesthesiology, Copenhagen University Hospital -",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neuroanaesthesiology,",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Anaesthesiology and Intensive Care, Copenhagen University",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Copenhagen University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Department of Anaesthesia and Intensive Care, Copenhagen University Hospital",
    "entities": [
      {
        "text": "12)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Intensive Care",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)Department of Respiratory Medicine, Copenhagen University Hospital - Amager",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Respiratory Medicine",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(14)Department of Anaesthesia and Intensive Care, Copenhagen University Hospital",
    "entities": [
      {
        "text": "14)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Intensive Care",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Department of Anaesthesia and Intensive Care, Copenhagen University Hospital",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Intensive Care",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "- North Zealand, Hillerod, Denmark.",
    "entities": [
      {
        "text": "North Zealand",
        "label": "GPE"
      },
      {
        "text": "Hillerod",
        "label": "GPE"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Department of Anaesthesia and Intensive Care, Zealand University Hospital,",
    "entities": [
      {
        "text": "16)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Intensive Care",
        "label": "GPE"
      },
      {
        "text": "Zealand University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(17)Department of Anaesthesia, Zealand University Hospital, Slagelse, Denmark.",
    "entities": [
      {
        "text": "17)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Anaesthesia",
        "label": "GPE"
      },
      {
        "text": "Zealand University Hospital",
        "label": "ORG"
      },
      {
        "text": "Slagelse",
        "label": "GPE"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Department of Infectious Diseases, Zealand University Hospital, Roskilde,",
    "entities": [
      {
        "text": "18)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Zealand University Hospital",
        "label": "ORG"
      },
      {
        "text": "Roskilde",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(19)Department of Intensive Care, Copenhagen University Hospital -",
    "entities": [
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(20)Center of Clinical Research and Disruption of Infectious Diseases (CREDID),",
    "entities": [
      {
        "text": "20)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical Research and Disruption of Infectious Diseases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(21)Centre for Physical Activity Research, Copenhagen University Hospital -",
    "entities": [
      {
        "text": "21)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Physical Activity Research",
        "label": "ORG"
      },
      {
        "text": "Copenhagen University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(22)Department of Infectious Diseases, Copenhagen University Hospital - Amager",
    "entities": [
      {
        "text": "22)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Copenhagen University Hospital - Amager",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: While dexamethasone has been shown to improve survival in COVID-19,",
    "entities": [
      {
        "text": "COVID-19",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "its dose-response relationship with plasma glucose (PG) levels and insulin",
    "entities": []
  },
  {
    "text": "requirements is poorly understood. This study investigated the impact of 12 mg",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(higher dose) versus 6 mg (standard dose) of dexamethasone on hyper- or",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypoglycemic events and the use of insulin.",
    "entities": []
  },
  {
    "text": "METHODS: A secondary analysis of a subpopulation of the COVID STEROID 2 trial.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Glycemic outcomes were assessed by time-to-event analysis of a hyperglycemic",
    "entities": []
  },
  {
    "text": "(two PG measurements \u2265 11.1 mmol/L), severe hyperglycemic (PG > 20 mmol/L),",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "PG",
        "label": "ORG"
      },
      {
        "text": "\u2265",
        "label": "GPE"
      },
      {
        "text": "11.1",
        "label": "CARDINAL"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hypoglycemic (< 3.8 mmol/L) event or use of insulin, adjusted for age, diabetes",
    "entities": [
      {
        "text": "3.8",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "status, hospital site, and mechanical ventilation. PG levels were compared",
    "entities": []
  },
  {
    "text": "before and after treatment allocation with linear mixed models to estimate",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Of 321 participants, 170 were allocated to the higher dose and 151 to",
    "entities": [
      {
        "text": "321",
        "label": "CARDINAL"
      },
      {
        "text": "170",
        "label": "CARDINAL"
      },
      {
        "text": "151",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the standard dose of dexamethasone. Time to a hyperglycemic event did not differ",
    "entities": []
  },
  {
    "text": "between groups, whereas severe hyperglycemic events were more frequent in the",
    "entities": []
  },
  {
    "text": "higher dose group (36%) than in the standard dose group (31%) with an adjusted",
    "entities": [
      {
        "text": "36%",
        "label": "PERCENT"
      },
      {
        "text": "31%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "subdistributional hazard ratio of 1.76 (95% CI [1.22-2.54], p = 0.003). Insulin",
    "entities": [
      {
        "text": "1.76",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.22-2.54",
        "label": "CARDINAL"
      },
      {
        "text": "0.003",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "use and hypoglycemic events did not differ between groups. The higher vs.",
    "entities": []
  },
  {
    "text": "standard dose group had an average PG increase of 0.5 mmol/L (95% CI [- 0.2 to",
    "entities": [
      {
        "text": "standard dose group",
        "label": "ORG"
      },
      {
        "text": "0.5",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Higher vs. standard doses of dexamethasone were associated with a",
    "entities": []
  },
  {
    "text": "higher incidence of severe hyperglycemia in patients with COVID-19 and severe",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hypoxemia, but the average increase in PG was similar between groups.",
    "entities": [
      {
        "text": "PG",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s13613-025-01512-5",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participate: The COVID STEROID 2 trial was approved by the Scientific Ethics",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "the Scientific Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Committee of the Capital Region of Denmark (H-20051056) and registered at",
    "entities": [
      {
        "text": "H-20051056",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "ClinicalTrials.gov (NCT04509973) and ctri.nic.in (CTRI/2020/10/028731) on August",
    "entities": [
      {
        "text": "August",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "11th, 2020. The secondary analysis was approved according to Danish Healthcare",
    "entities": [
      {
        "text": "11th",
        "label": "ORDINAL"
      },
      {
        "text": "2020",
        "label": "DATE"
      },
      {
        "text": "Danish Healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Law \u00a7 46, Sect. 2 by the Capital Region (R-24013197). Consent for publication:",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "the Capital Region",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Not applicable. Competing interests: T.B. reports grants from Novo Nordisk",
    "entities": [
      {
        "text": "T.B.",
        "label": "GPE"
      },
      {
        "text": "Novo Nordisk",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Foundation, Lundbeck Foundation, Simonsen Foundation, GSK, and Pfizer; personal",
    "entities": [
      {
        "text": "Lundbeck Foundation",
        "label": "ORG"
      },
      {
        "text": "Simonsen Foundation",
        "label": "ORG"
      },
      {
        "text": "GSK",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "fees from GSK, Pfizer, Bavarian Nordic, Gilead, MSD, Janssen, Moderna and Astra",
    "entities": [
      {
        "text": "GSK",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Bavarian Nordic",
        "label": "ORG"
      },
      {
        "text": "Gilead",
        "label": "ORG"
      },
      {
        "text": "MSD",
        "label": "ORG"
      },
      {
        "text": "Janssen",
        "label": "GPE"
      },
      {
        "text": "Moderna",
        "label": "GPE"
      },
      {
        "text": "Astra",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Zeneca; outside the submitted work. TPA holds stocks in Novo Nordisk A/S;",
    "entities": [
      {
        "text": "Zeneca",
        "label": "PERSON"
      },
      {
        "text": "Novo Nordisk A/S",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "outside the submitted work. No other disclosures were reported.",
    "entities": []
  },
  {
    "text": "78. J Nephrol. 2025 Jul 15. doi: 10.1007/s40620-025-02357-8. Online ahead of",
    "entities": [
      {
        "text": "78",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Long-term prediction of mortality by heart rate turbulence in hemodialysis",
    "entities": []
  },
  {
    "text": "patients and the impact of diabetes mellitus-a longitudinal observational study.",
    "entities": []
  },
  {
    "text": "(1)Department of Nephrology, TUM School of Medicine and Health, TUM",
    "entities": [
      {
        "text": "Nephrology, TUM School of Medicine and Health",
        "label": "ORG"
      },
      {
        "text": "TUM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ismaninger Str 22, 81675, Munich, Germany.",
    "entities": [
      {
        "text": "Ismaninger Str 22, 81675",
        "label": "ORG"
      },
      {
        "text": "Munich",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Center for Health & Bioresources, Medical Signal Analysis, AIT Austrian",
    "entities": [
      {
        "text": "2)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Health & Bioresources",
        "label": "ORG"
      },
      {
        "text": "Medical Signal Analysis",
        "label": "ORG"
      },
      {
        "text": "AIT",
        "label": "ORG"
      },
      {
        "text": "Austrian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Institute of Technology GmbH, Vienna, Austria.",
    "entities": [
      {
        "text": "Institute of Technology GmbH",
        "label": "ORG"
      },
      {
        "text": "Vienna",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Dialysis Center Munich Nord, Munich, Germany.",
    "entities": [
      {
        "text": "Center Munich Nord",
        "label": "PERSON"
      },
      {
        "text": "Munich",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Nephrocare Munich East, Munich, Germany.",
    "entities": [
      {
        "text": "Munich East",
        "label": "GPE"
      },
      {
        "text": "Munich",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Praxen Dr. Braun, Dialysis Center, Dingolfing, Germany.",
    "entities": [
      {
        "text": "Braun",
        "label": "PERSON"
      },
      {
        "text": "Dingolfing",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Klinik F\u00fcr Innere Medizin I, TUM School of Medicine and Health, TUM",
    "entities": [
      {
        "text": "TUM School of Medicine and Health",
        "label": "ORG"
      },
      {
        "text": "TUM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Munich, Germany.",
    "entities": [
      {
        "text": "Munich",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)TUM School of Medicine and Health, TUM Universit\u00e4tsklinikum, Klinikum Rechts",
    "entities": [
      {
        "text": "School of Medicine and Health",
        "label": "ORG"
      },
      {
        "text": "TUM Universit\u00e4tsklinikum",
        "label": "ORG"
      },
      {
        "text": "Klinikum Rechts",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Der Isar, Institute of AI and Informatics in Medicine, Technical University of",
    "entities": [
      {
        "text": "Der Isar",
        "label": "PERSON"
      },
      {
        "text": "Institute of AI",
        "label": "ORG"
      },
      {
        "text": "Technical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)National Heart and Lung Institute, Imperial College London, London, UK.",
    "entities": [
      {
        "text": "Lung Institute",
        "label": "ORG"
      },
      {
        "text": "Imperial College London",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Faculty of Medicine, Department of Internal Medicine and Cardiology, Masaryk",
    "entities": [
      {
        "text": "Medicine, Department of Internal Medicine and Cardiology",
        "label": "ORG"
      },
      {
        "text": "Masaryk\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, Brno, Czech Republic.",
    "entities": [
      {
        "text": "Brno",
        "label": "GPE"
      },
      {
        "text": "Czech Republic",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Department of Nephrology, TUM School of Medicine and Health, TUM",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "TUM School of Medicine and Health",
        "label": "ORG"
      },
      {
        "text": "TUM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ismaninger Str 22, 81675, Munich, Germany. Matthias.Braunisch@mri.tum.de.",
    "entities": [
      {
        "text": "Ismaninger Str 22, 81675",
        "label": "ORG"
      },
      {
        "text": "Munich",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      },
      {
        "text": "Matthias.Braunisch@mri.tum.de",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "BACKGROUND: Diabetes-driven impaired autonomic nervous system function might",
    "entities": []
  },
  {
    "text": "contribute to increased mortality in hemodialysis patients. Our study aimed to",
    "entities": []
  },
  {
    "text": "validate heart rate turbulence as a long-term predictor of mortality in this",
    "entities": []
  },
  {
    "text": "METHODS: Heart rate turbulence is a non-invasive, 24 h",
    "entities": [
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "electrocardiography-Holter-based assessment of cardiovascular autonomic",
    "entities": [
      {
        "text": "electrocardiography-Holter",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "responses. Hemodialysis patients of the \"rISk strAtification in end-stage Renal",
    "entities": [
      {
        "text": "the \"rISk strAtification",
        "label": "ORG"
      },
      {
        "text": "Renal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "disease\" (ISAR) study, a prospective, multicenter observational study, were",
    "entities": []
  },
  {
    "text": "followed up for six years. Mortality hazard, and correlations between",
    "entities": [
      {
        "text": "six years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "clinical characteristics and mortality, were assessed using Cox regression",
    "entities": [
      {
        "text": "Cox",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "RESULTS: Heart rate turbulence measurement at baseline was available in 290",
    "entities": [
      {
        "text": "290",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hemodialysis patients, 99 (34%) with diabetes mellitus. In a multivariable",
    "entities": [
      {
        "text": "34%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "analysis, abnormal heart rate turbulence was associated with a 2.1-fold (95% CI:",
    "entities": [
      {
        "text": "2.1-fold",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.4-3.2; p < 0.001) increased risk for all-cause and 3.1-fold (95% CI: 1.5-6.2;",
    "entities": [
      {
        "text": "1.4",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "3.1-fold",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.5-6.2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p = 0.001) increased risk for cardiovascular mortality. The co-occurrence of",
    "entities": [
      {
        "text": "0.001",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "abnormal heart rate turbulence and diabetes mellitus represented the strongest",
    "entities": []
  },
  {
    "text": "risk constellation, increasing all-cause mortality risk to a hazard ratio of 5.8",
    "entities": [
      {
        "text": "5.8",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(95% CI: 3.3-10.4; p < 0.001) and cardiovascular mortality risk to 6.1 (95% CI:",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "3.3",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "6.1",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "2.5-15.1; p < 0.001). This association with mortality risk remained significant",
    "entities": [
      {
        "text": "2.5",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "after multivariate adjustment. The interaction term between the two",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "comorbidities indicated an approximately additive effect on mortality risk.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Heart rate turbulence significantly contributed to the prediction",
    "entities": []
  },
  {
    "text": "of long-term mortality risk in hemodialysis patients. Diabetes mellitus is a",
    "entities": []
  },
  {
    "text": "major driver of cardiovascular autonomic dysfunction, which plays a crucial role",
    "entities": []
  },
  {
    "text": "in mortality among dialysis patients. Heart rate turbulence measurement",
    "entities": []
  },
  {
    "text": "identifies high-risk patients in the dialysis setting, enhancing precision in",
    "entities": []
  },
  {
    "text": "risk prediction and stratification, and allowing an opportunity for personalized",
    "entities": []
  },
  {
    "text": "monitoring and prevention.",
    "entities": []
  },
  {
    "text": "DOI: 10.1007/s40620-025-02357-8",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: The authors",
    "entities": []
  },
  {
    "text": "declare no conflicts of interest. MB reports travel support from Lilly Germany",
    "entities": [
      {
        "text": "Lilly Germany",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "and consulting fees from Samsung Bioepis, Takeda Pharma, and Boehringer",
    "entities": [
      {
        "text": "Samsung Bioepis",
        "label": "PERSON"
      },
      {
        "text": "Takeda Pharma",
        "label": "PERSON"
      },
      {
        "text": "Boehringer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ingelheim unrelated to the project. Ethical approval: This prospective",
    "entities": [
      {
        "text": "Ingelheim",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "longitudinal clinical study was reviewed and approved by the Medical Ethics",
    "entities": [
      {
        "text": "the Medical Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Committee of the Klinikum Rechts der Isar of the Technical University of Munich",
    "entities": [
      {
        "text": "the Technical University of Munich",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and the Bavarian State Board of Physicians. The study was performed in",
    "entities": [
      {
        "text": "the Bavarian State Board of Physicians",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "accordance with the ethical standards as laid down in the 1964 Declaration of",
    "entities": [
      {
        "text": "1964",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Helsinki and its later amendments. Informed consent to participate: All",
    "entities": [
      {
        "text": "Helsinki",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients/participants provided written informed consent to participate in this",
    "entities": []
  },
  {
    "text": "79. Eur Geriatr Med. 2025 Jul 15. doi: 10.1007/s41999-025-01266-0. Online ahead",
    "entities": [
      {
        "text": "79",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of print.",
    "entities": []
  },
  {
    "text": "Lifestyle interventions and medication burden in older adults: insights from the",
    "entities": []
  },
  {
    "text": "Lifestyle Intervention and Independence for Elders (LIFE) and the Sarcopenia and",
    "entities": [
      {
        "text": "Sarcopenia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Physical fRailty iN older people: multi-componenT Treatment strategies (SPRINTT)",
    "entities": [
      {
        "text": "SPRINTT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Aging, Orthopaedics and Rheumatological Sciences, Universit\u00e0",
    "entities": [
      {
        "text": "Aging, Orthopaedics and Rheumatological Sciences",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e0",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Aging, Orthopaedics and Rheumatological Sciences, Universit\u00e0",
    "entities": [
      {
        "text": "Aging, Orthopaedics and Rheumatological Sciences",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e0",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Principal Investigator of the LIFE Study, Independent Scholar, Miami, FL,",
    "entities": [
      {
        "text": "Investigator of the LIFE Study, Independent Scholar",
        "label": "ORG"
      },
      {
        "text": "Miami",
        "label": "GPE"
      },
      {
        "text": "FL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Medicine and Surgery, LUM University, Casamassima, Italy.",
    "entities": [
      {
        "text": "LUM University",
        "label": "ORG"
      },
      {
        "text": "Casamassima",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Italialongeva, Rome, Italy.",
    "entities": [
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: Polypharmacy is a growing public health problem and implementing",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      },
      {
        "text": "Polypharmacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "strategies to reduce its prevalence is considered a research and clinical",
    "entities": []
  },
  {
    "text": "priority. Healthy lifestyle impacts the onset and progression of chronic",
    "entities": []
  },
  {
    "text": "conditions. Yet, there is limited understanding of how this effect influences",
    "entities": []
  },
  {
    "text": "medication use. The aim of the study was to assess the impact of lifestyle",
    "entities": []
  },
  {
    "text": "interventions on use of medications for treatment of common chronic conditions.",
    "entities": []
  },
  {
    "text": "METHODS: We performed a secondary analyses from two randomized clinical trials:",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the Lifestyle Interventions and Independence for Elders Study (LIFE) and the",
    "entities": [
      {
        "text": "the Lifestyle Interventions and Independence for Elders Study (LIFE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment",
    "entities": [
      {
        "text": "Sarcopenia and Physical fRailty IN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "strategies (SPRINTT) trials. LIFE study enrolled community-dwelling men and",
    "entities": [
      {
        "text": "SPRINTT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "women aged 70 to 89 years old who were physically inactive and had reduced",
    "entities": [
      {
        "text": "70 to 89 years old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "physical function recruited in eight centers in the United States. SPRINTT",
    "entities": [
      {
        "text": "eight",
        "label": "CARDINAL"
      },
      {
        "text": "the United States",
        "label": "GPE"
      },
      {
        "text": "SPRINTT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "enrolled community-dwelling men and women aged 70 years or older with physical",
    "entities": [
      {
        "text": "70 years or",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "frailty and sarcopenia recruited in 16 clinical sites in Europe. Active",
    "entities": [
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "Europe",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "intervention groups consisted of a physical activity program in LIFE and a",
    "entities": []
  },
  {
    "text": "multicomponent intervention based on physical activity with technological",
    "entities": []
  },
  {
    "text": "support and nutritional counselling/dietary intervention in SPRINTT. The main",
    "entities": [
      {
        "text": "SPRINTT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "outcome measure was the change in cardiovascular, diabetes, mood and anxiety,",
    "entities": []
  },
  {
    "text": "and chronic pain medication use as measured by daily dose per day (DDD/day).",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 1519 LIFE participants (752 intervention vs 767 control",
    "entities": [
      {
        "text": "1519",
        "label": "CARDINAL"
      },
      {
        "text": "752",
        "label": "CARDINAL"
      },
      {
        "text": "767",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "group, mean age 78.9 years; 67.3% women) and 1,208 SPRINTT participants (602",
    "entities": [
      {
        "text": "age 78.9 years",
        "label": "DATE"
      },
      {
        "text": "67.3%",
        "label": "PERCENT"
      },
      {
        "text": "1,208",
        "label": "CARDINAL"
      },
      {
        "text": "SPRINTT",
        "label": "ORG"
      },
      {
        "text": "602",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "intervention vs 606 control group, mean age 78.8 years; 72.8% women) were",
    "entities": [
      {
        "text": "606",
        "label": "CARDINAL"
      },
      {
        "text": "age 78.8 years",
        "label": "DATE"
      },
      {
        "text": "72.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "evaluated. For both studies, no significant difference was observed in the",
    "entities": []
  },
  {
    "text": "median number of DDDs at baseline and follow-up assessments for any of the",
    "entities": []
  },
  {
    "text": "medication classes considered. Longitudinal analysis performed using linear",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mixed models revealed no significant association between DDDs/day and lifestyle",
    "entities": [
      {
        "text": "between DDDs/day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "interventions, with the only exception of an increase in DDD/day of pain",
    "entities": [
      {
        "text": "DDD/day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "medications in the intervention group of SPRINTT (\u03b2 = 0.16; CI 0.06-0.26 at",
    "entities": [
      {
        "text": "SPRINTT",
        "label": "ORG"
      },
      {
        "text": "0.16",
        "label": "CARDINAL"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.06-0.26",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "6 months; \u03b2 = 0.12; CI 0.01-0.22 at 12 months; \u03b2 = 0.12; CI 0.01-0.22 at",
    "entities": [
      {
        "text": "6 months",
        "label": "DATE"
      },
      {
        "text": "0.12",
        "label": "CARDINAL"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.01-0.22",
        "label": "CARDINAL"
      },
      {
        "text": "12 months",
        "label": "DATE"
      },
      {
        "text": "0.12",
        "label": "CARDINAL"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.01-0.22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "18 months).",
    "entities": [
      {
        "text": "18 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSION: Lifestyle interventions did not significantly impact on burden of",
    "entities": []
  },
  {
    "text": "medications used to treat chronic conditions in frail older adults. This finding",
    "entities": []
  },
  {
    "text": "does not undermine the beneficial effects of these interventions on health",
    "entities": []
  },
  {
    "text": "outcomes, but highlights the need for specifically designed trials to determine",
    "entities": []
  },
  {
    "text": "their effect on reducing polypharmacy.",
    "entities": []
  },
  {
    "text": "TRIAL REGISTRATION: ClinicalTrials.gov NCT01072500 (LIFE) and NCT02582138",
    "entities": [
      {
        "text": "NCT02582138",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to European Geriatric Medicine",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "European Geriatric Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "declare that they have no conflict of interest. Ethical approval: LIFE and",
    "entities": []
  },
  {
    "text": "SPRINTT were approved by ethics committees. Informed consent: All participants",
    "entities": [
      {
        "text": "SPRINTT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "provided a written informed consent prior to enrolment.",
    "entities": []
  },
  {
    "text": "80. Diabetologia. 2025 Jul 15. doi: 10.1007/s00125-025-06487-3. Online ahead of",
    "entities": [
      {
        "text": "80",
        "label": "CARDINAL"
      },
      {
        "text": "Diabetologia",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Societal and biological approaches to diabetes prevention and care for Inuit",
    "entities": [
      {
        "text": "Inuit",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "populations: a narrative review.",
    "entities": []
  },
  {
    "text": "Hoffmeyer B(7)(8), Larsen TLJ(7), Ayotte P(9), Narayanan ML(6), Thuesen ACB(10),",
    "entities": [
      {
        "text": "Larsen TLJ(7",
        "label": "PERSON"
      },
      {
        "text": "Ayotte P(9",
        "label": "PERSON"
      },
      {
        "text": "Narayanan ML(6",
        "label": "PERSON"
      },
      {
        "text": "Thuesen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Greenland Center for Health Research, Department of Health and Nature,",
    "entities": [
      {
        "text": "Center for Health Research, Department of Health and Nature",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ilisimatusarfik/University of Greenland, Nuuk, Greenland. hieh@peqqik.gl.",
    "entities": [
      {
        "text": "Ilisimatusarfik/University of Greenland",
        "label": "ORG"
      },
      {
        "text": "Nuuk",
        "label": "GPE"
      },
      {
        "text": "Greenland",
        "label": "GPE"
      },
      {
        "text": "hieh@peqqik.gl",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Public Health, University of Copenhagen, Copenhagen, Denmark.",
    "entities": [
      {
        "text": "Public Health",
        "label": "ORG"
      },
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Alaska Native Tribal Health Consortium Diabetes Program, Alaska Native Tribal",
    "entities": [
      {
        "text": "6)Alaska",
        "label": "CARDINAL"
      },
      {
        "text": "Native Tribal Health Consortium Diabetes Program",
        "label": "ORG"
      },
      {
        "text": "Alaska Native Tribal",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Health Consortium, Anchorage, AK, USA.",
    "entities": [
      {
        "text": "Health Consortium",
        "label": "ORG"
      },
      {
        "text": "Anchorage",
        "label": "GPE"
      },
      {
        "text": "AK",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Greenland Center for Health Research, Department of Health and Nature,",
    "entities": [
      {
        "text": "Center for Health Research, Department of Health and Nature",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ilisimatusarfik/University of Greenland, Nuuk, Greenland.",
    "entities": [
      {
        "text": "Ilisimatusarfik/University of Greenland",
        "label": "ORG"
      },
      {
        "text": "Nuuk",
        "label": "GPE"
      },
      {
        "text": "Greenland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of",
    "entities": [
      {
        "text": "Nordisk Foundation Center for Basic Metabolic Research, Faculty",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)National Institute of Public Health, Southern Denmark University,",
    "entities": [
      {
        "text": "11)National Institute of Public Health",
        "label": "ORG"
      },
      {
        "text": "Southern Denmark University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Clinical and Translational Research, Steno Diabetes Center Copenhagen,",
    "entities": [
      {
        "text": "Translational Research",
        "label": "ORG"
      },
      {
        "text": "Steno Diabetes Center Copenhagen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The Inuit populations that inhabit the Arctic regions have adapted to survive in",
    "entities": [
      {
        "text": "Inuit",
        "label": "NORP"
      },
      {
        "text": "Arctic",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "extreme conditions. However, recent societal changes and colonisation have led",
    "entities": []
  },
  {
    "text": "to rapid shifts in diet and physical activity, increasing the burden of chronic",
    "entities": []
  },
  {
    "text": "diseases, especially diabetes, in these regions. In addition, modern-day Inuit",
    "entities": [
      {
        "text": "Inuit",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "face significant challenges in accessing diabetes care and prevention and",
    "entities": []
  },
  {
    "text": "awareness programmes because of geographical isolation and fragmented healthcare",
    "entities": []
  },
  {
    "text": "services. This narrative review describes diabetes epidemiology in Inuit",
    "entities": [
      {
        "text": "Inuit",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "populations living in Canada, Alaska and Greenland and their genetic",
    "entities": [
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Alaska",
        "label": "GPE"
      },
      {
        "text": "Greenland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "architecture, as well as the organisation of healthcare related to diabetes and",
    "entities": []
  },
  {
    "text": "interventions aimed at creating awareness and preventing the onset and",
    "entities": []
  },
  {
    "text": "complications of diabetes in these regions. Despite their shared genetic",
    "entities": []
  },
  {
    "text": "architecture, differences are observed across Inuit populations in Canada,",
    "entities": [
      {
        "text": "Inuit",
        "label": "NORP"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Alaska and Greenland in diabetes prevalence and healthcare interventions, and",
    "entities": [
      {
        "text": "Alaska",
        "label": "GPE"
      },
      {
        "text": "Greenland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "especially in the organisation of diabetes healthcare. This narrative review",
    "entities": []
  },
  {
    "text": "highlights the importance of culturally sensitive healthcare interventions and",
    "entities": []
  },
  {
    "text": "comprehensive research and data collection that address the specific health",
    "entities": []
  },
  {
    "text": "needs of the Inuit. Integrating traditional knowledge with modern medical",
    "entities": [
      {
        "text": "Inuit",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "practices is essential for the development of effective, sustainable strategies",
    "entities": []
  },
  {
    "text": "for diabetes prevention and care for the Inuit living in the circumpolar Arctic",
    "entities": [
      {
        "text": "Inuit",
        "label": "NORP"
      },
      {
        "text": "Arctic",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany,",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Springer-Verlag GmbH",
        "label": "ORG"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "part of Springer Nature.",
    "entities": [
      {
        "text": "Springer Nature",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "DOI: 10.1007/s00125-025-06487-3",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Funding: MLN is funded by the Special Diabetes",
    "entities": [
      {
        "text": "MLN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Program for Indians. ACBT is funded by the BRIDGE \u2013 Translational Excellence",
    "entities": [
      {
        "text": "Indians",
        "label": "NORP"
      },
      {
        "text": "ACBT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Programme ( https://bridge.ku.dk ) at the Faculty of Health and Medical",
    "entities": [
      {
        "text": "the Faculty of Health and Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, University of Copenhagen, funded by the Novo Nordisk Foundation",
    "entities": [
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "the Novo Nordisk Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(NNF20SA0064340). The Novo Nordisk Foundation Center for Basic Metabolic",
    "entities": [
      {
        "text": "The Novo Nordisk Foundation Center for Basic Metabolic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research is supported by an unrestricted grant from the Novo Nordisk Foundation",
    "entities": [
      {
        "text": "the Novo Nordisk Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(NNF23SA0084103). The funders had no role in any part of this review. Authors\u2019",
    "entities": []
  },
  {
    "text": "relationships and activities: HN, MHN, BH, TLJL and MLP are employed at Steno",
    "entities": [
      {
        "text": "MHN",
        "label": "ORG"
      },
      {
        "text": "BH",
        "label": "ORG"
      },
      {
        "text": "TLJL",
        "label": "ORG"
      },
      {
        "text": "Steno",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Diabetes Center Greenland (SDCG), a public hospital and research institution,",
    "entities": [
      {
        "text": "SDCG",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "partly funded by a grant from the Novo Nordisk Foundation (NNF20SA0064190). A-LL",
    "entities": [
      {
        "text": "the Novo Nordisk Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "serves as a consultant for The Hill Group with contracted clients including the",
    "entities": [
      {
        "text": "The Hill Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Division of Diabetes Treatment and Prevention and Indian Health Services. MEJ",
    "entities": [
      {
        "text": "Division of Diabetes Treatment and Prevention and Indian Health Services",
        "label": "ORG"
      },
      {
        "text": "MEJ",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and SB own shares in Novo Nordisk A/S and are employed at SDCG and/or Steno",
    "entities": [
      {
        "text": "SB",
        "label": "ORG"
      },
      {
        "text": "Novo Nordisk A/S",
        "label": "ORG"
      },
      {
        "text": "SDCG",
        "label": "GPE"
      },
      {
        "text": "Steno",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Diabetes Center Copenhagen. TH owns stocks in Novo Nordisk and has received",
    "entities": [
      {
        "text": "Novo Nordisk",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "research support from Novo Nordisk and GSK. The authors declare that there are",
    "entities": [
      {
        "text": "Novo Nordisk",
        "label": "ORG"
      },
      {
        "text": "GSK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "no other relationships or activities that might bias, or be perceived to bias,",
    "entities": []
  },
  {
    "text": "their work. Contribution statement: All authors took part in writing the",
    "entities": []
  },
  {
    "text": "manuscript, HN and SB wrote the subsequent drafts of the manuscript, and all",
    "entities": [
      {
        "text": "SB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "authors critically revised the manuscript and approved the final manuscript for",
    "entities": []
  },
  {
    "text": "publication.",
    "entities": []
  },
  {
    "text": "Association between neighborhood deprivation and type 2 diabetes risks among",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "asthma patients: a nationwide population-based cohort study.",
    "entities": []
  },
  {
    "text": "(1)School of Public Health, Ningxia Medical University, Yinchuan, China.",
    "entities": [
      {
        "text": "1)School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Ningxia Medical University",
        "label": "ORG"
      },
      {
        "text": "Yinchuan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Key Laboratory of Environmental Factors and Chronic Disease Control, Ningxia",
    "entities": [
      {
        "text": "2)Key Laboratory of Environmental Factors",
        "label": "ORG"
      },
      {
        "text": "Ningxia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medical University, Yinchuan, China.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Yinchuan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Center for Primary Health Care Research, Department of Clinical Sciences,",
    "entities": [
      {
        "text": "Primary Health Care Research",
        "label": "ORG"
      },
      {
        "text": "Department of Clinical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)University Clinic Primary Care, Sk\u00e5ne University Hospital, Region Sk\u00e5ne,",
    "entities": [
      {
        "text": "Clinic Primary Care",
        "label": "ORG"
      },
      {
        "text": "Sk\u00e5ne University Hospital",
        "label": "ORG"
      },
      {
        "text": "Sk\u00e5ne",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(5)Departments of Family and Community Medicine and of Epidemiology, The",
    "entities": [
      {
        "text": "Family and Community Medicine",
        "label": "ORG"
      },
      {
        "text": "Epidemiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Texas Health Science Center, Houston, TX, USA.",
    "entities": [
      {
        "text": "University of Texas Health Science Center",
        "label": "ORG"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Center for Community-based Healthcare Research and Education (CoHRE),",
    "entities": [
      {
        "text": "6)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Community",
        "label": "ORG"
      },
      {
        "text": "Healthcare Research and Education",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Department of Functional Pathology, School of Medicine, Matsue, Shimane",
    "entities": [
      {
        "text": "Department of Functional Pathology",
        "label": "ORG"
      },
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Matsue",
        "label": "GPE"
      },
      {
        "text": "Shimane\n",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Matsue, Japan.",
    "entities": [
      {
        "text": "Matsue",
        "label": "PERSON"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Center for Primary Health Care Research, Department of Clinical Sciences,",
    "entities": [
      {
        "text": "Primary Health Care Research",
        "label": "ORG"
      },
      {
        "text": "Department of Clinical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)University Clinic Primary Care, Sk\u00e5ne University Hospital, Region Sk\u00e5ne,",
    "entities": [
      {
        "text": "8)University Clinic Primary Care",
        "label": "ORG"
      },
      {
        "text": "Sk\u00e5ne University Hospital",
        "label": "ORG"
      },
      {
        "text": "Sk\u00e5ne",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "This study aimed to investigate the potential impact of neighborhood deprivation",
    "entities": []
  },
  {
    "text": "on the incidence of type 2 diabetes mellitus (T2DM) among individuals with",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "asthma. This nationwide, open cohort study conducted in Sweden from 1997 to 2018",
    "entities": [
      {
        "text": "Sweden",
        "label": "GPE"
      },
      {
        "text": "1997",
        "label": "DATE"
      },
      {
        "text": "2018",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "included asthma patients of all ages (n = 1,051,240) to assess their subsequent",
    "entities": [
      {
        "text": "1,051,240",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "risk of developing T2DM. The study compared asthma patients residing in highly",
    "entities": []
  },
  {
    "text": "deprived neighborhoods with those living in moderately or less deprived areas",
    "entities": []
  },
  {
    "text": "(reference group). Cox proportional hazards regression models were employed to",
    "entities": []
  },
  {
    "text": "analyze the association between neighborhood deprivation and T2DM incidence,",
    "entities": []
  },
  {
    "text": "with results expressed as hazard ratios (HRs) and 95% confidence intervals (95%",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CIs). Analyses were stratified by sex and adjusted for potential confounders. A",
    "entities": [
      {
        "text": "CIs",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "significant association between neighborhood deprivation and T2DM risk in asthma",
    "entities": []
  },
  {
    "text": "patients was shown. These associations remained statistically significant after",
    "entities": []
  },
  {
    "text": "adjusting for confounders, with adjusted HRs of 1.44 (95% CI 1.38-1.50) for men",
    "entities": [
      {
        "text": "1.44",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.38-1.50",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and 1.51 (95% CI 1.46-1.57) for women. Furthermore, a graded relationship was",
    "entities": [
      {
        "text": "1.51",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.46-1.57",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "observed, with higher levels of neighborhood deprivation associated with an",
    "entities": []
  },
  {
    "text": "increased incidence of T2DM among asthma patients. These findings underscore",
    "entities": []
  },
  {
    "text": "critical clinical and public health concerns. The results of this study provide",
    "entities": []
  },
  {
    "text": "valuable insights for policymakers, highlighting the need to consider",
    "entities": []
  },
  {
    "text": "neighborhood deprivation when allocating resources in primary healthcare",
    "entities": []
  },
  {
    "text": "settings. They also offer guidance for optimizing clinical care strategies for",
    "entities": []
  },
  {
    "text": "patients in socioeconomically disadvantaged communities.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-09150-4",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665105 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "declare no competing interests. Ethics approval: This study was approved by the",
    "entities": []
  },
  {
    "text": "regional ethical review board in Lund, Sweden on Feb. 6th, 2013 (registration No",
    "entities": [
      {
        "text": "Lund",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      },
      {
        "text": "Feb. 6th, 2013",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2012/795) and later amendments. Guidelines of the Helsinki Declaration were",
    "entities": [
      {
        "text": "2012/795",
        "label": "CARDINAL"
      },
      {
        "text": "the Helsinki Declaration",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "followed. Data were obtained from the national registers collected by various",
    "entities": []
  },
  {
    "text": "Swedish health and social agencies. The agency Statistics Sweden linked the",
    "entities": [
      {
        "text": "Swedish",
        "label": "NORP"
      },
      {
        "text": "Statistics Sweden",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(pseudonymised) unique personal identification number assigned to all Swedish",
    "entities": [
      {
        "text": "Swedish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "residents at birth or migration. Informed consent: Informed consent was not",
    "entities": []
  },
  {
    "text": "applicable, as the study was based on secondary pseudonymized data from",
    "entities": []
  },
  {
    "text": "Unraveling the role of shrimp hydrolysate as a food supplement in the immune",
    "entities": []
  },
  {
    "text": "function and fecal microbiota of beagle dogs.",
    "entities": []
  },
  {
    "text": "(1)REQUIMTE, LAQV, ICBAS, School of Medicine and Biomedical Sciences, University",
    "entities": [
      {
        "text": "1)REQUIMTE",
        "label": "CARDINAL"
      },
      {
        "text": "LAQV",
        "label": "ORG"
      },
      {
        "text": "ICBAS",
        "label": "ORG"
      },
      {
        "text": "School of Medicine and Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)ICBAS, School of Medicine and Biomedical Sciences, University of Porto,",
    "entities": [
      {
        "text": "3)ICBAS",
        "label": "CARDINAL"
      },
      {
        "text": "School of Medicine and Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Porto",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Hohenheim Center for Livestock Microbiome Research, HoLMiR, University of",
    "entities": [
      {
        "text": "Center for Livestock Microbiome Research",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Institute of Animal Science, University of Hohenheim, Stuttgart, Germany.",
    "entities": [
      {
        "text": "Animal Science, University of Hohenheim",
        "label": "ORG"
      },
      {
        "text": "Stuttgart",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)LEAF - Linking Landscape, Environment, Agriculture and Food Research Center,",
    "entities": [
      {
        "text": "7)LEAF - Linking Landscape",
        "label": "ORG"
      },
      {
        "text": "Agriculture and Food Research Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)REQUIMTE, LAQV, ICBAS, School of Medicine and Biomedical Sciences, University",
    "entities": [
      {
        "text": "8)REQUIMTE",
        "label": "CARDINAL"
      },
      {
        "text": "LAQV",
        "label": "ORG"
      },
      {
        "text": "ICBAS",
        "label": "ORG"
      },
      {
        "text": "School of Medicine and Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The inclusion of protein hydrolysates from animal by-products in petfood may",
    "entities": []
  },
  {
    "text": "enhance the industry's sustainability, while contributing to dogs' health due to",
    "entities": []
  },
  {
    "text": "their nutritional and functional properties. However, inconsistent results of",
    "entities": []
  },
  {
    "text": "protein hydrolysates on gut microbiota, immune responses, among other health",
    "entities": []
  },
  {
    "text": "parameters, have been observed in dogs. This study aimed to evaluate the effects",
    "entities": []
  },
  {
    "text": "of diets supplemented with 5% shrimp hydrolysate, compared to non-supplemented",
    "entities": [
      {
        "text": "5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "diets, on hematological parameters, serum chemistry profile, innate and adaptive",
    "entities": []
  },
  {
    "text": "immune function, and fecal microbiota composition in adult Beagle dogs during a",
    "entities": [
      {
        "text": "Beagle",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "12-week feeding trial. Dietary inclusion of shrimp hydrolysate decreased blood",
    "entities": [
      {
        "text": "12-week",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "eosinophils (P = 0.017) and glucose levels (P = 0.023), while increasing levels",
    "entities": [
      {
        "text": "0.017",
        "label": "CARDINAL"
      },
      {
        "text": "0.023",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of white blood cells (P = 0.002), platelets (P = 0.038), neutrophils",
    "entities": [
      {
        "text": "0.002",
        "label": "CARDINAL"
      },
      {
        "text": "0.038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(P = 0.036), and CD4+ (P < 0.001) and CD8+ T cells (P < 0.001) single producers",
    "entities": [
      {
        "text": "0.036",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of tumor necrosis factor-alpha. It also led to a more extensive proliferation of",
    "entities": []
  },
  {
    "text": "CD4+ T cells in response to LipL32 antigen (P = 0.020) and to a decrease in",
    "entities": [
      {
        "text": "0.020",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "superoxide production in stimulated cells (P = 0.002). Additionally,",
    "entities": [
      {
        "text": "0.002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "supplemented diets increased Oscillospiraceae (P-adj = 0.005) and Clostridia",
    "entities": [
      {
        "text": "Oscillospiraceae",
        "label": "PERSON"
      },
      {
        "text": "0.005",
        "label": "CARDINAL"
      },
      {
        "text": "Clostridia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(P-adj = 0.017) abundance, and decreased such of Sellimonas (P-adj = 0.025).",
    "entities": [
      {
        "text": "0.017",
        "label": "CARDINAL"
      },
      {
        "text": "Sellimonas",
        "label": "GPE"
      },
      {
        "text": "0.025",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Overall, the results indicate that diet supplementation with shrimp hydrolysate",
    "entities": []
  },
  {
    "text": "at 5% modulates the immune response and fecal microbiota, highlighting its",
    "entities": [
      {
        "text": "5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "potential to be included in hypoallergenic and gastrointestinal diets, and in",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-09942-8",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665094 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665094",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: PhD",
    "entities": [
      {
        "text": "PhD",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "scholarship of JG-F was partially funded by Soja de Portugal. TA is employed by",
    "entities": [
      {
        "text": "JG-F",
        "label": "ORG"
      },
      {
        "text": "Soja de Portugal",
        "label": "PERSON"
      },
      {
        "text": "TA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "conflict of interest.",
    "entities": []
  },
  {
    "text": "From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated",
    "entities": []
  },
  {
    "text": "Respiratory Complications.",
    "entities": []
  },
  {
    "text": "(1)Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical",
    "entities": [
      {
        "text": "Geriatrics",
        "label": "GPE"
      },
      {
        "text": "The First Affiliated Hospital of Chongqing Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, No.1 Youyi Road, Yuzhong, Chongqing, 400016, China. yhm920@126.com.",
    "entities": [
      {
        "text": "No.1 Youyi Road",
        "label": "PERSON"
      },
      {
        "text": "Yuzhong",
        "label": "GPE"
      },
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "400016",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Geriatrics",
        "label": "GPE"
      },
      {
        "text": "The First Affiliated Hospital of Chongqing Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, No.1 Youyi Road, Yuzhong, Chongqing, 400016, China.",
    "entities": [
      {
        "text": "No.1 Youyi Road",
        "label": "PERSON"
      },
      {
        "text": "Yuzhong",
        "label": "GPE"
      },
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "400016",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Emerging evidence highlights glucose toxicity as a pivotal driver of diabetic",
    "entities": []
  },
  {
    "text": "respiratory complications, characterized by hyperglycemia-induced metabolic",
    "entities": []
  },
  {
    "text": "dysregulation and multi-organ damage. The lung, a metabolically active organ,",
    "entities": []
  },
  {
    "text": "exhibits unique susceptibility to glucose toxicity due to its exposure to",
    "entities": []
  },
  {
    "text": "oxidative stress, inflammatory cascades, and disrupted metabolic reprogramming,",
    "entities": []
  },
  {
    "text": "particularly in glycolysis and mitochondrial dysfunction. Diabetes-associated",
    "entities": []
  },
  {
    "text": "respiratory complications encompass increased susceptibility to respiratory",
    "entities": []
  },
  {
    "text": "infections, acute respiratory distress syndrome (ARDS) with macrophage-driven",
    "entities": []
  },
  {
    "text": "glycolytic shifts, and gestational diabetes mellitus (GDM)-associated fetal lung",
    "entities": []
  },
  {
    "text": "dysplasia via impaired epithelial differentiation. Future research should",
    "entities": [
      {
        "text": "dysplasia via",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "prioritize metabolic dysregulation-targeted therapies, gut-lung axis modulation,",
    "entities": [
      {
        "text": "prioritize metabolic dysregulation-targeted",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and personalized approaches to address the interplay between hyperglycemia,",
    "entities": []
  },
  {
    "text": "oxidative stress, and immune dysregulation. Elucidating genetic and epigenetic",
    "entities": []
  },
  {
    "text": "modifiers of glucotoxicity will further advance therapeutic strategies for",
    "entities": []
  },
  {
    "text": "diabetes-associated pneumopathy. This review provides an overview of",
    "entities": []
  },
  {
    "text": "epidemiological burden, lung structural and functional changes,",
    "entities": []
  },
  {
    "text": "pathophysiological mechanisms, clinical outcomes and complications, therapeutic",
    "entities": []
  },
  {
    "text": "and preventive strategies, unanswered questions, and future directions of",
    "entities": []
  },
  {
    "text": "diabetes-associated respiratory complications.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to Springer Science+Business",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Springer Science+Business\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Media, LLC, part of Springer Nature.",
    "entities": [
      {
        "text": "LLC",
        "label": "ORG"
      },
      {
        "text": "Springer Nature",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "DOI: 10.1007/s00408-025-00834-2",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665066 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665066",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "declare that they have no competing interests. Ethical Approval: Not applicable.",
    "entities": []
  },
  {
    "text": "Consent to Participate: Not applicable. Consent for Publication: The authors",
    "entities": []
  },
  {
    "text": "consent to publication. Clinical Trial Number: Not applicable.",
    "entities": []
  },
  {
    "text": "84. Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03790-9. Online ahead of print.",
    "entities": [
      {
        "text": "84",
        "label": "CARDINAL"
      },
      {
        "text": "Nat Med",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Deep phenotyping of health-disease continuum in the Human Phenotype Project.",
    "entities": [
      {
        "text": "the Human Phenotype Project",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Y(12), Stossel C(12), Raitses-Gurevich M(12), Golan T(4)(12), Dhir R(13),",
    "entities": [
      {
        "text": "Stossel C(12",
        "label": "ORG"
      },
      {
        "text": "Raitses-Gurevich M(12",
        "label": "PERSON"
      },
      {
        "text": "Golan T(4)(12",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "(1)Department of Computer Science and Applied Mathematics, Weizmann Institute of",
    "entities": [
      {
        "text": "Computer Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Science, Rehovot, Israel.",
    "entities": [
      {
        "text": "Rehovot",
        "label": "GPE"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot,",
    "entities": [
      {
        "text": "Molecular Cell Biology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Lis Maternity and Women's Hospital, Tel Aviv Sourasky Medical Center, Tel",
    "entities": [
      {
        "text": "Tel Aviv Sourasky Medical Center",
        "label": "ORG"
      },
      {
        "text": "Tel\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv,",
    "entities": [
      {
        "text": "4)Faculty of Medical and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Tel Aviv University",
        "label": "ORG"
      },
      {
        "text": "Tel Aviv",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes,",
    "entities": [
      {
        "text": "Jesse Z",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Sara Lea Shafer Institute for Endocrinology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "National Center for Childhood Diabetes, Schneider Children's Medical Center of",
    "entities": [
      {
        "text": "National Center for Childhood Diabetes",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Internal Medicine A, Shamir Medical Center (Assaf Harofeh),",
    "entities": [
      {
        "text": "Internal Medicine A",
        "label": "ORG"
      },
      {
        "text": "Shamir Medical Center",
        "label": "ORG"
      },
      {
        "text": "Assaf Harofeh",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(7)Department of Cardiology, Rabin Medical Center, Petah-Tikva, Israel.",
    "entities": [
      {
        "text": "Cardiology",
        "label": "GPE"
      },
      {
        "text": "Rabin Medical Center",
        "label": "ORG"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel.",
    "entities": [
      {
        "text": "Research Center",
        "label": "ORG"
      },
      {
        "text": "Sheba Medical Center",
        "label": "ORG"
      },
      {
        "text": "Ramat-Gan",
        "label": "ORG"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Institute of Breast Oncology, the Jusidman Cancer Center, Sheba Medical",
    "entities": [
      {
        "text": "Breast Oncology",
        "label": "ORG"
      },
      {
        "text": "the Jusidman Cancer Center",
        "label": "ORG"
      },
      {
        "text": "Sheba Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)The Department of Gastroenterology and Liver Disease, Tel Aviv Medical",
    "entities": [
      {
        "text": "10)The Department of Gastroenterology and Liver Disease",
        "label": "ORG"
      },
      {
        "text": "Tel Aviv Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, affiliated to the Grey Faculty of Medicine and Health Sciences, Tel Aviv",
    "entities": [
      {
        "text": "the Grey Faculty of Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Tel Aviv",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Tel Aviv, Israel.",
    "entities": [
      {
        "text": "Tel Aviv",
        "label": "GPE"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Department of Internal Medicine, SBS Shizuoka Health Promotion Center,",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "SBS Shizuoka Health Promotion Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)The Jusidman Cancer Center, Sheba Medical Center, Tel Hashomer, Israel.",
    "entities": [
      {
        "text": "Jusidman Cancer Center",
        "label": "ORG"
      },
      {
        "text": "Sheba Medical Center",
        "label": "ORG"
      },
      {
        "text": "Tel Hashomer",
        "label": "PERSON"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich,",
    "entities": [
      {
        "text": "13)Swiss Institute of Allergy and Asthma Research",
        "label": "ORG"
      },
      {
        "text": "University of Zurich",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, UAE.",
    "entities": [
      {
        "text": "15)Mohamed",
        "label": "CARDINAL"
      },
      {
        "text": "bin Zayed University of Artificial Intelligence",
        "label": "ORG"
      },
      {
        "text": "Abu Dhabi",
        "label": "GPE"
      },
      {
        "text": "UAE",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, UAE.",
    "entities": [
      {
        "text": "bin Zayed University of Artificial Intelligence",
        "label": "ORG"
      },
      {
        "text": "Abu Dhabi",
        "label": "GPE"
      },
      {
        "text": "UAE",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Carnegie Mellon University Pittsburgh, Pittsburgh, PA, USA.",
    "entities": [
      {
        "text": "18)Carnegie",
        "label": "CARDINAL"
      },
      {
        "text": "Mellon University",
        "label": "ORG"
      },
      {
        "text": "Pittsburgh",
        "label": "GPE"
      },
      {
        "text": "Pittsburgh",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)Department of Computer Science and Applied Mathematics, Weizmann Institute",
    "entities": []
  },
  {
    "text": "of Science, Rehovot, Israel. eran.segal@weizmann.ac.il.",
    "entities": [
      {
        "text": "Science, Rehovot",
        "label": "GPE"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(20)Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, UAE.",
    "entities": [
      {
        "text": "20)Mohamed",
        "label": "CARDINAL"
      },
      {
        "text": "University of Artificial Intelligence",
        "label": "ORG"
      },
      {
        "text": "Abu Dhabi",
        "label": "GPE"
      },
      {
        "text": "UAE",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The Human Phenotype Project (HPP) is a large-scale deep-phenotype prospective",
    "entities": [
      {
        "text": "The Human Phenotype Project",
        "label": "ORG"
      },
      {
        "text": "HPP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cohort. To date, approximately 28,000 participants have enrolled, with more than",
    "entities": [
      {
        "text": "approximately 28,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "13,000 completing their initial visit. The project is aimed at identifying novel",
    "entities": [
      {
        "text": "13,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "molecular signatures with diagnostic, prognostic and therapeutic value, and at",
    "entities": []
  },
  {
    "text": "developing artificial intelligence (AI)-based predictive models for disease",
    "entities": []
  },
  {
    "text": "onset and progression. The HPP includes longitudinal profiling encompassing",
    "entities": [
      {
        "text": "HPP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "medical history, lifestyle and nutrition, anthropometrics, blood tests,",
    "entities": []
  },
  {
    "text": "continuous glucose and sleep monitoring, imaging and multi-omics data, including",
    "entities": [
      {
        "text": "continuous glucose",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "immune profiling. Analysis of these data highlights the variation of phenotypes",
    "entities": []
  },
  {
    "text": "with age and ethnicity and unravels molecular signatures of disease by",
    "entities": []
  },
  {
    "text": "comparison with matched healthy controls. Leveraging extensive dietary and",
    "entities": []
  },
  {
    "text": "lifestyle data, we identify associations between lifestyle factors and health",
    "entities": [
      {
        "text": "lifestyle data",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "outcomes. Finally, we present a multi-modal foundation AI model, trained using",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "self-supervised learning on diet and continuous-glucose-monitoring data, that",
    "entities": []
  },
  {
    "text": "outperforms existing methods in predicting disease onset. This framework can be",
    "entities": []
  },
  {
    "text": "extended to integrate other modalities and act as a personalized digital twin.",
    "entities": []
  },
  {
    "text": "In summary, we present a deeply phenotyped cohort that serves as a platform for",
    "entities": []
  },
  {
    "text": "advancing biomarker discovery, enabling the development of multi-modal AI models",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and personalized medicine approaches.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Springer Nature America, Inc.",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "DOI: 10.1038/s41591-025-03790-9",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: Y.R., H.R. and Y.T.B are",
    "entities": [
      {
        "text": "Y.R.",
        "label": "GPE"
      },
      {
        "text": "H.R.",
        "label": "GPE"
      },
      {
        "text": "Y.T.B",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "employees at Pheno.AI. A.K., A.W. and E.S. are paid consultants of Pheno.AI.",
    "entities": [
      {
        "text": "Pheno",
        "label": "GPE"
      },
      {
        "text": "AI",
        "label": "ORG"
      },
      {
        "text": "A.K.",
        "label": "GPE"
      },
      {
        "text": "A.W.",
        "label": "GPE"
      },
      {
        "text": "E.S.",
        "label": "GPE"
      },
      {
        "text": "Pheno",
        "label": "GPE"
      },
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "N.M. has received speaking and consulting fees from Pfizer, Abbvie, Lilly,",
    "entities": [
      {
        "text": "N.M.",
        "label": "GPE"
      },
      {
        "text": "Pfizer, Abbvie, Lilly",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Takeda, Janssen, Ferring, BiomX, BMS, Nestle and Teva and grant support from",
    "entities": [
      {
        "text": "Ferring",
        "label": "GPE"
      },
      {
        "text": "BMS",
        "label": "ORG"
      },
      {
        "text": "Nestle",
        "label": "ORG"
      },
      {
        "text": "Teva",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Helmsely Charitable Trust. The other authors declare no competing interests.",
    "entities": [
      {
        "text": "the Helmsely Charitable Trust",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Prevalence and risk factors of hypertensive retinopathy in South Korea based on",
    "entities": [
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "national health survey data.",
    "entities": [
      {
        "text": "national health survey data",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Park SH(1), Nam D(2), Choi JY(3), Yoo TK(4).",
    "entities": [
      {
        "text": "Nam D(2",
        "label": "PERSON"
      },
      {
        "text": "Choi JY(3",
        "label": "PERSON"
      },
      {
        "text": "Yoo TK(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Ophthalmology, Hangil Eye Hospital, 35 Bupyeong-daero,",
    "entities": [
      {
        "text": "Ophthalmology, Hangil Eye Hospital",
        "label": "ORG"
      },
      {
        "text": "35",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Bupyeong-gu, Incheon, 21388, Republic of Korea.",
    "entities": [
      {
        "text": "Incheon",
        "label": "ORG"
      },
      {
        "text": "21388",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Internal Medicine, Graduate School, College of Medicine, Yonsei",
    "entities": [
      {
        "text": "Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Graduate School, College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Yonsei",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University, Seoul, South Korea.",
    "entities": [
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Biomedical Engineering, Yonsei University, Wonju, South Korea.",
    "entities": [
      {
        "text": "Biomedical Engineering",
        "label": "ORG"
      },
      {
        "text": "Yonsei University",
        "label": "ORG"
      },
      {
        "text": "Wonju",
        "label": "GPE"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Ophthalmology, Hangil Eye Hospital, 35 Bupyeong-daero,",
    "entities": [
      {
        "text": "Ophthalmology, Hangil Eye Hospital",
        "label": "ORG"
      },
      {
        "text": "35",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Bupyeong-gu, Incheon, 21388, Republic of Korea. fawoo2@yonsei.ac.kr.",
    "entities": [
      {
        "text": "Incheon",
        "label": "ORG"
      },
      {
        "text": "21388",
        "label": "DATE"
      },
      {
        "text": "Republic of Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "This study investigated the prevalence and risk factors of moderate to severe",
    "entities": []
  },
  {
    "text": "hypertensive retinopathy among non-diabetic South Korean adults using data from",
    "entities": [
      {
        "text": "South Korean",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2011.",
    "entities": [
      {
        "text": "the Korea National Health and Nutrition Examination Survey",
        "label": "ORG"
      },
      {
        "text": "KNHANES",
        "label": "ORG"
      },
      {
        "text": "2008-2011",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Hypertensive retinopathy was defined through standardized retinal image grading.",
    "entities": []
  },
  {
    "text": "A multivariable logistic regression model was developed using weighted analysis",
    "entities": []
  },
  {
    "text": "and predictor selection based on pathophysiological relevance and",
    "entities": []
  },
  {
    "text": "multicollinearity diagnostics. Final model features included age, systolic blood",
    "entities": []
  },
  {
    "text": "pressure, HbA1c, total cholesterol, creatinine, and hemoglobin. Among 5,075",
    "entities": [
      {
        "text": "5,075",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participants, the weighted prevalence of moderate to severe hypertensive",
    "entities": []
  },
  {
    "text": "retinopathy was 0.8%. The prevalence rate increased with higher systolic blood",
    "entities": [
      {
        "text": "0.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "pressure levels. The model demonstrated moderate discrimination, with an average",
    "entities": []
  },
  {
    "text": "area under the receiver operating characteristic curve (AUC) of 0.721 in 5-fold",
    "entities": [
      {
        "text": "0.721",
        "label": "CARDINAL"
      },
      {
        "text": "5-fold",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cross-validation and 0.679 in external validation using the KNHANES 2012",
    "entities": [
      {
        "text": "0.679",
        "label": "CARDINAL"
      },
      {
        "text": "KNHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dataset. External validation was performed using averaged predictions from the",
    "entities": []
  },
  {
    "text": "five internally validated models. The relatively low prevalence of hypertensive",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "retinopathy compared to Western populations may reflect differences in",
    "entities": []
  },
  {
    "text": "hypertension control, lifestyle, or genetic susceptibility. Future research",
    "entities": []
  },
  {
    "text": "should explore retinal image analysis and longitudinal datasets to enhance early",
    "entities": []
  },
  {
    "text": "detection and clarify the systemic implications of hypertensive retinopathy.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-11017-7",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664953 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664953",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: T K Yoo is an",
    "entities": [
      {
        "text": "T K Yoo",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "advisory board member of MediWhale and has received consultant fees as part of",
    "entities": [
      {
        "text": "MediWhale",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the standard compensation package. The remaining authors declare no conflicts of",
    "entities": []
  },
  {
    "text": "interest. Ethics approval and consent to participate: This study was conducted",
    "entities": []
  },
  {
    "text": "using anonymized data from the publicly available KNHANES dataset, which was",
    "entities": [
      {
        "text": "KNHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "approved by the Institutional Review Board (IRB) of the Korea Centers for",
    "entities": [
      {
        "text": "the Institutional Review Board",
        "label": "ORG"
      },
      {
        "text": "IRB",
        "label": "ORG"
      },
      {
        "text": "the Korea Centers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Disease Control and Prevention (IRB numbers: 2008-04EXP-01-C, 2009-01CON-03\u20132 C,",
    "entities": [
      {
        "text": "Disease Control and Prevention",
        "label": "ORG"
      },
      {
        "text": "IRB",
        "label": "ORG"
      },
      {
        "text": "2008",
        "label": "DATE"
      },
      {
        "text": "2009",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2010-02CON-21-C, 2011-02-CON-06-C, and 2012-01-EXP-01\u20132 C). Written informed",
    "entities": [
      {
        "text": "2010",
        "label": "DATE"
      },
      {
        "text": "2011-02",
        "label": "DATE"
      },
      {
        "text": "2012-01",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "consent was obtained from all participants prior to their inclusion in the",
    "entities": []
  },
  {
    "text": "survey. As the study exclusively utilized publicly available data, additional",
    "entities": []
  },
  {
    "text": "IRB approval was not required. The study complied with the principles outlined",
    "entities": [
      {
        "text": "IRB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in the Declaration of Helsinki, ensuring ethical standards were maintained",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "throughout. Consent for publication: Not applicable, as this study does not",
    "entities": []
  },
  {
    "text": "consent for publication.",
    "entities": []
  },
  {
    "text": "Biochemical and molecular evaluation of resveratrol and selenium nanoparticles",
    "entities": []
  },
  {
    "text": "in managing type 2 diabetes and its complications.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)Department of Biochemistry, Faculty of Science, Alexandria University,",
    "entities": [
      {
        "text": "Biochemistry, Faculty of Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo",
    "entities": [
      {
        "text": "Pharmaceutical Chemistry",
        "label": "ORG"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Kasr El\u2011Aini Street, Cairo, 11562, Egypt.",
    "entities": [
      {
        "text": "Cairo",
        "label": "GPE"
      },
      {
        "text": "11562",
        "label": "DATE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Epidemiological Surveillance Unit, Aweash El-Hagar Family Medicine Center,",
    "entities": [
      {
        "text": "Surveillance Unit",
        "label": "ORG"
      },
      {
        "text": "Aweash El-Hagar Family Medicine Center",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of Biochemistry, Faculty of Science, Alexandria University,",
    "entities": [
      {
        "text": "Biochemistry, Faculty of Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The therapeutic potential of dietary polyphenols, such as resveratrol (Res) and",
    "entities": []
  },
  {
    "text": "elemental selenium nanoparticles (SeNPs), has gained increasing attention for",
    "entities": []
  },
  {
    "text": "the treatment and management of type 2 diabetes mellitus (T2DM). In this study,",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "we investigated a novel therapeutic strategy using chitosan-stabilized Res/SeNPs",
    "entities": [
      {
        "text": "Res",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(CS/Res/SeNPs) in a mouse model of T2DM induced by high-fat diet (HFD) feeding",
    "entities": [
      {
        "text": "CS/Res/SeNPs",
        "label": "ORG"
      },
      {
        "text": "HFD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "combined with multiple low-dose streptozotocin (STZ) injections. We evaluated",
    "entities": [
      {
        "text": "STZ",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the effects of these nanoparticles on glucose and insulin levels,",
    "entities": []
  },
  {
    "text": "oxidative/antioxidant balance, expression of apoptotic and anti-apoptotic genes,",
    "entities": []
  },
  {
    "text": "and inflammatory mediators using biochemical, histopathological, and molecular",
    "entities": []
  },
  {
    "text": "docking analyses. Treatment with free Res, CS/Res/SeNPs-5, CS/Res/SeNPs-10, and",
    "entities": [
      {
        "text": "CS/Res",
        "label": "ORG"
      },
      {
        "text": "CS/Res",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Metformin (Met) improved hyperglycemia, insulin resistance (IR), and",
    "entities": [
      {
        "text": "Metformin (Met",
        "label": "ORG"
      },
      {
        "text": "IR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dyslipidemia, and normalized elevated liver and kidney biomarkers. These",
    "entities": []
  },
  {
    "text": "treatments also exhibited anti-inflammatory, antioxidant, and anti-apoptotic",
    "entities": []
  },
  {
    "text": "effects. CS/Res/SeNPs-10 showed the most potent hepatoprotective and",
    "entities": [
      {
        "text": "CS/Res",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anti-diabetic effects. The docking results revealed that Res binds to key",
    "entities": [
      {
        "text": "Res",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "insulin signaling proteins, such as phosphatidylinositol 3-kinase (PI3K)/protein",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "kinase B (AKT)/mammalian target of rapamycin (mTOR). Collectively, our findings",
    "entities": [
      {
        "text": "mTOR",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "highlight the therapeutic promise of CS/Res/SeNPs in managing T2DM complications",
    "entities": [
      {
        "text": "CS/Res/SeNPs",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and suggest a cost-effective strategy to enhance health outcomes and quality of",
    "entities": []
  },
  {
    "text": "life in diabetic patients.",
    "entities": []
  },
  {
    "text": "PMID: 40664894 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664894",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "declare no competing interests. Ethics approval: The study is reported in",
    "entities": []
  },
  {
    "text": "accordance with ARRIVE guidelines. All experimental procedures were carried out",
    "entities": []
  },
  {
    "text": "following the animal protocols approved by the Ethics Committee of the Faculty",
    "entities": [
      {
        "text": "the Ethics Committee of the Faculty\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Science, Alexandria University, Egypt (AU Approval No. 04231031102).",
    "entities": [
      {
        "text": "Science, Alexandria University",
        "label": "ORG"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Mental health risks in children with food allergies: a population-based",
    "entities": []
  },
  {
    "text": "comparison of food allergies with other chronic conditions.",
    "entities": []
  },
  {
    "text": "Flaks-Manov N(#)(1), Goldshtein I(#)(1), Yanover C(1), Lachover-Roth I(2)(3).",
    "entities": [
      {
        "text": "Flaks-Manov",
        "label": "ORG"
      },
      {
        "text": "Goldshtein",
        "label": "PERSON"
      },
      {
        "text": "Yanover",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)KI Research Institute, Kfar Malal, Israel.",
    "entities": [
      {
        "text": "1)KI Research Institute",
        "label": "ORG"
      },
      {
        "text": "Kfar Malal",
        "label": "PERSON"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Allergy and Clinical Immunology Unit, Meir Medical Center, Kfar Saba, Israel.",
    "entities": [
      {
        "text": "Clinical Immunology Unit",
        "label": "ORG"
      },
      {
        "text": "Meir Medical Center",
        "label": "ORG"
      },
      {
        "text": "Kfar Saba",
        "label": "PERSON"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv",
    "entities": [
      {
        "text": "Medicine, Faculty of Medical and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Tel Aviv",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Tel Aviv, Israel. idit.lachover@gmail.com.",
    "entities": [
      {
        "text": "Tel Aviv",
        "label": "GPE"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Children with chronic diseases face a higher risk of mental health disorders.",
    "entities": []
  },
  {
    "text": "However, the cognitive consequences of food allergies (FA), which are not",
    "entities": []
  },
  {
    "text": "classified as a chronic disease, remain insufficiently researched. The objective",
    "entities": []
  },
  {
    "text": "of this study is to examine the association between FA and mental health in",
    "entities": []
  },
  {
    "text": "children and adolescents, compared to children and adolescents without FA",
    "entities": []
  },
  {
    "text": "(controls) and those with other chronic conditions but no history of FA. This is",
    "entities": []
  },
  {
    "text": "a retrospective cohort study using IQVIA Medical Research Data from UK primary",
    "entities": [
      {
        "text": "IQVIA Medical Research Data",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "care practices. Five cohorts of children aged 0-18 between 2000 and 2021 were",
    "entities": [
      {
        "text": "Five",
        "label": "CARDINAL"
      },
      {
        "text": "0-18 between 2000",
        "label": "DATE"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "defined: FA, control, asthma, atopic dermatitis (AD), and type 1 diabetes (T1D).",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The study included 1,130,721 children without FA (control), 23,263 with FA,",
    "entities": [
      {
        "text": "1,130,721",
        "label": "CARDINAL"
      },
      {
        "text": "23,263",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "136,453 with asthma, 207,575 with AD, and 4835 with T1D. Compared to control, FA",
    "entities": [
      {
        "text": "136,453",
        "label": "CARDINAL"
      },
      {
        "text": "207,575",
        "label": "CARDINAL"
      },
      {
        "text": "4835",
        "label": "DATE"
      },
      {
        "text": "T1D.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients had higher risks of eating disorders (hazard ratio (HR) 1.85, 95% CI",
    "entities": [
      {
        "text": "1.85",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.42-2.41), anxiety (HR 1.35, 95% CI 1.25-1.45), and depression (HR 1.24, 95% CI",
    "entities": [
      {
        "text": "1.42",
        "label": "CARDINAL"
      },
      {
        "text": "1.35",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.25-1.45",
        "label": "CARDINAL"
      },
      {
        "text": "1.24",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.11-1.39). FA patients had lower depression risk than asthma and T1D patients",
    "entities": [
      {
        "text": "1.11-1.39",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(HR 0.77, 95% CI 0.68-0.87, 0.64, 95% CI 0.54-0.76, respectively) and lower",
    "entities": [
      {
        "text": "0.77",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "GPE"
      },
      {
        "text": "0.68-0.87",
        "label": "CARDINAL"
      },
      {
        "text": "0.64",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.54-0.76",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "anxiety risk than asthma patients (HR 0.86, 95% CI 0.79-0.91). FA patients' risk",
    "entities": [
      {
        "text": "0.86",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.79-0.91",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of eating disorders was not significantly different from asthma and T1D patients",
    "entities": []
  },
  {
    "text": "(HR 1.17, 95% CI 0.88-1.55, 1.58, 95% CI 0.81-3.10, respectively) but was",
    "entities": [
      {
        "text": "1.17",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.88-1.55",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.81-3.10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significantly higher than in the AD group (HR 1.43, 95% CI 1.07-1.90).",
    "entities": [
      {
        "text": "1.43",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.07-1.90",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: This study indicates that children with FA face elevated risks of",
    "entities": []
  },
  {
    "text": "anxiety, depression, and eating disorders compared to children without FA, and",
    "entities": []
  },
  {
    "text": "that these risks vary when compared to children with other chronic conditions.",
    "entities": []
  },
  {
    "text": "These findings highlight the need for integrated mental health support in FA",
    "entities": []
  },
  {
    "text": "management and greater awareness of FA's psychological impact among healthcare",
    "entities": []
  },
  {
    "text": "WHAT IS KNOWN: \u2022 Children with chronic illnesses such as asthma and diabetes are",
    "entities": []
  },
  {
    "text": "known to have an elevated risk of mental health disorders. However, research on",
    "entities": []
  },
  {
    "text": "the mental health impact of food allergies remains limited.",
    "entities": []
  },
  {
    "text": "WHAT IS NEW: \u2022 This study reveals that children with FA have significantly",
    "entities": []
  },
  {
    "text": "increased risks of anxiety, depression, and eating disorders compared to",
    "entities": []
  },
  {
    "text": "children without FA and provides comparative insights into the mental health",
    "entities": []
  },
  {
    "text": "risks of FA relative to other chronic conditions like asthma, atopic dermatitis,",
    "entities": []
  },
  {
    "text": "type 1 diabetes, and healthy controls.",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664887 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664887",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethical approval: This study was",
    "entities": []
  },
  {
    "text": "performed in line with the principles of the Declaration of Helsinki. Approval",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "was granted by the Ethics Committee of IQVIA Scientific Review Committee (SRC",
    "entities": [
      {
        "text": "the Ethics Committee of IQVIA Scientific Review Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Reference Number: 23SRC014). Competing interest: The authors declare no",
    "entities": [
      {
        "text": "23SRC014",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "88. Eur Radiol. 2025 Jul 15. doi: 10.1007/s00330-025-11799-4. Online ahead of",
    "entities": [
      {
        "text": "88",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Splanchnic hemodynamic parameters measured with 4D flow MRI can diagnose severe",
    "entities": []
  },
  {
    "text": "G(3)(4), Kennedy P(3)(4), Sharma H(3), Hectors SJ(3)(4), Thung S(6), Jin N(7),",
    "entities": [
      {
        "text": "Kennedy",
        "label": "PERSON"
      },
      {
        "text": "Sharma",
        "label": "NORP"
      },
      {
        "text": "Thung",
        "label": "GPE"
      },
      {
        "text": "Jin N(7",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Diagnostic, Molecular and Interventional Radiology, Icahn",
    "entities": [
      {
        "text": "Diagnostic, Molecular and Interventional Radiology",
        "label": "ORG"
      },
      {
        "text": "Icahn",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "School of Medicine at Mount Sinai, New York, NY, USA.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount Sinai",
        "label": "FAC"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)BioMedical Engineering and Imaging Institute, Icahn School of Medicine at",
    "entities": [
      {
        "text": "Imaging Institute",
        "label": "ORG"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mount Sinai, New York, NY, USA. octavia.bane@mountsinai.org.",
    "entities": [
      {
        "text": "Mount Sinai",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Diagnostic, Molecular and Interventional Radiology, Icahn",
    "entities": [
      {
        "text": "Diagnostic, Molecular and Interventional Radiology",
        "label": "ORG"
      },
      {
        "text": "Icahn",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(4)BioMedical Engineering and Imaging Institute, Icahn School of Medicine at",
    "entities": [
      {
        "text": "Imaging Institute",
        "label": "ORG"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mount Sinai, New York, NY, USA.",
    "entities": [
      {
        "text": "Mount Sinai",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Radiology, University Hospital Zurich, Zurich, Switzerland.",
    "entities": [
      {
        "text": "Radiology, University Hospital Zurich",
        "label": "ORG"
      },
      {
        "text": "Zurich",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Pathology, Icahn School of Medicine at Mount Sinai, New York,",
    "entities": [
      {
        "text": "Pathology",
        "label": "ORG"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount Sinai",
        "label": "FAC"
      },
      {
        "text": "New York",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Siemens Healthineers, Solon, OH, USA.",
    "entities": [
      {
        "text": "Healthineers",
        "label": "ORG"
      },
      {
        "text": "Solon",
        "label": "ORG"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Biomedical Engineering, McCormick School of Engineering,",
    "entities": [
      {
        "text": "Biomedical Engineering",
        "label": "ORG"
      },
      {
        "text": "McCormick School of Engineering",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Northwestern University, Evanston, IL, USA.",
    "entities": [
      {
        "text": "Northwestern University",
        "label": "ORG"
      },
      {
        "text": "Evanston",
        "label": "ORG"
      },
      {
        "text": "IL",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Radiology, Feinberg School of Medicine, Northwestern",
    "entities": [
      {
        "text": "Radiology, Feinberg School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Chicago, IL, USA.",
    "entities": [
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Department of Radiology, University of Wisconsin Madison, Madison, WI, USA.",
    "entities": [
      {
        "text": "10)Department of Radiology, University of Wisconsin Madison",
        "label": "MONEY"
      },
      {
        "text": "Madison",
        "label": "PERSON"
      },
      {
        "text": "WI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Recanati-Miller Transplantation Institute, Icahn School of Medicine at Mount",
    "entities": [
      {
        "text": "11)Recanati",
        "label": "CARDINAL"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount\n",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Sinai, New York, NY, USA.",
    "entities": [
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: To assess the diagnostic performance of splanchnic hemodynamic",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "parameters measured with 4D flow MRI for diagnosis of severe portal hypertension",
    "entities": []
  },
  {
    "text": "(PH; hepatic venous pressure gradient (HVPG) \u2265 12 mmHg), and prediction of liver",
    "entities": [
      {
        "text": "HVPG",
        "label": "ORG"
      },
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "decompensation in patients with chronic liver disease.",
    "entities": []
  },
  {
    "text": "MATERIALS AND METHODS: Our single-center prospective study (2018-2022) enrolled",
    "entities": [
      {
        "text": "2018-2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patients undergoing transjugular liver biopsy with wedge HVPG measurement for",
    "entities": []
  },
  {
    "text": "abdominal 4D flow MRI (MRI-HVPG interval = 28 \u00b1 18 (1-78) days). 4D flow MRI was",
    "entities": [
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "1-78) days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "acquired at 1.5 T, 10 min. after injection of gadoxetic acid, with a prototype",
    "entities": [
      {
        "text": "1.5",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "manually segmented the portal, superior mesenteric, splenic and middle hepatic",
    "entities": [
      {
        "text": "middle hepatic",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Time-averaged vessel cross-section area, through-plane time-averaged velocity",
    "entities": []
  },
  {
    "text": "and flow, and peak velocity were compared between patients with/without severe",
    "entities": []
  },
  {
    "text": "PH, and with/without future liver decompensation by Mann-Whitney U test and ROC",
    "entities": [
      {
        "text": "Mann-Whitney U",
        "label": "ORG"
      },
      {
        "text": "ROC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: 50 patients (M/F: 26/24, age = 52 \u00b1 15 years) were included, of which",
    "entities": [
      {
        "text": "50",
        "label": "CARDINAL"
      },
      {
        "text": "26/24",
        "label": "CARDINAL"
      },
      {
        "text": "52",
        "label": "DATE"
      },
      {
        "text": "15 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "47 had clinical follow-up 1084 \u00b1 618 days after MRI. Twenty-three of 50 (46%)",
    "entities": [
      {
        "text": "47",
        "label": "CARDINAL"
      },
      {
        "text": "1084",
        "label": "DATE"
      },
      {
        "text": "618 days",
        "label": "DATE"
      },
      {
        "text": "Twenty-three",
        "label": "CARDINAL"
      },
      {
        "text": "46%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "patients had PH, 8/50 (16%) had severe PH, and 12/47 (26%) had decompensation.",
    "entities": [
      {
        "text": "16%",
        "label": "PERCENT"
      },
      {
        "text": "12/47",
        "label": "CARDINAL"
      },
      {
        "text": "26%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Celiac trunk peak velocity [AUC (95% CI) = 0.90 (0.80-0.99)] and superior",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.90",
        "label": "CARDINAL"
      },
      {
        "text": "0.80-0.99",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mesenteric vein area [AUC (95% CI) = 0.88 (0.77-0.99)] identified severe PH with",
    "entities": [
      {
        "text": "AUC",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.88",
        "label": "CARDINAL"
      },
      {
        "text": "0.77",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the highest diagnostic performance. A logistic regression model combining celiac",
    "entities": []
  },
  {
    "text": "trunk peak velocity and superior mesenteric vein flow identified severe PH with",
    "entities": []
  },
  {
    "text": "AUC (95% CI) = 0.95 (0.88-1.00), sensitivity = 100%, specificity = 89%. Hepatic",
    "entities": [
      {
        "text": "AUC",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.95",
        "label": "CARDINAL"
      },
      {
        "text": "0.88-1.00",
        "label": "DATE"
      },
      {
        "text": "100%",
        "label": "PERCENT"
      },
      {
        "text": "89%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "[AUC (95% CI) = 0.74 (0.57-0.92)] and splenic artery [AUC (95% CI) = 0.74",
    "entities": [
      {
        "text": "AUC",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.74",
        "label": "CARDINAL"
      },
      {
        "text": "0.57",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.74",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mesenteric vein [AUC (95% CI) = 0.72 (0.55-0.89)] flow predicted liver",
    "entities": [
      {
        "text": "mesenteric vein",
        "label": "PERSON"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.72",
        "label": "CARDINAL"
      },
      {
        "text": "0.55-0.89",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "decompensation with good diagnostic performance.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Splanchnic 4D flow MRI measurements have excellent performance for",
    "entities": []
  },
  {
    "text": "diagnosing severe PH and good performance for predicting liver decompensation.",
    "entities": []
  },
  {
    "text": "KEY POINTS: Question Noninvasive detection of severe portal hypertension",
    "entities": [
      {
        "text": "Question Noninvasive",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(hepatic venous pressure gradient \u2265 12 mmHg) is important to prevent bleeding,",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "decompensation, and death in patients with chronic liver disease. Findings",
    "entities": []
  },
  {
    "text": "Splanchnic hemodynamic measurements by 4D flow MRI can identify patients with",
    "entities": []
  },
  {
    "text": "severe portal hypertension and predict liver decompensation with excellent/good",
    "entities": []
  },
  {
    "text": "diagnostic performance. Clinical relevance 4D flow MRI can potentially be",
    "entities": []
  },
  {
    "text": "integrated into the clinical MRI protocols of patients with liver cirrhosis.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to European Society of Radiology.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "European Society of Radiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.1007/s00330-025-11799-4",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Compliance with ethical standards. Guarantor:",
    "entities": []
  },
  {
    "text": "The scientific guarantor of this publication is Bachir Taouli. Conflict of",
    "entities": [
      {
        "text": "Bachir Taouli",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "interest: The authors of this manuscript declare relationships with the",
    "entities": []
  },
  {
    "text": "following companies: P.K. is an employee of Boston Scientific, and S.J.H. is an",
    "entities": [
      {
        "text": "P.K.",
        "label": "ORG"
      },
      {
        "text": "Boston Scientific",
        "label": "ORG"
      },
      {
        "text": "S.J.H.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "employee of Regeneron Pharmaceuticals, which are not sponsors of this project.",
    "entities": [
      {
        "text": "Regeneron Pharmaceuticals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "N.J. is an employee of Siemens Healthineers, which supported this project with a",
    "entities": [
      {
        "text": "N.J.",
        "label": "GPE"
      },
      {
        "text": "Siemens Healthineers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "prototype pulse sequence and data analysis software. B.T. received material",
    "entities": [
      {
        "text": "B.T.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "support for this research from Siemens, in the form of a research 4D flow MRI",
    "entities": [
      {
        "text": "Siemens",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pulse sequence and data analysis software. O.B., A.G., D.S., S.P., G.A., H.S.,",
    "entities": [
      {
        "text": "O.B.",
        "label": "GPE"
      },
      {
        "text": "A.G.",
        "label": "GPE"
      },
      {
        "text": "D.S.",
        "label": "GPE"
      },
      {
        "text": "S.P.",
        "label": "GPE"
      },
      {
        "text": "G.A.",
        "label": "GPE"
      },
      {
        "text": "H.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "A.F., M.M., S.T., T.D.S. and S.R. declare no relationships with any companies,",
    "entities": [
      {
        "text": "A.F.",
        "label": "GPE"
      },
      {
        "text": "M.M.",
        "label": "GPE"
      },
      {
        "text": "S.T.",
        "label": "GPE"
      },
      {
        "text": "T.D.S.",
        "label": "GPE"
      },
      {
        "text": "S.R.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "whose products or services may be related to the subject matter of the article.",
    "entities": []
  },
  {
    "text": "Statistics and biometry: No complex statistical methods were necessary for this",
    "entities": []
  },
  {
    "text": "paper. Informed consent: Written informed consent was obtained from all subjects",
    "entities": []
  },
  {
    "text": "(patients) in this study. Ethical approval: Institutional Review Board approval",
    "entities": [
      {
        "text": "Institutional Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was obtained from the Icahn School of Medicine at Mount Sinai Institutional",
    "entities": [
      {
        "text": "the Icahn School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount Sinai Institutional",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Review Board. Study subjects or cohorts overlap: All patients in our cohort",
    "entities": [
      {
        "text": "Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "underwent multiparametric MRI (diffusion-weighted, DCE-MRI, T1, T1\u03c1, MR",
    "entities": [
      {
        "text": "DCE-MRI",
        "label": "ORG"
      },
      {
        "text": "T1",
        "label": "NORP"
      },
      {
        "text": "T1\u03c1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "elastography and 4D flow). In the interest of clarity and brevity, we decided to",
    "entities": []
  },
  {
    "text": "present the data acquired with different MRI methods (e.g., 4D flow, T1 and T1\u03c1",
    "entities": [
      {
        "text": "T1",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "relaxometry, and elastography) separately. Some study subjects or cohorts have",
    "entities": []
  },
  {
    "text": "been previously reported in a published study on T1 and T1\u03c1 mapping in portal",
    "entities": [
      {
        "text": "T1",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "hypertension (Hectors et al [19]), native and contrast-enhanced T1 (Altinmakas",
    "entities": [
      {
        "text": "19",
        "label": "CARDINAL"
      },
      {
        "text": "T1",
        "label": "PRODUCT"
      },
      {
        "text": "Altinmakas",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "et al [18]), DCE-MRI (Hectors et al [17]) and MR elastography (Kennedy et al",
    "entities": [
      {
        "text": "18",
        "label": "CARDINAL"
      },
      {
        "text": "DCE-MRI",
        "label": "ORG"
      },
      {
        "text": "17",
        "label": "CARDINAL"
      },
      {
        "text": "Kennedy",
        "label": "PERSON"
      },
      {
        "text": "al\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "[16]). A subset of 10 patients was also included in a technical paper comparing",
    "entities": [
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "two 4D flow methods (Bane et al [20]). We have presented preliminary results of",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Bane",
        "label": "PERSON"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "this study in oral presentations at the annual meetings of the Society of",
    "entities": [
      {
        "text": "annual",
        "label": "DATE"
      },
      {
        "text": "the Society of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Abdominal Radiology (2024, 2020), the Society of Advanced Body Imaging (2023),",
    "entities": [
      {
        "text": "2024, 2020",
        "label": "DATE"
      },
      {
        "text": "the Society of Advanced Body Imaging",
        "label": "ORG"
      },
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and the International Society of Magnetic Resonance in Medicine (2020).",
    "entities": [
      {
        "text": "the International Society of Magnetic Resonance in Medicine",
        "label": "ORG"
      },
      {
        "text": "2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Methodology: Prospective Cross-sectional study/observational Performed at one",
    "entities": [
      {
        "text": "Prospective Cross",
        "label": "ORG"
      },
      {
        "text": "Performed",
        "label": "ORG"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "institution",
    "entities": []
  },
  {
    "text": "Risk factors, clinical presentation, stroke subtype and short-term outcome",
    "entities": []
  },
  {
    "text": "following acute stroke in a multi-ethnic population: a 10-year study from Qatar.",
    "entities": [
      {
        "text": "10-year",
        "label": "DATE"
      },
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Neurology, Stroke Program, University of Alberta, 11350 83 Ave,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Stroke Program",
        "label": "ORG"
      },
      {
        "text": "University of Alberta",
        "label": "ORG"
      },
      {
        "text": "11350 83",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology, Stroke Program, University of Alberta, 11350 83 Ave,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Stroke Program",
        "label": "ORG"
      },
      {
        "text": "University of Alberta",
        "label": "ORG"
      },
      {
        "text": "11350 83",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(3)Department of Neuroscience, Hamad Medical Corporation, Doha, Qatar.",
    "entities": [
      {
        "text": "Neuroscience",
        "label": "ORG"
      },
      {
        "text": "Hamad Medical Corporation",
        "label": "ORG"
      },
      {
        "text": "Doha",
        "label": "GPE"
      },
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Stroke remains a leading global cause of disability and mortality",
    "entities": []
  },
  {
    "text": "with over 100 million patients affected worldwide. Its incidence has risen in",
    "entities": [
      {
        "text": "over 100 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "recent decades, especially in low- and middle-income countries (LMICs), due to",
    "entities": [
      {
        "text": "recent decades",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "limited education, healthcare, and effective prevention measures. This study",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "investigates the association between ethnicity and outcomes of stroke in Qatar,",
    "entities": [
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "a country with a heterogeneous population.",
    "entities": []
  },
  {
    "text": "METHODS: Data from 18,174 stroke patients admitted to Hamad General Hospital",
    "entities": [
      {
        "text": "18,174",
        "label": "CARDINAL"
      },
      {
        "text": "Hamad General Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from 2014 to 2024 were analyzed. We assessed patient characteristics, stroke",
    "entities": [
      {
        "text": "2014 to 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "types, comorbidities, and outcomes using the NIH Stroke Scale and modified",
    "entities": [
      {
        "text": "NIH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: There were significant ethnic differences in stroke presentation and",
    "entities": []
  },
  {
    "text": "outcomes. Middle Easterns were older (59.7 \u00b1 14.2) than South East Asian",
    "entities": [
      {
        "text": "59.7",
        "label": "CARDINAL"
      },
      {
        "text": "14.2",
        "label": "CARDINAL"
      },
      {
        "text": "South East",
        "label": "LOC"
      },
      {
        "text": "Asian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(50.1 \u00b1 11.7) and Far Eastern (47.5 \u00b1 9.85) patients; p < 0.001. Middle Eastern",
    "entities": [
      {
        "text": "50.1 \u00b1",
        "label": "QUANTITY"
      },
      {
        "text": "Far Eastern",
        "label": "ORG"
      },
      {
        "text": "47.5",
        "label": "CARDINAL"
      },
      {
        "text": "9.85",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "Middle Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "patients had a higher prevalence of stroke risk factors (diabetes, hypertension,",
    "entities": []
  },
  {
    "text": "obesity) and stroke mimics (39.8%) than Southeast Asian (21.7%) and Far Eastern",
    "entities": [
      {
        "text": "39.8%",
        "label": "PERCENT"
      },
      {
        "text": "Southeast Asian",
        "label": "NORP"
      },
      {
        "text": "21.7%",
        "label": "PERCENT"
      },
      {
        "text": "Far Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(27.7%) patients (p < 0.0001). Far Eastern patients demonstrated a higher",
    "entities": [
      {
        "text": "27.7%",
        "label": "PERCENT"
      },
      {
        "text": "Far Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "incidence (17.6%) of intracerebral hemorrhage compared to Middle Easterns (6.2%)",
    "entities": [
      {
        "text": "17.6%",
        "label": "PERCENT"
      },
      {
        "text": "Middle Easterns",
        "label": "PERSON"
      },
      {
        "text": "6.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and East Asians (10.6%); p < 0.0001. However, ischemic stroke was more common",
    "entities": [
      {
        "text": "East Asians",
        "label": "NORP"
      },
      {
        "text": "10.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "among Southeast Asians (58.6%) than Middle Eastern (43.8%) and Far Eastern",
    "entities": [
      {
        "text": "Southeast Asians",
        "label": "NORP"
      },
      {
        "text": "58.6%",
        "label": "PERCENT"
      },
      {
        "text": "Middle Eastern",
        "label": "NORP"
      },
      {
        "text": "43.8%",
        "label": "PERCENT"
      },
      {
        "text": "Far Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(44.4%) patients; p < 0.0001. Lastly, there were significant differences in",
    "entities": [
      {
        "text": "44.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "outcomes as measured by mortality and the mRS.",
    "entities": []
  },
  {
    "text": "CONCLUSION: There are significant ethnic differences in stroke presentation,",
    "entities": []
  },
  {
    "text": "management, and outcomes in Qatar, some of which may reflect underlying",
    "entities": [
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "disparities driven by social and structural inequities. While genetic",
    "entities": []
  },
  {
    "text": "differences play a role, early management of vascular risk factors is a crucial,",
    "entities": []
  },
  {
    "text": "preventable measure to reduce stroke burden in LMICs and improve health",
    "entities": []
  },
  {
    "text": "\u00a9 2025. Springer-Verlag GmbH Germany, part of Springer Nature.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Springer-Verlag GmbH Germany",
        "label": "ORG"
      },
      {
        "text": "Springer Nature",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "PMID: 40664805 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: On behalf of",
    "entities": []
  },
  {
    "text": "all authors, the corresponding author states that there is no conflict of",
    "entities": []
  },
  {
    "text": "interest. Ethical standards: For this type of study formal consent is not",
    "entities": []
  },
  {
    "text": "required.",
    "entities": []
  },
  {
    "text": "Linear inverse association between prognostic nutritional index and colorectal",
    "entities": [
      {
        "text": "Linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cancer risk based on NHANES data.",
    "entities": [
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of General Surgery, The Affiliated Wuxi No.2 People's Hospital of",
    "entities": [
      {
        "text": "Surgery",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Nanjing Medical University, Wuxi, China.",
    "entities": [
      {
        "text": "Nanjing Medical University",
        "label": "ORG"
      },
      {
        "text": "Wuxi",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of General Surgery, Institute of General Surgical Research, School",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "General Surgery, Institute of General Surgical Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, Jiangnan University Medical Center, Jiangnan University, Wuxi,",
    "entities": [
      {
        "text": "Medicine, Jiangnan University Medical Center, Jiangnan University",
        "label": "ORG"
      },
      {
        "text": "Wuxi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of General Surgery, The Affiliated Wuxi No.2 People's Hospital of",
    "entities": [
      {
        "text": "Surgery",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Nanjing Medical University, Wuxi, China. xjz_wuxi@alumni.sjtu.edu.cn.",
    "entities": [
      {
        "text": "Nanjing Medical University",
        "label": "ORG"
      },
      {
        "text": "Wuxi",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of General Surgery, Institute of General Surgical Research, School",
    "entities": [
      {
        "text": "General Surgery, Institute of General Surgical Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Despite the Prognostic Nutritional Index (PNI) serving as a crucial prognostic",
    "entities": [
      {
        "text": "the Prognostic Nutritional Index (",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "marker for predicting survival outcomes in cancer patients, its association with",
    "entities": []
  },
  {
    "text": "the risk of Colorectal Cancer (CRC) is not well comprehended. We hypothesized",
    "entities": [
      {
        "text": "Colorectal Cancer",
        "label": "ORG"
      },
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "that lower PNI levels are associated with a higher risk of CRC. The datasets",
    "entities": [
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from the National Health and Nutrition Examination Survey (NHANES) spanning from",
    "entities": [
      {
        "text": "the National Health and Nutrition Examination Survey",
        "label": "ORG"
      },
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "2007 to 2016 were employed in this study, incorporating data on demographics,",
    "entities": [
      {
        "text": "2007 to 2016",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "laboratory tests, and questionnaires. Participants aged \u2265 20 years were",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "20 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "included, while those with missing tumor history or incomplete laboratory data",
    "entities": []
  },
  {
    "text": "for PNI calculation (serum albumin or lymphocyte count) were excluded. A total",
    "entities": []
  },
  {
    "text": "of 26,229 participants who met the inclusion criteria were evaluated, of which",
    "entities": [
      {
        "text": "26,229",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "176 had a history of CRC. The PNI was calculated as 0.005 \u00d7 absolute lymphocyte",
    "entities": [
      {
        "text": "176",
        "label": "CARDINAL"
      },
      {
        "text": "CRC",
        "label": "ORG"
      },
      {
        "text": "PNI",
        "label": "ORG"
      },
      {
        "text": "0.005",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "count + 10 \u00d7 serum albumin, and categorized into quartiles. CRC status was",
    "entities": [
      {
        "text": "+ 10 \u00d7",
        "label": "FAC"
      },
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "determined via self-reported medical history. To investigate the linear",
    "entities": []
  },
  {
    "text": "relationship between PNI and CRC, multivariable logistic regression models,",
    "entities": [
      {
        "text": "PNI",
        "label": "ORG"
      },
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "restricted cubic spline analysis, and subgroup analyses were used. Covariates",
    "entities": []
  },
  {
    "text": "were adjusted using multiple imputation, and all analyses were conducted using",
    "entities": []
  },
  {
    "text": "DecisionLinnc v1.0. Statistical significance was set at P < 0.05. The average",
    "entities": [
      {
        "text": "DecisionLinnc",
        "label": "ORG"
      },
      {
        "text": "P < 0.05",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PNI score was 42.55 \u00b1 3.42. Fully adjusted multivariable logistic regression",
    "entities": [
      {
        "text": "42.55",
        "label": "CARDINAL"
      },
      {
        "text": "3.42",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "models identified a significant inverse relationship between higher PNI scores",
    "entities": [
      {
        "text": "PNI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and lower odds of CRC. Specifically, each one-unit increase in PNI was",
    "entities": [
      {
        "text": "CRC",
        "label": "ORG"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "PNI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with a 6.43% reduction in the odds of CRC [OR: 0.9357; 95% CI:",
    "entities": [
      {
        "text": "6.43%",
        "label": "PERCENT"
      },
      {
        "text": "CRC",
        "label": "ORG"
      },
      {
        "text": "0.9357",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "0.8942, 0.9807; p = 0.005]. Restricted cubic spline analysis further validated a",
    "entities": [
      {
        "text": "0.8942",
        "label": "CARDINAL"
      },
      {
        "text": "0.9807",
        "label": "CARDINAL"
      },
      {
        "text": "0.005",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "linear association between PNI and CRC risk. Subgroup analyses demonstrated that",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      },
      {
        "text": "PNI",
        "label": "ORG"
      },
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the association remained consistent across factors including gender, age,",
    "entities": []
  },
  {
    "text": "marital status, education level, BMI, alcohol consumption, smoking habits,",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "history of hypertension, hyperlipidemia, and diabetes. Males exhibited a more",
    "entities": [
      {
        "text": "Males",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "pronounced inverse correlation between PNI and CRC risk. Higher PNI scores are",
    "entities": [
      {
        "text": "PNI",
        "label": "ORG"
      },
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "independently associated with reduced odds of CRC. PNI may serve as a valuable",
    "entities": [
      {
        "text": "CRC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "enhance large-scale screening strategies.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-10574-1",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664778 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664778",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "91. Eye (Lond). 2025 Jul 15. doi: 10.1038/s41433-025-03919-7. Online ahead of",
    "entities": [
      {
        "text": "91",
        "label": "CARDINAL"
      },
      {
        "text": "Lond",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Tear proteomics reveals expressed proteins and potential pathways associated",
    "entities": []
  },
  {
    "text": "with diabetic keratopathy.",
    "entities": []
  },
  {
    "text": "(1)Department of Ophthalmology, Zhujiang Hospital of Southern Medical",
    "entities": [
      {
        "text": "Ophthalmology, Zhujiang Hospital of Southern Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Putian Maternal and Child Health Hospital, Putian City, Fujian Province,",
    "entities": [
      {
        "text": "2)Putian",
        "label": "CARDINAL"
      },
      {
        "text": "Maternal and Child Health Hospital",
        "label": "ORG"
      },
      {
        "text": "Putian City",
        "label": "GPE"
      },
      {
        "text": "Fujian Province",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Ophthalmology, Zhujiang Hospital of Southern Medical",
    "entities": [
      {
        "text": "Ophthalmology, Zhujiang Hospital of Southern Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Ophthalmology, Zhujiang Hospital of Southern Medical",
    "entities": [
      {
        "text": "Ophthalmology, Zhujiang Hospital of Southern Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Guangzhou, Guangdong, PR China. zhongyanyan07@163.com.",
    "entities": [
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "Guangdong",
        "label": "GPE"
      },
      {
        "text": "PR China",
        "label": "ORG"
      },
      {
        "text": "zhongyanyan07@163.com",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "BACKGROUND: Patients with diabetes are at risk of developing diabetic",
    "entities": []
  },
  {
    "text": "keratopathy (DK). The pathophysiological mechanisms of DK and associated",
    "entities": [
      {
        "text": "keratopathy",
        "label": "PERSON"
      },
      {
        "text": "DK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "biomarkers remain unclear. However, tear analysis provides crucial insights into",
    "entities": []
  },
  {
    "text": "DK. Thus, we conducted a quantitative proteomic analysis of tears from DK",
    "entities": [
      {
        "text": "DK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients to identify differentially expressed proteins and potential pathways",
    "entities": []
  },
  {
    "text": "associated with DK.",
    "entities": [
      {
        "text": "DK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: This prospective case-controlled study included patients admitted to",
    "entities": []
  },
  {
    "text": "Zhujiang Hospital between October 2022 and February 2023. We examined 22 eyes",
    "entities": [
      {
        "text": "Zhujiang Hospital",
        "label": "ORG"
      },
      {
        "text": "between October 2022",
        "label": "DATE"
      },
      {
        "text": "February 2023",
        "label": "DATE"
      },
      {
        "text": "22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with DK and 11 control eyes without DK. General characteristics and dry",
    "entities": [
      {
        "text": "DK",
        "label": "ORG"
      },
      {
        "text": "11",
        "label": "CARDINAL"
      },
      {
        "text": "DK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "eye-related features were recorded, including those observed using ocular",
    "entities": []
  },
  {
    "text": "surface analysis, conjunctival impression cytology, and tear ferning tests. Tear",
    "entities": []
  },
  {
    "text": "fluid was collected using Schirmer strips after ensuring group similarity in",
    "entities": [
      {
        "text": "Schirmer",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "confounders. Proteins were analysed through four-dimensional label-free mass",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "spectrometry. Differential proteins were subjected to analyses of Gene Ontology",
    "entities": [
      {
        "text": "Gene Ontology\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. A",
    "entities": [
      {
        "text": "Kyoto Encyclopedia of",
        "label": "ORG"
      },
      {
        "text": "Genes and Genomes",
        "label": "ORG"
      },
      {
        "text": "KEGG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "protein-protein interaction network map was constructed.",
    "entities": []
  },
  {
    "text": "RESULTS: Of the 2733 proteins identified, 313 (156 upregulated and 157",
    "entities": [
      {
        "text": "2733",
        "label": "DATE"
      },
      {
        "text": "313",
        "label": "CARDINAL"
      },
      {
        "text": "156",
        "label": "CARDINAL"
      },
      {
        "text": "157",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "downregulated) differentially expressed proteins were screened. GO analysis",
    "entities": []
  },
  {
    "text": "revealed that these differentially expressed proteins mainly participated in",
    "entities": []
  },
  {
    "text": "mRNA decay, nuclear transcription, and receptor-mediated endocytosis. KEGG",
    "entities": [
      {
        "text": "KEGG\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "analysis showed that these differentially expressed proteins could be involved",
    "entities": []
  },
  {
    "text": "in pathways, such as arginine biosynthesis, extracellular matrix-receptor",
    "entities": []
  },
  {
    "text": "interactions.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Arginine biosynthesis and extracellular matrix-receptor",
    "entities": []
  },
  {
    "text": "interactions may be involved in DK pathogenesis, and VDAC3 may be a potential",
    "entities": [
      {
        "text": "DK",
        "label": "GPE"
      },
      {
        "text": "VDAC3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "biomarker for DK. These findings would enhance the understanding of DK among",
    "entities": [
      {
        "text": "DK",
        "label": "ORG"
      },
      {
        "text": "DK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ophthalmologists as well as help in developing novel strategies for its",
    "entities": []
  },
  {
    "text": "treatment.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to The Royal College of",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "The Royal College of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ophthalmologists.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41433-025-03919-7",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "competing interests. Ethics approval and consent to participate: This study was",
    "entities": []
  },
  {
    "text": "approved by the Medical Ethics Committee of Zhujiang Hospital, Southern Medical",
    "entities": [
      {
        "text": "the Medical Ethics Committee of Zhujiang Hospital",
        "label": "ORG"
      },
      {
        "text": "Southern Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University (2022-KY-219-01). All participants have read and understood the",
    "entities": [
      {
        "text": "2022-KY-219-01",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "study\u2019s nature, purpose, risks, and procedures and signed an informed consent",
    "entities": []
  },
  {
    "text": "92. Eye (Lond). 2025 Jul 15. doi: 10.1038/s41433-025-03924-w. Online ahead of",
    "entities": [
      {
        "text": "92",
        "label": "CARDINAL"
      },
      {
        "text": "Lond",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Effect of sitagliptin on diabetes-induced hyperpermeability of blood-retinal",
    "entities": []
  },
  {
    "text": "(1)Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute,",
    "entities": [
      {
        "text": "Metabolism Research Unit",
        "label": "ORG"
      },
      {
        "text": "Vall d'Hebron Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute,",
    "entities": [
      {
        "text": "Metabolism Research Unit",
        "label": "ORG"
      },
      {
        "text": "Vall d'Hebron Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Barcelona, Spain.",
    "entities": [
      {
        "text": "Barcelona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Madrid, Spain.",
    "entities": [
      {
        "text": "Madrid",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute,",
    "entities": [
      {
        "text": "Metabolism Research Unit",
        "label": "ORG"
      },
      {
        "text": "Vall d'Hebron Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Barcelona, Spain. cristina.hernandez@vhir.org.",
    "entities": [
      {
        "text": "Barcelona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: Two of the authors (RS and",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      },
      {
        "text": "RS",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "CH) are inventors of the patent PCT/EP2017/060234, which is related to the use",
    "entities": []
  },
  {
    "text": "of dipeptidyl peptidase-4 inhibitors (sitagliptin) for topical eye treatment of",
    "entities": []
  },
  {
    "text": "93. Eye (Lond). 2025 Jul 15. doi: 10.1038/s41433-025-03928-6. Online ahead of",
    "entities": [
      {
        "text": "93",
        "label": "CARDINAL"
      },
      {
        "text": "Lond",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Does completion time of the initiation phase of anti-vascular growth factor",
    "entities": []
  },
  {
    "text": "affect visual and anatomical outcomes?: The MARMASIA study group report No.5.",
    "entities": [
      {
        "text": "MARMASIA",
        "label": "ORG"
      },
      {
        "text": "No.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(1)University of Health Sciences, \u00dcmraniye Training and Research Hospital,",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "\u00dcmraniye Training",
        "label": "ORG"
      },
      {
        "text": "Research Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Department of Ophthalmology, Istanbul, Turkey. tuay1@hotmail.com.",
    "entities": [
      {
        "text": "Department of Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "Istanbul",
        "label": "GPE"
      },
      {
        "text": "Turkey",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Memorial \u015ei\u015fli Hospital, Department of Ophthalmology, Istanbul, Turkey.",
    "entities": [
      {
        "text": "\u015ei\u015fli Hospital",
        "label": "ORG"
      },
      {
        "text": "Department of Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "Istanbul",
        "label": "GPE"
      },
      {
        "text": "Turkey",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Marmara University School of Medicine, Department of Ophthalmology, Istanbul,",
    "entities": [
      {
        "text": "3)Marmara University School of Medicine, Department of Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "Istanbul",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)University of Health Sciences, \u00dcmraniye Training and Research Hospital,",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "\u00dcmraniye Training",
        "label": "ORG"
      },
      {
        "text": "Research Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Department of Ophthalmology, Istanbul, Turkey.",
    "entities": [
      {
        "text": "Department of Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "Istanbul",
        "label": "GPE"
      },
      {
        "text": "Turkey",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Kocaeli University School of Medicine, Department of Ophthalmology, Kocaeli,",
    "entities": [
      {
        "text": "University School of Medicine, Department of Ophthalmology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)University of Health Sciences, Kartal Dr. L\u00fctfi K\u0131rdar City Hospital,",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)University of Health Sciences, Fatih Sultan Mehmet Training and Research",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Fatih",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospital, Department of Ophthalmology, Istanbul, Turkey.",
    "entities": [
      {
        "text": "Hospital, Department of Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "Istanbul",
        "label": "GPE"
      },
      {
        "text": "Turkey",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Sakarya University School of Medicine, Department of Ophthalmology, Sakarya,",
    "entities": [
      {
        "text": "University School of Medicine, Department of Ophthalmology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)University of Health Sciences, Derince Training and Research Hospital,",
    "entities": [
      {
        "text": "9)University",
        "label": "CARDINAL"
      },
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Derince Training and Research Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Department of Ophthalmology, Kocaeli, Turkey.",
    "entities": [
      {
        "text": "Department of Ophthalmology",
        "label": "ORG"
      },
      {
        "text": "Kocaeli",
        "label": "GPE"
      },
      {
        "text": "Turkey",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)University of Health Sciences, Haydarpa\u015fa Numune Training and Research",
    "entities": [
      {
        "text": "10)University",
        "label": "CARDINAL"
      },
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Haydarpa\u015fa Numune Training",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "OBJECTIVES: To demonstrate effect of completion time of initiation phase of",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anti-vascular endothelial growth factor (anti-VEGF) agents on visual and",
    "entities": []
  },
  {
    "text": "METHODS: This multicentre, retrospective, comparative study included a subgroup",
    "entities": []
  },
  {
    "text": "of patients from MARMASIA Study. Two groups were formed according to completion",
    "entities": [
      {
        "text": "MARMASIA Study",
        "label": "ORG"
      },
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "time of initiation phase of anti-VEGF treatment as ideal and extended completion",
    "entities": []
  },
  {
    "text": "time groups (ICT and ECT groups). Changes in best corrected visual acuity (BCVA)",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      },
      {
        "text": "ECT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "as ETDRS letter score, central macular thickness (CMT) were compared between the",
    "entities": [
      {
        "text": "ETDRS",
        "label": "ORG"
      },
      {
        "text": "CMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "groups at 3rd, 6th, 12th months. At 12th month injection, visit numbers were",
    "entities": [
      {
        "text": "3rd",
        "label": "ORDINAL"
      },
      {
        "text": "6th, 12th months",
        "label": "DATE"
      },
      {
        "text": "12th month",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "also evaluated.",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 328 eyes of 239 patients were included. Ninety-five eyes",
    "entities": [
      {
        "text": "328",
        "label": "CARDINAL"
      },
      {
        "text": "239",
        "label": "CARDINAL"
      },
      {
        "text": "Ninety-five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were in ICT, 233 eyes were in ECT group. Mean BCVA was significantly better than",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      },
      {
        "text": "233",
        "label": "CARDINAL"
      },
      {
        "text": "ECT",
        "label": "ORG"
      },
      {
        "text": "BCVA",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "the baseline at 3rd, 6th, 12th months in ICT and ECT groups (p < 0.001 for all).",
    "entities": [
      {
        "text": "3rd",
        "label": "ORDINAL"
      },
      {
        "text": "6th, 12th months",
        "label": "DATE"
      },
      {
        "text": "ICT",
        "label": "ORG"
      },
      {
        "text": "ECT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mean change in BCVA at months 3, 6, 12 was significantly better in the ICT group",
    "entities": [
      {
        "text": "BCVA",
        "label": "GPE"
      },
      {
        "text": "months 3, 6",
        "label": "DATE"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "ICT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "than the ECT group (p < 0.001, p = 0.003, p = 0.03, respectively). The mean CMT",
    "entities": [
      {
        "text": "ECT",
        "label": "ORG"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "0.003",
        "label": "CARDINAL"
      },
      {
        "text": "0.03",
        "label": "CARDINAL"
      },
      {
        "text": "CMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from baseline to at 3rd, 6th, 12th months was significantly decreased in the ICT",
    "entities": [
      {
        "text": "3rd",
        "label": "ORDINAL"
      },
      {
        "text": "6th, 12th months",
        "label": "DATE"
      },
      {
        "text": "ICT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and ECT groups (p < 0.0001 for all). Change in mean CMT was significantly higher",
    "entities": [
      {
        "text": "ECT",
        "label": "ORG"
      },
      {
        "text": "CMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in the ICT group than in the ECT group at 3rd, 6th, 12th months (p < 0.0001 for",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      },
      {
        "text": "ECT",
        "label": "ORG"
      },
      {
        "text": "3rd",
        "label": "ORDINAL"
      },
      {
        "text": "6th, 12th months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "all). Mean number of injections, visits were not significantly different between",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Initiation phase injections must be completed within a maximum of",
    "entities": []
  },
  {
    "text": "70 days (between injections 28 + 7 days) for better visual and anatomical",
    "entities": [
      {
        "text": "70 days",
        "label": "DATE"
      },
      {
        "text": "28 + 7 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DOI: 10.1038/s41433-025-03928-6",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: The authors declare that",
    "entities": []
  },
  {
    "text": "there is no conflict of interests. All authors attest that they meet the current",
    "entities": []
  },
  {
    "text": "ICMJE criteria for authorship.",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Feasibility of extracting usable DNA from blood samples stored up to 21 years in",
    "entities": [
      {
        "text": "up to 21 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the DiPiS study.",
    "entities": [
      {
        "text": "DiPiS",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "study group.",
    "entities": []
  },
  {
    "text": "Collaborators: Ramelius A, Andersson C, Bennet R, Ask M, Bremer J, Brundin C,",
    "entities": [
      {
        "text": "Ramelius A",
        "label": "PERSON"
      },
      {
        "text": "Andersson C",
        "label": "ORG"
      },
      {
        "text": "Bremer J",
        "label": "PERSON"
      },
      {
        "text": "Brundin C",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Clinical Sciences, Lund University, Lund, Sweden.",
    "entities": [
      {
        "text": "Clinical Sciences",
        "label": "ORG"
      },
      {
        "text": "Lund University",
        "label": "ORG"
      },
      {
        "text": "Lund",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Clinical Sciences, Lund University, Lund, Sweden.",
    "entities": [
      {
        "text": "Clinical Sciences",
        "label": "ORG"
      },
      {
        "text": "Lund University",
        "label": "ORG"
      },
      {
        "text": "Lund",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Clinical Sciences, Lund University, Lund, Sweden.",
    "entities": [
      {
        "text": "Clinical Sciences",
        "label": "ORG"
      },
      {
        "text": "Lund University",
        "label": "ORG"
      },
      {
        "text": "Lund",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Pediatrics, Sk\u00e5ne University Hospital, Kristianstad, Sweden.",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Sk\u00e5ne University Hospital",
        "label": "ORG"
      },
      {
        "text": "Kristianstad",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "This study assesses the feasibility of extracting high-quality DNA from blood",
    "entities": []
  },
  {
    "text": "samples stored at - 20 \u00b0C for up to 21 years under suboptimal conditions. It",
    "entities": [
      {
        "text": "at - 20",
        "label": "CARDINAL"
      },
      {
        "text": "up to 21 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "addresses sample mishandling in research, where many samples lack proper biobank",
    "entities": []
  },
  {
    "text": "protocols. Prior studies focused on short-term storage and controlled",
    "entities": []
  },
  {
    "text": "conditions, highlighting the negative effects of freeze-thaw cycles. This study",
    "entities": []
  },
  {
    "text": "evaluates whether DNA from long-term stored samples under suboptimal conditions",
    "entities": []
  },
  {
    "text": "can still meet quality standards for research purposes. Genomic DNA was",
    "entities": []
  },
  {
    "text": "extracted from 1012 capillary blood samples from the Diabetes Prediction in",
    "entities": [
      {
        "text": "1012",
        "label": "DATE"
      },
      {
        "text": "the Diabetes Prediction",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sk\u00e5ne study. Samples were stored at - 20 \u00b0C for 7-21 years, and DNA was isolated",
    "entities": [
      {
        "text": "at - 20",
        "label": "CARDINAL"
      },
      {
        "text": "7-21 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "using QIAamp DNA Blood Mini kits. DNA quantity, purity, and quality were",
    "entities": [
      {
        "text": "QIAamp DNA Blood Mini",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analysed using spectrophotometry and automated electrophoresis. Overall, 75.7%",
    "entities": [
      {
        "text": "75.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "of samples met quality standards for DNA quantity (\u2265 20 ng/\u00b5L) and purity",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(A260/280 ratio 1.7-1.9), with the highest proportion in 12-year samples",
    "entities": [
      {
        "text": "1.7-1.9",
        "label": "CARDINAL"
      },
      {
        "text": "12-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(83.5%). DNA quality was further assessed in 270 samples, where 57.8% had a DNA",
    "entities": [
      {
        "text": "83.5%",
        "label": "PERCENT"
      },
      {
        "text": "270",
        "label": "CARDINAL"
      },
      {
        "text": "57.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Integrity Number (DIN) of 7 or higher. This study suggests that historical blood",
    "entities": [
      {
        "text": "7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "samples stored under suboptmal conditions can still be viable for modern genomic",
    "entities": []
  },
  {
    "text": "PMID: 40664750 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664750",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "declare no competing interests. Ethical approval: The samples analysed in this",
    "entities": []
  },
  {
    "text": "study were collected as part of the DiPiS study at Lund University. The DiPiS",
    "entities": [
      {
        "text": "DiPiS",
        "label": "CARDINAL"
      },
      {
        "text": "Lund University",
        "label": "ORG"
      },
      {
        "text": "DiPiS",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "study was approved by the Regional Ethical Review Board in Lund (Dnr 2009/244,",
    "entities": [
      {
        "text": "the Regional Ethical Review Board",
        "label": "ORG"
      },
      {
        "text": "Dnr 2009/244",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Dnr 2014/196, Dnr 2015/861and Dnr 2019-03,222) and complied with institutional",
    "entities": [
      {
        "text": "Dnr 2014/196",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and national research ethics standards including the 1964 Helsinki declaration",
    "entities": [
      {
        "text": "1964",
        "label": "DATE"
      },
      {
        "text": "Helsinki",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and its later amendments or comparable ethical standards. In the DiPiS study,",
    "entities": [
      {
        "text": "DiPiS",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "initiated in 200041,42, application of a eutectic mixture of lidocaine cream",
    "entities": [
      {
        "text": "200041,42",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "preceded blood draws to reduce pain. Informed consent was obtained from the",
    "entities": []
  },
  {
    "text": "parents of the research subjects to participate in the present cross-sectional",
    "entities": []
  },
  {
    "text": "follow-up investigation",
    "entities": []
  },
  {
    "text": "Experiences and perspectives during the transition from paediatric to adult care",
    "entities": []
  },
  {
    "text": "in type 1 diabetes mellitus: systematic review of qualitative studies.",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Investigaciones Cient\u00edficas (CSIC), Network for Research On Chronicity, Primary",
    "entities": [
      {
        "text": "Investigaciones Cient\u00edficas",
        "label": "PERSON"
      },
      {
        "text": "CSIC",
        "label": "ORG"
      },
      {
        "text": "Network for Research On Chronicity, Primary",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Care, and Health Promotion (RICAPPS), C\u00f3rdoba, Spain.",
    "entities": [
      {
        "text": "Health Promotion",
        "label": "ORG"
      },
      {
        "text": "C\u00f3rdoba",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Network for Research On Chronicity, Primary Care, and Health Promotion",
    "entities": [
      {
        "text": "Health Promotion",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(RICAPPS), Canary Islands Health Research Institute Foundation, Carretera Gral.",
    "entities": [
      {
        "text": "Canary Islands Health Research Institute Foundation",
        "label": "ORG"
      },
      {
        "text": "Carretera Gral",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Network for Research On Chronicity, Hospital Universitario Costa del Sol,",
    "entities": [
      {
        "text": "Universitario",
        "label": "GPE"
      },
      {
        "text": "Costa del Sol",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Primary Care, and Health Promotion (RICAPPS), Marbella, Spain.",
    "entities": [
      {
        "text": "Primary Care",
        "label": "PERSON"
      },
      {
        "text": "Health Promotion",
        "label": "ORG"
      },
      {
        "text": "Marbella",
        "label": "NORP"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Preventive Medicine and Public Health, University of La Laguna,",
    "entities": [
      {
        "text": "Preventive Medicine and Public Health",
        "label": "ORG"
      },
      {
        "text": "University of La Laguna",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "38200, Canary Islands, Spain.",
    "entities": [
      {
        "text": "38200",
        "label": "DATE"
      },
      {
        "text": "Canary Islands",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Preventive Medicine and Public Health, University of La Laguna,",
    "entities": [
      {
        "text": "Preventive Medicine and Public Health",
        "label": "ORG"
      },
      {
        "text": "University of La Laguna",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "38200, Canary Islands, Spain. angarias@ull.edu.es.",
    "entities": [
      {
        "text": "38200",
        "label": "DATE"
      },
      {
        "text": "Canary Islands",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), Unidad",
    "entities": [
      {
        "text": "Health Promotion",
        "label": "ORG"
      },
      {
        "text": "Unidad",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "When Type 1 diabetes mellitus (T1DM) patients transition from paediatric to",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "adult healthcare providers, the risk of deteriorating health outcomes rises. The",
    "entities": [
      {
        "text": "adult healthcare providers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "aim of this study is to integrate the experiences and perspectives regarding",
    "entities": []
  },
  {
    "text": "interventions for the management of T1DM during the transition from paediatric",
    "entities": []
  },
  {
    "text": "to adult care, from a patient and professional perspective. A systematic review",
    "entities": []
  },
  {
    "text": "was conducted with a framework analysis guided by the Cochrane Qualitative and",
    "entities": [
      {
        "text": "the Cochrane Qualitative",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Implementation Methods Group approach. Three online databases (Medline, Embase",
    "entities": [
      {
        "text": "Implementation Methods Group",
        "label": "ORG"
      },
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "Medline",
        "label": "NORP"
      },
      {
        "text": "Embase",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and Web of Science) were searched. We included qualitative articles that were",
    "entities": []
  },
  {
    "text": "available in English or Spanish. Twenty-five references met the inclusion",
    "entities": [
      {
        "text": "English",
        "label": "LANGUAGE"
      },
      {
        "text": "Spanish",
        "label": "LANGUAGE"
      },
      {
        "text": "Twenty-five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "criteria of the study and were included. Four main themes were identified: (a)",
    "entities": [
      {
        "text": "Four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "teen experience, (b) acceptability, (c) implementation considerations and (d)",
    "entities": []
  },
  {
    "text": "equity.",
    "entities": []
  },
  {
    "text": "CONCLUSION: During the care transition, adolescents with T1DM undergo a critical",
    "entities": []
  },
  {
    "text": "phase of increasing care independence in which fostering autonomy and",
    "entities": []
  },
  {
    "text": "strengthening continuity of care may achieve a more satisfying care.",
    "entities": []
  },
  {
    "text": "WHAT IS KNOWN: \u2022 Transitions from pediatric to adult healthcare providers are",
    "entities": []
  },
  {
    "text": "associated with an increased risk of adverse health outcomes.",
    "entities": []
  },
  {
    "text": "WHAT IS NEW: \u2022 This study highlights that enhancing the transition process",
    "entities": []
  },
  {
    "text": "requires improved information transfer, reinforced continuity of care, and",
    "entities": []
  },
  {
    "text": "effective coordination among healthcare providers.",
    "entities": []
  },
  {
    "text": "DOI: 10.1007/s00431-025-06303-5",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664737 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interest: The authors",
    "entities": []
  },
  {
    "text": "Conducting the National Health and Morbidity Survey 2023 in Malaysia with focus",
    "entities": [
      {
        "text": "the National Health and Morbidity Survey 2023",
        "label": "ORG"
      },
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "on methodology and main findings on non-communicable diseases.",
    "entities": []
  },
  {
    "text": "Mat Rifin H(1), Mohd Yusoff MF(2), Abd Hamid HA(2).",
    "entities": [
      {
        "text": "Mohd Yusoff MF(2",
        "label": "PERSON"
      },
      {
        "text": "Abd Hamid HA(2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Institute for Public Health, National Institutes of Health, Ministry of",
    "entities": [
      {
        "text": "National Institutes of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health, Blok B5 & B6,Kompleks NIH, No. 1, Jalan Setia Murni U13/52, Seksyen U13",
    "entities": [
      {
        "text": "Blok B5 &",
        "label": "ORG"
      },
      {
        "text": "NIH",
        "label": "ORG"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "Jalan Setia Murni",
        "label": "PERSON"
      },
      {
        "text": "U13",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "(2)Institute for Public Health, National Institutes of Health, Ministry of",
    "entities": [
      {
        "text": "National Institutes of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The National Health and Morbidity Survey (NHMS), which focuses on",
    "entities": [
      {
        "text": "The National Health and Morbidity Survey (NHMS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "non-communicable diseases (NCDs), their risk factors and healthcare demand, is a",
    "entities": []
  },
  {
    "text": "cross-sectional, nationwide, population-based survey conducted every four-year",
    "entities": [
      {
        "text": "four-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "cycle since 2011. NHMS 2023 was the 7th cycle of NCDs, their risk factors and",
    "entities": [
      {
        "text": "2011",
        "label": "DATE"
      },
      {
        "text": "NHMS 2023",
        "label": "DATE"
      },
      {
        "text": "7th",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "healthcare demand, which aimed to monitor trends in diseases and healthcare",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "utilisation. This article outlines the methodology, sociodemographic",
    "entities": []
  },
  {
    "text": "characteristics, and overall findings from the population surveyed in 2023",
    "entities": [
      {
        "text": "2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "regarding NCDs, their risk factors, and various health-related topics. This",
    "entities": []
  },
  {
    "text": "survey utilised a two-stage stratified random sampling design and encompassed",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "fifteen main scopes, with sample sizes calculated to meet the specific",
    "entities": [
      {
        "text": "fifteen",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "requirements of each scope. Conducted from July to September 2023, it involved",
    "entities": [
      {
        "text": "July to September 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the random selection of 499 enumeration blocks(EBs) by the Department of",
    "entities": [
      {
        "text": "499",
        "label": "CARDINAL"
      },
      {
        "text": "the Department of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Statistics Malaysia (DOSM) across all states and federal territories in",
    "entities": [
      {
        "text": "DOSM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Malaysia. The step resulted in the selection of 5,988 living quarters (LQs).",
    "entities": [
      {
        "text": "Malaysia",
        "label": "GPE"
      },
      {
        "text": "5,988",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Data collection methods included validated questionnaires administered through",
    "entities": []
  },
  {
    "text": "face-to-face interviews and self-administered questionnaires, alongside clinical",
    "entities": []
  },
  {
    "text": "assessments and blood investigations using calibrated devices. To ensure the",
    "entities": []
  },
  {
    "text": "high quality of the collected data, we implemented stringent quality control",
    "entities": []
  },
  {
    "text": "measures. Furthermore, we applied complex sampling analyses to ensure that the",
    "entities": []
  },
  {
    "text": "findings accurately represented the population in Malaysia. The survey received",
    "entities": [
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "responses from 13,616 individuals out of the 5,006 LQs that were successfully",
    "entities": [
      {
        "text": "13,616",
        "label": "CARDINAL"
      },
      {
        "text": "5,006",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "visited, resulting in an overall response rate of the survey of 83.2%, which",
    "entities": [
      {
        "text": "83.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "includes individuals aged 5 years and above. A substantial segment of the",
    "entities": [
      {
        "text": "5 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "population lived in urban regions, comprising 77.6% of the total. About half of",
    "entities": [
      {
        "text": "77.6%",
        "label": "PERCENT"
      },
      {
        "text": "About half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the population consisted of males (51.9%), Malay (54.6%), and individuals who",
    "entities": [
      {
        "text": "51.9%",
        "label": "PERCENT"
      },
      {
        "text": "Malay",
        "label": "PERSON"
      },
      {
        "text": "54.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "had attained secondary education (54.2%). Additionally, 20.0% of the population",
    "entities": [
      {
        "text": "54.2%",
        "label": "PERCENT"
      },
      {
        "text": "20.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "were within the age range of 30 to 39 years. The weighted prevalence of diabetes",
    "entities": [
      {
        "text": "30 to 39 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "was 15.6%, hypertension 29.2%, hypercholesterolaemia 33.3%, overweight and",
    "entities": [
      {
        "text": "15.6%",
        "label": "PERCENT"
      },
      {
        "text": "29.2%",
        "label": "PERCENT"
      },
      {
        "text": "33.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "obesity 54.4%. Depression among adults was 4.6%, while mental health problems",
    "entities": [
      {
        "text": "54.4%",
        "label": "PERCENT"
      },
      {
        "text": "4.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "among children were reported at 16.5%. The current tobacco smokers prevalence",
    "entities": [
      {
        "text": "16.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "was 19.0%, and 29.9% of adults in Malaysia were physically inactive. The known",
    "entities": [
      {
        "text": "19.0%",
        "label": "PERCENT"
      },
      {
        "text": "29.9%",
        "label": "PERCENT"
      },
      {
        "text": "Malaysia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "asthma prevalence among adults was 6.2%, while the current asthma among children",
    "entities": [
      {
        "text": "6.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "was 3.4%. Additionally, 37.7% of adults experienced sleep insufficiency. The",
    "entities": [
      {
        "text": "3.4%",
        "label": "PERCENT"
      },
      {
        "text": "37.7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "results indicate that the higher proportion of diabetes, hypertension, and",
    "entities": []
  },
  {
    "text": "hypercholesterolaemia, particularly among the young age group, and the high",
    "entities": []
  },
  {
    "text": "prevalence of overweight and obesity, as well as mental health problems, are",
    "entities": []
  },
  {
    "text": "making the healthcare system deal with more non-communicable diseases,",
    "entities": []
  },
  {
    "text": "complications, and problems. The methodology of this survey is robust for a",
    "entities": []
  },
  {
    "text": "population-based study. We took comprehensive steps to ensure the validity and",
    "entities": []
  },
  {
    "text": "reliability of the findings. The findings indicate an urgent need for targeted",
    "entities": []
  },
  {
    "text": "public health interventions to address the escalating health issues. By focusing",
    "entities": []
  },
  {
    "text": "on prevention and early intervention strategies, we can mitigate the impact of",
    "entities": []
  },
  {
    "text": "NCDs on the healthcare system and improve overall population health.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41598-025-08311-9",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664716 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "participate: All respondents provided written informed consent prior to",
    "entities": []
  },
  {
    "text": "interviews. The survey protocol was approved by the Medical Research and Ethics",
    "entities": [
      {
        "text": "the Medical Research and Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Committee (MREC), Ministry of Health Malaysia (22-00545-XAC (2)). All methods",
    "entities": [
      {
        "text": "Ministry of Health Malaysia",
        "label": "ORG"
      },
      {
        "text": "22-00545-XAC",
        "label": "DATE"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "adhered to the principles of the Declaration of Helsinki and the Malaysian Good",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Malaysian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Clinical Practice Guidelines. Competing interests: The authors declare no",
    "entities": [
      {
        "text": "Clinical Practice Guidelines",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "97. Nat Commun. 2025 Jul 15;16(1):6534. doi: 10.1038/s41467-025-61815-w.",
    "entities": [
      {
        "text": "97",
        "label": "CARDINAL"
      },
      {
        "text": "Nat Commun",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Activated GDF11/8 subforms predict cardiovascular events and mortality in",
    "entities": []
  },
  {
    "text": "Bhasin S(9), Rubin LL(1)(10), Wagers AJ(1)(11)(12), Thompson TB(4), Ganz P(13),",
    "entities": [
      {
        "text": "Rubin LL(1)(10",
        "label": "PERSON"
      },
      {
        "text": "Thompson TB(4",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell",
    "entities": [
      {
        "text": "Stem Cell and Regenerative Biology",
        "label": "ORG"
      },
      {
        "text": "the Harvard Stem Cell",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institute, Harvard University, Cambridge, MA, USA.",
    "entities": [
      {
        "text": "Harvard University",
        "label": "ORG"
      },
      {
        "text": "Cambridge",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)SomaLogic Inc, Boulder, CO, USA.",
    "entities": [
      {
        "text": "2)SomaLogic Inc",
        "label": "MONEY"
      },
      {
        "text": "Boulder, CO, USA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Standard Biotools Inc, San Francisco, CA, USA.",
    "entities": [
      {
        "text": "3)Standard Biotools Inc",
        "label": "ORG"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Molecular & Cellular Biosciences, University of Cincinnati",
    "entities": [
      {
        "text": "Molecular & Cellular Biosciences",
        "label": "ORG"
      },
      {
        "text": "University of Cincinnati",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Medicine, Cincinnati, OH, USA.",
    "entities": [
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Cincinnati",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Cardiology and Cardiovascular Research Institute Basel (CRIB),",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiology and Cardiovascular Research Institute Basel",
        "label": "ORG"
      },
      {
        "text": "CRIB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Hospital Basel, University of Basel, Basel, Switzerland.",
    "entities": [
      {
        "text": "University Hospital Basel",
        "label": "ORG"
      },
      {
        "text": "University of Basel",
        "label": "ORG"
      },
      {
        "text": "Basel",
        "label": "GPE"
      },
      {
        "text": "Switzerland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Laboratory of Behavioral Neuroscience, Intramural Research Program, National",
    "entities": [
      {
        "text": "Behavioral Neuroscience",
        "label": "ORG"
      },
      {
        "text": "Intramural Research Program",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institute on Aging, Baltimore, MD, USA.",
    "entities": [
      {
        "text": "Institute on Aging,",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,",
    "entities": [
      {
        "text": "Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins Bloomberg School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Welch Center for Prevention, Epidemiology, and Clinical Research, Johns",
    "entities": [
      {
        "text": "Center for Prevention, Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Clinical Research",
        "label": "ORG"
      },
      {
        "text": "Johns",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.",
    "entities": [
      {
        "text": "Hopkins Bloomberg School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Research Program in Men's Health: Aging and Metabolism, Boston Claude D.",
    "entities": [
      {
        "text": "Men's Health",
        "label": "ORG"
      },
      {
        "text": "Boston Claude",
        "label": "PERSON"
      },
      {
        "text": "D.",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Pepper Older Americans Independence Center, Brigham and Women's Hospital,",
    "entities": [
      {
        "text": "Pepper Older Americans Independence Center,",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Harvard Medical School, Boston, MA, USA.",
    "entities": [
      {
        "text": "Harvard Medical School",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard,",
    "entities": [
      {
        "text": "Center for Psychiatric Research",
        "label": "ORG"
      },
      {
        "text": "Broad Institute of MIT",
        "label": "ORG"
      },
      {
        "text": "Harvard",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Joslin Diabetes Center, Boston, MA, USA.",
    "entities": [
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Paul F. Glenn Center for the Biology of Aging, Harvard Medical School,",
    "entities": [
      {
        "text": "the Biology of Aging",
        "label": "ORG"
      },
      {
        "text": "Harvard Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boston, MA, USA.",
    "entities": [
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Division of Cardiology, Zuckerberg San Francisco General Hospital and",
    "entities": [
      {
        "text": "13)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Zuckerberg San Francisco",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Department of Medicine, University of California, San Francisco, CA, USA.",
    "entities": [
      {
        "text": "Department of Medicine, University of California,",
        "label": "ORG"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell",
    "entities": [
      {
        "text": "14)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Stem Cell and Regenerative Biology",
        "label": "ORG"
      },
      {
        "text": "the Harvard Stem Cell",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institute, Harvard University, Cambridge, MA, USA. richard_lee@harvard.edu.",
    "entities": [
      {
        "text": "Harvard University",
        "label": "ORG"
      },
      {
        "text": "Cambridge",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Circulating Growth Differentiation Factors 11 and 8 (GDF11/8) exist in both",
    "entities": []
  },
  {
    "text": "latent and active forms, and it is unclear if specific forms can predict disease",
    "entities": []
  },
  {
    "text": "outcomes. Our data suggest that a dual-specific aptamer selectively binds",
    "entities": []
  },
  {
    "text": "GDF11/8 after prodomain activation. In 11,609 patients at risk for future",
    "entities": [
      {
        "text": "11,609",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "strongly predicted adverse outcomes, including cardiovascular events (HR = 0.43,",
    "entities": [
      {
        "text": "0.43",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p = 9.1 \u00d7 10\u207b\u2076\u00b3) and all-cause mortality (HR = 0.33, p = 4.8 \u00d7 10\u207b\u2074\u2070). Use of",
    "entities": [
      {
        "text": "9.1",
        "label": "CARDINAL"
      },
      {
        "text": "0.33",
        "label": "CARDINAL"
      },
      {
        "text": "4.8",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "selective aptamers suggested that results observed with the dual-specific",
    "entities": []
  },
  {
    "text": "aptamer for cardiovascular and mortality risk replicated with a GDF8 aptamer",
    "entities": [
      {
        "text": "GDF8",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "although with a smaller effect size. In a second cohort of 4110 individuals",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      },
      {
        "text": "4110",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(ARIC), low dual-specific aptamer-detected GDF11/8 levels also predicted",
    "entities": []
  },
  {
    "text": "increased 8 year dementia risk (HR = 0.66, p = 0.00148). Our findings reveal",
    "entities": [
      {
        "text": "8 year",
        "label": "DATE"
      },
      {
        "text": "0.66",
        "label": "CARDINAL"
      },
      {
        "text": "0.00148",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "that activation of GDF11/8 may be a factor in future aging-related",
    "entities": []
  },
  {
    "text": "PMID: 40664633 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664633",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: R.T.L., R.G.W., L.L.R.,",
    "entities": [
      {
        "text": "R.T.L.",
        "label": "ORG"
      },
      {
        "text": "R.G.W.",
        "label": "ORG"
      },
      {
        "text": "L.L.R.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "A.J.W, and T.B.T. are inventors of patents related to GDF11 and GDF8 through",
    "entities": [
      {
        "text": "A.J.W",
        "label": "ORG"
      },
      {
        "text": "GDF11",
        "label": "PERSON"
      },
      {
        "text": "GDF8",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "their institutions which are directly related to the proteins studied in this",
    "entities": []
  },
  {
    "text": "work. SomaLogic, Inc. provided research support and aptamers used in this study",
    "entities": [
      {
        "text": "SomaLogic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to the Lee Lab. J.E.W. was employed at Roche Diagnostics Switzerland in 2021 for",
    "entities": [
      {
        "text": "the Lee Lab",
        "label": "FAC"
      },
      {
        "text": "Roche Diagnostics Switzerland",
        "label": "ORG"
      },
      {
        "text": "2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "9 months as an expert in personalized healthcare oncology, unrelated to the",
    "entities": [
      {
        "text": "9 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "present work. P.G. has served on the medical advisory board of SomaLogic without",
    "entities": [
      {
        "text": "P.G.",
        "label": "GPE"
      },
      {
        "text": "SomaLogic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "receiving financial compensation. S.B. has received research grants from AbbVie,",
    "entities": [
      {
        "text": "S.B.",
        "label": "GPE"
      },
      {
        "text": "AbbVie",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MIB, and FPT, and consultation fees from Novartis for work unrelated to the",
    "entities": [
      {
        "text": "MIB",
        "label": "ORG"
      },
      {
        "text": "FPT",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "present study. The remaining authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "The Effect of Liver Transplantation on Anti-Glycaemic Agents in Patients With",
    "entities": [
      {
        "text": "The Effect of Liver Transplantation on Anti-Glycaemic Agents",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pre-Existing Diabetes Mellitus: A Population-Based Cohort Study.",
    "entities": []
  },
  {
    "text": "Armstrong M(1), Mostaf S(1)(2), Hanif W(1).",
    "entities": [
      {
        "text": "Mostaf",
        "label": "PERSON"
      },
      {
        "text": "Hanif",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)University Hospitals Birmingham NHSFT, Birmingham, UK.",
    "entities": [
      {
        "text": "Birmingham",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)The Department of Metabolism and Systems Science, College of Medicine and",
    "entities": [
      {
        "text": "2)The Department of Metabolism and Systems Science, College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health, University of Birmingham, Birmingham, UK.",
    "entities": [
      {
        "text": "Health, University of Birmingham",
        "label": "ORG"
      },
      {
        "text": "Birmingham",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Anecdotally, patients with diabetes mellitus after undertaking a",
    "entities": []
  },
  {
    "text": "liver transplant have reported improved glycaemic control and reduced insulin",
    "entities": []
  },
  {
    "text": "requirements, compared to other organ transplants where glycaemic control often",
    "entities": []
  },
  {
    "text": "worsens. This study aimed to evaluate possible changes in anti-glycaemic agent",
    "entities": []
  },
  {
    "text": "requirements pre- and post-liver transplantation and correlate them with the",
    "entities": []
  },
  {
    "text": "immunosuppression used and the reason for transplant.",
    "entities": []
  },
  {
    "text": "METHODS: In this observational, retrospective study, we investigated 258 adults",
    "entities": [
      {
        "text": "258",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with pre-existing diabetes mellitus who underwent liver transplant from October",
    "entities": [
      {
        "text": "October",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2009 to January 2020 at a tertiary UK center. We compared pre- and",
    "entities": [
      {
        "text": "2009 to January 2020",
        "label": "DATE"
      },
      {
        "text": "tertiary",
        "label": "ORDINAL"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: The mean age was 56 years, and the median duration of diabetes was",
    "entities": [
      {
        "text": "56 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "96 months. From a subgroup of 100 patients (38.8%) using insulin therapy, there",
    "entities": [
      {
        "text": "96 months",
        "label": "DATE"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "38.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "was a reduction in insulin requirements from 60.5 \u00b1 44.6 units/day before",
    "entities": [
      {
        "text": "60.5",
        "label": "CARDINAL"
      },
      {
        "text": "44.6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "transplant to 51.1 \u00b1 31.2 units/day at 1 month post-transplantation (15.5%,",
    "entities": [
      {
        "text": "51.1",
        "label": "CARDINAL"
      },
      {
        "text": "31.2",
        "label": "CARDINAL"
      },
      {
        "text": "1 month",
        "label": "DATE"
      },
      {
        "text": "15.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "p < 0.0001) and 33.6 \u00b1 29.7 units/day at 6 months post-transplantation (44.4%,",
    "entities": [
      {
        "text": "33.6",
        "label": "CARDINAL"
      },
      {
        "text": "29.7",
        "label": "CARDINAL"
      },
      {
        "text": "6 months",
        "label": "DATE"
      },
      {
        "text": "44.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "p < 0.0001). There was a significant correlation between the difference in",
    "entities": []
  },
  {
    "text": "insulin requirement before and 6 months post-transplant and the tacrolimus dose",
    "entities": [
      {
        "text": "6 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "used as immunosuppressive therapy post-liver transplant. There was no",
    "entities": []
  },
  {
    "text": "correlation with the use of other immunosuppressive therapies and change in",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Insulin requirements significantly reduced post-liver transplant by",
    "entities": []
  },
  {
    "text": "almost 50%, despite initiation of immunosuppressive therapy. This is one of the",
    "entities": [
      {
        "text": "almost 50%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "first studies showing this effect, highlighting the role of the liver in",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "regulating glucose metabolism, insulin utilization, and insulin resistance.",
    "entities": []
  },
  {
    "text": "Pooled data from other specialist centers need to be examined.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Journal of Diabetes published by Ruijin Hospital, Shanghai",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Ruijin Hospital",
        "label": "FAC"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "JiaoTong University School of Medicine and John Wiley & Sons Australia, Ltd.",
    "entities": [
      {
        "text": "JiaoTong University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "John Wiley & Sons Australia, Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40664615 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "99. Clin Exp Pharmacol Physiol. 2025 Sep;52(9):e70056. doi:",
    "entities": [
      {
        "text": "99",
        "label": "CARDINAL"
      },
      {
        "text": "Clin Exp Pharmacol Physiol",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "M2 Macrophages-Derived Exosomes Inhibited Podocyte Pyroptosis via lncRNA",
    "entities": [
      {
        "text": "M2 Macrophages-Derived",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Endocrinology and Metabolism, the First Affiliated Hospital,",
    "entities": [
      {
        "text": "the First Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Jiangxi Medical College, Nanchang University, Nanchang, China.",
    "entities": [
      {
        "text": "Jiangxi Medical College",
        "label": "ORG"
      },
      {
        "text": "Nanchang University",
        "label": "ORG"
      },
      {
        "text": "Nanchang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Endocrinology and Metabolism, Fengcheng People's Hospital of",
    "entities": [
      {
        "text": "Fengcheng People's Hospital",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Jiangxi Province, Fengcheng, China.",
    "entities": [
      {
        "text": "Jiangxi Province",
        "label": "GPE"
      },
      {
        "text": "Fengcheng",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Macrophage infiltration was closely associated with inflammatory injury of",
    "entities": []
  },
  {
    "text": "podocytes in diabetic nephropathy (DN), while how macrophages affected podocytes",
    "entities": []
  },
  {
    "text": "remained not entirely clear. Here, we not only investigated the relationship",
    "entities": []
  },
  {
    "text": "between macrophages and high glucose (HG)-treated podocytes, but the underlying",
    "entities": []
  },
  {
    "text": "mechanisms were also explored. Transmission electron microscopy, nanoparticle",
    "entities": []
  },
  {
    "text": "tracking analysis, and western blot of CD9, CD63, CD81, and Calnexin were",
    "entities": [
      {
        "text": "Calnexin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "performed to identify exosomes; QRT-PCR was performed to detect AFAP1-AS1",
    "entities": [
      {
        "text": "QRT-PCR",
        "label": "ORG"
      },
      {
        "text": "AFAP1-AS1\n",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "expression; Western blot was performed to examine NLRP3, Cleaved caspase-1, and",
    "entities": [
      {
        "text": "NLRP3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "GSDMD-N protein levels; Immunofluorescence was performed to assess",
    "entities": [
      {
        "text": "Immunofluorescence",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "co-localisation of NLRP3 and ASC; ELISA was performed to detect IL-18 and IL-1\u03b2",
    "entities": [
      {
        "text": "NLRP3",
        "label": "ORG"
      },
      {
        "text": "ASC",
        "label": "ORG"
      },
      {
        "text": "ELISA",
        "label": "ORG"
      },
      {
        "text": "IL-18",
        "label": "PRODUCT"
      },
      {
        "text": "IL-1\u03b2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "levels; Cytotoxicity LDH Assay Kit was performed to detect LDH level; RNA",
    "entities": [
      {
        "text": "Cytotoxicity",
        "label": "GPE"
      },
      {
        "text": "Kit",
        "label": "PERSON"
      },
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pulldown was performed to determine the interaction of AFAP1-AS1 and EZH2; ChIP",
    "entities": [
      {
        "text": "AFAP1-AS1",
        "label": "PRODUCT"
      },
      {
        "text": "ChIP",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "was employed to determine the interaction of EZH2 and H3K27me3 in the NLRP3",
    "entities": [
      {
        "text": "EZH2 and H3K27me3",
        "label": "ORG"
      },
      {
        "text": "NLRP3",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "promoter region. The results showed that AFAP1-AS1 expression was down-regulated",
    "entities": [
      {
        "text": "AFAP1-AS1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "in the peripheral blood of DN patients, and exosomes derived from M2 macrophages",
    "entities": [
      {
        "text": "M2",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "transfected with si-AFAP1-AS1 enhanced HG-induced podocyte pyroptosis via",
    "entities": [
      {
        "text": "si-AFAP1-AS1",
        "label": "PRODUCT"
      },
      {
        "text": "HG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly elevating NLRP3, Cleaved caspase-1, and GSDMD-N protein levels,",
    "entities": [
      {
        "text": "NLRP3",
        "label": "ORG"
      },
      {
        "text": "GSDMD-N",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immunofluorescence intensity of NLRP3 and ASC, as well as IL-18, IL-1\u03b2, and LDH",
    "entities": [
      {
        "text": "NLRP3",
        "label": "ORG"
      },
      {
        "text": "ASC",
        "label": "ORG"
      },
      {
        "text": "IL-18",
        "label": "NORP"
      },
      {
        "text": "IL-1\u03b2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "levels. Mechanistically, AFAP1-AS1 interacted with EZH2 to transcriptionally",
    "entities": [
      {
        "text": "AFAP1-AS1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "regulate H3K27me3 level in the NLRP3 promoter region, thus epigenetically",
    "entities": [
      {
        "text": "NLRP3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "repressing NLRP3 level to inhibit podocyte pyroptosis. These results may provide",
    "entities": [
      {
        "text": "NLRP3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "an important target for improving kidney injury in DN.",
    "entities": [
      {
        "text": "DN",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "\u00a9 2025 John Wiley & Sons Australia, Ltd.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "John Wiley & Sons Australia, Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40664611 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664611",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "100. Biomed Pharmacother. 2025 Jul 15:118321. doi: 10.1016/j.biopha.2025.118321.",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Corrigendum to \"Empagliflozin attenuating renal interstitial fibrosis in",
    "entities": []
  },
  {
    "text": "diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic",
    "entities": []
  },
  {
    "text": "endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway\" [Biomed.",
    "entities": [
      {
        "text": "Biomed",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pharmacother. 180 (2024) 117589].",
    "entities": [
      {
        "text": "180",
        "label": "CARDINAL"
      },
      {
        "text": "2024) 117589",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(1)Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western",
    "entities": [
      {
        "text": "Provincial Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "Western",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Medicine for Liver and Kidney Diseases, Shijiazhuang 05000, China; Hebei",
    "entities": [
      {
        "text": "Kidney Diseases",
        "label": "PERSON"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "Hebei",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University of Traditional Chinese Medicine, No.326, Xinshi South Road, Qiaoxi",
    "entities": [
      {
        "text": "University of Traditional Chinese Medicine",
        "label": "ORG"
      },
      {
        "text": "Xinshi South Road",
        "label": "PERSON"
      },
      {
        "text": "Qiaoxi",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western",
    "entities": [
      {
        "text": "Provincial Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "Western",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Medicine for Liver and Kidney Diseases, Shijiazhuang 05000, China; Acupuncture",
    "entities": [
      {
        "text": "Kidney Diseases",
        "label": "PERSON"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and moxibustion and Massage College of Hebei University of Chinese Medicine,",
    "entities": [
      {
        "text": "Massage College of Hebei University of Chinese Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western",
    "entities": [
      {
        "text": "Provincial Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "Western",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Medicine for Liver and Kidney Diseases, Shijiazhuang 05000, China.",
    "entities": [
      {
        "text": "Kidney Diseases",
        "label": "PERSON"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)The Third Hospital of Hebei Medical University, Shijiazhuang 050200, China.",
    "entities": [
      {
        "text": "Hebei Medical University",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang",
    "entities": [
      {
        "text": "Provincial Hospital of Traditional Chinese Medicine",
        "label": "ORG"
      },
      {
        "text": "Shijiazhuang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western",
    "entities": [
      {
        "text": "Provincial Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "Western",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "District, Shijiazhuang 05000, China. Electronic address:",
    "entities": [
      {
        "text": "District, Shijiazhuang 05000",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Hebei Provincial Key Laboratory of Integrated Traditional Chinese and Western",
    "entities": [
      {
        "text": "Provincial Key Laboratory",
        "label": "ORG"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "Western",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "District, Shijiazhuang 05000, China; The Second Affiliated Hospital of Hebei",
    "entities": [
      {
        "text": "District, Shijiazhuang 05000",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      },
      {
        "text": "The Second Affiliated Hospital of",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Traditional Chinese Medicine, Dingzhou 073000, China. Electronic",
    "entities": [
      {
        "text": "University of Traditional Chinese Medicine",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Biomed Pharmacother. 2024 Nov;180:117589. doi: 10.1016/j.biopha.2024.117589.",
    "entities": [
      {
        "text": "2024",
        "label": "CARDINAL"
      },
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  }
]